date :- 20-05-2013 gujarat technological university...

Row ID Exam Date

Hall No Enrolment No Name

Col ID instname Thesis Titel(Final)

1 15-05-2013 H-01 112270803001SURENDRA KUMAR SONI 227

L. J. INSTITUTE OF PHARMACY, AHMEDABAD

TO INVESTIGATE THE HYPOGLYCEMIC EFFECT OF ACACIA CATECHU ANDPHASEOLUS VULGARIS (RED KIDNEY BEANS) ON TYPE II DIABETES AND ASSOCIATED VASCULAR DYSFUNCTION

2 15-05-2013 H-01 112270803002

PATEL ARPITKUMAR ASOKBHAI 227


TO INVESTIGATE THE EFFECT OF COMBINATION OF REPAGLINIDE WITH BROMOCRIPTINE MESYLATE IN EXPERIMENTALLY INDUCED TYPE-2 DIABETES IN RATS.

3 15-05-2013 H-01 112270803003SHAIKH IRFAN IQBAL 227


TO INVESTIGATE THE COMBINATION EFFECT OF THIAZIDE, PROBIOTIC AND POTASSIUM CITRATE IN GLYOXYLATE INDUCED NEPHROLITHIASIS IN EXPERIMENTAL ANIMAL.

4 15-05-2013 H-01 112270803004

DAVE VIDHI RAJESHKUMAR 227


A COMPARATIVE STUDY OF ATORVASTATIN, ROSUVASTATIN AND SIMVASTATIN IN PATIENTS WITH DYSLIPIDEMIA IN INDIAN POPULATION

5 15-05-2013 H-01 112270803005

HARIYANI RIDDHI BHARATBHAI 227


A RANDOMIZED COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EXTENDED RELEASE VERSUS CONVENTIONAL RELEASE PARACETAMOL IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

6 15-05-2013 H-01 112270803006

JHA ABHISHEKKUMAR BRAJESHKUMAR 227


TO INVESTIGATE PROPHYLACTIC EFFECT OF METFORMIN AND MELATONIN COMBINATION ON ATHEROSCLEROSIS IN RAT MODEL.

7 15-05-2013 H-01 112270803007SHAH MANSI KETANBHAI 227


BIOEQUIVALENCE STUDY OF CEFIXIME 200 MG AND DICLOXACILLIN 500 MG IN HEALTHY HUMAN VOLUNTEERS UNDER FASTING CONDITIONS.

8 15-05-2013 H-01 112270803008

PATEL SEEMABEN RAMANBHAI 227


TO INVESTIGATE THE EFFECT OF COMBINATION OF THIOCOLCHOCOSIDE AND COENZYME Q10 IN EXPERIMENTALLY INDUCED RHEUMATOID ARTHRITIS IN RATS.

DATE :- 20-05-2013GUJARAT TECHNOLOGICAL UNIVERSITY-DETAILED TIME TABLE

FINAL DISSERTATION EXAM M.PHARMA SEM-IV (SUMMER-2013) FROM 15-05-2013 TO 27-05-2013( PHASE-I)

Row ID Exam Date





9 15-05-2013 H-01 112270803009

VAGHASIYA NITINKUMAR BHAGAVANBHAI 227


TO STUDY THE COMBINATION OF ROSUVASTATIN AND PIOGLITAZONE IN EXPERIMENTALLY INDUCED HYPERLIPIDEMIA AND HYPERGLYCEMIA IN RATS

10 15-05-2013 H-01 112270803010PATEL MILAN DILIPBHAI 227


TO EVALUATE THE EFFECT OF COMBINATION OF VILDAGLIPTIN AND ORLISTAT IN EXPERIMENTALLY INDUCED TYPE 2 DIABETES AND OBESITY IN RATS.

11 15-05-2013 H-01 112270803011

THAKKAR DIMPLE NATVARLAL 227


TO INVESTIGATE THE ANTIARTHRITIC ACTIVITY OF PSORALIA CORYLIFOLIA EXTRACT AND CLOZAPINE IN RATS.

12 15-05-2013 H-01 112270803012

SUTHAR KINJALBEN GIRISHKUMAR 227


TO STUDY ANTI-ULCER ACTIVITY & POSSIBLE MECHANISM OF ACTION OF BRASSICA OLERACEA VAR.CAPITATA IN EXPERIMENTALLY INDUCED ULCERS IN RATS

13 15-05-2013 H-02 112270803013ADESARA HARSH K 227


EVALUATION OF SYNERGISTIC EFFECT OF A COMBINATION OF AMBRISENTAN AND OLMESARTAN

14 15-05-2013 H-02 112270803014

PATEL PALAK BIPINCHANDRA 227


TO INVESTIGATE THE ANTIDIABETIC EFFECT OF GABA A RECEPTOR AGONIST IN TYPE II DIABETES MELLITUS INDUCED RAT MODEL.

15 15-05-2013 H-02 112270803015PATEL KINJALBEN V. 227


TO INVESTIGATE THE PROTECTIVE EFFECT OF COMBINATION OF WITHANIA SOMNIFERA AND MUCUNA PRURIENS ON TESTICULAR TOXICITY

16 15-05-2013 H-02 112270803016

PATEL BANSARI NANALAL 227


BIOEQUIVALENCE STUDY OF VERAPAMIL ER 180MG IN HEALTHY HUMAN SUBJECTS UNDER FASTING CONDITIONS.

17 15-05-2013 H-02 112270803017PATEL DISHA MANOJBAHI 227


A PROSPECTIVE COMPARATIVE STUDY OF CHLORTHALIDONE AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION.

18 15-05-2013 H-02 112270803018

PATEL BINAL NAVINCHANDRA 227


TO STUDY THE ANTI-ULCER ACTIVITY OF PRAMIPEXOLE IN STRESS INDUCED ULCERS IN RATS

Row ID Exam Date





19 15-05-2013 H-02 112270803019

PANDYA DISHITA KAUSHIKKUMAR 227


A PROSPECTIVE COMPARATIVE STUDY OF POVIDONE IODINE AND CHLORHEXIDINE ON RADIOTHERAPY INDUCED ORAL MUCOSITIS IN CANCER PATIENTS.

20 15-05-2013 H-02 112270803020

PATEL DARSHANA RAJESHBHAI 227


TO STUDY THE EFFECT OF OLMESARTAN MEDOXOMIL IN EXPERIMENTALLY INDUCED HYPERGLYCEMIA AND HYPERLIPIDEMIA IN RATS

21 15-05-2013 H-02 112270803021

MISTRI KHYATI INDRAVADANBHAI 227


A NEW APPROACH FOR INDUCTION OF HYPERGLYCEMIA IN RATS USING VARIOUS DRUGS.

22 15-05-2013 H-02 112270803022

RATHOD RONAK MULCHANDBHAI 227


EVALUATION OF ANTIHYPERLIPIDEMIC ACTIVITY OF THE COMBINATION OF PITAVASTATIN AND GINSENG USING EXPERIMENTALLY INDUCED HYPERLIPIDEMIA IN RATS.

23 15-05-2013 H-02 112270803023

PRAJAPATI SANI DAHYABHAI 227


ORAL BIOEQUIVALENCE STUDY OF VALSARTAN (320MG) TABLET UNDER FASTING AND FED CONDITIONS.

24 15-05-2013 H-02 112270803024MODI SAGAR M 227


STUDY OF EFFECT OF DEXMEDETOMIDINE ON DOSE REQUIREMENT OF MIDAZOLAM AND FENTANYL AS SEDATIVE AND ANALGESIC IN POST CARDIAC SURGICAL INTENSIVE CARE UNIT PATIENTS

25 15-05-2013 H-03 112270803026

PANCHAL RIDDHI SANJAYBHAI 227


BIOEQUIVALENCE STUDY OF VALSARTAN 320 MG AND HYDROCHLOROTHIAZIDE 25 MG TABLET IN HEALTHY HUMAN VOLUNTEERS UNDER FASTING CONDITIONS

26 15-05-2013 H-03 112270803027DARJI HETARTHI R. 227


BIOEQUIVALENCE STUDY OF CANDESARTAN CILEXETIL 32MG TABLET IN HEALTHY HUMAN VOLUNTEERS UNDER FASTING CONDITION.

27 15-05-2013 H-03 112270803028

PATEL SUMMUM RAJIV 227


TO INVESTIGATE THE EFFECT OF COMBINATION OF LINAGLIPTIN AND NATEGLINIDE IN EXPERIMENTALLY INDUCED TYPE II DIABETES IN RATS.

Row ID Exam Date





28 15-05-2013 H-03 112270803029SHAH HIRVA BHARATBHAI 227


A COMPARATIVE STUDY OF METFORMIN WITH VARIOUS ANTIDIABETIC COMBINATION IN TYPE 2 INDIAN DIABETIC PATIENTS

29 15-05-2013 H-03 112270803030

SHAH NISARG SANJAYKUMAR 227


TO STUDY THE HYPOGLYCEMIC POTENTIAL OF GEMFIBROZIL AGAINST EXPERIMENTALLY INDUCED TYPE-2 DIABETES

30 15-05-2013 H-03 112270803031

SHAH AMI HASMUKHLAL 227


A comparative study of dual anti-platelet (Aspirin+Clopidogrel) therapy versus triple anti-platelet (Aspirin+Clopidogrel+Cilostazole) therapy in post-surgical patients of PTCA and stenting

31 15-05-2013 H-03 112270803032

PATEL DARSHANKUMAR P. 227


TO INVESTIGATE THE EFFECT OF POLYHERBAL FORMULATION IN EXPERIMENTALLY INDUCED KIDNEY STONE IN RATS.

32 15-05-2013 H-03 112270803033

UPADHYAY ARCHISH HARVADAN 227


A COMPARATIVE STUDY OF LOSARTAN, OLMESARTAN, TELMISARTAN AND VALSARTAN IN PATIENTS WITH HYPERTENSION.

33 15-05-2013 H-03 112270803034

PATEL NIRMALKUMAR R 227


TO EVALUATE THE EFFECT OF COMBINATION OF Α-LIPOIC ACID AND SODIUM SELENITE USING INDOMETHACIN INDUCED ULCER MODEL IN RATS

34 15-05-2013 H-03 112270803035

DUDHAT RONAK ASHOKBHAI 227


TO EVALUATE THE HYPOLIPIDEMIC ACTIVITY OF COMBINATION OF Α-LIPOIC ACID, NIACIN AND Α-LINOLENIC ACID IN EXPERIMENTALLY INDUCED HYPERLIPIDEMIA IN RATS.

35 15-05-2013 H-03 112270803036PATEL HARDIK N 227


TO INVESTIGATE THE EFFECT OF ANTIINFLAMMATORY AGENTS IN THE TREATMENT OF RESERPINE INDUCED DEPRESSION IN RATS.

36 15-05-2013 H-03 112270803701 JOSHI NIHAR 227


EFFECT OF EXTRACT OF GLYCYRRHIZA GLABRA ON NEPHROTOXICITY IN RATS.

37 15-05-2013 H-04 112670809001

CHOTHANI ROSHANI RAJESHBHAI 267

VEERAYATAN INSTITUTE OF PHARMACY, JAKHANIA

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF VARDENAFIL AND DAPOXETINE HYDROCHLORIDE IN COMBINED DOSAGE FORM.

Row ID Exam Date





38 15-05-2013 H-04 112670809002

GADHVI BHUMI MORARDAN 267


PROFILES FOR NEW ANALYTICAL METHOD APPROCHES TO LAFUTIDINE & RABEPRAZOLE

39 15-05-2013 H-04 112670809003

CHAKI IMRAN AAMAD 267


STABILITY INDICATING RP- HPLC METHOD FOR NEBIVOLOL HCL & INDAPAMIDE IN THEIR COMBINED DOSAGE FORM

40 15-05-2013 H-04 112670809004

PATEL ANKITKUMAR H. 267


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LORNOXICAM AND EPIRISONE BY HPLC METHOD

41 15-05-2013 H-04 112670809005KATHIRIYA ROHIT H 267


DEVELOPMENT OF ANALYTICAL METHOD AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METFORMINE HYDROCHLORIDE AND LINAGLIPTIN.

42 15-05-2013 H-04 112670809006

RATHI PRATIK KISHORBHAI 267


ANALYTICAL METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST AND RUPATADINE IN BULK AND TABLET DOSAGE FORM.

43 15-05-2013 H-04 112670809007MEGHANI PRADIP J. 267


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SILDENAFIL CITRATE & DULOXETINE HYDROCHOLORIDE IN THEIR COMBINED DOSAGE FORMS.

44 15-05-2013 H-04 112670809008ACHARYA HARDIK M. 267


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE & DICLOFENAC SODIUM IN BULK AND DOSAGE FORM.

45 15-05-2013 H-04 112670809009

GOHIL MAYURDHVAJSINH JITENDRASINH 267


ANALYTICAL METHOD DEVELOPMENT & VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR ANTIHYPERTENSIVE & DIURETIC DRUGS IN THEIR COMBINED SOLID DOSAGE FORMS BY RP- HPLC METHOD.

Row ID Exam Date





46 15-05-2013 H-04 112670809010

SUMRA BASIRHUSEN SIDHIK 267


DEVELOPMENT OF ANALYTICAL METHOD AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MEROPENEM AND SULBACTAM.

47 15-05-2013 H-04 112670809012

BHINDE MEET HARSHAD 267


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF METOPROLOL & CHLORTHALIDONE IN BULK AND DOSAGE FORM

48 15-05-2013 H-05 112410807005

PATEL PRIYANK DINESHBHAI 241

INDUBHAI PATEL COLLEGE OF PHARMACY AND RESEARCH CENTRE, DHARMAJ

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND RUPATIDINE FUMARATE IN COMBINED DOSAGE FORM

49 15-05-2013 H-05 112410807006

JAISWAL REEMA ARVINDBHAI 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF QUINAPRIL HCL AND HYDROCHLORTHIAZIDE IN COMBINED PHARMACEUTICAL FORMULATION

50 15-05-2013 H-05 112410807007

BHAVSAR DHRUVAL KAMLESHBHAI 241


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ETHAMBUTOL , ISONIAZIDE AND PYRAZINAMIDE IN HUMAN PLASMA USING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY & MASS SPECTROSCOPY (UPLC/MS/MS)

51 15-05-2013 H-05 112410807008

PUNJABI BANSRI PRITHVIRAJ 241


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS ESTIMATION OF BETAHISTINE DIHYDROCHLORIDE AND DOMPERIDONE IN THEIR COMBINED PHARMACEUTICAL FORMULATION.

52 15-05-2013 H-05 112410807009

MAHESHWARI HETAL RAMESHBHAI 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF GATIFLOXACIN SESQUIHYDRATE AND LOTEPREDNOL ETABONATE IN THEIR OPTHALMIC FORMULATION

Row ID Exam Date





53 15-05-2013 H-05 112410807010

PATEL KHUSHBUBEN INDRAVADAN 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DROSPIRENONE AND ETHIYLESTRADIOL IN THEIR COMBINED TABLET DOSAGE FORM.

54 15-05-2013 H-05 112670809013

PATEL PRATIKKUMAR SURESHBHAI 267


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND LINEZOLID BY HPLC.

55 15-05-2013 H-05 112670809014

PARMAR MANOGNA BABULAL 267


METHOD DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF CEFUROXIME SODIUM & SULBACTUM SODIUM IN PARENTERAL DASAGE FORM.

56 15-05-2013 H-05 112670809015

PANDEY PRAVINKUMAR SHRIBACHCHA 267


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR RELATIVE IMPURITY OF ANTI HYPERTENSIVE DRUGS IN COMBINED SOLID DOSAGE FORMS BY RP- HPLC METHOD.

57 15-05-2013 H-05 112670809016

PATEL ANKITKUMAR VINODCHANDRA 267


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CYLCOBENZAPRINE & ACECLOFENAC IN BULK AND COMBINED DOSAGE FORM.

58 15-05-2013 H-05 112670809017

PATEL VIKINKUMAR HASMUKHBHAI 267


METHOD DEVELOPMENT, VALIDATION AND STABILITY ANALYSIS FOR ESTIMATION OF ANTI MIGRAINE DRUG IN SOLID ORAL DOSAGE FORM.

59 15-05-2013 H-05 112670809018

JARSANIA KANDARPKUMAR SATISHKUMAR 267


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR CEFIXIME AND AZITHROMYCIN IN TABLET DOSAGE FORMS BY RP- HPLC.

60 15-05-2013 H-06 112410807001

PATEL RIKENKUMAR ASHOKBHAI 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF NEPAFENAC FROM ITS OPHTHALMIC PHARMACEUTICAL FORMULATION.

Row ID Exam Date





61 15-05-2013 H-06 112410807002

PATEL AMIBAHEN BHUPENDRAKUMAR 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN HEMIHYDRATE AND CEFPODOXIMEPROXETIL IN THEIR COMBINED TABLET DOSAGE FORM.

62 15-05-2013 H-06 112410807003

PATEL AJAYKUMAR SHAILESHBHAI 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF ACIPIMOX FROM ITS PHARMACEUTICAL FORMULATION.

63 15-05-2013 H-06 112410807004

SHELADIYA SONAL VIJAYBHAI 241


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF ARTESUNATE AND MEFLOQUINE HYDROCHLORIDE IN THEIR COMBINED TABLET DOSAGE FORM.

64 15-05-2013 H-06 112410807011PATEL MITALBEN S. 241


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF LINEZOLIDE IN THEIR PHARMACEUTICAL DOSAGE FORM.

65 15-05-2013 H-06 112410807012

PATEL BHUMIKABEN YOGENDRAKUMAR 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SILDENAFIL CITRATE AND FLUOXETINE HCL IN THEIR COMBINED PHARMACEUTICAL FORMULATION.

66 15-05-2013 H-06 112410807013

MAYAVANSHI HETALBEN RAMESHBHAI 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF MOXIFLOXACIN HCL AND KETOROLAC TROMETHAMINE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM.

67 15-05-2013 H-06 112410807014

MIRZA MOHAMMADNADIM ISMAILBEG 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD AND STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF SILODOSIN FROM ITS PHARMACEUTICAL FORMULATION.

Row ID Exam Date





68 15-05-2013 H-06 112410807015

Vaishnav Nirav Sureshchandra 241


DEVELOPMENT AND VALIDATION OFANALYTICAL METHODS FOR ESTIMATION OF BROMFENAC SODIUM AND MOXIFLOXACIN HCL IN THEIR PHARMACEUTICAL DOSAGE FORM TION

69 15-05-2013 H-06 112410807016

Prajapati Dilip Prabhubhai 241


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC AND SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF PROCYCLIDINE HCL FROM ITS PHARMACEUTICAL DOSAGE FORM

70 15-05-2013 H-07 112390804001

RANPARIYA ANKIT PRAGJIBHAI 239

ROFEL, SHRI G. M. BILAKHIA COLLEGE OF PHARMACY, VAPI

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF METFORMINE AND METTHYLCOBALAMINE IN COMBINED DOSAGE FORM

71 15-05-2013 H-07 112390804002

RANA DIVYA NARESHKUMAR 239


Analytical method development and validation of Gatifloxacin and Loteprednol etobonate in combined dosage form

72 15-05-2013 H-07 112390804003

RANA MINAL HASMUKHBHAI 239


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MEROPENEM AND SULBACTAM IN THEIR PHARMACEUTICAL DASAGE FORM

73 15-05-2013 H-07 112390804004

DESAI SHUCHI PRAFULLBHAI 239


Analytical Method development and validation of moxifloxacin hydrochloride and bromfenac sodium in combined dosage form

74 15-05-2013 H-07 112390804005

PATEL SANDIPBHAI M 239


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR DICYCLOMINE HCL AND OMEPRAZOLE IN COMBINED DOSAGE FORM

75 15-05-2013 H-07 112390804006

VIRADIYA DHANSUKHBHAI SAVJIBHAI 239


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFPODOXIME PROXETIL AND LEVOFLOXACINE HEMIHYDRATE IN COMBINED TABLET DOSAGE FORM

76 15-05-2013 H-07 112390804007

CHAMPANERI DIVYESHBHAI HARISHBHAI 239


Analytical method development and validation for simultaneous estimation of Dicyclomine Hydrochloride and Ranitidine Hydrochloride in tablet dosage form

Row ID Exam Date





77 15-05-2013 H-07 112390804008

LAD CHAITANYA HASMUKHBHAI 239


Development and Validation of analytical methods for simultaneous estimation of Ceftazidime and Sulbactam in combined dosage form

78 15-05-2013 H-07 112390804009

PINAL FATABHAI BARIA 239


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF TAPENTADOL AND PARACETAMOL IN COMBINED DOSAGE FORM

79 15-05-2013 H-07 112390804010

SHAH RAJANKUMAR HARIBHAI 239


Development and Validation of stability indicating RP-HPLC assay method for Benzocaine and Chloramphenicol in combined dosage form

80 15-05-2013 H-07 112390804011

HALPATI ANILKUMAR A. 239


Analytical Method Development and Validation for simultaneous estimation of Diclofenac sodium and Eperisone hydrochloride in combined Dosage form

81 15-05-2013 H-07 112390804012SHAH MANSI NITINKUMAR 239


DEVELOPMENT AND VALIDATION OF VARIOUS ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CHLORTHALIDONE IN COMBINED DOSAGE FORM.

82 15-05-2013 H-08 112390804013

PATEL HEMANGINI HARESHBHAI 239


Analytical method development and validation of memantine hydrochloride and donepezil hydrochloride in tablet dosage form

83 15-05-2013 H-08 112390804014

PATEL NIKITABAHEN KHUSHALBHAI 239


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION FOR MIGLITOL AND METFORMIN IN COMBINED DOSAGE FORM

84 15-05-2013 H-08 112390804015DESAI HIRAL JANAK 239


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND PAMABROM IN PHARMACEUTICAL DOSAGE FORM.

85 15-05-2013 H-08 112390804016

DESAI PAYAL BANKIMCHANDRA 239


Analytical method development and validation of pantoprazole sodium and levosulpiride in capsule dosage form

Row ID Exam Date





86 15-05-2013 H-08 112390804018

VASANI CHARMEE KAUSHIKBHAI 239


Development and validation of various analytical methods for simultaneous estimation of Moxifloxin hydrochloride and Loteprednol Etabonate in combined dosage form.

87 15-05-2013 H-08 112390804019

MAHIDA RAJVI JAGDISHSINH 239


Analytical method development and validation of sparfloxacin and dexamethasone in combined dosage form

88 15-05-2013 H-08 112420804001

PRAJAPATI TARALKUMAR KANTIBHAI 242

SARASWATI INSTITUTE OF PHARMACEUTICAL SCIENCES, CHILODA

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF VARDENAFIL AND DAPOXETIN HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION.

89 15-05-2013 H-08 112420804002

DOBARIYA TWINKALBEN DAHYABHAI 242


DEVELOPMENT AND VALIDATION OF METHODS FOR ESTIMATION OF PIMOBENDAN FROM ITS DOSAGE FORM.

90 15-05-2013 H-08 112420804003

PATEL HARDIK GIRISHBHAI 242


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DROSPIRENONE AND ETHINYL ESTRADIAOL IN ITS DOSAGE FORM.

91 15-05-2013 H-08 112420804004VYAS VISMAY LALITKUMAR 242


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN ITS DOSAGE FORM.

92 15-05-2013 H-08 112420804005

SATODIA DISHA BHIKHUBHAI 242


DEVELOPMENT AND VALIDATION OF METHODS FOR ESTIMATION OF ADRENOCHROME MONOSEMICARBAZONE IN INJECTION.

93 15-05-2013 H-08 112420804006

PATEL NITINKUMAR RAMESHCHANDRA 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF SILDENAFIL AND FLUOXETINE IN TABLET.

94 15-05-2013 H-09 112420804007

SAVALIYA SANJAY DAMJIBHAI 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF AVANAFIL IN ITS DOASGE FORM.

Row ID Exam Date





95 15-05-2013 H-09 112420804008PRAJAPATI JAIMIN K 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL AND INDAPAMIDE IN TABLET DOSAGE FORM.

96 15-05-2013 H-09 112420804009

SHARMA SANDIP KAILASHCHAND 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF PARACETAMOL, FLUNARIZINE AND DOMPERIDONE IN THE TABLET DOSAGE FORM.

97 15-05-2013 H-09 112420804010

SHAH RAHULKUMAR BHAGVANDAS 242


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DETERMINATIONOF ANALGESIC AND ANTI-INFLAMMATORY DRUGS IN PHARMACEUTICAL DOSAGE FORM.

98 15-05-2013 H-09 112420804011

PATEL PRAKASH KODARBHAI 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF CELECOXIB AND DIACEREIN IN PHARMACEUTICAL FORMULATION.

99 15-05-2013 H-09 112420804012

BAROT GAURANG BHUPENDRAKUMAR 242


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HCL AND LOTEPREDNOL ETABONATE IN OPTHALMIC FORMULATION.

100 15-05-2013 H-09 112420804013

GANDHI RONAK JITENDRAKUMAR 242


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR ANTIHYPERTENSIVE DRUGS BY RP-HPLC FOR ESTIMATION IN TABLET DOSAGE FORM.

101 15-05-2013 H-09 112420804014

SOLANKI NITESH DINESHMHAI 242


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ANTIHYPERTENSIVE CLASS OF DRUG BY USING LC-MS.

102 15-05-2013 H-09 112420804015

CHAUDHARY TULSIBEN JASHUBHAI 242


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE SODIUM AND LEVOSULPIRIDE IN BULK AND THEIR COMBINED DOSAGE FORM.

103 15-05-2013 H-09 112420804016

TRIVEDI KULDIP DILIPKUMAR 242


DEVELOPMNET AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF METRONIDAZOLE AND NORFLOXACIN IN PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





104 15-05-2013 H-09 112420804017

BHATT YATRI JAGDISHCHANDRA 242


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF OLOPATADINE HYDROCHLORIDE AND KETOROLAC TROMETHAMINE IN OPTHALMIC PREPARATION.

105 15-05-2013 H-10 112130808001

PATEL KEDAR KIRANKUMAR 213

BABARIA INSTITUTE OF PHARMACY, VARNAMA

FORMULATION AND EVALUATION OF ORODISPERSIBLE FILM OF METOCLOPRAMIDE HYDROCHLORIDE

106 15-05-2013 H-10 112130808002DESAI NEIL BANKIMBHAI 213


FORMULATION AND EVALUATION OF INTRANASAL MUCOADHESIVE MICROEMULSION FOR BRAIN TARGETING OF QUETIAPINE FUMARATE

107 15-05-2013 H-10 112130808003

KHANT NIRAVKUMAR P. 213


FORMULATION CHARACTERISATION AND EVALUATION OF SOLID SELF EMULSIFYING DRUG DELIVERY OF ROSUVASTATIN CALCIUM

108 15-05-2013 H-10 112130808004

FADADU SACHINKUMAR JAYANTILAL 213


FORMULATION EVALUATION AND OPTIMIZATION OF EXTENDED RELEASE PELLETS OF SIMVASTATIN

109 15-05-2013 H-10 112130808005

PARIKH NIRAL MAYANKKUMAR 213


FORMULATION,OPTIMIZATION AND EVALUATION OF ORAL AEROSOL OF VARDENAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTIONING

110 15-05-2013 H-10 112130808006

KOTHARI DEEP MAYURKUMAR 213


FORMULATION, EVALUATION AND OPTIMIZATION OF TELMISARTAN TABLETS BY LIQUISOLID TECHNIQUE

111 15-05-2013 H-10 112130808007

PARMAR JAYENDRAKUMAR G 213


FORMULATION EVALUATION AND OPTIMIZATION OF SUBLINGUAL TABLET OF CLONIDINE HCL

112 15-05-2013 H-10 112130808008

VITHTHANI SHAILESH HARIBHAI 213


FORMULATION AND EVLAUTION OF STOMACH SPECIFIC ORAL IN SITU GEL OF CIPROFLOXACIN HCL

113 15-05-2013 H-10 112130808009

PRAJAPATI HARDIK MAHENDRABHAI 213


FORMULATION, EVALUATION AND OPTIMIZATION OF MULTIPARTICULATE FLOATING PULSATILE SYSTEM OF FLURBIPROFEN

114 15-05-2013 H-10 112130808010

KARELIYA NIMISHA JAGDISHBHAI 213


FORMULATION AND EVALUATION OF OPTHALMIC IN SITU GEL OF DICLOFENAC SODIUM

Row ID Exam Date





115 15-05-2013 H-10 112130808011

SAVALIYA POONAM DEVCHANDBHAI 213


DESIGN AND EVALUATION OF BUCOADHESIVE BILAYER PATCH OF PRAZOSIN HCL

116 15-05-2013 H-11 112130808012

KAMOTHI NIDHI JITENDRABHAI 213


FORMULATION, EVALUATION AND OPTIMIZATION OF BI-LAYER TABLETS CONTAINING FLUVASTATIN SODIUM

117 15-05-2013 H-11 112130808013

PATEL TEJALKUMARI SHANTUBHAI 213


FORMULATION,EVALUATION AND OPTIMIZATION OF GUM BASED SUSTAINED RELEASE MATRIX TABLET OF PREGABALIN

118 15-05-2013 H-11 112130808014

MAHIDA VIJAY SHAMJIBHAI 213


FORMULATION AND EVALUATION OF CITICOLINE SUSTAINED RELEASE TABLET

119 15-05-2013 H-11 112130808016

PATEL NIMESH PRADIPBHAI 213


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF ROPINIROLE HCL USING HYDROPHOBIC POLYMER

120 15-05-2013 H-11 112130808017

PATEL RIPALKUMAR MANUBHAI 213


FORMULATION, EVALUATION AND OPTIMIZATION OF TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE PELLETS

121 15-05-2013 H-11 112130808018NAIK MAHEK SHASHIKANT 213


FORMULATION EVALUATION AND OPTIMIZATION OF COLON TARGETED TABLET OF BUPROPION HYDROCHLORIDE

122 15-05-2013 H-11 112130810001GOKANI JAYKAR K 213


FORMULATION AND EVALUATION OF PHENYTOIN SODIUM EXTENDED RELEASE DOSAGE FORMS

123 15-05-2013 H-11 112130810002PATEL NEHA MANUBHAI 213


FORMULATION, EVALUATION AND OPTIMIZATION OF ORODISPERSIBLE TABLET OF TIAGABINE HYDROCHLORIDE

124 15-05-2013 H-11 112130810003

ABHIJIT ANILKUMAR DAVE 213


FORMULATION AND EVALUATION OF ACECLOFENAC TOPICAL SPRAY

125 15-05-2013 H-11 112130810004

PARIKH MANALI SUNIL 213


FORMULATION, CHARACTERIZATION AND EVALUATION OF MICROEMULSION BASED TOPICAL GEL OF BIFONAZOLE

Row ID Exam Date





126 15-05-2013 H-11 112130810005

ARPITA BHARATBHAI PUROHIT 213


FORMULATION, EVALUATION AND OPTIMIZATION OF TABLETS CONTAINING CRYSTALLINE AND AMORPHOUS FORM OF ATORVASTATIN CALCIUM USING SOLUBILITY ENHANCEMENT TECHNIQUE

127 15-05-2013 H-11 112130810006

CHAUHAN SONAMBEN KIRANKUMAR 213


FORMULATION,EVALUATION AND OPTIMIZATION OF FAST DISSOLVING SUBLINGUAL FILM OF ZOLMITRIPTAN

128 15-05-2013 H-12 112130810007

NIKI NARENDRA PATEL 213


FORMULATION,EVALUATION AND OPTIMIZATION OF TOPICAL GEL OF ADAPALENE FOR TREATMENT OF ACNE VULGARIS

129 15-05-2013 H-12 112130810009

JIGARKUMAR SATISHBHAI BRAHMBHATT 213


EFFECT OF DIFFERENT SOLUBILITY ENHANCEMENT TECHNIQUES ON IN VITRO RELEASE PROFILE OF CANDESARTAN CILEXETIL FORMULATION

130 15-05-2013 H-12 112130810010

PATEL DHRUMILKUMAR V 213


FORMULATION AND EVALUATION OF GASTRORETENTIVE DRUG DELIVERY SYSTEM OF CLARITHROMYCIN USING LOW DENSITY CARRIER

131 15-05-2013 H-12 112130810011MEHTA JATIN R 213


DESIGN, DEVELOPMENT AND EVALUATION OF LIQUISOLID TABLETS OF NIMODIPINE

132 15-05-2013 H-12 112130810012VELANI CHIRAG N 213


FORMULATION EVALUTAION AND OPTIMIZARION OF CLOMIPRAMINE HCL SUBLINGUAL TABLET.

133 15-05-2013 H-12 112130810013

SHAH RAJAN BHUPENDRABHAI 213


FORMULATION AND EVALUATION OF GRANISETRON TRANSDERMAL THERAPEUTIC SYSTEM

134 15-05-2013 H-12 112130810014PRAJAPATI RUCHI P 213


FORMULATION AND EVALUATION OF ITRACONAZOLE TOPICAL SPRAY

Row ID Exam Date





135 15-05-2013 H-12 112130810015

GAUR PRIYANKA CHHAIL BIHARI 213


FORMULATION AND OPTIMIZATION OF INDOMETHACIN TOPICAL GEL.

136 15-05-2013 H-12 112130810016

SINDHA VISHWAJITSINH R 213


FORMULATION, EVALUATION AND OPTIMIZATION OF TASTE MASKED SUSPENSION OF OFLOXACIN WITH ORNIDAZOLE

137 15-05-2013 H-12 112130810017Gandhi Sagar Shankerlal 213


FORMULATION CHARACTERIZATION AND OPTIMIZATION OF ITRACONAZOLE ETHOSOMAL GEL

138 15-05-2013 H-12 112130810018

PATEL HIMALIBEN BIPINBHAI 213


FORMULATION, EVALUATION AND OPTIMIZATION OF FIX COMBINATION OF PIPERACILLIN WITH TAZOBACTUM INJECTION

139 15-05-2013 H-13 112080808001

SHAH VANDAN KAMLESHKUMAR 208

ARIHANT SCHOOL OF PHARMACY & BIO-RESEARCH INSTITUTE, ADALAJ

APPLYING SPHERICAL AGGLOMERATION TECHNIQUES TO IMPROVE MICROMERITICS AND DISSOLUTION CHARACTERISTICS OF CANDESARTAN CILEXETIL IN DOSAGE FORM

140 15-05-2013 H-13 112080808002

CHANIYARA SANKETKUMAR SUBHASHBHAI 208


FORMULATION & EVALUATION OF FLOATABLE IN-SITU GEL FOR STOMACH SPECIFIC DRUG DELIVERY OF OFLOXACIN

141 15-05-2013 H-13 112080808003

PATEL SACHINKUMAR RANJITBHAI 208


FORMULATION AND EVALUATION OF INLAY TABLET OF NAPROXEN SODIUM WITH SUSTAIN RELEASE CIPROFLOXACIN HYDROCHLORIDE

142 15-05-2013 H-13 112080808004

PATEL FAIRY KIRTANKUMAR 208


FORMULATION & EVALUATION OF FAST DISSOLVING FILM OF CHLORPHENIRAMINE MALEATE

143 15-05-2013 H-13 112080808005

DEKAVADIYA VIREN BABULAL 208


FORMULATION OPTIMIZATION AND IN-VITRO EVALUATION OF FLOATING MICROCAPSULES

Row ID Exam Date





144 15-05-2013 H-13 112080808006

KAMANI DARSHAN JAYSUKHLAL 208


FORMULATION AND EVALUATION OF TASTE MASKED ORALLY DISINTEGRATING TABLET OF ANTIANGINAL DRUG

145 15-05-2013 H-13 112080808007

MODI PRIYANKABEN RAMESHBHAI 208


DESIGN AND EVALUATION OF MODIFIED PULSINCAP OF TRAMADOL HCL ACCORDING TO CIRCADIAN RHYTHM

146 15-05-2013 H-13 112080808008PATEL PALAK VIJAYKUMAR 208


FORMULATION & EVALUATION OF BIOADHESIVE GEL INCORPORATING AMOXYCILLNE TRIHYDRATE LOADED MICROSPHERES FOR PRIODONTAL THERAPY

147 15-05-2013 H-13 112080808009

KANZARIA KAILASH NANJIBHAI 208


FORMULATION AND EVALUATION OF EMULGEL CONTANING CLOTRIMAZOLE FOR TOPICAL DRUG DELIVERY

148 15-05-2013 H-13 112080808010

PARMAR BHARGAVKUMAR DALPATBHAI 208


FORMULATION & EVALUATION OF LOW DENSITY MATRIX OF BACLOFEN FOR SUSTAINED DRUG DELIVERY

149 15-05-2013 H-13 112080808011

DOLAR DIPAKKUMAR BHURABHAI 208


FORMULATION & EVALUATION OF SUSTAINED RELEASE MATRIX PELLETS OF QUETIAPINE FUMARATE

150 15-05-2013 H-14 112080808012

SANDHI AFSANA ALARAKHBHAI 208


APPLYING SPHERICAL AGGLOMERATION TECHNIQUES TO IMPROVE MICROMERITICS OF ROSUVASTATIN CALCIUM AND DISSOLUTION CHARACTERISTICS OF ITS DOSAGE FORM

151 15-05-2013 H-14 112080808013

SOLANKI JIGNESHKUMAR K 208


A SOLUBILITY ENHANCEMENT OF TELMISARTAN BY LIQUISOLID COMPACTS

Row ID Exam Date





152 15-05-2013 H-14 112080808014

MACHHAR BHAVESHBHAI KAHAJIBHAI 208


FORMULATION & EVALUATION OF ION SENSITIVE IN SITU GELLING SYSTEM OF LEVOFLOXACIN

153 15-05-2013 H-14 112080808015

TRIVEDI ISHITA RASHMIKANT 208


FORMULATION, OPTIMIZATION AND EVALUATION OF FLOATABLE MUCOADHESIVE TABLET OF CEPHALEXIN

154 15-05-2013 H-14 112080808016

CHAVDA YASHAVANTSINH J 208


PREPARATION & EVALUATION OF LAMIVADINE MICROSPHERES WITH ACRYLIC POLYMERS (EUDRAGIT®) BY SOLVENT EVAPORATION METHOD FOR LYMPHATIC SYSTEM

155 15-05-2013 H-14 112080808017PATEL GAURAV M. 208


FORMULATION & EVALUATION OF RECONSTITUTABLE SUSPENSIONS CONTAINING CEFLXIMETRIHYRATE LOADED EUDRAGIT MICROSPHERE

156 15-05-2013 H-14 112080808018 PATEL RAVI K 208


FORMULATION, OPTIMIZATION AND IN-VITRO EVALUATION OF BIOADHESIVE BILAYER BUCCAL TABLETS OF SIMVASTATINE

157 15-05-2013 H-14 112080810001

PATEL PRATIKKUMAR S 208


FORMULATIN, OPTIMIZATION AND IN-VITRO EVALUATION OF IMMEDIATE RELEASE FILM OF SUMATRIPTAN SUCCINATE

158 15-05-2013 H-14 112080810002PRAGATI GUPTA 208


FORMULATION, OPTIMIZATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF SOLIFENACIN SUCCINATE BY WET GRANULATION METHOD

159 15-05-2013 H-14 112080810003

TRIVEDI VARUN MADHUSUDAN 208


FORMULATION AND EVALUATION OF THERMOSENSITIVE IN SITU GEL OF NEOMYCINE SULPHATE

Row ID Exam Date





160 15-05-2013 H-14 112080810004

PATEL VISHAL HASMUKHBHAI 208


FORMULATION AND EVALUATION OF PULSATILE RELEASE TABLET OF KETOROLAC TROMETHAMINE

161 15-05-2013 H-14 112080810005

PATEL HARSHKUMAR BHARATBHAI 208


DEVELOPMENT AND EVALUATION OF OSMOTIC PUMP TABLETS OF GLIMEPIRIDE

162 15-05-2013 H-15 112080810006

PATEL PARTH MANOJBHAI 208


FORMULATION AND IN VITRO EVALUATION OF pH DEPENDENT COMPRESSION COAT COLON TARGETED TABLET OF ESOMEPRAZOLE MAGNESIUM TRIHYDRATE

163 15-05-2013 H-15 112080810007

BHANDARI VISHANI PINAKINBHAI 208


FORMULATION AND EVALUATION OF TASTE MASKED FAST DISINTIGRATING TABLET OF CHLORAPHENIRAMINE MALEATE

164 15-05-2013 H-15 112080810008

PATEL DEEP JAGDISHKUMAR 208


FORMULATION AND EVALUATION OF FLOATING PULSATILE DRUG DELIVERY SYSTEM OF METOPROLOL SUCCINATE

165 15-05-2013 H-15 112080810009

TRIVEDI PRIYANKA YOGESHKUMAR 208


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF GABAPENTIN IN NEUROPATHIC PAIN.

166 15-05-2013 H-15 112080810010

PANCHAL RAKESH VIRAMBHAI 208


FORMULATION AND EVALUATION OF BIOADHESIVE BILAYER BUCCAL TABLET OF LERCANADIPINE HCL

167 15-05-2013 H-15 112080810011

PATNI CHANDRA BIPINCHANDRA 208


FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF MYCOFENOLATE MOFETIL

Row ID Exam Date





168 15-05-2013 H-15 112080810012

SAPARA MUKESHKUMAR J 208


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF RIZATRIPTAN BENZOATE

169 15-05-2013 H-15 112080810013

NATHJI DHAVAL CHHOTUNATH 208


DESIGN AND EVALUATION OF TRANSDERMAL FILM OF LISINOPRIL DIHYDRATE EMPLOYING DIFFERENT PENETRATION ENHANCERS

170 15-05-2013 H-15 112080810014

THAKKAR DADHICHI KIRITBHAI 208


FORMULATION, DEVELOPMENT AND EVALUATION OF MEDICATED CHEWING GUM

171 15-05-2013 H-15 112080810015SOLANKI URVI M 208


FORMULATION, AND EVALUATION OF BILAYER GESTRORETENTIVE DRUG DELIVERY SYSTEM OF NICORENDIL

172 15-05-2013 H-15 112080810016

PANCHAL VIJAY CHIMANLAL 208


FORMULATION AND EVALUATION OF MEDICTAE LOZENGES OF CINNARAZINE

173 15-05-2013 H-15 112080810017CHAUDHARY ASHOK A 208


FORMULATION & DEVELOPMENT OF GASTRIC MUCOADHESIVE MICROCAPSULE OF TIZANIDINE HYDROCHLORIDE

174 16-05-2013 H-01 112460803001GOUR RAJEEV 246

SAT KAIVAL COLLEGE OF PHARMACY, SARSA

EFFECTS OF METFORMIN & LEAF EXTRACT OF MORINGA OLEIFERA COMBINATION THERAPY IN TYPE 2 DIABETIC PATIENT.

175 16-05-2013 H-01 112460803002

PATEL RIPA ALKESHKUMAR 246


EPIDEMIOLOGICAL STUDY OF BRONCHITIS AND ASSESSMENT OF PRESCRIPTION PATTERN AT SPANDAN HOSPITAL, ANAND-A PROSPECTIVE OBSERVATIONAL STUDY

Row ID Exam Date





176 16-05-2013 H-01 112460803003PATEL PARTH V. 246


PREVALENCE OF INTRA-OPERATIVE AND POST OPERATIVE COMPLICATION IN PATIENT UNDERGOING CATARACT SURGERY-A RETROSPECTIVE OBSERVATIONAL STUDY.

177 16-05-2013 H-01 112460803004

JIYANI MEHULKUMAR NARESHBHAI 246


A PROSPECTIVE STUDY OF THERAPEUTIC TREATMENT IN HUMAN PAPILLOMA VIRAL INFECTION

178 16-05-2013 H-01 112460803005

SHAH URMI MANISHKUMAR 246


A PROSPECTIVE STUDY OF THE PREVALENCE AND TREATMENT APPROCH OF POLYCYSTIC OVARIAN SYNDROME IN STERLING HOSPITAL & MANAV HOSPITAL, BARODA

179 16-05-2013 H-01 112460803006

SURTI VISHAL MUKESHBHAI 246


EVALUATION OF THE RATIONALITY OF THE DRUG PRESCRIBED IN THE DIFFERENT DISORDER OF EYE -A PROSPECTIVE OBSERVATIONAL STUDY

180 16-05-2013 H-01 112460803007PREETI KUMARI 246


EPIDEMIOLOGICAL STUDY ON AGE RELATED MACULAR DEGENERATION -A PROSPECTIVE OBSERVATIONAL STUDY AT SAT KAIVAL EYE HOSPITAL,SARSA.

181 16-05-2013 H-01 112460803008

PATEL KRUSHIBHAI B 246


A PROSPECTIVE STUDY OF PRESCRIPTION PATTERN AND PREVALENCE OF ACNE IN KARMDEEP SKIN CARE HOSPITAL, AHMEDABAD.

182 16-05-2013 H-01 112460803009

PATEL NIKITABEN SURESHBHAI 246


STUDY OF PREVALENCE AND ASSOCIATION BETWEEN STROKE AND DEPRESSION- A PROSPECTIVE OBSERVATIONAL STUDY IN ANAND DISTRICT.

183 16-05-2013 H-01 112460803010

PATEL HARESHKUMAR D. 246


EPIDEMIOLOGY OF MYOPIA AND COMPARATIVE STUDY OF VISUAL FUNCTION OF MYOPIC PATIENT WEARING CONTACT LENSES VS. SPECTACLES

184 16-05-2013 H-01 112460803011PATEL ANKIT VISHNUBHAI 246


PRESCRIPTION PATTERN STUDY OF EYE INFLAMMATORY DISORERS AT SAT KAIVAL EYE HOSPITAL,SARSA

Row ID Exam Date





185 16-05-2013 H-02 112460803013

PATEL UJAS PRAKASHKUMAR 246


BIOEQIVALENCE STUDY OF FIXED DOSE COMBINATION OF CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 32MG/25MG TABLET IN HEALTHY HUMAN VOLUNTEERS UNDER FASTING CONDITION.

186 16-05-2013 H-02 112460803014

PATEL NAINESHKUMAR H 246


PATTERN OF COMMON EYE COMPLICATIONS IN MENTALLY RETARDED PEDIATRICS-A RETROSPECTIVE OBSERVATIONAL STUDY.

187 16-05-2013 H-02 112460803015SHAH JAIMIN DILIPBHAI 246


PRESCRIBING PATTERNS IN MANAGEMENT OF DIFFERENT TYPES OF ARTHRITIS -A PROSPECTIVE OBSERVATIONAL STUDY.

188 16-05-2013 H-02 112460803016

PATEL RONAK NILESHBHAI 246


PATTERNS OF PRESCRIPTION AND DRUG USE IN PNEUMONIA IN PAEDIATRIC PATIENTS

189 16-05-2013 H-02 112460803017

PATEL AVANIKABEN ARUNBHAI 246


COMPARATIVE EPIDEMIOLOGICAL STUDY OF TYPE 2 DIABETES IN RURAL AND URBAN AREA OF KHEDA REGION.

190 16-05-2013 H-02 112460803018

PATEL SHIVANI JAYESHBHAI 246


COMPARATIVE STUDY OF DIFFERENT DRUGS OF EPILEPSY-A RETROSPECTIVE OBSERVATIONAL STUDY

191 16-05-2013 H-02 112540803001

MODI FERAL SURESHCHANDRA 254

SHREE DHANVANTARY PHARMACY COLLEGE, KIM, SURAT

INVESTIGATION OF ANTIDEPRESSANT AND ANXIOLYTIC EFFECTS OF CURCUMA LONGA EXTRACTS ON CHRONIC ADMINISTRATION OF SOME SYNTHETIC DRUGS IN RATS AND MICE.

192 16-05-2013 H-02 112540803002

PRAJAPATI PIYUSHKUMAR MOHANBHAI 254


INVESTIGATION OF ANTICANCER ACTIVITY OF URSOLIC ACID ON WISTAR ALBINO RATS.

193 16-05-2013 H-02 112540803003CHAUDHARI DHIREN L 254


INVESTIGATION OF PROTECTIVE EFFECTS OF ETHANOLIC EXTRACTS OF COCCINIA INDICA (CUCURBETACEAE) LEAVES ON EXPERIMENTALLY INDUCED EARLY DIABETIC NEPHROPATHY IN RATS.

Row ID Exam Date





194 16-05-2013 H-02 112540803004RAKHOLIYA UMESH B 254


NOOTROPIC ACTIVITY OF MADHUCA LONGIFOLIA IN VARIOUS EXPERIMENTAL MODELS ON RATS AND MICE.

195 16-05-2013 H-02 112540803005RUDANI MITALBEN G. 254


SCREENING OF FRACTIONS OF ENDOPHYTES OF CATHARANTHUS ROSEUS AGAINST HT 29 CELL LINE INDUCED COLON CANCER IN RATS.

196 16-05-2013 H-02 112540803006RAJPUT VICKY J 254


EVALUATION OF ANTIEPILEPTIC ACTIVITY OF JETROPHA GOSSYPIFOLIA LINN. ON EXPERIMENTAL ANIMALS

197 16-05-2013 H-03 112540803007PATEL NEHA A. 254


EVALUATION OF ANTICANCER ACTIVITY OF FRACTIONS OF ENDOPHYTES OF CATHARANTHUS ROSEUS IN EHRLICH ASCITIC CELL INDUCED CARCINOMA IN MICE.

198 16-05-2013 H-03 112540803008

KARKAR VIPULKUMAR VITTHALBHAI 254


EVALUATION OF ANTI-PARKINSON ACTIVITY OF TABEBUIA IMPETIGINOSA AND BIOCHEMICAL ESTIMATION OF DOPAMINE IN BRAIN HOMOGENATES OF RATS.

199 16-05-2013 H-03 112540803009

THAKOR CHAULAKUMARI BHUPENDRASINH 254


EVALUATION OF THE POTENTIAL ANTIULCER ACTIVITY OF METHANOLIC FRUIT EXTRACTS OF RANDIA DUMETORUM(MERD) IN EXPERIMENTALLY INDUCED ULCER IN RATS”.

200 16-05-2013 H-03 112540803011PATEL ANKUR B 254


EVALUATION OF THE GASTRIC-ULCER PROTECTIVE ACTIVITY OF JASMINUM MULTIFLORUM IN EXPERIMENTAL ANIMAL MODELS.

201 16-05-2013 H-03 112540803012

PATEL ANKITKUMAR RAJESHBHAI 254


EVALUATION OF ANTI-CANCER EFFECTS OF OLEANOLIC ACID AGAINST BLADDER CANCER BY IN-VITRO AND IN-VIVO MODELS.

202 16-05-2013 H-03 112540803013

MAHIDA JAYDIPSINH M 254


EVALUATION OF WOUND HEALING ACTIVITY OF TABERNAEMONTANA HEYNEANA WALL. ON EXPERIMENTAL ANIMALS

Row ID Exam Date





203 16-05-2013 H-03 112540803014

GADHAVI KOMAL BHASKARBHAI 254


EVALUATION OF THE ANTIDEPRESSANT AND ANXIOLYTIC EFFECTS OF MIMOSA PUDICA EXTRACTS(MPE) ON RATS AND MICE AND STUDY SOME IMPORTANT POTENTIAL HERBAL DRUG INTERACTIONS.

204 16-05-2013 H-03 112540803015

LAKHANI AJAYKUMAR R 254


INVESTIGATION OF THE POTENTIAL ANTI-ASTHAMATIC ACTIVITY OF FLOWER EXTRACTS OF NELUMBO NUCIFERA IN VARIOUS EXPERIMENTAL ANIMALS.

205 16-05-2013 H-03 112540803016

KEVAT RITESH SHARADKUMAR 254


CANCER PROTECTIVE ACTIVITY OF ZEAXANTHIN AGAINST HT 29 CELL LINE INDUCED COLON CANCER.

206 16-05-2013 H-03 112540803017

PATEL NILANJ MANHARLAL 254


INVESTIGATION OF ANTI-STRESS ACTIVITY OF THE ETHANOLIC EXTRACTS OF MADHUCA LONGIFOLIA (KOENIG) BARK IN EXPERIMENTAL ANIMALS.

207 16-05-2013 H-03 112540803018

BHALALA RITESHKUMAR RAGHAVBHAI 254


INVESTIGATION OF ANTI-DEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY OF LAGENARIA SICERARIA(MOLINA)SEEDS USING VARIOUS EXPERIMENTAL ANIMAL MODELS.

208 16-05-2013 H-03 112540803019

HADIA MUKESHKUMAR BABUBHAI 254


EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF CAESALPINIA DIGYNA ON EXPERIMENTAL ANIMAL MODELS.

209 16-05-2013 H-04 112640804001

GATHANI RUPALI BIMAL 264

SURYABEN JASHUBHAI THAKKAR PHARMACY COLLEGE, RAJKOT

METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF RACECADOTRIL AND OFLOXACIN IN FIXED COMBINED DOSAGE FORM.

210 16-05-2013 H-04 112640804002

SAVSANI JYOTI JAYNTILAL 264


ANALYTICAL METHOD DEVELOPMENT FOR ESTIMATION OF CONTENT UNIFORMITY OF EBASTINE AND MONTELUKAST SODIUM IN THEIR TABLET DOSAGE FORM

Row ID Exam Date





211 16-05-2013 H-04 112640804003

SAVJIYANI NIRAVKUMAR BHUPATRAY 264


SIMULTANEOUS ESTIMATION OF VARDENAFIL HYDROCHLORIDE AND DAPOXETINE HYDROCHLORIDE IN COMBINED PHARMACEUTICAL DOSAGE FORM BY SPECTROPHOTOMETRY AND RP-HPLC

212 16-05-2013 H-04 112640804004

SORIYA SMITABEN VASANTLAL 264


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TIZANIDINE HYDROCHLORIDE AND MEFENAMIC ACID IN PHARMACEUTICAL DOSAGE FORM.

213 16-05-2013 H-04 112640804005

VAGHASIA BHARTIBEN BABUBHAI 264


ANALYTICAL METHOD DEVELOPMENT FOR ESTIMATION OF CONTENT UNIFORMITY OF CETRIZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE IN COMBINED DOSAGE FORM

214 16-05-2013 H-04 112640804006

KALOLA VIDHI NARAYAN 264


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CITICOLINE AND METHYLCOBALAMIN IN COMBINED DOSAGE FORM

215 16-05-2013 H-04 112640804007

THUMAR RAKSHITKUMAR VALLABHBHAI 264


(A) ESTIMATION OF BUPIVACAINE HYDROCHLORIDE IN PRESENCE OF ITS MAJOR IMPURITY BY UV SPECTROSCOPY METHOD (B) CONCURRENT PROCESS VALIDATION OF AZATHIOPRINE TABLET

216 16-05-2013 H-04 112640804008

UTKARSH KUMARILBHAI BHATT 264


VALIDATED SIMULTANEOUS ESTIMATION OF DOSULEPIN HYDROCHLORIDE AND METHYLCOBALAMIN BY VARIOUS ANALYTICAL TECHNIQUES IN COMBINED DOSAGE FORM

217 16-05-2013 H-04 112640804009

DESAI KINJALBEN NATHABHAI 264


METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF METFORMIN HYDROCHLORIDE AND ALPHA LIPOIC ACID IN FIXED COMBINED DOSAGE FORM

218 16-05-2013 H-04 112640804010

NADPARA NISHENDU PARSOTTAMBHAI 264


SIMULTANEOUS ESTIMATION OF DULOXETINE HYDROCHLORIDE AND METHYLCOBALAMIN IN THEIR COMBINED DOSAGE FORM USING VARIOUS MODERN ANALYTICAL TECHNIQUES

Row ID Exam Date





219 16-05-2013 H-05 112630804001

PARAG DUNGARBHAI NASIT 263

SMT. R. D. GARDI B. PHARMACY COLLEGE, NYARA, RAJKOT

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF FLUPIRTINE MALEATE AND PARACETAMOL IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM.

220 16-05-2013 H-05 112630804002KARIA MONA PANKAJBHAI 263


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF ETAMSYLATE AND MEFENAMIC ACID IN HUMAN PLASMA AND URINE

221 16-05-2013 H-05 112630804003THANKI BINA SHANTILAL 263


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LAFUTIDINE AND DOMPERIDONE IN HUMAN PLASMA

222 16-05-2013 H-05 112630804004

MANAVAR DAINIKKUMAR MOHANLAL 263


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DOXOFYLLINE AND TERBUTLINE SULPHATE IN BULK DRUG AND THEIR PHARMACEUTICAL DOSAGE FORM

223 16-05-2013 H-05 112630804005

KAVAR RAJESHREE CHANDRAKANTBHAI 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFPODOXIME PROXETIL AND LEVOFLOXACIN HEMIHYDRATE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM

224 16-05-2013 H-05 112630804006

SUVAGIYA PRIYAL LALITBHAI 263


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR QUANTIFICATION OF EPERISONE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

225 16-05-2013 H-05 112640804011

THESIA UDAYKUMAR DHIRAJLAL 264


STABILITY INDICATING HPLC METHOD DEVELOPMENT FOR ESTIMATION OF MONTELUKAST SODIUM AND ACEBROPHYLLINE IN COMBINED DOSAGE FORM

226 16-05-2013 H-05 112640804012

JUNEJA AFSANA MAMADBHAI 264


BIOANALYTICAL AND ANALYTICAL METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN CALCIUM AND CLOPIDOGREL BISULPHATE IN CAPSULE DOSAGE FORM

Row ID Exam Date





227 16-05-2013 H-05 112640804013MAKWANA DALSUKH H 264


DEVELOPMENT OF NEW ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF ALPRAZOLAM AND MEBEVERINE HYDROCHLORIDE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM

228 16-05-2013 H-05 112640804014

MAKWANA KAMLESHKUMAR KALABHAI 264


BIOANALYTICAL AND ANALYTICAL METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE SODIUM AND LEVOSULPIRIDE IN THEIR COMBINED DOSAGE FORM

229 16-05-2013 H-05 112640804015GOTI PRATIK PRAVINBHAI 264


(A) SIMULTANEOUS ESTIMATION OF GABAPENTIN, METHYLCOBALAMIN AND ALPHA LIPOIC ACID IN MULTICOMPONENT DOSAGE FORM BY RP-HPLC AND UV-VISIBLE SPECTROSCOPY; (B) IVIVC STUDY OF ALPHA LIPOIC ACID IN CONVENTIONAL TABLET FORMULATION

230 16-05-2013 H-05 112640804016KANSAGRA NIRAV S 264


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF BUDESONIDE AND SALBUTAMOL SULPHATE IN COMBINE DOSAGE FORM.

231 16-05-2013 H-06 112630804007

GANDHI POOJA PRATAPRAY 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFPODOXIME PROXETIL AND AZITHROMYCIN DIHYDRATE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM.

232 16-05-2013 H-06 112630804008

KOTHARI CHIRAG PRADIPKUMAR 263


ANALYTICAL METHOD VALIDATION FOR SIMULTANEOUS ESTIMATION OF AMPICILLINE AND CLOXACILLINE IN BULK DRUG AND PHARMACEUTICAL ORAL SUSPENSION

233 16-05-2013 H-06 112630804009

TALAVIYA NIMISH MANSUKHBHAI 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND PAMABROM IN BULK DRUG AND IN SYNTHETIC MIXTURE

Row ID Exam Date





234 16-05-2013 H-06 112630804010

JOSHI CHANDANI MANILAL. 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF TAPENTADOL HYDROCHLORIDE AND PARACETAMOL IN BULK DRUG AND IN PHARMACEUTICAL DOSAGE FORM

235 16-05-2013 H-06 112630804011

PARMAR DEVANG GIRISHBHAI 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CARISOPRODOL AND MELOXICAM IN BULK DRUG IN PHARMACEUTICAL DOSAGE FORM

236 16-05-2013 H-06 112630804012KUBAVAT HETALBEN B 263


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND CHLORZOXAZONE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM.

237 16-05-2013 H-06 112630804013MANSURI JASHMIN M 263


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ILAPRAZOLE IN PHARMACEUTICAL DOSAGE FORM AND IN DISSOLUTION MEDIUM

238 16-05-2013 H-06 112630804014VYAS JAIMIN R 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ANALYSIS OF CYCLOBENZAPRINE HYDROCHLORIDE AND ACECLOFENAC IN BULK AND DOSAGE FORM.

239 16-05-2013 H-06 112630804015HARIYANI HETAL N 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFTAZIDIME AND CLAVULANIC ACID IN BULK AND PHARMACEUTICAL DOSAGE FORM

240 16-05-2013 H-06 112630804016

VEKARIYA SANJAYKUMAR H. 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE AND LEVOSULPIRIDE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM

241 16-05-2013 H-06 112630804017

PATEL MAULIKKUMAR V 263


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND LINEZOLID IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





242 16-05-2013 H-06 112630804018

CHOVATIA PURVIL HARISHBHAI 263


DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION FOR EPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN PHARMACEUTICAL DOSAGE FORM

243 16-05-2013 H-07 112540804001

MANGUKIYA MANOJKUMAR ARJANBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF AVANAFIL AND DAPOXETINE HYDROCHLORIDE IN COMBINED DOSAGE FORM

244 16-05-2013 H-07 112540804002MANIYA JIGNESH B 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ACEBROPHYLLINE AND MONTELUKAST SODIUM IN PHARMACEUTICAL FORMULATION

245 16-05-2013 H-07 112540804003

KHANPARA BHAVIKBHAI BHUPATBHAI 254


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION OF TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM IN BULK AND PHARMACEUTICAL FORMULATION

246 16-05-2013 H-07 112540804004

PANCHAL VIHANG UMESHKUMAR 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF TIAPRIDE HYDROCHLORIDE IN PHYSICAL MIXTURE

247 16-05-2013 H-07 112540804005

SWAMI MINAKSHI DHANRAJ 254


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MONTELUKAST SODIUM AND OLOPATADINE HYDROCHLORIDE

248 16-05-2013 H-07 112540804006

PATEL RASHMIKANT KANTILAL 254


PROCESS VALIDATION OF NIFEDIPINE SUSTAINED RELEASE 20 MG COATED TABLET

249 16-05-2013 H-07 112540804007KASAD PINAZ ASPI 254


DEVELOPMENT OF ANALYTICAL METHOD, DISSOLUTION PROFILE AND STABILITY STUDY OF RIVAROXABAN AND ITS VALIDATION

250 16-05-2013 H-07 112540804008

PRAJAPATI NEELAMBEN S 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CELECOXIB AND DIACEREIN IN BULK AND COMBINED DOSAGE FORM.

Row ID Exam Date





251 16-05-2013 H-07 112540804009

PATEL CHIRAGBHAI HARIBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ALPRAZOLAM AND OMEPRAZOLE IN BULK AND PHARMACEUTICAL FORMULATION

252 16-05-2013 H-07 112540804010

CHAUHAN PRAKASHBHAI SIDIBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DOXOFYLLINE AND AMBROXOL HYDROCHLORIDE IN PURE AND COMBINED DOSAGE FORM

253 16-05-2013 H-07 112540804011

GANVIT ROHANBHAI HARJIBHAI 254


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM

254 16-05-2013 H-07 112540804012

PATEL CHIRAGKUMAR JITUBHAI 254


ANALYTICAL METHOD DEVELOPMENT OF PRASUGREL HYDROCHLORIDE AND ASPIRIN IN BULK AND PHARMACEUTICAL DOSAGE FORM

255 16-05-2013 H-08 112450804001

PANCHAL NAYANKUMAR HASMUKHBHAI 245

SHRI SARVAJANIK PHARMACY COLLEGE, MEHSANA

DEVELOPMENT & VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF CEFIXIME & AZITHROMYCIN AND RELATED SUBSTANCE IN TABLET FORMULATION

256 16-05-2013 H-08 112450804003

PATEL RAVI BHARATKUMAR 245


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF CEFTAZIDIME AND TAZOBACTAM IN AN INJECTABLE DOSAGE FORM

257 16-05-2013 H-08 112450804004

TRIVEDI RUCHA BHARATBHAI 245


CHROMATOGRAPHIC METHODS FOR ESTIMATION OF ACYCLOVIR & HYDROCORTISONE IN CREAM FORMULATION & VALINE ESTER OF ACYCLOVIR(VALACYCLOVIR) IN TABLET FORMULATION

258 16-05-2013 H-08 112450804005

BHAVSAR JAIMIN CHANDRAKANT R 245


ISOLATION, PURIFICATION, CHARACTERIZATION OF EMBELIN PLANT MARKER AND ITS ESTIMATION BY ANALYTICAL METHODS.

259 16-05-2013 H-08 112450804006

PATEL PANKAJKUMAR V 245


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF SILYMARIN

Row ID Exam Date





260 16-05-2013 H-08 112540804013

GAMIT NILAMKUMARI MUKESHBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF INDAPAMIDE AND NEBIVOLOL HYDROCHLORIDE IN BULK AND COMBINED DOSAGE FORM

261 16-05-2013 H-08 112540804014

KANANI NILESHKUMAR LALLUBHAI 254


PROCESS VALIDATION OF LOPERAMIDE HYDROCHLORIDE BP 2 MG TABLETS

262 16-05-2013 H-08 112540804015

DUDHAT PRADIPKUMAR RAMESHBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF PAMABROM IN BULK AND TABLET DOSAGE FORM

263 16-05-2013 H-08 112540804016THADHANI KUMAR S 254


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION OF METFORMIN HYDROCHLORIDE AND ALPHA LIPOIC ACID IN BULK DOSAGE FORM

264 16-05-2013 H-08 112540804017

PATEL JATINKUMAR RANCHHODBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM AND CHLORTHALIDONE IN PHARMACEUTICAL FORMULATION AND PROCESS VALIDATION OF PRAVASTATIN SODIUM USP TABLETS (40 MG)

265 16-05-2013 H-08 112540804018

PATEL KEYURKUMAR DIPAKBHAI 254


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND PANTOPRAZOLE SODIUM IN CAPSULE DOSAGE FORM

266 16-05-2013 H-09 112450804007

PATEL DISHA ALKESHKUMAR 245


STABILITY STUDIES OF ATAZANAVIR AND RITONAVIR IN COMBINED TABLET DOSAGE FORM

267 16-05-2013 H-09 112450804008

CHAUDHARY BHAMINIBAHEN RAMJIBHAI 245


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND OLOPATADINE HYDROCHLORIDE IN BULK AND SIMULATED DOSAGE FORM

Row ID Exam Date





268 16-05-2013 H-09 112450804009

VALA SANJAYKUMAR GOVINDBHAI 245


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF GLUCOSAMINE AND BOSWELLIC ACIDS IN COMMERCIAL PREPARATION .

269 16-05-2013 H-09 112450804010

PRAJAPATI NILESHKUMAR NATVARBHAI 245


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RAMIPRIL AND ITS METABOLITE RAMIPRILAT IN HUMAN PLASMA BY USING HYPHENETED LIQUID CHROMATOGRAPHY- TANDEM MASS SPECTROSCOPY( LC-MS/MS)

270 16-05-2013 H-09 112450804011SOLANKI SHRINIL A 245


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC ASSAY METHOD FOR CEFPODOXIME AND POTASSIUM CLAVULANATE TABLET.

271 16-05-2013 H-09 112450804013

TAVIYAD GIRISHBHAI MAVJIBHAI 245


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CARBAMAZEPINE IN HUMAN PLASMA BY USING HYPHENETED LIQUID CHROMATOGRAPHY- TANDEM MASS SPECTROSCOPY( LC-MS/MS)

272 16-05-2013 H-09 112450804014CHAUDHRY PALAKBEN G 245


STRESS TESTING AND DEVELOPMENT OF SIAM FOR DARUNAVIR ETHANOLATE IN ITS DOSAGE FORM

273 16-05-2013 H-09 112450804015

PATEL VIPULKUMAR D 245


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF RABEPRAZOLE SODIUM AND LEVOSULPIRIDE IN THEIR PHARMACEUTICAL DOSAGE FORM

274 16-05-2013 H-09 112450804016

CHAUDHARI BHARATIBEN VANAVIRBHAI 245


STUDIES ON STABILITY AND ANALYSIS OF CEFADROXIL AND POTASSIUM CLAVULANATE IN PHARMACEUTICAL DOSAGE FORM

275 16-05-2013 H-09 112450804017

PATEL DIGMABEN BABULAL 245


DEVELOPMENT AND VALIDATION OF ANALYICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF MOXOFLOXACIN HYDROCHLORIDE AND PREDNISOLONE ACETEATE IN BULK AND IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





276 16-05-2013 H-09 112450804018

PATEL CHAHANABEN A 245


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF CEFEPIME AND TAZOBACTAM IN AN INJECTABLE DOSAGE FORM

277 16-05-2013 H-10 112240808001

PATEL DHARTIBAHEN MAHESHBHAI 224

K. B. RAVAL COLLEGE OF PHARMACY, KASTURINAGAR, SHERTHA

SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUG SIMVASTATIN BY SOLID DISPERSION

278 16-05-2013 H-10 112240808002TRIVEDI KUSH M 224


FORMULATION & EVALUATION OF SELF-EMULSIFYING DRUG DELIVERY SYSTEM OF SIROLIMUS

279 16-05-2013 H-10 112240808003

JIVANI RAJ GURUMUKHDAS 224


FORMULATION & EVALUATION OF IMMEDIATE RELEASE CILOSTAZOL PELLETS BY EXTRUSION SPHERONISATION

280 16-05-2013 H-10 112240808004

SOJITRA SHARMILA BHARATBHAI 224


FORMULATION & EVALUATION OF GASTRORETENTIVE MUCOADHESIVE TABLET OF REPAGLINIDE

281 16-05-2013 H-10 112240808005PATEL POOJA TIKENDRA 224


PREPARATION & EVALUATION OF ACECLOFENAC MICROSPONGES

282 16-05-2013 H-10 112240808006

KALARIA KHUSHBUBEN JAYANTILAL 224


DEVELOPMEN & CHARACTERIZATION OF ORALLY DISINTEGRATING TABLET OF TRAMADOL HCL USING NOVEL EXCIPIENT

283 16-05-2013 H-10 112240808007

PRIYDARSHI DARSHANKUMAR PASHABHAI 224


FORMULATION & EVALUATION OF FAST DISSOLVING TABLET OF CILOSTAZOL USING QUALITY BY DESIGN APPROACH

284 16-05-2013 H-10 112240808008

PANDYA KUNAL PANKAJKUMAR 224


FORMULATION & EVALUATION OF SUBLINGUAL FILM OF CHLORPHENIRAMINE MALEATE

285 16-05-2013 H-10 112240808009

KHOKHARA JAYDEEP PRAFULBHAI 224


FORMULATION & EVALUATION OF FLOATING TABLET OF VALACYCLOVIR HCL

Row ID Exam Date





286 16-05-2013 H-10 112240808010

BHAVSAR MEET PRAKASHKUMAR 224


PREPARATION & EVALUATION OF SUSTAINED RELEASE RANOLAZINE LOADED MICROSPHERES

287 16-05-2013 H-10 112240808011

SHAH HELY PRAVINCHANDRA 224


FORMUATION & EVALUATION OF FLOATING OSMOTIC TABLET OF METOCLOPRAMIDE HCL

288 16-05-2013 H-10 112240808012

TRIVEDI MANAN PANKAJKUMAR 224


FORMULATION & EVALUATION OF ORODISPERSIBLE TABLET OF ONDANSETRON USING QUALITY BY DESIGN APPROACH

289 16-05-2013 H-11 112240808013

PUJARA ZALAKBAHEN KIRITBHAI 224


FORMULATION & EVALUATION OF SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM OF FEXOFENADINE TO ENHANCE DISSOLUTION RATE

290 16-05-2013 H-11 112240808014

THACKER ANKITA PRADIPBHAI 224


FORMULATION & EVALUATION OF SUBLINGUAL TABLET OF RABEPRAZOLE SODIUM USING BIOADHESIVE POLYMER

291 16-05-2013 H-11 112240808015

BAROT DHARA SURESHKUMAR 224


FORMULATION & EVALUATION OF IMMEDIATE RELEASE FLUNARIZINE HYDROCHLORIDE PELLETS BY EXTRUSION SPHERONISATION

292 16-05-2013 H-11 112240808016

PATEL HINESHABEN HASMUKHBHAI 224


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF TELMISARTAN

293 16-05-2013 H-11 112240808017

PRAJAPATI NIKITA MAHENDRABHAI 224


PREPARATION AND EVALUATION OF ROPINIROLE HCL MICROSPHERES

294 16-05-2013 H-11 112240808018

CHAUHAN NEHABEN RAMNIKBHAI 224


FORMULATION & EVALUATION OF FLOATING TABLET OF BACLOFEN

295 16-05-2013 H-11 112240808019

DABHI KHUSHBU DILJITSINH 224


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF ZOLMITRIPTAN FOR SUBLINGUAL USE

Row ID Exam Date





296 16-05-2013 H-11 112240808020

NAYAK ROMILKUMAR ASHOKKUMAR 224


FORMULATION & EVALUATION OF OCCULAR INSITU GEL OF LEVOFLOXACIN HEMIHYDRATE

297 16-05-2013 H-11 112240808021

GORAJIYA AMRUTA BHARATBHAI 224


FORMULATION, DEVELOPEMENT & OPTIMIZATION OF CONTROLLED RELEASE MULTI UNIT PARTICULATE SYSTEM OF ANTI INFLAMATORY DRUG

298 16-05-2013 H-11 112240808022

MODI PRATIKKUMAR PRAVINCHANDRA 224


PREPARATION & OPTIMIZATION OF PENTOXIFYLLINE SUSTAINED RELEASE MICROSPHERES BY SPRAY DRYING TECHNIQUE

299 16-05-2013 H-11 112240808023

PARMAR HARDEEPSINH HANUBHAI 224


SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUG RAPAMYCIN BY SOLID DISPERSION

300 16-05-2013 H-11 112240808024

GANVIT NILAMKUMARI RAMESHBHAI 224


FORMULATION & EVALUATION OF MOUTH DISPERSIBLE FILM OF DOMEPERIDONE

301 16-05-2013 H-12 112240808025

SOLANKI RINA SUDHIRKUMAR 224


FORMUATION & EVALUATION OF FAST DISINTEGRATING TABLET OF INDOMETHACIN BY SOLID DIPERSION METHOD

302 16-05-2013 H-12 112240808026CHAUDHARI JEENALBEN D 224


FORMULATION AND EVALUATION OF HYDROGEL OF CHLORPHENIRAMINE MALEATE

303 16-05-2013 H-12 112240808027DANGI ARATI AMARSINH 224


FORMULATION & EVALUATION OF LORNOXICAM MATRIX TABLET

304 16-05-2013 H-12 112240808028PATEL UTSAV SURESHBHAI 224


FORMULATION & EVALUATION OF ORODISPERSIBLE TABLETS OF OLMESARTAN MEDOXOMIL BY SOLID DISPERSION TECHNIQUE

305 16-05-2013 H-12 112240808029

PATEL JIGNESHKUMAR KANAIYALAL 224


FORMULATION & EVALUATION OF COLON TARGETED MELOXICAM TABLET FOR PROPHYLAXIS OF COLORECTAL CANCER

Row ID Exam Date





306 16-05-2013 H-12 112240808030PATEL BIRANJ K 224


FORMULATION , OPTIMIZATION & EVALUATION OF MOUTH DISSOLVING TABLET OF AMBROXOL HCL

307 16-05-2013 H-12 112240808031

PATEL TEJAS RAMESHBHAI 224


FORMUATION & EVALUATION OF GASTRO RETENTIVE FLOATING TABLET OF LAFUTIDINE

308 16-05-2013 H-12 112240808032BHETARIYA NISHIT A 224


FORMULATION & EVALUATION OF MICROSPHERES CONTAINING CARVEDILOL PHOSPHATE

309 16-05-2013 H-12 112240808034

KAKADIYA PRANAVKUMAR VINODBHAI 224


FORMULATION & EVALUATION OF BILAYER TABLET OF GLIBENCLAMIDE AND METFORMIN HCL

310 16-05-2013 H-12 112240808035PATEL CHINTAN M. 224


FORMULATION & EVALUATION OF AMINOPHYLLINE DELAYED RELEASE TABLET FOR NOCTURNAL ASTHMA

311 16-05-2013 H-13 112020808001JOSHI JAY RAKESHBHAI 202

A. R. COLLEGE OF PHARMACY & G. H. PATEL INSTITUTE OF PHARMACY, VALLABH VIDYANAGAR

Formulation and Characterization of Gastroretentive Matrix tablet containing Baclofen

312 16-05-2013 H-13 112020808002

PATOLIYA SANDIPKUMAR VRAJLAL 202


PREPARATION, CHARACTERIZATION AND OPTIMIZATION OF CONTROLLED POROSITY OSMOTIC PUMP OF METOPROLOL SUCCINATE

313 16-05-2013 H-13 112020808003

PARIKH HARDIKKUMAR ASHWINBHAI 202


FORMULATION AND CHARACTERIZATION OF NANOPARTICULATE DRUG DELIVERY SYSTEM OF VALSARTAN

Row ID Exam Date





314 16-05-2013 H-13 112020808004

ANDANI ASHISH SHABIRBHAI 202


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF CONTROLLED POROSITY OSMOTIC PUMP OF SELECTED DRUG

315 16-05-2013 H-13 112020808005

THAKKAR CHAITALIBEN JANAKKUMAR 202


FORMULATION, OPTIMIZATION AND EVALUATION OF NANOSUSPENSION OF A POORLY SOLUBLE DRUG

316 16-05-2013 H-13 112020808006

GAMBHAVA JIGAR AMARSHIBHAI 202


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF COLON TARGETED TABLETS OF AZATHIOPRINE

317 16-05-2013 H-13 112020808007

PATEL VANITKUMAR MAHESHBHAI 202


Formulation development and Optimization of Tadalafil Fast dissolving tablet of by Solid Dispersion technique

318 16-05-2013 H-13 112020808008

PANDEY AAKASH RAMNIVAS 202


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF COLON TARGETED DRUG DELIVERY OF SELECTED DRUG

319 16-05-2013 H-13 112020808009

MEETKUMAR AVINASH PATEL 202


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF SOLID LIPID NANOPARTICLES OF A POORLY SOLUBLE DRUG

320 16-05-2013 H-13 112020808010

KHATIWALA BHAVIK DILIPKUMAR 202


PROCESS VALIDATION OF TABLET CONTAINING ANTI-TUBERCULAR DRUG

Row ID Exam Date





321 16-05-2013 H-13 112020808011

KARGATHIYA SANDIP BABUBHAI 202


Formulation develpoment and evaluation of oral Fast Dissolving Film of an antidepressant drug

322 16-05-2013 H-13 112020808012

BELIM SHABANA HABIB 202


Formulation and Characterization of Nanosuspension of antihyperlipidic drug by Microemulsification

323 16-05-2013 H-14 112020808013

PANCHAL KRISHNAKUMARI KAMLESHKUMAR 202


FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLET OF ETODOLAC

324 16-05-2013 H-14 112020808014

MAKWANA PANKAJBHAI NAGINBHAI 202


Formulation and Evaluation of Orally Disintegrating tablets of Trazodone hydrochloride

325 16-05-2013 H-14 112020808015

PATEL BHAUMIKKUMAR RAJESHBHAI 202


Formulation and Characterization of Self Microemulsifying drug delivery of Etoricoxib

326 16-05-2013 H-14 112020808016

PATEL DISHANT KAMLESHKUMAR 202


Formulation, Characterization and Optimization of Nano emulsion of a selected drug

327 16-05-2013 H-14 112020808017

PATEL RONAKKUMAR PRAVINBHAI 202


FAST DISSOLVING FILM OF METOPROLOL TARTARATE: FORMULATION AND CHARACTERIZATION

Row ID Exam Date





328 16-05-2013 H-14 112020808018PATEL ANKITA S 202


PREPARATION AND CHARACTERIZATION OF MUCOADHESIVE MICROSPHERES CONTAINING ANTI HYPERTENSIVE AGENT

329 16-05-2013 H-14 112050812001PATEL RIPALBEN V 205

ANAND PHARMACY COLLEGE, ANAND

FORMULATION AND OPTIMIZATION OF METFORMIN ER, PIOGLITAZONE AND GLIMEPIRIDE IR TABLET - QBD APPROACH

330 16-05-2013 H-14 112050812002

SHAH NISARGKUMAR VIMALBHAI 205


DESIGN EXPERT ASSISTED FORMULATION AND OPTIMIZATION OF BILAYER TABLET OF ACECLOFENAC, RABEPRAZOLE AND THIOCOLCHICOSIDE

331 16-05-2013 H-14 112050812003DESAI POOJA ANILBHAI 205


PROCESS VALIDATION OF FAMCICLOVIR TABLET

332 16-05-2013 H-14 112050812004

PATEL CHETAN KIRTIBHAI 205


FORMULATION, OPTIMIZATION, IN-VITRO EVALUATION AND STABILITY STUDY OF BUDENOSIDE AND LEVO-SALBUTAMOL SUSPENSION USING SPRAY DRYING TECHNOLOGY FOR PULMONARY ADMINISTRATION

333 16-05-2013 H-14 112050812005

DHAMELIYA DHRUMANKUMAR RAMESHBHAI 205


DEVELOPMENT OF CLEANING VALIDATION METHOD FOR BAROPEN RESIDUE IN PRODUCT MANUFACTURING ZONE

334 16-05-2013 H-14 112050812006

ANJARIA HAARD HEMANT 205


DESIGN AND CHARACTERIZATION OF THE TABLET FORMULATION CONTAINING HERBAL DRUGS FOR TREATMENT OF URINARY CARE

335 16-05-2013 H-15 112050812007SHAIKH RAHIDALI A 205


FORMULATION AND OPTIMIZATION OF FLUID BED PROCESS BASED FORMULATION OF ROXITHROMYCIN AND OMEPRAZOLE: A NOVEL COMBINATION FOR H. PYLORI TREATMENT

336 16-05-2013 H-15 112050812008

SHAH HIRAKKUMAR HASHUMUKHLAL 205


DEVELOPMENT, CHARACTERIZATION AND INCLUSIVE STUDY OF PROCESS PARAMETER ON FORMULATION CONTAINING DORZOLAMIDE IN-SITU OPTHALMIC GEL

Row ID Exam Date





337 16-05-2013 H-15 112050812009

PATEL KHUSHBOOBEN SUNILBHAI 205


OPTIMIZATION OF PROCESS VARIABLES AND STABILITY ASSASMENT OF CONTROLLED RELEASE SELF EMULSIFYING FORMULATION OF TABLET DOSAGE FORM CONTAINING GLIPIZIDE

338 16-05-2013 H-15 112050812010

PATEL MONALIBEN DILIPBHAI 205


SOLUBILITY ENHANCEMENT OF TELMISARTAN BY LIQUID SOLID COMPACTION TECHNIQUE - DESIGN SPACE APPROACH

339 16-05-2013 H-15 112050812011

PATEL JAYMINKUMAR N 205


FORMULATION AND OPTIMIZATION OF FOLIC ACID COATED PYRIDOXINE SR TABLET

340 16-05-2013 H-15 112050812012

SHAH DHARA SANJAYKUMAR 205


FORMULATION AND PROCESS OPTIMIZATION OF METRONIDAZOLE TABLET

341 16-05-2013 H-15 112050812013

PATEL RIPALKUMAR K. 205


PROCESS VALIDATION OF CIPROFLOXACIN AND TINIDAZOLE TABLET

342 16-05-2013 H-15 112050812014

MULANI NISHA DILIPKUMAR 205


CLEANING VALIDATION AND CROSS-CONTAMINATION STUDY OF CIPROFLOXACIN IN PARENTERAL MANUFACTURING UNIT

343 16-05-2013 H-15 112050812015

SHAH PARAGKUMAR K 205


IMPROVISATION IN DISSOLUTION OF LEVONORGESTREL BY ENHANCING ITS SOLUBILITY USING SOLID DISPERSION TECHNIQUE

344 16-05-2013 H-15 112050812016

SHAH MITUL HASMUKHBHAI 205


INVESTIGATION OF RISK BASED APPROACH FOR COMPRESSION COATED TABLET: A CASE STUDY ON ANTI-HYPERTENSIVE DRUG

345 16-05-2013 H-15 112050812017

PATEL VIKASKUMAR CHANDRAKANTBHAI 205


PROCESS OPTIMIZATION OF ARTIFICIAL TEAR FLUID OF CARMELLOSE SODIUM AS AN EYE DROPS

346 16-05-2013 H-15 112050812018

CHETTRI APPU KIRANKUMAR 205


FORMULATION, EVALUATION AND PROCESS OPTIMIZATION OF ORO-DISPERSIBLE TABLET OF LEVETIRACETAM

347 17-05-2013 H-02 112130803001

BHADANI NIKUNJKUMAR NARSHIBHAI 213


EVALUATION OF IMMUNOMODULATORY EFFECT OF BETA VULGARIS VAR. CONDITIVA (BEET ROOT)

Row ID Exam Date





348 17-05-2013 H-02 112130803002

MEHTA HARDIK DEVDATT 213


PHARMACOLOGICAL INVESTIGATION OF POLYHERBAL FORMULATION IN BENIGN PROSTATIC HYPERPLASIA

349 17-05-2013 H-02 112130803003

PATEL DARSHANKUMAR A 213


EXPERIMENTAL EVALUATION OF VORINOSTAT ON MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

350 17-05-2013 H-02 112130803004

JAGDEV ARVIND DEVIDAS 213


EVALUATION OF HEPATOPROTECTIVE EFFECT OF HIBISCUS ROSA SINENSIS LINN AGAINST PARACETAMOL INDUCED LIVER DAMAGE IN RATS

351 17-05-2013 H-02 112130803005

NAIK SHIVANGI NITINBHAI 213


EVALUATION OF NEUROPROTECTIVE EFFECT OF HIBISCUS ROSA SINENSIS LINN. ON ETHANOL INDUCED BEHAVIOURAL CHANGES IN RATS

352 17-05-2013 H-02 112130803006

KHUMAN SWETA KANJIBHAI 213


EXPERIMENTAL EVALUATION OF CALOTROPIS GIGANTEA IN GENTAMICIN- INDUCED NEPHROTOXICITY

353 17-05-2013 H-02 112130803009SHAH NIDHI A. 213


PHARMACOLOGICAL INVESTIGATION OF A POLYHERBAL FORMULATION IN HYPERLIPIDAEMIC RATS

354 17-05-2013 H-02 112130803011KANDACHIA JALAK M. 213


PHARMACOLOGICAL INVESTIGATION OF POLYHERBAL FORMULATIONS IN OSTEOPOROSIS

355 17-05-2013 H-02 112130803012

PATEL BHAVISHABEN S. 213


EFFECT OF HIBISCUS ROSA SINENSIS LINN ON PARACETAMOL- INDUCED RENAL DAMAGE IN RATS

356 17-05-2013 H-03 112130803014SHAH ANKUR VIJAYKUMAR 213


EVALUATION OF POLYHERBAL FORMULATION FOR ANTIULCER ACTIVITY AGAINST ETHANOL AND ACETIC ACID INDUCED GASTRIC ULCER IN RATS

357 17-05-2013 H-03 112130803015

PATEL DHRUV NARENDRABHAI 213


EXPERIMENTAL EVALUATION OF EZETIMIBE ON MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

358 17-05-2013 H-03 112130803016Jigme Wangmo 213


EVALUATION OF POLYHERBAL FORMULATIONS FOR DIGESTIVE AND ANTIULCER ACTIVITY

359 17-05-2013 H-03 112280803002PATEL RUCHI HARESH 228

L. M. COLLEGE OF PHARMACY, AHMEDABAD

Health related Quality of life in patients after Total knee replacement.

Row ID Exam Date





360 17-05-2013 H-03 112280803003

PATEL UNNATIBEN MUKESHBHAI 228


Evalution of guideline adherence by physicians for diagnosis and management of COPD.

361 17-05-2013 H-03 112280803004

ACHARYA SAGAR BHARATKUMAR 228


Evaluation of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Chemically Induced Cognitive Impairment in Mice

362 17-05-2013 H-03 112280803005

PATEL KHUSHBU RAMESHCHANDRA 228


A STUDY OF METFORMIN/GLIMEPIRIDE WITH TELMISARTAN IN DIABETIC PATIENTS SUFFERING FROM ISCHEMIC HEART DISEASE

363 17-05-2013 H-03 112280803006

LAKHANI JITENDRABHAI LALJIBHAI 228


A PROSPECTIVE STUDY OF NEWER ANTIDIABETIC DRUGS IN TYPE II DIABETIC PATIENTS WITH REFERENCE TO CARDIOVASCULAR RISK ASSESSMENT

364 17-05-2013 H-03 112280803007

PATEL BINALKUMARI VINUBHAI 228


A STUDY ON SAFETY OF TAMOXIFEN AND AROAMTASE INHIBITOR WITH SPECIAL REFERENCE TO VENOUS THROMBOSIS IN BREAST CANCER PATIENTS

365 17-05-2013 H-03 112280803008

MISTRY JINAL MUKESH 228


ANTIBIOTIC RESISTANCE IN GANDHINAGAR DISTRICT- A RETROSPECTIVE STUDY

366 17-05-2013 H-03 112280803009

PRAJAPATI BHUMIKABEN KANUBHAI 228


INVESTIGATION INTO VITAMIN D STATUS AND ASTHMA - A CLINICAL STUDY.

367 17-05-2013 H-03 112280803010

MEENA RATAN MANILAL 228


EVALUATION OF ANTIDIABETIC ACTIVITY OF AQUEOUS EXTRACT OF LEAVES AND ETHANOLIC EXTRACT OF SEEDS OF MORINGA OLEIFERA IN STREPTOZOTOCIN INCLUDED DIABETES IN RATS.

368 17-05-2013 H-04 112520807001

Upadhyay Manankumar R 252

SHRI B. M. SHAH COLLEGE OF PHARMACEUTICAL EDUCATION AND RESEARCH, MODASA

ANAYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF THEOPHYLLINE AND ETOFYLLINE IN COMBINED DOSAGE FORM.

Row ID Exam Date





369 17-05-2013 H-04 112520807002 Patel Rikita D 252


ANAYTICAL METHOD DEVELOPMENT &ANALYSIS OF VARIOUS API: LEVOFLOXACIN, STRONTIUM RANELATE, FLUTICASONE PROPIONATE.

370 17-05-2013 H-04 112520807003Prajapati nitin C. 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF THIOCOLCHICOSIDE AND DEXKETOPROFEN TROMETAMOL IN BULK AND COMBINED DOSAGE FORM

371 17-05-2013 H-04 112520807004Dalal Vaishali D 252


ANAYTICAL METHOD DEVELOPMENT &ANALYSIS OF VARIOUS API: RASAGILLIN MESYLATE, GEFITINIB, CINACALCET HYDROCHLORIDE.

372 17-05-2013 H-04 112520807005

Patel Sanjaykumar P 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SILDENAFIL CITRATE & FLUXETINE HCL IN TABLET DOSAGE FORM.

373 17-05-2013 H-04 112520807006

Patel Nileshkumar M 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN & ORNIDAZOLE IN SUSPENSION DOSAGE FORM.

374 17-05-2013 H-04 112520807007Patel Jigisha R 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ENALAPRIL MALEATE AND ROSUVASTATIN CALCIUM IN TABLET DOSAGE FORM.

375 17-05-2013 H-04 112520807009

Shah Nishitkumar J 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF LEVOFLOXACIN HEMIHYDRATE AND CEFIXIME TRIHYDRATE IN BULK AND COMBINED DOSAGE FORM.

Row ID Exam Date





376 17-05-2013 H-04 112520807010

Prajapati nikeshkumar A. 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DIAZEPAM & IMIPRAMINE HCL IN TABLET DOSAGE FORM.

377 17-05-2013 H-05 112520807011Patel Ravikumar B 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF CHLORZOXAZONE & DICLOFENAC SODIUM IN TABLET DOSAGE FORM.

378 17-05-2013 H-05 112520807012Patel Nimisha H 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF PENTOPRAZOL AND LEVOSULPRIDE IN BULK AND COMBINED DOSAGE FORM

379 17-05-2013 H-05 112520807013

Patel Divyangkumar A 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR EPERISONE HCL & DICLOFENAC SODIUM IN CAPSULE DOSAGE FORM.

380 17-05-2013 H-05 112520807014Solanki Hasmukh D 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CLOPIDOGREL & ROSUVASTATIN IN BULK DRUG AND IN COMBINED DOSAGE FORM.

381 17-05-2013 H-05 112520807015Trivedi Hardik K. 252


ANALYTICAL METHOD DEVELOPMENT & PHARMACEUTICAL ANALYSIS OF VARIOUS API: TOLVAPTAN, TELMISARTAN, PALIPERIDONE.

382 17-05-2013 H-05 112520807016

Patel kinjalkumar R 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC & TRAMADOL HCL IN TABLET DOSAGE FORM.

Row ID Exam Date





383 17-05-2013 H-05 112520807017 Soni Priya N 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF TAPENTADOL AND PARACETAMOL IN BULK AND COMBINED DOSAGE FORM.

384 17-05-2013 H-05 112520807018 Jani Nimesh 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF LAFUTIDIN AND DOMPERIDONE IN BULK AND COMBINED DOSAGE FORM.

385 17-05-2013 H-05 112520807019Panchal sanket H 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF METRONIDAZOLE & FURAZOLIDONE IN BULK AND COMBINED DOSAGE FORM

386 17-05-2013 H-07 112020814001

DADHANIYA CHANDANI CHANDULAL 202


Synthesis and Characterization of some new Thiadiazole derivative as Anti-Tubercular agents

387 17-05-2013 H-07 112020814002

RATHOD PRAVIN LAVJIBHAI 202


Design,Synthesis and screening of novel Benzimidazole derivatives as a PTP 1B Inhibitor

388 17-05-2013 H-07 112020814003

BHAYANI DHARATIBEN ASHOK 202


Synthesis and evaluation of some Phthalimide analogues as potential Anti-cancer agents

389 17-05-2013 H-07 112020814004

PATEL CHETAN MAHENDRABHAI 202


Synthesis and biological evaluation of 2-Arylsulfonylamino Benzothiazole analogues as Antidiabetic agents

Row ID Exam Date





390 17-05-2013 H-07 112020814005

THAKOR JAGRUTI RAJENDRASINH 202


SYNTHESIS AND BIOLOGICAL EVALUATION OF PIPERAZINE DERIVATIVES AS ANTHELMINTIC AGENTS

391 17-05-2013 H-07 112020814006

PRIYANKA NISHEETH DESAI 202


Design, Synthesis and Antimicrobial screening of some novel Heterocyclic compounds containing 1,3,4-Oxadiazol, Pyrazole and Quinoline as core moiety

392 17-05-2013 H-07 112020814007RAJA NIDHI SHASHIKANT 202


SYNTHESIS AND SCREENING OF QUINOXALINE DERIVATIVES AS PTP 1B INHIBITORS

393 17-05-2013 H-07 112020814008

POKAL UMESHKUMAR MULJIBHAI 202


SYNTHESIS AND EVALUATION OF NOVEL THIADIAZOLOPYRIMIDINE DERIVATIVES AS AN ANTI-CANCER AGENTS

394 17-05-2013 H-07 112020814009

GEDIYA SHWETA KAMLESHBHAI 202


Design, synthesis and evaluation of 2-amino-4-aryl-3-carboethoxy-4H-1-benzopyran derivatives as potential antihypertensive agents

395 17-05-2013 H-07 112020814010BORISHA ANKIT C 202


SYNTHESIS AND SCREENING OF NOVEL HYDANTOIN DERIVATIVES AS A PTP 1B INHIBITOR

396 17-05-2013 H-07 112020814011

THAKKAR SHWETA VASANTBHAI 202


SYNTHESIS & PHARMACOLOGICAL SCREENING OF NOVEL PHTHALIMIDE DERIVATIVE AS HUMAN PANCREATIC LIPASE INHIBITORS

Row ID Exam Date





397 17-05-2013 H-07 112020814012

DHOBI DARSHANKUMAR VINODBHAI 202


Synthesis and biological evaluation of Pyrazole-3-one derivatives as Anti-diabetic agents

398 17-05-2013 H-08 112020814013

PANDYA HARSHIL NILESHBHAI 202


Synthesis and evaluation of novel Bipyridine and Terpyridine derivatives as an antimicrobial agents

399 17-05-2013 H-08 112020814014DODIYA DHIREN B 202


Design, Synthesis and evaluation of some synthetic Flavone derivatives as Pencriatic Lipase Inhibitor to Treat Obesity

400 17-05-2013 H-08 112020814015

PATEL MITTAL KIRTIKUMAR 202


DESIGN, SYNTHESIS AND EVALUATION OF SOME NOVEL CHALCONE AND THEIR PYRAZOLE DERIVATIVES AS POTENTIAL ANTI-PSORIASIS AGENTS

401 17-05-2013 H-08 112020814016

PENDAL PALMI NAVINCHANDRA 202


Design, Synthesis and Biological screening of new Pyridazine derivatives as an Anti-inflammatory agents

402 17-05-2013 H-08 112020814017

CHAUDHRI MANOJKUMAR S 202


SYNTHESIS AND BIOLOGICAL EVALUATION OF COUMARIN DERIVATIVES AS ANTI-COAGULANT AGENTS

403 17-05-2013 H-08 112020814018

PRAJAPATI HARDIKKUMAR GIRDHARLAL 202


Synthesis and evaluation of novel Benzimidazole bearing 1,2,4-triazole derivatives for Anticancer activity

Row ID Exam Date





404 17-05-2013 H-08 112330801001

SHAH SAURABH SHAILESHBHAI 233

PARUL INSTITUTE OF PHARMACY, LIMDA

SYNTHESIS AND BRONCHODILATOR ACTIVITY OF TRICYCLIC QUINAZOLINONE DERIVATIVES.

405 17-05-2013 H-08 112330801002

YAGNIKKUMAR ASHVINBHAI PATEL 233


SYNTHESIS AND CHARACTERIZATION OF SUBSTITUTED BENZIMIDAZOLE AS ANTI-TUBERCULAR AGENT

406 17-05-2013 H-08 112330801003

PRAJAPATI PRASANT JAGDISHBHAI 233


SYNTHESIS OF NOVEL FLAVONES AS AROMATASE INHIBITORS IN BREAST CANCER TREATMENT

407 17-05-2013 H-08 112330801004

GAJJAR DHARTIBEN BHARATBHAI 233


SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL PYRAZOLE DERIVATIVES

408 17-05-2013 H-08 112330801005

PRAJAPATI CHIRAG RAMESHBHAI 233


QSAR STUDY AND SYNTHESIS OF PYRAZOLE DERIVATIVE AS ANTI-CANCER AGENT

409 17-05-2013 H-08 112330801006

DHOLARIYA ANKITA HARISHBHAI 233


DESIGN, SYNTHESIS AND BIOLOGICAL SCREENING OF NOVEL TRIAZINE DERIVATIVES

410 17-05-2013 H-09 112330801007

BHIMANI BHARGAV CHANDULAL 233


SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 3,5-DISUBSTITUTED ISOXAZOLE DERIVATIVES

411 17-05-2013 H-09 112330801008MODI ARJUN M 233


SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NEW CHALCONE-GEMINAL BISPHOSPHONIC ACIDS

412 17-05-2013 H-09 112330801009

KOTHARI REENA BHAGVANJI 233


SYNTHESIS AND BIOLOGICAL EVALUATION OF NITROGEN CONTAINED NOVEL HETEROCYCLIC MOIETIES AS PTP-1B INHIBITOR

413 17-05-2013 H-09 112330801010KAUR PRABHJOT K 233


SYNTHESIS, CHARACTERIZATION AND ANTI-INFLAMMATORY ACTIVITY OF OXICAM METAL COMPLEXES

Row ID Exam Date





414 17-05-2013 H-09 112330801011

PATEL PRATIKKUMAR SHAILESHBHAI 233


SYNTHESIS AND EVALUATION OF NEW 1,2,3,4-TETRAHYDROQUINOLONES AS ANTI-CANCER AGENT

415 17-05-2013 H-09 112330801012

KAKADIYA MEERABEN PRAPHULBHAI 233


SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF NEW 1-AMINO-INDANE DERIVATIVES

416 17-05-2013 H-09 112330801013

TRIVEDI AMITKUMAR N 233


SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES

417 17-05-2013 H-09 112330801014

DAVE MONIKA MAHENDRABHAI 233


SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF QUINAZOLINE DERIVATIVES.

418 17-05-2013 H-09 112330801015

PRAJAPATI PRIYANKABAHEN J 233


SYNTHESIS AND ANTIBACTERIAL SCREENING OF 2,3 DISUBSTITUTED THIAZOLIDIN - 4 - ONE DERIVATIVES

419 17-05-2013 H-09 112330801016PATEL MIRANG B 233


SYNTHESIS AND EVALUATION OF NEW THIAZOLIDINEDIONE AS AN ANTI-DIABETIC DRUG

420 17-05-2013 H-09 112330801017DESAI NISHA YOGESHBHAI 233


SYNTHESIS OF NEW PYRIDOQUINOXALINE AND CHALCONES DERIVATIVES AND THEIR BIOLOGICAL EVALUATION

421 17-05-2013 H-09 112330801018

VAGHASIYA ANKURKUMAR 233


SYNTHESIS OF NEW 2,3- DIHYDROQUINAZOLIN -4(3H)-ONE DERIVATIVES AND THEIR BIOLOGICAL EVALUATION.

422 17-05-2013 H-10 112390808001

FAROOQUI ZAKERA SANAULLAH 239


PREPARATION AND EVALUATION OF SUSTAINED RELEASE PELLETS OF PREGABALIN FOR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY.

Row ID Exam Date





423 17-05-2013 H-10 112390808002

KAPADIA MAYUR DILIPKUMAR 239


FORMULATION AND CHARACTERIZATION OF MULTIPARTICULATE COLON SPECIFIC DRUG DELIVERY OF ESOMEPRAZOLE AND CURCUMIN FOR TREATMENT OF ULCERATIVE COLITIS

424 17-05-2013 H-10 112390808003

SHAH MOHITKUMAR BHARATKUMAR 239


SOLID DISPERSION- A WAY TO ENHANCE WATER SOLUBILITY OF QUETIAPINE FUMARATE

425 17-05-2013 H-10 112390808004

BHAVSAR DHRUVESH KAMLESHBHAI 239


FORMULATION AND EVALUATION OF COLON TARGETED CELECOXIB PELLETS FOR TREATMENT OF COLON CANCER

426 17-05-2013 H-10 112390808005

PATEL ANKITA MANHARBHAI 239


DEVELOPMENT AND CHARACTERIZATION OF COMBINATION OF BUDESONIDE AND SALBUTAMOL SULPHATE NANOSUSPENSION FOR PULMONARY DELIVERY IN TREATMENT FOR ASTHAMA

427 17-05-2013 H-10 112390808006

PATEL HETALBEN DILIPBHAI 239


FORMULATION AND EVALUATION OF SOLID DISPERSION OF LANSOPRAZOLE TO ENHANCE WATER SOLUBILITY

428 17-05-2013 H-10 112390808007

PATEL YAMINI VIJAYBHAI 239


DESIGN AND EVALUATION OF BILAYER ENTERIC COATED TABLET OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN RECEPTOR BLOCKER

429 17-05-2013 H-10 112390808008

NAGAR BHANU JIVRAJBHAI 239


FORMULATION AND EVALUATION OF ORODISPERSIBLE LABETALOL TABLET FOR HYPERTENSIVE CRISES

430 17-05-2013 H-10 112390808009PATEL ANAND N 239


FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLET OF LOSARTAN

431 17-05-2013 H-10 112390808010DESAI HINAL PANKAJBHAI 239


DESIGN AND EVALUATION OF COLON SPECIFIC MULTIPARTICULATE SYSTEM CONTAINING ETODOLAC AND CURCUMIN FOR TREATMENT OF COLON CANCER

Row ID Exam Date





432 17-05-2013 H-11 112270810001

GOR TRUSHABEN KIRITKUMAR 227


FORMULATION AND DEVELOPMENT OF ANTI ASTHMATIC CHEWABLE TABLET.

433 17-05-2013 H-11 112270810002

PATEL ADITYAKUMAR SUBHASHCHANDRA 227


FORMULATION & EVALUATION OF MODIFIED RELEASED MULTIPARTICULATE DRUG DELIVERY SYSTEM FOR ACECLOFENAC AND SERRATIOPEPTIDASE

434 17-05-2013 H-11 112270810003PATEL BINAL VIKRAMBHAI 227


FORMULATION DEVELOPMENT AND OPTIMIZATION OF GASTRORETENTIVE MATRIX TABLET OF CAPTOPRIL.

435 17-05-2013 H-11 112270810004

HALANI KRISHNA SHAILESHKUMAR 227


FORMULATION, DEVELOPMENT, & EVALUATION OF DISPERSIBLE TABLET OF CEFPODOXIME PROXETIL.

436 17-05-2013 H-11 112840808002PATEL SHITAL S. 284

SMT. R. B. PATEL MAHILA PHARMACY COLLEGE, (ONLY FOR GIRLS), ATKOT

FORMULATION AND EVALUATION OF TOPICAL EMULGEL OF FLUCONAZOLE

437 17-05-2013 H-11 112840808004

PATEL PAYALBEN VINODBHAI 284


FORMULATION AND EVALUATION OF FLOATING BIOADHESIVE TABLET OF ZIDOVUDINE

438 17-05-2013 H-11 112840808005

PATEL FALGUNI ARUNBHAI 284


FORMULATION AND EVALUATION OF COLON TARGETED TABLET OF BALSALAZINE

439 17-05-2013 H-11 112840808008

JULASANA JEMI DINESHKUMAR 284


UTILIZATION OF VARIOUS TASTE MASKING APPROACHES FOR BITTER ANTIMALARIAL DRUG CHLOROQUINE

440 17-05-2013 H-11 112840808009

GHANDHI GOPI RAMESHBHAI 284


FORMULATION AND EVALUATION OF LIQUISOLID TABLET OF LABETALOL HYDROCHLORIDE

Row ID Exam Date





441 17-05-2013 H-11 112840808010

SOLANKI PRIYANKABEN MAHENDRASINH 284


FORMULATION AND EVALUATION OF TOPICAL SOFT GEL OF NITROGLYCERIN

442 17-05-2013 H-11 112840808011

KATBA MONIKA VITHTHALBHAI 284


FORMULATION AND EVALUATION OF NASAL IN SITU GEL OF SELEGILINE HYDROCHLORIDE

443 17-05-2013 H-12 112270810005

SHAH KHUSHBU KIRANKUMAR 227


FORMULATION AND DEVELOPMENT OF TASTE-MASKED MOUTH DISSOLVING TABLET OF CINNARIZINE HCL AND DOMPERIDONE MALEATE

444 17-05-2013 H-12 112270810006

PATEL ANIKET SOMABHAI 227


FORMULATION DEVELOPMENT, OPTIMIZATION AND EVALUATION OF PELLETS FILLED CAPSULE FOR THE COMBINATION THERAPY OF HYPERTENSION.

445 17-05-2013 H-12 112270810007

VAGHASIYA HARDIKKUMAR KALUBHAI 227


FORMULATION, OPTIMIZATION AND EVALUATION OF FLOATING BILAYER TABLET OF DILTIAZEM HYDROCHLORIDE.

446 17-05-2013 H-12 112270810008

RAMLAVAT MAHIPALSINH YOGENDRASINH 227


FORMULATION AND EVALUATION OF PROVESICULAR DRUG DELIVERY SYSTEM FOR FLURBIPROFEN

447 17-05-2013 H-12 112270810009

PATEL CHIRAG SHANKARBHAI 227


FORMULATION AND EVALUATION OF TASTE MASKED ORAL LIQUID PREPARATION OF ANTI-MIGRAINE AGENT

448 17-05-2013 H-12 112270810010

PATEL UTKARSH SHAILESHKUMAR 227


FORMULATION, EVALUATION AND OPTIMISATION OF PH INDUCED IN SITU OPHTHALMIC GEL FOR SUSTAINED DELIVERY OF ANTI INFLAMMATORY DRUG.

449 17-05-2013 H-12 112270810011

PRAJAPATI NISHITH DILIPBHAI 227


FORMULATION AND DEVELOPMENT OF FLOATING TABLET CONTAINING QUETIAPINE FUMARATE.

Row ID Exam Date





450 17-05-2013 H-12 112270810012

PATEL KUNAL KUMAR RAMANBHAI 227


SOLUBILITY ENHANCEMENT, FORMULATION AND EVALUATION OF TABLET CONTAINING AN ANTI-HYPERTENSIVE DRUG.

451 17-05-2013 H-12 112270810013

TULSI PRAMODBHAI PARIKH 227


PREPARATION AND EVALUATION OF COLON TARGETED DRUG DELIVERY SYSTEM USING COMBINE APPROACH OF PH & MICROBIAL TRIGGERED DRUG DELIVERY SYSTEM.

452 17-05-2013 H-12 112270810014

VESACHIYA DILEEPKUMAR BABUBHAI 227


FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF COLON DRUG DELIVERY SYSTEM OF VERAPAMIL PRESS COATED TABLET.

453 17-05-2013 H-12 112270810015

MISHRA DURGAVATI VACHASPATI 227


FORMULATION AND EVALUATION OF DELAYED RELEASE TABLET OF RABEPRAZOLE SODIUM.

454 17-05-2013 H-12 112270810016TARJANI K BHAVSAR 227


FORMULATION AND EVALUATION OF COLON TARGETED TABLET OF MEBENDAZOLE.

455 17-05-2013 H-13 112270810017

KHAMAR DISHA JAGDISHCHANDRA 227


FORMULATION, DEVELOPMENT AND AND OPTIMIZATION OF ANTIBIOTIC DISPERSIBLE TABLET

456 17-05-2013 H-13 112270810018

MODI MONALIBEN MANUBHAI 227


FORMULATION AND EVALUATION OF THE ANTIPSYCHOTIC BUCCAL TABLET

457 17-05-2013 H-13 112270810019MODI HALLY PINAKINBHAI 227


FORMULATION AND DEVELOPMENT OF IMMEDIATE RELEASE ONCE A DAILY ANTIHYPERTENSIVE TABLET.

458 17-05-2013 H-13 112270810020

PATEL DHARABEN MANILAL 227


FORMULATION AND EVALUTION OF SUBLINGUAL FILM FOR THE TREATMENT OF COLD AND SINUS

459 17-05-2013 H-13 112270810021

PANCHAL MITTAL ASHOKBHAI 227


FORMULATION, DEVELOPMENT, EVALUATION AND OPTIMIZATION OF ORODISPERSIBLE TABLET OF MALOXICAM.

Row ID Exam Date





460 17-05-2013 H-13 112270810022

PATEL SUHANI DINESHKUMAR 227


FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLE BASED GEL AS TOPICAL DRUG DELIVERY CONTAINING ANTIFUNGAL AGENT

461 17-05-2013 H-13 112270810023

SOLANKI NIRAV DIPAKKUMAR 227


FORMULATION AND EVALUATION OF ONCE A DAY BILAYER FLOATING TABLET OF ANTI-HYPERTENSIVE DRUG INVOLVING DISSOLUTION ENHANCEMENT APPROACH

462 17-05-2013 H-13 112270810024PATEL SETU DINESHBHAI 227


FORMULATION AND EVALUATION OF OCULAR NANOSUSPENSION FOR INFLAMMATORY EYE CONDITIONS.

463 17-05-2013 H-13 112270810025

SHAH NIDHI PRAKASHKUMAR 227


FORMULATION AND EVALUATION OF MICROEMULSION BASED TRANSDERMAL GEL OF ANTIFUNGAL DRUG

464 17-05-2013 H-13 112270810026

[ATEL NIKUNJKUMAR VITTHALBHAI 227


SOLUBILITY ENHANCEMENT OF AMIODARONE BY SOLID DISPERSION AND CYCLODEXTRIN COMPLEX.

465 17-05-2013 H-13 112270810027

PRAJAPATI NARAYANBHAI DEVJIBHAI 227


FORMULATION AND EVALUATION OF BILAYER FLOATING TABLETS OF SPASTICITY TREATING AGENT - BASED ON LOW DENSITY APPROACH

466 17-05-2013 H-13 112270810028

PANCHAL HITESH ASHOKKUMAR 227


FORMULATION, DEVELOPMENT AND OPTIMIZATION OF MUCOADHESIVE SUSTAINED RELEASE TABLET OF DRUG COMBINATION FOR THE TREATMENT OF PARKINSON’S DISEASE.

467 17-05-2013 H-14 112270810029

BRAHMABHAT JHHIL PRAKASHCHANDRA 227


FORMULATION AND EVALUATION OF BILAYER TABLET OF TELMISARTAN AND HYDROCHLOROTHIAZIDE

468 17-05-2013 H-14 112270810030

SAGAR CHIRAG TRIBHOVANDAS 227


FORMULATION AND EVALUATION OF BUCCAL TABLET OF ANTI-HYPERTENSIVE DRUG.

Row ID Exam Date





469 17-05-2013 H-14 112270810031

GANDHI DIVYABEN JAYENDRAKUMAR 227


STUDY ON SOLUBILITY ENHANCEMENT OF CLOPIDOGREL USING DIFFERENT APPROACHES

470 17-05-2013 H-14 112270810032

KATARA SAROJKUMAR S 227


FORMULATION AND EVALUATION OF PULSATILE TABLET FOR THE TREATMENT OF RHEUMATIOD ARTHRITIS.

471 17-05-2013 H-14 112270810033

SATHAVARA RAKESHKUMAR VALLABHBHAI 227


FORMULATION AND EVALUATION OF GASTRORETENTIVE DOSAGE FORM OF ANTIBIOTIC

472 17-05-2013 H-14 112270810034

PARMAR MIHIR KAMLESHBHAI 227


FORMULATION AND EVALUATION OF AN EMULGEL CONTAINING SILVER SULFADIAZINE FOR TOPICAL USE

473 17-05-2013 H-14 112270810037

CHANDANA SUHANGINI LALSINHBHAI 227


FORMULATION AND EVALUATION OF COLON TARGETED DRUG DELIVERY FOR ANTI-SPASMODIC DRUG.

474 17-05-2013 H-14 112270810038

TANK VIJAYKUMAR MANIKCHAND 227


FORMULATION AND OPTIMIZATION OF FIXED DOSE COMBINATION OF ORAL SOLID DOSAGE FORM FOR THE TREATMENT OF CARDIOVASCULAR DISEASE.

475 17-05-2013 H-14 112270810039

PRAJAPATI VIPULKUMAR BALDEVBHAI 227


FORMULATION AND EVALUATION OF FAST DISSOLVING DOSAGE FORM OF ANTI-HISTAMINIC DRUG

476 17-05-2013 H-14 112270810040SAPRA HANSABEN J 227


TO COMPARE THE DIFFERENT TECHNIQUES FOR THE PREPARATION OF MOUTH DISSOLVING TABLET USING LAMOTRIGINE AS A MODEL DRUG

477 17-05-2013 H-14 112270810041SHAH SHREY B 227


FORMULATION, DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE COMBINATION THERAPY FOR ARTHRITIS.

Row ID Exam Date





478 17-05-2013 H-14 112270810042

SHAH SAHILKUMAR CHANDULAL 227


FORMULATION AND EVALUATION OF BILAYER TABLET CONTAINING ANTI-DIABETIC AND LIPID LOWERING DRUG

479 17-05-2013 H-15 112270810043

PORIYA MANISHKUMAR DAHYABHAI 227


FORMULATION DEVELOPMENT AND CHARACTERIZATION OF LIDOCAINE HCL PRONIOSOMAL GEL FOR TOPICAL APPLICATION.

480 17-05-2013 H-15 112270810044PATEL POOJA M. 227


FORMULATION AND EVALUATION OF FLOATING TABLET OF GATIFLOXACIN AND FAMOTIDINE.

481 17-05-2013 H-15 112270810045

PATEL BHAUMIK VASUDEVBHAI 227


FORMULATION AND EVALUATION OF IN SITU FLOATING GEL OF ANTI-DIABETIC DRUGS.

482 17-05-2013 H-15 112270810046

PATEL ASHISHKUMAR GOVINDBHAI 227


FORMULATION AND EVALUATION OF GASTRO RETENTIVE MULTI-PARTICULATE SYSTEM OF ANTI-ULCER AGENT

483 17-05-2013 H-15 112270810047

DARJI HARDIK BABULAL 227


FORMULATION AND EVALUATION OF ANTIPSYCHOTIC EXTENDED RELEASE TABLET.

484 17-05-2013 H-15 112270810048

PATEL NIYANTKUMAR V 227


TO FORMULATE AND EVALUATE TASTE MASKED ORAL RECONSTITUTED SUSPENSION OF CIPROFLXACIN AND ORNIDAZOLE

485 17-05-2013 H-15 112270810049

PATEL HIMESH DINESHBHAI 227


FORMULATION AND EVALUATION OF MULTI-PARTICULATE FLOATING DRUG DELIVERY SYSTEM OF LEVOFLOXACIN HEMIHYDRATES

486 17-05-2013 H-15 112270810050

VAGHELA YUVRAJ RANUBHAI 227


FORMULATION AND EVALUATION OF FLOATING MATRIX DRUG DELIVERY SYSTEM FOR ARTHRITIS USING LORNOXICAM.

487 17-05-2013 H-15 112270810051

SAIYED FAZILKADIR MUSIBURREHMAN 227


FORMULATION AND EVALUATION OF BILAYER TABLET OF LORATADINE AND PSUEDOEPHEDRINE HCL.

Row ID Exam Date





488 17-05-2013 H-15 112270810052

PATEL ANKITKUMAR DASHRATHBHAI 227


FORMULATION AND EVALUATION OF BUCCAL DRUG DELIVERY SYSTEM CONTAINING GLYBURIDE WITH ENHANCED SOLUBILITY

489 17-05-2013 H-15 112270810053

PATEL MANISHA RAMESHBHAI 227


FORMULATION AND EVALUATION OF COLON TARGETED DRUG DELIVERY OF ORNIDAZOLE

490 17-05-2013 H-15 112270810054PATEL VISMAY J 227


DEVELOPMENT AND FORMULATE TASTE MASKED TABLET FOR ONDANSETRON HCL

491 18-05-2013 H-01 112450803001

PATEL CHARMI ARVINDKUMAR 245


EVALUATION OF CARDIOPROTECTIVE EFFECT OF JASMINUM GRANDIFLORUM LINN. ON EXPERIMENTALLY INDUCED MYOCARDIAL INFARCTION

492 18-05-2013 H-01 112450803002

KAKLOTAR MANOJKUMAR LAVJIBHAI 245


PHYTOPHARMACOLOGICAL EVALUATION OF MYRISTICA FRAGRANS HOUTT. SEED : ROLE IN HYPERTENSION

493 18-05-2013 H-01 112450803003PATEL GOPI ARVINDBHAI 245


EVALUATION OF ANTIULCEROGENIC POTENTIAL OF HYDROXYCHAVICOL EXTRACTED FROM PIPER BETLE LEAVES IN EXPERIMENTALLY INDUCED GASTRIC ULCERS IN RATS.

494 18-05-2013 H-01 112450803004

PATEL ANKITA MANOJBHAI 245


BIOEQUIVALENCE STUDY OF CANDESARTAN CILEXETIL (16 MG) PLUS HYDROCHLOROTHIAZIDE (12.5 MG) TABLET IN HEALTHY HUMAN VOLUNTEER UNDER FASTING CONDITION

495 18-05-2013 H-01 112450803005

PATEL HARSHIL PIYUSHBHAI 245


EVALUATION OF THE NEUROPROTECTIVE EFFECT OF POLY HERBAL FORMULATION ON ISCHEMIC RATS

496 18-05-2013 H-01 112450803006

JETHVA PRATIK KANTIBHAI 245


CORRELATION BETWEEN CLINICAL PRESENTATION AND TREATMENT PROTOCOL ON OUTCOME OF ACUTE LYMPHOBLASTIC LEUKEMIA AT TERTIARY CARE CENTER

Row ID Exam Date





497 18-05-2013 H-01 112450803007

SONI JALPABEN ASHOKBHAI 245


GENOTOXICITY OF FUROSEMIDE IN THE BONE MARROW AND GERM CELLS OF LABORATORY MICE

498 18-05-2013 H-01 112450803008PATEL JIGNA SHASHIKANT 245


GENOTOXICITY OF ALISKIREN IN THE BONE MARROW AND GERM CELLS OF LABORATORY MICE

499 18-05-2013 H-01 112450803009PATEL POOJA BABULAL 245


TO EVALUATE THE EFFECT OF VITAMIN B12 ON DNA DAMAGE INDUCED BY RIFAMPICIN

500 18-05-2013 H-01 112450803010

MODH SNEHA PRAVINCHANDRA 245


COMPARATIVE SAFETY AND EFFICACY STUDY OF THREE MARKETED POLYHERBAL FORMULATIONS AGAINST PARACETAMOL AND ANTITUBERCULAR DRUGS INDUCED HEPATOTOXICITY IN RAT

501 18-05-2013 H-01 112450803011

BRAHMBHATT BHAVIK BHARATBHAI 245


EVALUATION OF ANTI CONVULSANT ACTIVITY OF METHANOLIC EXTRACT OF LAGENARIA SICERARIA(MOL)STANDLY FRUIT ON SWISS ALBINO MICE

502 18-05-2013 H-01 112450803012

MODI TUSHAR BIPINCHANDRA 245


STUDY ON DRUG UTILIZATION PATTERN OF ANTI DIABETIC DRUGS IN SEMI URBAN AREA.

503 18-05-2013 H-03 112440803002

PATEL DIPEN RAJESHKUMAR 244

SARDAR PATEL COLLEGE OF PHARMACY, BAKROL

EVALUATION OF ANTIDIABETIC ACTIVITY OF COPTIS TEETA WALL. EXTRACT USING EXPERIMENTAL ANIMALS.

504 18-05-2013 H-03 112440803003

PATEL TUSHARKUMAR RAMESHBHAI 244


EVALUATION OF ANTINEPHROLITHIATIC ACTIVITY OF MALLOTUS PHILIPPINENSIS LINN. IN RATS.

511 18-05-2013 H-03 112440803006PATEL KHYATI M 244


SAFETY EVALUATION AND SIGNAL DETECTION OF VARIOUS CARDIOVASCULAR DRUGS.

512 18-05-2013 H-03 112440803010

Mayur Surendrakumar Patel 244


EVALUATION OF ANTIDIABETIC ACTIVITY OF PRUNUS DULCIS VAR. DULCIS ON EXPERIMENTALLY INDUCED DIABETIC ANIMALS.

Row ID Exam Date





513 18-05-2013 H-03 112440803011

Patel Hardik Shailendrabhai 244


EVALUATION OF THE EFFECT OF RHODODENDRON ARBOREUM EXTRACT ON BIOAVAILABILITY OF ISRADIPINE IN RATS.

514 18-05-2013 H-03 112440803016Patel Urvashi Kantibhai 244


EVALUATION OF THE EFFECT OF FUMARIA INDICA AGAINST EXPERIMENTALLY INDUCED ARTHRITIS.

505 18-05-2013 H-03 112450803013

SOLANKI AMIT DALABHAI 245


EVOLUTION OF CARDIOPROTECTIVE ACTIVITY OF DELONIX REGIA LEAF IN MYOCARDIAL INFARCTION.

506 18-05-2013 H-03 112450803014

DESAI MAHESHKUMAR MAGANBHAI 245


EVALUATION OF ANTI-DIABETIC POTENTIAL OF HYDROALCOHOLIC EXTRACT OF CORM OF AMORPHOPHALLUS CAMPANULATUS IN STREPTOZOTOCIN- NICOTINAMIDE INDUCED TYPE 2 DIABETIC RATS.

507 18-05-2013 H-03 112450803015

PATEL HIRALBEN BHARATBHAI 245


EVALUATION OF PROTECTIVE EFFECT OF METHANOLIC EXTRACT OF CATHARANTHUS ROSEUS LINN. ON CISPLATIN INDUCED NEPROTOXICITY IN RATS.

508 18-05-2013 H-03 112450803016

PATEL HIMANI HARSIDDHALAL 245


CARDIOPROTECTIVE EFFECT OF CUCUMIS SATIVUS LINN. FRUIT AGAINST ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION

509 18-05-2013 H-03 112450803017

MAKWANA GHANSHYAM P. 245


CLINICAL PRESENTATION AND TREATMENT PATTERN OF BREAST CANCER AT HEMATO ONCOLOGY CLINIC, AHMEDABAD

510 18-05-2013 H-03 112450803018

CHAUDHARY TEJAL DINESHBHAI 245


COMPARATIVE BIOAVAILABILITY STUDIES OF THREE DIFFERENT FORMULATIONS OF SILYMARIN

515 18-05-2013 H-04 112520804001

PATEL KHUSHBU RASIKBHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF NEWER ANTICANCER DRUGS IN BULK & PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





516 18-05-2013 H-04 112520804002

MEHTA KETULKUMAR DIPAKKUMAR 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTENOUS ESTIMATION OF ETHAMSYLATE AND TRANEXAMIC ACID IN TABLET DOSAGE FORM.

517 18-05-2013 H-04 112520804003

PANDYA VISHVABEN NIRANJANKUMAR 252


CLEANING VALIDATION OF EQUIPMENT USED IN MANUFACTURING OF PARENTERAL PHARMACEUTICAL INDUSTRY

518 18-05-2013 H-04 112520804004

PATEL JAYMINKUMAR BHIKHABHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF ILOPERIDONE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

519 18-05-2013 H-04 112520804005

SHARMA BHAUMIK AMRUTALAL 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MIFEPRISTONE IN BULK DRUG AND IN TABLET DOSAGE FORM

520 18-05-2013 H-04 112520804006

SHAH MAULIK KUMAR AJITKUMAR 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN OPTHALMIC DOSAGE FORM

521 18-05-2013 H-04 112520804007

CHAUDHARI PINKESHKUMAR BABUBHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF OLANZAPINE AND FLUOXETINE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

522 18-05-2013 H-04 112520804008

PATEL PRIYANKA VADIBHAI 252


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF GLIPIZIDE IN HUMAN PLASMA BY USING LIQUID CHROMATOGRAPHY – MASS SPECTROSCOPY [LC-MS/MS]

Row ID Exam Date





523 18-05-2013 H-04 112520804009

MAKWANA SNEH KANTIBHAI 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF NATEGLINIDE AND METFORMIN HYDROCHLORIDE IN TABLET DOSAGE FORM

524 18-05-2013 H-04 112520804010

NAYI SARASWATIBAHEN PRABHUDAS 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF THIOCOLCHICOSIDE AND ACECLOFENAC IN BULK AND PHARMACEUTICAL DOSAGE FORM

525 18-05-2013 H-04 112520804011

PATEL DHARAMSHIBHAI JETHABHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF SILDENAFIL AND DAPOXETINE IN BULK AND COMBINED DOSAGE FORM.

526 18-05-2013 H-04 112520804012

VASAVA HEMANTKUMAR RAJNIKANT 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TRIHEXYPHENIDYL HYDROCHLORIDE AND CHLORPROMAZINE HYDROCHLORIDE IN TABLET DOSAGE FORM

527 18-05-2013 H-05 112520804013

DAMOR ASMITABAHEN B. 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF ITOPRIDE HCL AND RABEPRAZOLE SODIUM IN CAPSULE DOSAGE FORM

528 18-05-2013 H-05 112520804014

PATEL NIKUNJKUMAR K. 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF HYDROCHLORTHAIZIDE AND LISINOPRIL IN BULK AND COMBINED DOSAGE FORM.

529 18-05-2013 H-05 112520804015

PATEL PINAKIN RAMESHCHANDRA 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF EZETIMIBE AND SIMVASTATIN IN TABLET DOSAGE FORM

Row ID Exam Date





530 18-05-2013 H-05 112520804016

SHAH PARTHKUMAR DIPAKBHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF ALPRAZOLAM AND SERTRALINE IN BULK AND COMBINED DOSAGE FORM.

531 18-05-2013 H-05 112520804017

CHAUDHARI RONAKKUMAR HARSHADBHAI 252


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MEFENAMIC ACID AND TIZANIDINE IN TABLET DOSAGE FORM

532 18-05-2013 H-05 112520804018

PATEL BHAVESHKUMAR DEVKARANBHAI 252


ANAYTICAL METHOD DEVELOPMENT AND VALIDATION OF NORFLOXACINE AND ORNIDAZOLE IN BULK AND COMBINED DOSAGE FORM.

533 18-05-2013 H-05 112660804001

SANDIP MUKESHBHAI GORASIYA 266

V. B. MANVAR PHARMACY COLLEGE, UPLETA

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC AND TRAMADOL HYDROCHLORIDE IN THEIR TABLET DOSAGE FORM.

534 18-05-2013 H-05 112660804002

MAHESHWARI VINODKUMAR VISHANDAS 266


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND CHLORZOXAZONE IN BULK AND TABLET DOSAGE FORM.

535 18-05-2013 H-05 112660804003

SANGANI JAYDEEP VALLABHBHAI 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ORNIDAZOLE AND MICONAZOLE IN THEIR TABLET DOSAGE FORM.

536 18-05-2013 H-05 112660804004DARSHNA PATEL 266


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC POTASSIUM AND FEBUXOSTAT IN BULK AND IN TABLET DOSAGE FORM.

Row ID Exam Date





537 18-05-2013 H-05 112660804005

PATEL SAURABHKUMAR DAHYABHAI 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR (1)SIMULTANEOUS SPECTROPHOTOMETRIC ESTIMATION OF VARDENAFIL AND DEPOXETINE HYDROCHLORIDE,(2)RP-HPLC ESTIMATION OF DEPOXETINE HYDROCHLORIDE IN THEIR TABLET DOSAGE FORM.

538 18-05-2013 H-05 112660804006

PATEL NITINKUMAR ARVINDBHAI 266


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FEXOFENADINE HYDROCHLORIDE IN HUMAN PLASMA BY USING LIQUID CHROMATOGRAPHY-MASS SPECTROSCOPY (LC-MS/MS)

539 18-05-2013 H-06 112660804007

BARAIYA RAHULKUMAR GHANSHYAMBHAI 266


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR AMOXICILLIN AND CALVULANATE POTASSIUM IN THEIR TABLET DOSAGE FORM BY RP-HPLC.

540 18-05-2013 H-06 112660804008

PATEL SUNILKUMAR BABUBHAI 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DONEPEZIL HYDROCHLORIDE AND MEMANTINE HYDROCHLORIDE IN THEIR TABLET DOSAGE FORM.

541 18-05-2013 H-06 112660804009

KAPADIYA ANILKUMAR D 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFPODOXIME PROXETIL AND LEVOFLOXACIN HEMIHYDRATE IN THEIR TABLET DOSAGE FORM.

542 18-05-2013 H-06 112660804010

RADADIYA RAKESHKUMAR BHIKHABHAI 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND LEVOFLOXACIN HEMIHYDRATE IN THEIR TABLET DOSAGE FORM.

543 18-05-2013 H-06 112660804011

BHUVA HARESHKUMAR H 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND TRAMADOL HYDROCHLORIDE IN BULK AND PHARMACEUTICAL FORMULATION.

Row ID Exam Date





544 18-05-2013 H-06 112660804012

MAVANI AMIT MAVJIBHAI 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF NAPROXEN AND PARACETAMOL IN THEIR TABLET DOSAGE FORM.

545 18-05-2013 H-06 112660804013

RAVAL HIMANSHU MAHENDRAKUMAR 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICYCLOMINE AND TRAMADOL HYDROCHLORIDE IN THEIR TABLET DOSAGE FORM.

546 18-05-2013 H-06 112660804014

RAMANUJ MITULKUMAR S 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF FURAZOLIDON AND TINIDAZOLE IN THEIR TABLET DOSAGE FORM.

547 18-05-2013 H-06 112660804015

PARMAR HITESHKUMAR MUKESHKUMAR 266


METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR ANTIDEPRESSANT DRUG IN TABLET DOSAGE FORM BY RP-HPLC.

548 18-05-2013 H-06 112660804016SOLANKI HITESH K 266


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF CEFADROXIL AND PROBENECID IN COMBINE SOLID DOSAGE FORM.

549 18-05-2013 H-06 112660804017

Tilva Komalben Jayantilal 266


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND LINEZOLIDE IN BULK AND IN TABLET DOSAGE FORM.

550 18-05-2013 H-06 112660804018

Kariya Naimishkumar Kishorbhai 266


SIMULTANEOUS ESTIMATION OF AZITHROMYCIN AND LEVOFLOXACIN HEMIHYDRATE IN TABLET DOSAGE FORM BY USING SPECTOPHOTOMETRIC AND RP-HPLC METHODS.

551 18-05-2013 H-07 112460801002

PATEL RITIXABEN CHANDRAKANT 246


DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF OXADIAZOLE DERIVATIVES AS ANTICONVULSANT AGENTS.

552 18-05-2013 H-07 112460801003PATEL RADHIKA H. 246


DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF QUINAZOLINONE DERIVATIVES AS ANTI INFLAMMATORY AGENTS.

Row ID Exam Date





553 18-05-2013 H-07 112500801002

POORNAMSH UMESHBHAI BUCH 250

SHREE H. N. SHUKLA INSTITUTE OF PHARMACEUTICAL EDUCATION & RESEARCH, RAJKOT

SYNTHESIS AND PHARMACOLOGICAL SCREENING OF SOME NOVEL PYRROLOPYRIMIDINES

554 18-05-2013 H-07 112500801003

PATEL PREKSHA VIJAYKUMAR 250


SYNTHESIS, PHARMACOLOGICAL AND ANTIMICROBIAL EVALUATION OF SOME NOVEL SUBSTITUTED PYRIMIDINE DERIVATIVES

555 18-05-2013 H-07 112500801004

PARASANIYA PRIYA AMRUTLAL 250


SYNTHESIS, PHARMACOLOGICAL AND ANTIMICROBIAL SCREENING OF SOME NOVEL DIHYDROPYRIMIDINES AND ITS PYRAZOLE DERIVATIVES

556 18-05-2013 H-07 112500801005

GODHANI PIYUSH BHIMJI 250


SYNTHESIS AND ANTIMICROBIAL EVALUATION OF SOME NOVEL BENZOTHIAZOLE DERIVATIVES

557 18-05-2013 H-07 112500801006DAVE SARTHAK B. 250


SYNTHESIS AND PHARMACOLOGICAL SCREENING OF SOME NOVEL 2-AMINOSUBSTITUTED-1,3,4-OXADIAZOLE DERIVATIVES

558 18-05-2013 H-07 112500801007

SAPARIYA PRAGNA CHANDULAL 250


SYNTHESIS OF SOME NOVEL DIHYDROPYRIMIDIN-6-ONE DERIVATIVES FOR ITS ANTIMICROBIAL ACTIVITY

559 18-05-2013 H-07 112500801008

DUNGRANI RAVIKUMAR BHAGVANBHAI 250


SYNTHESIS AND ANTIMICROBIAL EVALUATION OF SOME NOVEL BENZIMIDAZOLE DERIVATIVES

Row ID Exam Date





560 18-05-2013 H-07 112500801009

GANATRA PARTH VIRENDRA 250


SYNTHESIS OF SOME NOVEL THIOPHENE ANALOGUES FOR ANTIMICROBIAL SCREENING

561 18-05-2013 H-08 112260801001

PATEL SWATIBEN RAMESHCHANDRA 226

L.B.RAO INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH, KHAMBHAT

SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF SOME SUBSTITUTED BENZOTHIAZOLE DERIVATIVES OF BENZAMIDE

562 18-05-2013 H-08 112260801002

PRAJAPATI SONALBEN N. 226

L.B.RAO INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH, KHAMBHAT

SYNTHESIS AND PHARMACOLOGICAL SCREENING OF SOME SUBSTITUTED PYRAZOLONES

563 18-05-2013 H-08 112280801001

RATHORE DEEPAK SADASHIV 228


DESIGN,SYNTHESIS AND PHARMACIOLOGICAL SCREENING OF NEWER CASPASE-1 INHIBITORS AS POTENTIAL ANTI INFLAMMATORY AGENTS

564 18-05-2013 H-08 112280801002

GOYANI PARTHKUMAR BABULAL 228


SYNTHESIS OF SOME NOVEL QUINOLINE DERIVATIVES AS POTENTIAL ANTI BACTERIAL AGENTS

565 18-05-2013 H-08 112280801003

PATEL POONAMBEN BHARATBHAI 228


SYNTHESIS OF SOME NOVEL DIAZEPINE DERIVATIVES AS POTENTIAL BIOACTIVE AGENTS

566 18-05-2013 H-08 112280801004

SHINGALA DHAVAL MUKESHBHAI 228


DESIGN,SYNTHESIS AND SCREENING OF SOME NOVEL DPP-4 INHIBITORS - USING PHARMACOPHORE MODELING STUDY

567 18-05-2013 H-08 112280801005

PATEL RIDDHISIDDHIBEN ZAVERBHAI 228


SYNTHESIS AND ANTI BACTERIAL SCREENING OF SOME NOVEL ISOXAZOLE DERIVATIVES

568 18-05-2013 H-08 112280801006

PRAJAPATI BHADRESHKUMAR AMBALAL 228


LEAD MODIFICATION OF A SERIES OF MALANOMIDE DERIVATIVES AS A POTENTIAL ANTIINFLAMMATORY AGENTS.

Row ID Exam Date





570 18-05-2013 H-08 112280801008

RATHOD SUBODHINIBEN RAMANBHAI 228


1] SYNTHESIS OF VARIOUS S,S ACETAL USING WATER AS SOLVENT-A GREEN CHEMISTRY APPROACH AND 2] SYNTHESIS OF SOME NOVEL AZITIDINONE AS POTENTIAL ACYL CO ENZYME A ACYL TRANSFERASE INHIBITORS

571 18-05-2013 H-09 112070801001SHIVANI P PATEL 207

APMC COLLEGE OF PHARMACEUTICAL EDUCATION AND RESEARCH, HIMMATNAGAR

SYNTHETIC APPROACH TO TRIAZOLE AND TRIAZOLOTHIADIAZINE COMPRISING WITH IMIDAZOLE FOR THEIR ANTIMICROBIAL AND ANTI INFLAMMATORY ACTIVITY

572 18-05-2013 H-09 112070801002

RAVAL KISHORKUMAR N 207


SYNTHESIS AND EVALUATION OF ACTIVE MOLECULE OF TRIAZOLE ANALOGUES FOR THEIR ANTIMICROBIAL AND ANTICONVULSANT ACTIVITY

573 18-05-2013 H-09 112070801004

PATEL ASHWINKUMAR GORDHANDAS 207


SYNTHESIS, CHARACERIZATION AND BIOLOGICAL SCREENING OF FLUORO SUBSTITUTED BENZOTHIAZOLE COMPRISING WITH DIFFERENT HETEROCYCLIC MOLECULES.

574 18-05-2013 H-09 112070801005

PATEL KAUSHIKKUMAR S. 207


SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF NOVEL PYRIMIDINE DERIVATIVES VIA BIGINELLI REACTION FOR THEIR ANTIINFLAMMATORY AND ANTIMICROBIAL SPECTRUM

575 18-05-2013 H-09 112070801006

IPROLIYA SAMIRA MAHAMADKASIM 207


SYNTHESIS, STRUCTURE, CHARACTERIZATION, ANTIMICROBIAL AND ANTIINFLAMMATORY ACTIVITY OF SOME NEW DERIVATIVES OF QUINAZOLINE

576 18-05-2013 H-09 112200801001

PATEL SACHINKUMAR ANILBHAI 220

B. PHARMACY COLLEGE, RAMPURA KANKANPUR

SYNTHESIS, CHARACTERISATION AND ANTIMICROBIAL ACTIVITY OF NOVEL3,5- SUBSTITUTED NICOTINIC ACID DERIVATIVES.

577 18-05-2013 H-09 112200801002SHAH VISHAL ATULKUMAR 220


SYNTHESIS , CHARACTERISATION AND ANTI MICROBIAL ACTIVITY OF NOVEL SUBSTITUTED PURINE DERIVATIVES

Row ID Exam Date





578 18-05-2013 H-09 112200801003PATEL MEET H 220


SYNTHESIS , CHARACTERISATION AND ANTI MICROBIAL ACTIVITY OF NOVEL 2,5-DI SUBSTITUTED BENZOXAZOLE DERIVATIVES

579 18-05-2013 H-09 112200801005PATEL TUSHAR K. 220


SYNTHESIS , CHARACTERISATION AND ANTICONVULSANT ACTIVITY OF NOVEL SUBSTITUTED ISOXAZOLE DERIVATIVES

580 18-05-2013 H-09 112200801006

SISODYA BINALKUMARI BAHADURSINHJI 220


SYNTHESIS , CHARACTERISATION AND ANTI INTI MICROBIAL ACTIVITY OF NOVEL SUBSTITUTED ISOXAZOLE DERIVATIVES.

581 18-05-2013 H-09 112200801007

PATEL CHETANKUMAR DOLATRAY 220


SYNTHESIS , CHARACTERISATION AND ANTI INFLAMMATERY ACTIVITY OF NOVEL 1,5-DISUBSTITUTED INDOLE DERIVATIVES.

582 18-05-2013 H-09 112200801008

MNSURI AZAZ YASHINBHAI 220


SYNTHESIS , CHARACTERISATION AND ANTI DIABETIC ACTIVITY OF NOVEL 2-SUBSTITUTED INDOLE DERIVATIVES.

583 18-05-2013 H-10 112520808001

JOSHI PRANAV BHARATKUMAR 252


DESIGN AND DEVELOPMENT OF CARVEDILOL PHOSPHATE FLOATING MICROSPHERE

584 18-05-2013 H-10 112520808002

SONASANIYA BALVIR BHARATSINH 252


DESIGN AND DEVELOPMENT OF METHOTREXATE COLON TARGETED TABLET

585 18-05-2013 H-10 112520808003PATEL ANKIT KUMUDBHAI 252


DESIGN AND DEVELOPMENT OF ESOMEPRAZOLE MAGNESIUM SUSTAINED RELEASE TABLET

Row ID Exam Date





586 18-05-2013 H-10 112520808005

SUNDHIYA AKAR GIRISHBHAI 252


DESIGN AND DEVELOPMENT OF AZITHROMYCIN MICROCAPSULE SUSPENSION

587 18-05-2013 H-10 112520808006

SHAH RADHIKA SHAILESHKUMAR 252


DESIGN AND DEVELOPMENT OF METOPROLOL TARTRATE FLOATING MICROCAPSULES

588 18-05-2013 H-10 112520808007

SHAH MEGHA ANILKUMAR 252


DESIGN AND DEVELOPMENT OF ALFUZOSIN HCL FLOATING MICROSPHERES

589 18-05-2013 H-10 112520808008

MAJETHIYA KARANKUMAR ANILKUMAR 252


DESIGN AND DEVELOPMENT OF BACLOFEN FLOATING TABLET

590 18-05-2013 H-10 112520808009

PRAJAPATI MEHULKUMAR NARAYANBHAI 252


DESIGN AND DEVELOPMENT OF FEBUXOSTAT TOPICAL EMULGEL

591 18-05-2013 H-10 112520808010

PARMAR PRATIKKIMAR BABUBHAI 252


DESIGN AND DEVELOPMENT OF CEFIXIME PEDIATRIC DRY SYRUP

592 18-05-2013 H-10 112520808011

MENAT AGNESWARI KACHARABHAI 252


DESIGN AND DEVELOPMENT OF LAMOTRIGINE FAST DISSOLVING TABLET

Row ID Exam Date





593 18-05-2013 H-10 112520808012

MODI HIRENKUMAR GORDHANDAS 252


DESIGN AND DEVELOPMENT OF CO-PROCESSED METFORMIN HCL SUSTAINED RELEASE TABLET

594 18-05-2013 H-10 112520808013

PATEL JITENDRAKUMAR CHELABHAI 252


DESIGN AND DEVELOPMENT OF MONTELUKAST SODIUM FAST DISSOLVING FILM

595 18-05-2013 H-11 112520808014

PANDYA KETULKUMAR PRAMODCHANDRA 252


DESIGN AND DEVELOPMENT OF TELMISARTAN FAST DISSOLVING FILM

596 18-05-2013 H-11 112520808015

PRAJAPATI GHANSHYAM K. 252


DESIGN AND DEVELOPMENT OF CEFIXIME FLOATING TABLET

597 18-05-2013 H-11 112520808016

PATEL PRIYANK BHARATKUMAR 252


DESIGN AND DEVELOPMENT OF SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM OF CLOPIDOGREL BISULPHATE

598 18-05-2013 H-11 112520808017

DOSHI NIDHIBEN RAJENDRAKUMAR 252


DESIGN AND DEVELOPMENT OF AMOXICILLIN FLOATING IN SITU GEL

599 18-05-2013 H-11 112520808018

PATEL DHAVAL ATULKUMAR 252


DESIGN AND DEVELOPMENT OF SILDENAFIL CITRATE MOUTH DISSOLVING FILM

Row ID Exam Date





600 18-05-2013 H-11 112520808019PATEL SMITA D 252


DESIGN AND DEVELOPMENT OF SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM OF OLMESARTAN MEDOXOMIL

601 18-05-2013 H-12 112520812001

POKAR HITESHKUMAR GOVINDBHAI 252


FORMULATION AND IN VITRO EVALUATION OF LOSARTAN POTASSIUM FLOATING MICROSPHERE

602 18-05-2013 H-12 112520812002

PATEL SACHIN NARAYANBHAI 252


FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLET OF ANTIPSYCHOTIC DRUGS.

603 18-05-2013 H-12 112520812003

KAPADIYA ANKUR PRAVINCHANDRA 252


DESIGN AND DEVELOPMENT OF DICLOFENAC SODIUM LOADED CHITOSAN MICROSPHERE

604 18-05-2013 H-12 112520812004

DIVANI MEHULKUMAR JAYANTILAL 252


FORMULATION AND IN VITRO EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF LOSARTAN POTASSIUM

605 18-05-2013 H-12 112520812005

PATEL SUNILKUMAR SOMABHAI 252


ENHANCEMENT OF DISSOLUTION RATE AND MICROMERITIC PROPERTIES OF IBUPROFEN IN TABLET DOSAGE FORM

606 18-05-2013 H-12 112520812006BHOL ISMAIL M 252


FORMULATION AND IN VITRO EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF SUMATRIPTAN SUCCINATE

Row ID Exam Date





607 18-05-2013 H-12 112520812007PATEL NISHANT S. 252


DESIGN AND DEVELOPMENT OF CEFPODOXIME-PROXETIL DISPERSIBLE TABLET

608 18-05-2013 H-12 112520812009

PATEL RONAKKUMAR ASHOKKUMAR 252


DESIGN AND DEVELOPMENT OF ALFIZOSIN HCL FLOATING TABLET

609 18-05-2013 H-12 112520812010

PATEL MIHIRKUMAR BABULAL 252


DESIGN AND DEVELOPMENT OF ITOPRIDE HCL FLOATING TABLET

610 18-05-2013 H-12 112520812011

CHAUHAN PARTH HASMUKHLAL 252


DESIGN AND DEVELOPMENT OF KETOPROFEN FLOATING TABLET

611 18-05-2013 H-12 112520812013

DARJI RIKIKUMAR VISHNUKUMAR 252


FORMULATION AND EVALUATION OF TRAMADOL MATRIX TYPE TRANSDERMAL PATCH

612 18-05-2013 H-12 112520812014

MODI KUNAL HITENDRAKUNMAR 252


DESIGN AND DEVELOPMENT OF TIME DEPENDANT MONTELUKAST SODIUM TABLET

613 18-05-2013 H-12 112520812015PATEL MITESH G. 252


VALIDATION OF METFORMIN HCL ER TABLET IN NEW EQUIPMENT SETUP COMPRISED OF EQUIPMENT QUALIFICATION, AREA QUALIFICATION AND PROCESS VALIDATION

Row ID Exam Date





614 18-05-2013 H-13 112100808001SHAH AKASH KIRITKUMAR 210

ATMIYA INSTITUTE OF PHARMACY, RAJKOT

DEVELOPMENT OF CO-PROCESSED EXCIPIENT FOR FAST DISSOLVING TABLETS OF RACECADOTRIL BY MULTIVARIATE ANALYSIS AND EXPERIMENTAL DESIGN

615 18-05-2013 H-13 112100808002

RADADIA HARESHKUMAR NAGJIBHAI 210


DEVELOPMENT AND CHARACTRIZATION OF MICROEMULSION BASED GEL FOR TANSDERMAL DELIVERY OF LORNOXICAM

616 18-05-2013 H-13 112100808003

LADVA CHETAN MANSUKHBHAI 210


PREPARATION AND OPTIMIZATION OF SPHERICAL AGGLOMERATES OF IRBESARTAN BY PRINCIPAL COMPONENT ANALYSIS AND EXPERIMENTAL DESIGN

617 18-05-2013 H-13 112100808004

MANKAD ANKUR DHIRENBHAI 210


DESIGN AND EVALUATION OF MOUTH DISSOLVING FILM OF METHYLPHENIDATE HYDROCHLORIDE

618 18-05-2013 H-13 112100808005

GHODASARA MITESH VINODKUMAR 210


FORMULATION AND EVALUATION OF SPHERICAL CRYSTAL AGGLOMERATES OF CELECOXIB BY CRYSTALLO-CO-AGGLOMERATION

619 18-05-2013 H-13 112100808006

FULTARIYA DIPAK TRIBHOVANBHAI 210


FORMULATION AND EVALUATION OF FLOATING MATRIX TABLET OF CAPTOPRIL AND LOSARTAN POTASSIUM FOR TRATEMENT OF HYPERTENTION

620 18-05-2013 H-13 112100808007

VYAS KALYANI MAHENDRAKUMAR 210


FORMULATION AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM FOR TINIDAZOLE

621 18-05-2013 H-13 112100808008

JANI SAURABH YOGESHBHAI 210


DESIGN AND CHARACTERIZATION OF PRESS COATED TABLET FOR PULSATILE DELIVERY OF BISOPROLOL FUMARATE

622 18-05-2013 H-13 112100808009

VISHAL VINODRAY DOBARIYA 210


FORMULATION AND OPTIMIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF OLMESARTAN BY EXPERIMNETAL DESIGN

623 18-05-2013 H-13 112100808010

DUDHAT KIRANBEN RAMESHBHAI 210


DESIGN AND DEVELOPMENT OF BILAYER TABLETS OF ONDANSETRON HCL AND PENTOPRAZOLE NA FOR TARGETED DELIVERY

624 18-05-2013 H-13 112100808011

JINJANA HARESHBHAI NANABHAI 210


DEVELOPMENT OF EVALUATION OF MOUTH DISSOLVING FILM OF AMITRIPTYLINE HYDROCHLORIDE

Row ID Exam Date





625 18-05-2013 H-13 112100808012JIVANI PANKTI S. 210


DEVELOPMENT AND CHARACTERIZATION OF DULOXETINE HYDROCHLORIDE SOLID SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM FOR SOLUBILITY ENHANCEMENT

626 18-05-2013 H-14 112100808013

JAKASANIA PRATIK GHANSHYAMBHAI 210


DESIGN AND DEVELOPMENT OF FLOATING IN-SITU GEL OF PREGABALIN

627 18-05-2013 H-14 112100808014

RATHOD ASHISH JAYANTILAL 210


PREPARATION AND CHARACTERIZATION OF SWELLABLE POLYMER BASED INTERPENETRATING POLYMERIC NETWORK (IPN) HYDROGEL BEADS FOR MODIFIED RELEASE OF MONTELUKAST SODIUM

628 18-05-2013 H-14 112100808015

DHOLAKIYA ARPANA BHAILALBHAI 210


DESIGN AND DEVELOPMENT OF SELF NANOEMULSIFYING SYSTEMS OF HYDROCHLOROTHIAZIDE

629 18-05-2013 H-14 112100808016

AVIYA KETANKUMAR RATILAL 210


DEVELOPMENT AND CHARACTERIZATION OF MOUTH DISSOLVING TABLET OF PREDNISOLONE

630 18-05-2013 H-14 112100808017SUTARIYA JAYDEEP M. 210


DISSOLUTION ENHANCEMENT OF CANDESARTAN CILEXETIL BY LIQUISOLID COMPACTION

631 18-05-2013 H-14 112100808018

CHAUHAN SHEFALIBEN SHANTIBHAI 210


FORMULATION AND CHARACTERIZATION OF BILAYER TABLET OF DICYCLOMINE HYDROCHLORIDE AND MEFENAMIC ACID FOR COLON TARGETED DRUG DELIVERY

632 18-05-2013 H-14 112120808001

PANDYA JATINKUMAR BHARATBHAI 212

B. K. MODI GOVERMENT PHARMACY COLLEGE, RAJKOT

DEVELOPMENT AND EVALUATION OF TELMISARTAN LOADED SOLID LIPID NANOPARTICLES

633 18-05-2013 H-14 112120808002

PANJWANI MANISH FIROZBHAI 212


DEVELOPMENT AND CHARACTERISATION OF CLOFAZIMINE SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM

634 18-05-2013 H-14 112120808003

PATEL APEKSHA NAVINCHANDRA 212


DEVELOPMENT AND CHARACTERISATION OF FLOATING ZOLPIDEM TARTRATE SMART GEL

Row ID Exam Date





635 18-05-2013 H-14 112120808004

PATEL DHARMISTHABEN VRAJLAL 212


FORMULATION AND IN VITRO EVALUATION OF BILAYER MATRIX TABLET CONTAINING SUSTAINED RELEASE MONTELUKAST SODIUM AND IMMEDIATE RELEASE LEVOCETRIZINE DIHYDROCHLORIDE.

636 18-05-2013 H-14 112120808005

PATEL DHAVAL RAMESHBHAI 212


FORMULATION AND DEVELOPMENT OF ENVIRONMENTALLY RESPONSIVE OPHTHALMIC IN-SITU GEL FOR BRIMONIDINE TARTRATE

637 18-05-2013 H-14 112120808006

SAPRA PRAKASHKUMAR BHUPATBHAI 212


DEVELOPMENT AND OPTIMIZATION OF IN SITU PERIODONTAL GEL CONTAINING LEVOFLOXACIN FOR THE TREATMENT OF PERIODONTAL DISEASES

638 18-05-2013 H-15 112120808007

BHIMANI NIRAV BALKRUSHNA 212


FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF RALOXIFENE HYDROCHLORIDE

639 18-05-2013 H-15 112120808008

PANDYA NIRAVKUMAR ANILKUMAR 212


DEVELOPMENT AND EVALUATION OF COMPRESSION COATED VENLAFAXINE TABLET FOR ZERO ORDER RELEASE

640 18-05-2013 H-15 112120808009

CHAVDA VIVEK PRAKASHBHAI 212


DEVELOPMENT AND EVALUATION OF A NOVEL FLOATING-OSMOTIC CAPSULE FOR ZERO ORDER DELIVERY OF ZIDOVUDINE

641 18-05-2013 H-15 112120808010

RATHOD SWETA BHARATKUMAR 212


FORMULATION, DEVELOPMENT AND EVALUATION OF SUGAR COATED HYOSCINE BUTYL BROMIDE IMMEDIATE RELEASE TABLET

642 18-05-2013 H-15 112120808011

MEHTA MAUNITKUMAR BACHUBHAI 212


DEVELOPMENT AND CHARACTERIZATION OF DIACEREIN AND ACECLOFENAC PULSATILE RELEASE TABLET

643 18-05-2013 H-15 112120808012VALA HAMIR BHANBHAI 212


DEVELOPMENT AND EVALUATION OF PULSATILE RELEASE COATED TABLET OF CARVEDILOL

Row ID Exam Date





644 18-05-2013 H-15 112120808013

GURJAR RITESHKUMAR BALDEVBHAI 212


FORMULATION AND DEVELOPMENT OF MULTIFUNCTIONAL DIRECTLY COMPRESSIBLE COPROCESSED ORODISPERSIBLE EXCIPIENT

645 18-05-2013 H-15 112120808014

MAKWANA JALPABEN SUBODHBHAI 212


DEVELOPMENT AND OPTIMIZATION OF NANOCRYSTALS OF FELODIPINE

646 18-05-2013 H-15 112120808015

MASI MAHAMMADINYAT ABDULHAFIJ 212


FORMULATION AND EVALUATION CHITOSAN BASED THERMOSENSITIVE MOXIFLOXACIN SMART GEL FOR LOCAL PERIODONTAL DELIVERY

647 18-05-2013 H-15 112120808016

SANGADA DHAVALKUMAR RANGJIBHAI 212


PREPARATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC TABLET OF LAMIVUDINE

648 18-05-2013 H-15 112120808017

PATEL RUCHITA DEEPAK 212


DEVELOPMENT AND OPTIMIZATION OF MULTIFUNCTIONAL DIRECTLY COMPRESSIBLE CO-PROCESSED EXCIPIENTS USING MELT GRANULATION TECHNIQUE

649 18-05-2013 H-15 112120808018

BHABHOR GAURAV KAMLESHKUMAR 212


FORMULATION AND EVALUATION OF STOMACH SPECIFIC MUCOADHESIVE CHITOSAN BASED VALSARTAN MICROSPHERES BY SPRAY DRYING

650 20-05-2013 H-01 112230810002

MITALI HARISHBHAI PATEL 223

INDUKAKA IPCOWALA COLLEGE OF PHARMACY, NEW V.V.NAGAR

FORMULATION AND EVALUATION OF MUCOADHESIVE NANOEMULSION FOR INTRANASAL DELIVERY OF PSYCHOTROPIC DRUG

651 20-05-2013 H-01 112230810003

DAVE MANAN DHANESHBHAI 223


FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF LOSARTAN POTASSIUM

652 20-05-2013 H-01 112230810004BHAVIN G BHALANI 223


FORMULATION DESIGN AND EVALUATION OF FAST DISSOLVING TABLETS BY LYOPHILIZATION TECHNIQUE OF FEXOFENADINE HYDROCHLORIDE

Row ID Exam Date





653 20-05-2013 H-01 112230810005

PATEL KUNJAL RASIKLAL 223


DEVELOPMENT AND EVALUATION OF FLOATING IN SITU GELLING SYSTEM OF RANITIDINE HYDROCHLORIDE

654 20-05-2013 H-01 112230810006

GARDHARIA DARSHANA RAMESHBHAI 223


DESIGN AND DEVELOPMENT OF MUCOADHESIVE VAGINAL GEL OF ITRACONAZOLE

655 20-05-2013 H-01 112230810007

PATEL GAURAV CHATURBHAI 223


FORMULATION AND EVALUATION OF BILAYER TABLETS OF ARTESUNATE AND AMODIAQUINE HYDROCHLORIDE FOR THE TREATMENT OF UNCOMPLICATED P.FALCIPARUM MALARIA

656 20-05-2013 H-01 112230810009

PATEL SONAMBEN PRAFULBHAI 223


FORMULATION DESIGN AND EVALUATION OF COMPRESSION COATED TABLETS OF LORNOXICAM FOR CHRONOTHERAPEUTICTREATMENT OF RHEUMATOID ARTHRITIS

657 20-05-2013 H-01 112230810010

SORATHIYA UMESH KANTIBHAI 223


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF METFORMIN HYDROCHLORIDE

658 20-05-2013 H-01 112230810012

MODI PAREV PARESHKUMAR 223


DEVELOPMENT AND EVALUATION OF PH DEPENDENT INSITU OPTHALMIC GEL OF FLURBIPROFEN

659 20-05-2013 H-02 112230810013

MISTRY KARANKUMAR DIPAKKUMAR 223


FORMULATION AND EVALUATION OF MEDICATED TABLET LOZENGES OF AN ANTI TUSSIVE DRUG

660 20-05-2013 H-02 112230810014

NAGAR SWATI KHODABHAI 223


LIQUISOLID COMPACT: A NOVEL TECHNIQUE TO ENHANCE SOLUBILITY AND DISSOLUTION RATE OF OLMESARTAN MEDOXOMIL

Row ID Exam Date





661 20-05-2013 H-02 112230810015

LADAVA PRAFUL KARABHAI 223


DESIGN DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED RELEASE CAPSULES CONTAINING ANTIDIABETIC DRUG

662 20-05-2013 H-02 112230810016MODI KINJAL JAYESHBHAI 223


FORMULATION AND CHARACTERISATION OF KETOCONAZOLE PRONIOSOMAL GEL FOR TOPICAL APPLICATION

663 20-05-2013 H-02 112230810017

PATEL PRASHANTKUMAR J. 223


FORMULATION AND CHARACTERISATION OF FAST DISSOLVING FILM OF GRANISETRON HYDROCHLORIDE

664 20-05-2013 H-02 112230810018

PATEL KRISHNABEN GOPALBHAI 223


FAST DISSOLVING FILM OF PHENYLEPHRINE FOR PEDIATRIC USE

665 20-05-2013 H-02 112410808001

SONI DHARMESH SUDHIRANJANDAS 241


FORMULATION AND CHARACTERIZATION OF IN-SITU OPHTHALMIC GEL OF TOBRAMYCIN.

666 20-05-2013 H-02 112410808002

SHABHAI SAFWARA IDRIS 241


FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE MICROSPHERES OF CLINDAMYCIN PHOSPHATE FOR PERIODONTAL THERAPY.

667 20-05-2013 H-02 112410808003

PATEL HARSH ASHOKKUMAR 241


FORMULATION AND EVALUATION OF ISOTRETINOIN LOADED ETHOSOMAL GEL FOR IMPROVED TOPICAL DELIVERY SYSTEM

668 20-05-2013 H-02 112410808004

PATEL RAJANIKANT VISHNUBHAI 241


FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF ACYCLOVIR FOR THE TREATMENT OF OROFACIAL HERPES INFACTION.

Row ID Exam Date





669 20-05-2013 H-02 112410808005

VYAS BIJAL NAINESHBHAI 241


STABILITY ENHANCEMENT OF COMBINATION OF DIHYDROARTEMISININ AND PIPERAQUINE PHOSPHATE DRY SUSPENSION FOR THE EFFECTIVE TREATMENT OF MALARIA IN PAEDIATRICS

670 20-05-2013 H-02 112410808006

PRAJAPATI HITESHKUMAR BAKULBHAI 241


FORMULATION AND OPTIMIZATION OF IN SITU OPTHALMIC GEL OF ACYCLOVIR

671 20-05-2013 H-03 112410808007

MAKWANA SAMEEPKUMAR MAFATLAL 241


FORMULATION AND EVALUATION OF ELETRIPTAN HYDROBROMIDE SUBLINGUAL TABLETS FOR EFFECTIVE TREATMENT OF MIGRAINE

672 20-05-2013 H-03 112410808008

RAVAL KUSHALKUMAR YOGESHKUMAR 241


FORMULATION AND OPTIMIZATION OF ALBENDAZOLE SOLID LIPID NANOPARTICLE SUSPENSION

673 20-05-2013 H-03 112410808009

MALANI MUKESHKUMAR GOKALBHAI 241


FORMULATION AND EVALUATION OF INTRANASAL MICROEMULSION OF VALPROIC ACID

674 20-05-2013 H-03 112410808010

PATEL BHUMIKABEN SHANTILAL 241


FORMULATION AND OPTIMIZATION OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF CYCLOSPORINE

675 20-05-2013 H-03 112410808011PADHIAR MRUNALI M. 241


FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF AGOMELATINE.

676 20-05-2013 H-03 112410808012

SINDHA VIJAYKUMAR KHODSINH 241


FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE FOR INTRANASAL DELIVERY OF ROPINIROLE

Row ID Exam Date





677 20-05-2013 H-03 112410808013

VAGHELA VIJAYKUMAR L. 241


FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL FILMS OF PERINDOPRIL

678 20-05-2013 H-03 112410808014

PATEL ANKITKUMAR H 241


FORMULATION AND EVALAUTION OF SUSTAIN RELEASE TABLETS CONTAINING TAPENTADOL HCL

679 20-05-2013 H-03 112410808015

PATEL DARSHANKUMAR HARSHADBHAI 241


FORMULATION AND EVALUATION OF BILAYAR TABLETS OF TRAMADOL AND PARACETAMOL

680 20-05-2013 H-03 112410808016KAPATEL MRUGESH A 241


FORMULATION AND EVALUATION OF GASTRO RETENTIVE OF FLOATING IN-SITU GELLING SYSTEM OF GABAPENTIN.

681 20-05-2013 H-03 112410808017

VAHORA ANISHMAHAMAD NAZIRMAHAMAD 241


FORMULATION OF RIZATRIPTAN MICROEMULSION FOR INTRANASAL DRUG DELIVERY.

682 20-05-2013 H-03 112410808018

PATEL MONAL MUKESHBHAI 241


TO FORMULATE AND EVALUATE SUSTAIN RELEASE TABLET OF 4- AMINOPYRIDINE FOR MULTIPLE SCLEROSIS

688 20-05-2013 H-04 102500804010

DEVANI SANDIP JITENDRABHAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN HEMIHYDRATE AND CEFIXIME TRIHYDRATE IN ITS TABLET DOSAGE FORM

Row ID Exam Date





689 20-05-2013 H-04 112500804001

SHELIYA DHARMESH LAXMANBHAI 250


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SPECTROMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF OMEPRAZOLE MAGNESIUM AND DICYCLOMINE HYDROCHLORIDE IN COMBINED DOSAGE FORM

690 20-05-2013 H-04 112500804002

BHAYANI DEVANSHI HARESHKUMAR 250


PROCESS VALIDATION OF EBEDOL(PARACETAMOL, IBUPROFEN AND CAFFEINE) CAPSULE AND ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TAPENTADOL HYDROCHLORIDE AND PARACETAMOL IN COMBINED DOSAGE FORM

691 20-05-2013 H-04 112500804003

KADIVAR CHIRAG MANSHUKLAL 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CHLORTHALIDONE AND LOSARTAN POTASSIUM IN COMBINED ORAL DOSAGE FORM

692 20-05-2013 H-04 112500804004

GOSALIA MAULIK VINODRAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF KETOROLAC TROMETHAMINE AND OLOPATADINE HYDROCHLORIDE IN OPTHALMIC DOSAGE FORM

693 20-05-2013 H-04 112500804005

TRIVEDI DHARA BALVANTRAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND CHLORZOXAZONE IN SYNTHETIC MIXTURE

683 20-05-2013 H-04 112610804001

PARMAR HARDIK PRAVINSINH 261

SIGMA INSTITUTE OF PHARMACY, BAKROL

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND CHLORTHALIDONE IN BULK AND TABLET DOSAGE FORM

Row ID Exam Date





684 20-05-2013 H-04 112610804003NAIK MIRAL VIJAYBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND TRAMADOL HYDROCHLORIDE IN BULK AND SYNTHETIC MIXTURE

685 20-05-2013 H-04 112610804015

PATEL MADHAVI DILIPBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF VARDENAFIL AND DAPOXETINE HYDROCHLORIDE IN BULK AND COMBINED DOSAGE FORM

686 20-05-2013 H-04 112610804016

LAKHANI HARSH JAGDISHKUMAR 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DRUGS IN SOFT GELATIN CAPSULE (COUGH AND COLD PREPARATION)

687 20-05-2013 H-04 112610804017

PATEL MAYUR ARVINDBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE IN BULK AND COMBINED DOSAGE FORM

694 20-05-2013 H-05 112610804002

JOSHI KRISHNABEN ASHWINBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF GATIFLOXACIN AND LOTEPREEDNOL ETABONATE IN BULK AND COMBINED DOSAGE FORM

695 20-05-2013 H-05 112610804004

SHAH SHREYABEN RAJENDRAPRASAD 261


BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF "ALBENDAZOLE AND PRAZIQUANTEL" IN BULK AND ITS SYNTHETIC MIXTURE AND ITS SYNTHETIC MIXTURE BY HPLC/UV DETECTION :OPTIMIZATION OF THE METHOD

696 20-05-2013 H-05 112610804005

THUMMAR JAYESHKUMAR MAGANBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF RAMIPRIL AND CHLORTHALIDONE IN BULK AND COMBINED DOSAGE FORM

Row ID Exam Date





697 20-05-2013 H-05 112610804006

PATEL CHILKA RAMESHBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND GEFITINIB IN BULK AND SYNTHETIC MIXTURE

698 20-05-2013 H-05 112610804007

LAD BHAVINIBEN RAMESHBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND EPERISONE HCl IN BULK AND COMBINED DOSAGE FORM

699 20-05-2013 H-05 112610804008

NIRANJANI DHARABEN HARESHBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SULBACTUM AND MEROPENEM IN BULK AND COMBINED DOSAGE FORM

700 20-05-2013 H-05 112610804009

CHAUDHARI HETALKUMARI MANUBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND PANTOPRAZOLE SODIUM IN BULK AND COMBINED DOSAGE FORM

701 20-05-2013 H-05 112610804010

PARMAR ARVINDKUMAR VINODBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST AND EBASTINE IN BULK AND COMBINED DOSAGE FORM

702 20-05-2013 H-05 112610804011

CHAUDHARI FALGUNIKUMARI UDESINHBHAI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFUROXIME SODIUM AND POTASSIUM CLAVULANATE IN BULK AND COMBINED DOSAGE FORM

703 20-05-2013 H-05 112610804012

GOSWAMI KUNTAL PRAKASHGIRI 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LORNOXICAM AND EPERISONE IN BULK AND SYNTHETIC MIXTURE

Row ID Exam Date





704 20-05-2013 H-05 112610804013

PRAJAPATI NIRAV BABULAL 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SALICYLIC ACID AND BECLOMETHASONE DIPROPIONATE IN BULK AND COMBINED DOSAGE FORM

705 20-05-2013 H-05 112610804014DESAI KIRANGI B. 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SPARFLOXACIN AND DEXAMETHASONE IN BULK AND COMBINED DOSAGE FORM

706 20-05-2013 H-05 112610804018

SHITOLE PRATIK SUBHASHKUMAR 261


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DRUGS IN SOFT GELATIN CAPSULE (VAGINAL PESSARIES)

707 20-05-2013 H-06 112500804006

PATEL RIDDHAM NARESHBHAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ARTESUNATE AND MEFLOQUINE IN THEIR COMBINED SOLID ORAL DOSAGE FORM

708 20-05-2013 H-06 112500804007

DHAVANKUMAR PRAFULBHAI CHOTHANI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM IN SYNTHETIC MIXTURE

709 20-05-2013 H-06 112500804008

ODEDARA BHARATKUMAR DUDABHAI 250


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HCL & DEXAMETHASONE SODIUM PHOSPHATE IN OPHTHALMIC DOSAGE FORM

710 20-05-2013 H-06 112500804009

GOHIL PARTHRAJ DHARMENDRASINH 250


DEVELOPMENT & VALIDATION OF NEW ANALYTICAL METHODS FOR THE ESTIMAATION OF AMBROXOL HYDROCHLORIDE AND DOXYFYLLINE IN COMBINED DOSAGE FORM

Row ID Exam Date





711 20-05-2013 H-06 112500804010

BHOJAVANI ANIL GOPALDAS 250


METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF GATIFLOXACIN AND LOTEPREDNOL ETABONATE IN COMBINED DOSAGE FORM

712 20-05-2013 H-06 112500804011RATHOD JAYESH H 250


DEVELOPEMENT AND VALIDATION OF NEW ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF METRONIDAZOLE AND NALIDIXIC ACID IN ORAL-LIQUID DOSAGE FORM

713 20-05-2013 H-06 112500804012JINJALA HARESH E 250


DEVELOPEMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN COMBINED SOLID DOSAGE FORM

714 20-05-2013 H-06 112500804013KANJARIA DHARA S 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND OLOPATADINE HYDROCHLORIDE IN SYNTHETIC MIXTURE

715 20-05-2013 H-06 112500804014

VORA SANDIPKUMAR SURESHBHAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF TRAMADOL HCL AND PARACETAMOL IN COMBINED SOLID ORAL DOSAGE FORM

716 20-05-2013 H-06 112500804015

HINSU HARDIK MANSUKHLAL 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF EPERISONE AND DICLOFENAC IN THEIR COMBINED SOLID ORAL DOSAGE FORMS

717 20-05-2013 H-06 112500804016

GOTECHA NAKUL BHARATBHAI 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC AND THIOCOLCHICOSIDE IN COMBINED DOSAGE FORM.

Row ID Exam Date





718 20-05-2013 H-06 112500804017CHANGELA DILIP C 250


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR PANTOPRAZOLE AND LEVOSULPIRIDE IN PHARMACEUTICAL DOSAGE FORM.

719 20-05-2013 H-06 112500804018

VAGHASIYA AMISHKUMAR BABUBHAI 250


DEVELOPMENT AND VALIDATION OF NEW ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF MEROPENEM AND SULBACTAM IN PARENTRAL FOMULATION

720 20-05-2013 H-07 112450801001

PATEL KETULKUMAR MAHENDRABHAI 245


SYNTHESIS & BIOLOGICAL EVALUATION OF 2-AMINO,3-CARBOXAMIDE THIOPHENE DERIVATIVES.

721 20-05-2013 H-07 112450801002

JATAKIYA VIRAJ PARESHBHAI 245


SYNTHESIS OF N-SUBSTITUTED PIPERAZINE DERIVATIVES BY HIGHER GREENER SOLVENTS AND IT'S ANTI-MALARIAL ACTIVITY.

722 20-05-2013 H-07 112450801003

PRAJAPATI BHUMIKABEN KANUBHAI 245


DESIGN, SYNTHESIS AND BIOLOGICAL SCREENING OF SOME NOVEL BENZIMIDAZOLE DERIVATIVES.

723 20-05-2013 H-07 112450801004

PATEL NIKULKUMAR BHARATBHAI 245


SYNTHESIS AND BIOLOGICAL SCREENING OF N-[2-(5-BENZYLIDENE-2,4-DIOXOTHIAZOLIDIN-3-YL)-2-OXOETHYL)]BENZENSULFONAMIDE AND ITS DERIVATIVES AS ANTIDIABETIC AGENT

724 20-05-2013 H-07 112450801005

PATEL ANKITABEN DASHRATHLAL 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF 2H-CHROMENE DERIVATIVES.

725 20-05-2013 H-07 112450801006

PATEL ARPITA RAMESHKUMAR 245


DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME PYRAZOLE DERIVATIVES

Row ID Exam Date





726 20-05-2013 H-07 112450801007

PATEL NIRAJBHAI VISHNUBHAI 245


SYNTHESIS OF SUBSTITUTED 7-METHYL-2,8-DIHYDROPYRAZOLO [1,5-A] [1,3,5]TRIAZINE DERIVATIVES FOR ANTI INFLAMMATORY AND ANTI MICROBIAL SCREENING.

727 20-05-2013 H-07 112450801008PATEL ANKIT MOTILAL 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL THIAZOLO - AZETIDINONE DERIVATIVES.

728 20-05-2013 H-07 112450801009

BASVECHA ARCHANABEN BHARATKUMAR 245


SYTHESIS AND BIOLOGICAL EVALUATION OF 6,7,8,9-TETRAHYDRO-5H-THIAZOLO[2,3-B]QUINAZOLIN -3(2H)-ONE DERIVATIVES

729 20-05-2013 H-07 112450801010

CHAUDHRY PRATIKKUMAR RANCHODBHAI 245


COMPLEXATION : EFFECT OF METAL ON MICROBIOLOGICAL ACTIVITY OF SULFONAMIDE DERIVATIVES.

730 20-05-2013 H-07 112450801011

PRAJAPATI VAHAN GOVINDBHAI 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL SUBSTITUTED COUMARIN AND GUANIDINE DERIVATIVES.

731 20-05-2013 H-07 112450801012

CHAUDHARY BHARATKUMAR GANESHBHAI 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF DIHYDROPYRIDINE AS ANTIHYPERTENSIVE AGENTS.

732 20-05-2013 H-08 112270801002

AMIN BHAVNABEN NARSINHBHAI 227


SYNTHESIS OF SOME NOVEL 2, 4-DIHYDROPYRANO [2,3-C] PYRAZOLES AND PYRAZOLO[3,4-E] [1,2,4] TRIAZINES AS POTENT ANTIMICROBIAL AGENTS.

733 20-05-2013 H-08 112270801003

GAJERA KASHMEERABEN B 227


SYNTHESIS AND ANTIMICROBIAL SCREENING OF NOVEL 3-AMINO,2-CYONOCHROMENES AND BENZOCHROMENES.

734 20-05-2013 H-08 112270801004

PATEL DILIPKUMAR RAMESHBHAI 227


SYNTHESIS AND ANTIMICROBIAL EVALUATION 1H PYRAZOLO[3,4-D]PYRIMIDIN,6,(7H)-ONES AND 3,4,5,6-TETRAHYDRO BENZO (H) QUINAZOLIN 2-(1H) ONES AND THIONES.

Row ID Exam Date





735 20-05-2013 H-08 112450801013

CHAUDHARY BHARATKUMAR R 245


SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL ISATIN DERIVATIVES.

736 20-05-2013 H-08 112450801014

PATEL DHAVALKUMAR K. 245


SYNTHESIS AND SAR OF NOVEL AZETIDINONES AS ANTI MICROBIAL AGENTS.

737 20-05-2013 H-08 112450801015PATEL RINKU KANAIYALAL 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED OXAZOLIDINONE.

738 20-05-2013 H-08 112450801016

PATEL KARTIK RASIKLAL 245


SYNTHESIS, SAR AND ANTIMICROBIAL SCREENING OF POLY SUBSTITUTED PYRIMIDINE ANALOGUES

739 20-05-2013 H-08 112450801017

CHAUDHARY YATINKUMAR MAHENDRABHAI 245


SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL SUBSTITUTED THIAZOLE AND TRIAZOLE DERIVATIVES.

740 20-05-2013 H-08 112450801018

PATEL SUNILKUMAR JAYANTIBHAI 245


SYNTHESIS AND ANTIMICROBIAL SCREENING OF SOME NOVEL SUBSTITUTED OXADIAZOLE ANALOGUES.

741 20-05-2013 H-09 112270801005MORI MIRAL P 227


MULTICOMPONENT SYNTHESIS OF NOVEL 2,4-DIHYDRO-4(ARYL/HETEROARYL)PYRANO[2,3-C]PYRAZOLE DERIVATIVES AND EVALUATION OF ITS ANTIMICROBIAL ACTIVITY.

742 20-05-2013 H-09 112270801006PATEL PRATIK V 227


SYNTHESIS AND ANTIMICROBIAL SCREENING OF HETEROCYCLES DERIVED FROM 2-CHLORO-6-METHYL QUINOLINE CARBALDEHYDE.

743 20-05-2013 H-09 112270801007JAIN SANJYOT T 227


SYNTHESIS OF SOME 6-ALKOXY-3-ALKYL-4-ARYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBONITRILES AS ANTIMICROBIAL AGENT.

Row ID Exam Date





744 20-05-2013 H-09 112270801008PATEL SURAJ CHIMANBHAI 227


SYNTHESIS AND ANTIMICROBIAL EVALUATION OF NOVEL 1, 3-BIS (ARYL/ HETERO ARYL ) METHYL)-2-ARYL IMIDAZOLIDINES.

745 20-05-2013 H-09 112270801009PATEL DIPTI KIRTIKUMAR 227


SYNTHESIS AND CHARACTERISATION OF SOME NOVEL FORMAZANS OF BIOLOGICAL INTEREST.

746 20-05-2013 H-09 112270801010

PRAJAPATI NAISHADH NATUBHAI 227


SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF SOME NOVEL 2- ETHYL BENZIMIDAZOLES.

747 20-05-2013 H-09 112270801011

VYAS ADITYA DIVYANGKUMAR 227


SYNTHESIS CHARACTERISATION AND BIOLOGICAL EVALUATION OF SOME NOVEL GALLIC ACID DERIVATIVES.

748 20-05-2013 H-09 112270801012BHAYANI RAJUBHAI N 227


MOLECULAR DOCKING, SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF SOME NOVEL PYRAZOLOLONE DERIVATIVES.

749 20-05-2013 H-09 112270801013

PARMAR NEHAL PARIMAL 227


SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRIDO [2, 3-D;6,5-D1] DIPYRIMIDINES AND PYRIMIDO [4,5-B]QUINOLINE 2,4-DIONES.

750 20-05-2013 H-09 112270801014

GAJJAR KWISHA PRADEEP 227


SYNTHESIS AND EVALUATION OF SOME NOVEL ISOXAZOLE DERIVATIVES.

751 20-05-2013 H-09 112270801015

KUMBHANI SHAISHAVKUMAR GORDHANBHAI 227


SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL DIHYDRO-2H-THIAZOLO [3,2-A] PYRIMIDINES AND PYRAZOLO[3,4-D]PYRIMIDINE-6-THIONES.

752 20-05-2013 H-09 112270801016SHAH NIDHI MAYURBHAI 227


SYNTHESIS AND ANTI DIABETIC ACTIVITY OF SOME NOVEL CINNAMIC ACID DERIVATIVES.

753 20-05-2013 H-10 112660808001

SHAH UMANGKUMAR JITENDRABHAI 266


DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLET OF LABETALOL HYDROCHLORIDE.

Row ID Exam Date





754 20-05-2013 H-10 112660808002

PATEL PARTHKUMAR LILABHAI 266


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF AMLODIPINE BESYLATE

755 20-05-2013 H-10 112660808003

VYAS MAHARSHI MUKESHKUMAR 266


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF SIMVASTATIN.

756 20-05-2013 H-10 112660808004

CHHATRALA NIKUNJKUMAR RAMNIKBHAI 266


DEVELOPMENT AND EVALUATION OF SELF MICRO EMULSIFYING DRUG DELIVERY OF ATORVASTATIN.

757 20-05-2013 H-10 112660808005

GAJJAR ALPESH MAHESHBHAI 266


FORMULATION AND EVALUATION OF NIOSOMAL TRANSDERMAL DRUG DELIVERY SYSTEM OF NIFEDIPINE.

758 20-05-2013 H-10 112660808006

BHALODIYA MALAYKUMAR HASMUKHBHAI 266


FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF FENOFIBRATE

759 20-05-2013 H-10 112660808007

KUNDARIA MIHIR KRISHNAKANT 266


FORMULATION, DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF LOSARTAN POTASSIUM

760 20-05-2013 H-10 112660808009

JOSHI ATULKUMAR ARVINDBHAI 266


DESIGN, DEVELOPMENT AND EVALUATION OF GESTRORETENTIVE, SUSTAINED RELEASE DRUG DELIVERY SYSTEM OF LEVOFLOXACINE HEMIHYDRATATE

761 20-05-2013 H-10 112660808010

PANDYA PARTH JITENDRABHAI 266


DESIGN, DEVELOPMENT AND EVALUATION OF COMBINED SUCRALFATE & ONDANSETRON MUCOADHESIVE GEL

762 20-05-2013 H-10 112660808012SAIJA SAMIR JAMNADAS 266


FORMULATION AND EVALUATION OF CONTROLLED RELEASE FLOATING MICROSPHERE OF AMOXYCILLIN TRIHYDRATE

763 20-05-2013 H-10 112660808013

PATEL MAYANKKUMAR HEMCHANDBHAI 266


FORMULATION AND EVALUATION OF SUSTAIN RELEASE MATRIX TABLET OF FLURBIPROFEN

764 20-05-2013 H-11 112660808014

PATEL PIYUSHKUMAR DILIPKUMAR 266


DESIGN DEVELOPMENT AND EVALUATION OF COMBINED ORALLY ADMINISTERED JELLY OF SILDENAFIL CITRATE AND DAPOXETINE

Row ID Exam Date





765 20-05-2013 H-11 112660808015

ZALA SHIVRAJSINH DIGVIJAYSINH 266


FORMULATION AND EVALUATION OF FAST DISINTEGRATION TABLET OF CANDESARTAN CILEXETIL

766 20-05-2013 H-11 112660808016

MODHA ANANDKUMAR PRABHASHANKAR 266


DESIGN AND DEVELOPMENT OF MUCOADHESIVE BUCCAL DRUG DELIVERY SYSTEM OF ROPINIROLE HYDROCHLORIDE.

767 20-05-2013 H-11 112660808017

LANGALIA MAULIKKUMAR PRAKASHKUMAR 266


FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLET OF AMLODIPINE BESYLATE

768 20-05-2013 H-11 112660808018PATEL RITESH B. 266


FORMULATION AND EVALUATION OF CONTROLLED RELEASE MICROSPHERE OFTRAMADOL HYDROCHLORIDE

769 20-05-2013 H-11 112660808019

PATEL DIVYESHKUMAR HARIKISHANBHAI 266


FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC TABLET OF LEVETIRACETAM

770 20-05-2013 H-11 112660808020

PATEL KAUSHAL SURESHBHAI 266


DESIGN AND EVALUATION OF FAST DISINTEGRATING SUBLINGUAL TABLET OF TELMISARTAN.

771 20-05-2013 H-11 112660808021

PATEL RONAKKUMAR BHOGILAL 266


STUDIES ON DEVELOPMENT AND EVALUATION OF TOPICAL GEL OF METHOTREXATE

772 20-05-2013 H-11 112660808022

ADROJA MAYUR BALUBHAI 266


FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF ENALAPRIL MALEATE.

773 20-05-2013 H-11 112660808024

MANDAVIYA MAYURKUMAR MAGANLAL 266


DESIGN AND EVALUATION OF COLON TARGETTED DRUG DELIVERY SYSTEM OF LORNOXICAM.

774 20-05-2013 H-11 112660808025

MEHTA RUSHIKUMAR HARSHADBHAI 266


SOLUBILITY ENHANCEMENT OF CHLORZOXAZONE BY SOLID DISPERSION AND FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET

775 20-05-2013 H-11 112660808026

PARMAR HITESHKUMAR BHUPATSINH 266


DESIGN AND EVALUATION OF SUSTAINED RELEASE GASTRO RETENTIVE DRUG DELIVERY SYSTEM OF RAMIPRIL.

Row ID Exam Date





776 20-05-2013 H-12 112660808027RAVAL RAVINDRA J 266


DESIGN AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF MONTELUKAST SODIUM

777 20-05-2013 H-12 112660808028

GOPANI VIJAYKUMAR KISHORBHAI 266


FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLET OF LORNOXICAM.

778 20-05-2013 H-12 112660808029PATEL AKASH K 266


FORMULATION AND EVALUATION OF TRANSMUCOSAL BUCCAL TABLE OF GLIBENCLAMIDE

779 20-05-2013 H-12 112660808031PATEL NIKITA ASHOKBHAI 266


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF ASENAPINE MALEATE.

780 20-05-2013 H-12 112660808032PATEL NIRALI BHAGIRATH 266


FORMULATION AND EVALUATION OF MICRO EMULSION BASED TRANSDERMAL DRUG DELIVERY SYSTEM OF TRIAMCINOLONE ACETONIDE

781 20-05-2013 H-12 112660808033

PATEL AANIKAKUMARI ASHOKBHAI 266


FORMULATION AND EVALUATION OF CONTROLLED RELEASE OCCULAR NANOSUSPENSION OF SPARFLOXACIN.

782 20-05-2013 H-12 112660808034

TRIVEDI MOHITKUMAR SURESHCHANDRA 266


FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF OLMESARTAN MEDOXOMIL

783 20-05-2013 H-12 112660808035R RANISH PATEL 266


FORMULATION AND EVALUATION OF GASTRORETENTIVE BIOADHESIVE TABLET OF QUETIAPINE FUMARATE

784 20-05-2013 H-12 112660808036

Zalavadia Bansi Harsukhlal. 266


FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF ISO-SORBIDE MONONITRATE

785 20-05-2013 H-12 112660808037

Patel Dipenkumar Bharatbhai. 266


FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF ENALAPRIL MALEATE

786 20-05-2013 H-12 112660808038

Sukhadia Chiragkumar Rameshbhai. 266


FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF ENALAPRIL MALEATE.

Row ID Exam Date





787 20-05-2013 H-12 112660808039

Jadav Hareshkumar Vinodray 266


STUDIES ON SOLUBILITY AND DISSOLUTION ENHANCEMENT BY LIQUID SOLID TECHNIQUE AND DEVELOPMENT OF FAST DISSOLVING TABLET OF VALSARTAN.

788 20-05-2013 H-13 112630808001

VYAS MANAN PRAKASHKUMAR 263


DESIGN, DEVELOPMENT AND EVALUATION OF FAST DISSOLVING FILM OF DOXYLAMINE SUCCINATE

789 20-05-2013 H-13 112630808002

ROJAMALA DHARMESH MAGANBHAI 263


DESIGN, DEVELOPMENT AND EVALUATION OF ROPINIROLE HYDROCHLORIDE SUBLINGUAL TABLETS

790 20-05-2013 H-13 112630808003

AMRUTIYA FORAM DHIRUBHAI 263


DEVELOPMENT AND CHARACTERIZATION OF NOVEL FLOATING IN-SITU GELLING SYSTEM FOR STOMACH SPECIFIC DELIVERY OF LAFUTIDINE

791 20-05-2013 H-13 112630808004

DAVE PANKAJKUMAR BHARATBHAI 263


FORMULATION AND EVALUATION OF TERBUTALINE SULPHATE MOUTH DISSOLVING FILM.

792 20-05-2013 H-13 112630808005BHUT SANDEEP K. 263


FORMULATION DEVELOPMENT AND EVALUATION OF BILAYER TABLETS OF KETOPROFEN.

793 20-05-2013 H-13 112630808006BHALANI CHANDANI C. 263


DEVELOPMENT AND EVALUATION OF SUPERPOROUS HYDROGEL AS A GASTRORETENTIVE SYSTEM FOR FAMOTIDINE.

794 20-05-2013 H-13 112630808007DOSHI HARSHIL B. 263


FORMULATION AND EVALUATION OF LIPOSOMAL GEL CONTAINING TERBINAFINE HCL

795 20-05-2013 H-13 112630808008

PATEL PRAVINKUMAR JIVANBHAI 263


FORMULATION AND EVALUATION OF BILAYERED TABLETS CONTAINING MIGLITOL AS IMMIDEATE RELEASE AND METFORMIN AS SUSTAINED RELEASE.

Row ID Exam Date





796 20-05-2013 H-13 112630808009GAJERA BRINJU R 263


DESIGN AND EVALUATION OF PERIODONTAL FILMS CONTAINING SECNIDAZOLE.

797 20-05-2013 H-13 112630808010VAMJA RAVI SHANTILAL 263


FORMULATION AND EVALUATION OF COLON TARGETED TABLET OF PREDNISOLONE.

798 20-05-2013 H-13 112630808011

PATEL SUMANKUMAR K 263


FORMULATION AND EVALUATION OF SUBLINGUAL TABLET OF CHLORPROMAZINE HCL

799 20-05-2013 H-13 112630808012

SAVALIYA BIRJU MAHENDRABHAI 263


DESIGN AND EVALUATION OF MICONAZOLE NITRATE MICROSPONGE FOR TOPICAL DRUG DELIVERY SYSTEM.

800 20-05-2013 H-14 112450808001

KIRANKUMAR GANPAT RANGAPADIYA 245


FORMULATION & EVALUATION OF QUICK DISSOLVING STRIP OF HALOPERIDOL.

801 20-05-2013 H-14 112450808002

PATEL MANOJKUMAR VINODKUMAR 245


FORMULATION & EVALUATION OF SUBLINGUAL DOSAGE FORM OF ZOLMITRIPTAN.

802 20-05-2013 H-14 112450808003

SHAH PRIYANK MUKESHBHAI 245


FORMULATION & EVALUATION OF TASTE MASKED AZITHROMYCIN DIHYDRATE ORAL SUSPENSION.

803 20-05-2013 H-14 112450808004

PATEL GIRISHKUMAR RAMESHKUMAR 245


FORMULATION & EVALUATION OF FAST DISSOLVING STRIP OF FELODIPINE.

804 20-05-2013 H-14 112450808005

BULCHANDANI HITESH HIRALAL 245


FORMULATION & EVALUATION OF LIQUISOLID COMPACTS FOR OLMESARTAN MEDOXOMIL.

805 20-05-2013 H-14 112450808006P-ATEL BHUMIN M 245


FORMULATION AND EVALUATION OF PRONIOSOMAL TOPICAL GEL OF CELECOXIB

Row ID Exam Date





806 20-05-2013 H-14 112630808013

SOLANKI DEEPAK NANJIBHAI 263


DEVELOPMENT AND EVALUATION OF FLOATING STOMACH SPECIFIC IN-SITU GEL OF TIZANIDINE HYDROCHLORIDE

807 20-05-2013 H-14 112630808014

PARMAR BHARATBHAI KALUBHAI 263


FORMULATION AND EVALUATION OF PERPHENAZINE BUCCAL TABLETS

808 20-05-2013 H-14 112630808015

DESAI DHAVAL SATISHCHANDRA 263


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF EMULGEL CONTAINING BIFONAZOLE

809 20-05-2013 H-14 112630808016

GARAMBHA RAHULKUMAR N 263


FORMULATION, DEVELOPMENT AND EVALUATION OF BUCCAL FILM OF PIROXICAM

810 20-05-2013 H-14 112630808017MESURIYA BHARGAV B 263


DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE BILAYER TABLET CONTAINING TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM.

811 20-05-2013 H-14 112630808018BALDANIYA HARDIK R 263


DESIGN DEVELOPMENT AND EVALUATION OF BILAYER FLOATING TABLET OF TRAZODONE HCL

812 20-05-2013 H-15 112450808007

PATEL JIMIK CHETANKUMAR 245


FORMULATION AND EVALUATION OF TIZANIDINE HYDROCHLORIDE GASTRORETENTIVE AND DICLOFENAC POTASSIUM SUSTAINED RELEASE DUAL DRUG DELIVERY SYSTEM

813 20-05-2013 H-15 112450808008PATEL JAIMEEN S 245


PREPARATION AND CHARACTERIZATION OF SOLID SELF EMULSIFYING DRUG DELIVERY SYSTEM OF ISOTRETINOIN

814 20-05-2013 H-15 112450808009

DUMANIYA SURESHBHAI KHIMAJIBHAI 245


FORMULATION & EVALUATION OF SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM FOR EZETIMIBE

815 20-05-2013 H-15 112450808010

VISHWAKARMA BHARAT NARESHBHAI 245


FORMULATION & EVALUATION OF GASTRO-RETENTIVE DRUG DELIVERY SYSTEM OF FERROUS FUMARATE.

Row ID Exam Date





816 20-05-2013 H-15 112450808011

DABHI AJAYKUMAR NARANBHAI 245


FORMULATION AND CHARACTERIZATION OF SILYMARIN SPRAY DRIED DISPERSIONS

817 20-05-2013 H-15 112450808012

MAKWANA PRATIKKUMAR KANTILAL 245


DESIGN AND CHARACTERIZATION OF FLOATING TABLET OF ITOPRIDE HCL USING NATURAL POLYMERS

818 20-05-2013 H-15 112450808013

CHAVADA GORDHAN LALABHAI 245


FORMULATION & EVALUATION OF MUCOADHESIVE SUPER POROUS HYDROGEL BASED VAGINAL DRUG DELIVERY SYSTEM

819 20-05-2013 H-15 112450808014

BIRARI JIGNESHBHAI MULJIBHAI 245


FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF ROPINIROLE HYDROCHLORIDE

820 20-05-2013 H-15 112450808015CHAUDHRI MAULIK B 245


FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF TIZANIDINE HYDROCHLORIDE

821 20-05-2013 H-15 112450808016

PATEL KEYURKUMAR KANTILAL 245


DISSOLUTION ENHANCEMENT OF ROSUVASTATIN CALCIUM BY SOLID DISPERSION.

822 20-05-2013 H-15 112450808017

PATEL RAKESHKUMAR KANTILAL 245


FORMULATION AND EVALUATION OF SUSTAIN RELEASE MATRIX TABLETS OF THIOCOLCHICOSIDE

823 20-05-2013 H-15 112450808018

SOLANKI DARSHITKUMAR GIRISHKUMAR 245


FORMULATION & EVALUATION OF OPHTHALMIC IN-SITU GELLING DRUG DELIVERY SYSTEM OF BROMFENAC SODIUM.

824 21-05-2013 H-01 102400808019

PATEL KUNJAL PRAVINBHAI 240

B. S. PATEL PHARMACY COLLEGE, LINCH

PREPARATION AND EVALUATION OF GASTRORETENTIVE INDOMETHACIN MICROCAPSULE USING HPMC, CMC AND CAP POLYMERS

825 21-05-2013 H-01 112400808002

THAKAR BHAUMIK ASHOKKUMAR 240


FORMULATION AND EVALUATION OF ORO DISPERSIBLE TABLET OF NARATRIPTAN HYDROCHLORIDE BY USING DIFFERENT SUPERDISINTEGRANTS

Row ID Exam Date





826 21-05-2013 H-01 112400808003

SONI SHAILESHKUMAR JITENDRAKUMAR 240


FORMULATION, OPTIMIZATION AND EVALUATION OF DESLORATADINE RAPIDLY DISSOLVING FILM

827 21-05-2013 H-01 112400808004

SONI AMI MANOJKUMAR 240


FORMULATION, OPTIMIZATION AND EVALUATION OF MUCOADHESIVE BUCCAL PATCH OF DILTIAZEM HYDROCHLORIDE

828 21-05-2013 H-01 112400808005

PATEL KAMESHKUMAR VISABHAI 240


FORMULATION ,OPTIMIZATION AND EVALUATION OF FAST DISINTIGRATING TABLET CONTAINING CARVEDILOL

829 21-05-2013 H-01 112400808006

PATEL TARUNKUMAR VISHNUBHAI 240


FORMULATION, OPTIMIZATION AND EVALUATION OF BILAYER FLOATING TABLETS OF ATORVASTATIN CALCIUM AND DILTIAZEM HYDROCHLORIDE.

830 21-05-2013 H-01 112400808007

PANDYA DHARTIBEN PRAFULCHANDRA 240


TO STUDY IMPACT OF PROCESS PARAMETER ON SELECTED DRUG USING COMPACTION PROCESS

831 21-05-2013 H-01 112400808009

PATEL PURVIKKUMAR RAMJIBHAI 240


FORMULATION AND EVALUTION OF KETOPROFEN PULSATILE RELEASE TABLET.

832 21-05-2013 H-01 112400808010

THKKAR POOJA PRAVINCHANDRA 240


FORMULATION , OPTIMIZATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF VERAMPIL HYDROCHLORIDE

833 21-05-2013 H-01 112400808011

PRAJAPATI VIJAYKUMAR SHANKARBHAI 240


SOLUBILITY ENHANCEMENT OF IRBESARTAN BY DIFFERENT TECHNIQUES

834 21-05-2013 H-02 112400808012

RAVAL PRATIKKUMAR KANULAL 240


FORMULATION,OPTIMIZATION AND EVALUATION OF SUBLINGUAL FILM OF TERBUTALINE SULPHATE

835 21-05-2013 H-02 112400808013

CHAUDHARI MEGHANA JASHUBHAI 240


FORMULATION, OPTIMIZATION AND EVALUATION OF TRAMADOL HYDROCHLORIDE TRANSDERMAL PATCH

836 21-05-2013 H-02 112400808015

PATEL PRANAV RAMANBHAI 240


FORMULATION AND EVALUATION OF ORAL BILAYER TABLETS CONTAINING ANTIHYPERLIPIDEMIC AND ANTIHYPERGLYCEMIC DRUGS

837 21-05-2013 H-02 112400808016

PATEL VIBHAV ANILBHAI 240


FORMULATION,OPTIMIZATION AND EVALUTION OF LORNOXICAM PULSATILE RELEASE TABLET

Row ID Exam Date





838 21-05-2013 H-02 112400808017

MEHTA SHAYAN KASHYAPBHAI 240


FORMULATION AND EVALUATION OF ATORVASTATIN NANOSUSPENSION BY ANTI SOLVENT TECHNIQUE

839 21-05-2013 H-02 112400808018

PATEL BRIJESHKUMAR MAHENDRABHAI 240


FORMULATION AND EVALUATION OF REPAGLINIDE FLOATING TABLET

840 21-05-2013 H-02 112400810001

PATEL NIRMALABEN VISHNUBHAI 240


FORMULATION AND EVALUATION OF DISPERSIBLE TABLETS OF TRAMADOL HYDROCHLORIDE.

841 21-05-2013 H-02 112400810002

JAIN MAHAVIR DINESHKUMAR 240


DESIGN, DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE IMPLANT OF SELECTED ANTI-HYPERTENSIVE DRUG

842 21-05-2013 H-02 112400810003

VAGHELA ANKIT MAHENDRABHAI 240


FORMULATION AND EVALUATION OF TRILAYER IMMEDIATE RELEASE TABLETS FOR ANTIHYPERTENSIVE THERAPY.

843 21-05-2013 H-02 112400810004

GADHIYA PRAGNA GOVINDBHAI 240


DESIGN,OPTIMIZATION AND EVALUTION OF BUCCAL TABLET OF PROCHLORPERAZINE MALEATE

844 21-05-2013 H-02 112400810005

PATEL RAMILABEN DINESHKUMAR 240


TO STUDY EFFECT OF COMPACTION PROCESS ON TABLET FORMULATION OF SELECTED DRUG

845 21-05-2013 H-03 112400810006

PATEL AKASH DASHRATHBHAI 240


FORMULATION OPTIMIZATION AND EVALUATION OF FLOATING INSITU GEL OF CEPHALEXIN AS A STOMACH SPECIFIC DRUG DELIVERY SYSTEM

846 21-05-2013 H-03 112400810007

PATEL PRATIKKUMAR RAJESHBHAI 240


FORMULATION AND EVALUATION OF VENLAFAXINE HYDROCHLORIDE CONTROLLED RELEASE PELLETS BY EXTRUSION SPHERONIZATION TECHNIQUE

847 21-05-2013 H-03 112400810008

PATEL NISHABEN MUKUNDBHAI 240


FORMULATION ,OPTIMIZATION AND EVALUATION OF FLOATING BEADS OF CEFPODOXIME PROXETIL AS A STOMACH SPECIFIC DRUG DELIVERY SYSTEM.

Row ID Exam Date





848 21-05-2013 H-03 112400810009PATEL NIRAL PRAVINBHAI 240


FORMULATION, OPTIMIZATION AND EVALUATION OF BILAYER TABLET OF METOPROLOL TARTRATE

849 21-05-2013 H-03 112400810011LIMBACHIYA HARDIK D 240


PREPERATION AND EVALUATION OF SUSTAINED RELEASE PARENTRAL FORMULATION OF SELECTED ANTIHYPERTENSIVE DRUG

850 21-05-2013 H-03 112400810012

PRAJAPATI RAXITKUMAR JITENDRABHAI 240


FORMULATION, OPTIMIZATION AND EVALUATION OF ETODOLAC PULSATILE RELEASE TABLET

851 21-05-2013 H-03 112400810013DESAI NIRAV ISHWARBHAI 240


FORMULATION ,OPTIMIZATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF QUETIAPINE FUMARATE.

852 21-05-2013 H-03 112400810014

VORA MEHULKUMAR SHANTILAL 240


FORMULATION AND EVALUATION OF SOLID SELF-EMULSIFYING PELLETS OF CARVEDILOL BY EXTRUSION SPHERONIZATION TECHNOLOGY

853 21-05-2013 H-03 112400810015SHUKLA SOHAM M. 240


FORMULATION, OPTIMIZATION AND EVALUTION OF BILAYER IMMEDIATE RELEASE TABLETSOF TELMISARTAN AND AMLODIPINE BESYLATE

854 21-05-2013 H-03 112400810016PARMAR CHETNA K 240


FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF PROMETHAZINE HYDROCHLORIDE

855 21-05-2013 H-03 112400810017

SHAH NAITIKKUMAR Y. 240


FORMULATION ,OPTIMIZATION AND EVALUATION OF FLOATING TABLET OF ITOPRIDE HYDROCHLORIDE

856 21-05-2013 H-03 112400810018

PATEL MEGHANABEN BABUBHAI 240


IMPROVEMENT SOLUBILITY OF POORLY WATER SOLUBLE CELECOXIB FOR PARENTRAL BY USING HYDROTOPES AND CO-SOLVENTS

Row ID Exam Date





857 21-05-2013 H-04 112310804001

KHYATI NITINKUMAR BHAGDEV 231

N. R. VEKARIA INSTITUTE OF PHARMACY, JUNAGADH

SIMULTANEOUS ESTIMATION OF RANITIDINE HYDROCHLORIDE AND DOMPERIDONE IN PHARMACEUTICAL DOSAGE FORMS BY UV-SPECTROPHOTOMETRY AND RP-HPLC.

858 21-05-2013 H-04 112310804002

RABADIA PANKAJ JAMANBHAI 231


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CETIRIZINE DIHYDROCHLORIDE AND KETOTIFEN FUMARATE IN THEIR COMBINED MARKETED FORMULATION.

859 21-05-2013 H-04 112310804003

KHOKHAR VISHALKUMAR GANDALAL 231


DEVELOPMENT AND VALIDATION OF RP-HPLC AND SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF DOMPERIDONE AND FAMOTIDINE IN THEIR COMBINED DOSAGE FORM

860 21-05-2013 H-04 112310804004

SUVAGYA VIJAYKUMAR JAYANTILAL 231


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF CINITAPRIDE HYDROGEN TARTRATE AND RABEPRAZOLE SODIUM IN THEIR PHARMACEUTICAL DOSAGE FORM

861 21-05-2013 H-04 112310804005

NIRAVKUMAR VINODBHAI KAKKAD 231


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DEFLAZACORT AND TAMSULOSIN HYDROCHLORIDE IN THEIR COMBINED DOSAGE FORM

862 21-05-2013 H-04 112310804006

BHIMANI PUJABEN RAMNIKBHAI 231


DEVELOPMENT AND VALIDATION OF RP-HPLC AND SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF DROTAVERINE HYDROCHLORIDE AND DICLOFENAC POTASSIUM IN THEIR COMBINED DOSAGE FORM.

863 21-05-2013 H-04 112670807001CHAUHAN MEERA D 267


ESTIMATION OF PROCYCLIDINE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM-NEW APPROACH.

Row ID Exam Date





864 21-05-2013 H-04 112670807002

GOTHI DHAVALKUMAR M 267


NEWER APPROACH FOR ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULATANEOUS ESTIMATION OF DICLOFENAC SODIUM AND EPERISONE HYDROCHLORIDE.

865 21-05-2013 H-04 112670807003

PATEL PRIYANK BABUBHAI 267


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR RELATED SUBSTANCES AND UV METHOD FOR ASSAY OF ANTI-DEPRESSANT DRUG.

866 21-05-2013 H-05 112130804001

KHIRWADKAR MANSI TUSHAR 213


VALIDATION OF ANALYTICAL METHODS FOR THE FIXED DOSE COMBINATION OF DEX-KETOPROFEN TROMETAMOL & DICYCLOMIN HCl

867 21-05-2013 H-05 112130804002SHAH NISHITA S 213


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR COMBINATION OF PIRACETAM AND CITICOLINE SODIUM.

868 21-05-2013 H-05 112130804003

PANCHAL HARSH KANAIYALAL 213


QUALITY BY DESIGN APPROACH IN TABLET MANUFACTURING AND DOCUMENTATION IN PROCESS VALIDATION OF TABLETS

869 21-05-2013 H-05 112130804004

PATEL HIRALBEN MANUBHAI 213


DEVELOPMENT & VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF EPALRESTAT AND METHYLCOBALAMIN IN BULK & THEIR COMBINED DOSAGE FORM

870 21-05-2013 H-05 112130804005

PADALIYA HARDIK MANSHUKHBHAI 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND PAMABROM IN BULK AND PHARMACEUTICAL DOSAGE FORM

871 21-05-2013 H-05 112130804006

SANJAYSINH VIJAYSINH BHATI 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF EPERISONE HCL AND DICLOFENAC SODIUM IN BULK AND PHARMACEUTICAL DOSAGE FORM

872 21-05-2013 H-05 112170804001RASHMI LATTI 217

C.U. SHAH COLLEGE OF PHARMACY & RESEARCH, WADHWAN

SIMULTANEOUS ESTIMATION OF PARACETAMOL, CETRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE & DEXTROMETHORPHAN HYDROBROMIDE IN SOLID DOSAGE FORM BY HPLC

Row ID Exam Date





873 21-05-2013 H-05 112170804002SHETH DISHA DILIPKUMAR 217


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ANALYSIS OF PARACETAMOL AND PAMABROM IN ITS BULK AND COMBINED DOSAGE FORM

874 21-05-2013 H-05 112170804003VORA PRIYANKA P 217


STUDIES IN CONCURRENT PROCESS VALIDATION OF ACECLOFENAC (100MG) AND PARACETAMOL(500MG) TABLET DOSAGE FORM

875 21-05-2013 H-05 112170804004CHAUHAN SWATI R 217


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING SPECTROPHOTOMETRIC & HPLC METHODS FOR MESALAMINE & ITS SOLID DOSAGE FORM

876 21-05-2013 H-05 112170804005

SOLANKI NITINKUMAR VIRABHAI 217


DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF OFLOXACIN AND CEFIXIME TRIHYDRATE AND THEIR DEGRADATION PRODUCTS.

877 21-05-2013 H-05 112170804006

PESWANI MONIKA VIJAYKUMAR 217


ANALYTICAL METHOD VALIDATION FOR ASSAY AND RELATED SUBSTANCES BY HPLC OF CIPROFLOXACIN

878 21-05-2013 H-06 112130804007

BHARUCHA RINAL VINODCHANDRA 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS DETERMINATION OF MEROPENEM & SULBACTAM SODIUM IN COMBINED PHARMACEUTICAL DOSAGE FORM.

879 21-05-2013 H-06 112130804008

HINGU KOMALHIMATLAL 213


PROCESS VALIDATION OF TABLET DOSAGE FORM MANUFACTURING IN PHARMACEUTICAL INDUSTRY

880 21-05-2013 H-06 112130804009

GOHIL MANISHABEN HARIBHAI 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF VARDENAFIL IN BULK AND PHARMACEUTICAL DOSAGE FORM

881 21-05-2013 H-06 112130804010

PADHIYAR PRATIKKUMAR V 213


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ILAPRAZOL IN BULK AND PHARMACEUTICAL FORMULATION

Row ID Exam Date





882 21-05-2013 H-06 112130804011

PRAJAPATI HASMUKHBHAI NARBHERAM 213


METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF PIPERINE AND CURCUMINOIDS IN POLYHERBAL FORMULATION

883 21-05-2013 H-06 112130804012

PATEL MEHAKUMARI B 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF BROMFENAC SODIUM IN THE PHARMACEUTICAL FORMULATION.

884 21-05-2013 H-06 112130804013

PATEL VANDITAKUMARI AMRUTBHAI 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CARISOPRODOL AND ASPIRIN IN BULK AND PHARMACEUTICAL DOSAGE FORM

885 21-05-2013 H-06 112130804014PATEL BHOOMI P. 213


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR THE DETERMINATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE IN TABLET DOSAGE FORM

886 21-05-2013 H-06 112130804015

VAGHELA NIKITA HITENDRASINH 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF SALBUTAMOL SULPHATE, AMBROXOL HCL AND DEXTROMETHORPHAN HBR IN COMBINED PHARMACEUTICAL DOSAGE FORM.

887 21-05-2013 H-06 112130804016

MUNJAPARA ASHVINKUMAR H 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN COMBINED PHARMACEUTICAL FORMULATION

888 21-05-2013 H-06 112130804017KACHHADIYA KRUTIBEN P. 213


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND LEVOFLOXACIN HEMIHYDRATE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

889 21-05-2013 H-06 112130804018PATEL NISANG U. 213


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THREE DRUG COMBINATION IN TABLET DOSAGE FORM.

Row ID Exam Date





890 21-05-2013 H-07 112310804007KANTARIYA BHUMI D 231


ANALYTICAL METHOD DEVELOPMENT FOR ESTIMATION OF RANITIDINE HYDROCHLORIDE AND DICYCLOMINE HYDROCHLORIDE IN THEIR PHARMACEUTICAL DOSAGE FORM.

891 21-05-2013 H-07 112310804008

DHADUK SANDIPBHAI DHIRUBHAI 231


DEVELOPMENT OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FAMOTIDINE AND IBUPROFEN IN FIXED DOSE COMBINATION.

892 21-05-2013 H-07 112310804009

PANSARA VASUNDHARA H 231


DEVELOPMENT AND VALIDATION OF RP-HPLC AND SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF NAPROXEN AND PARACETAMOL IN THEIR COMBINED SOLID DOSAGE FORM.

893 21-05-2013 H-07 112310804010

GHETIA URJA HARSUKHBHAI 231


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE AND PARACETAMOL IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM.

894 21-05-2013 H-07 112310804011

YADAV MILINDKUMAR VINAYKUMAR 231


DEVELOPMENT OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF KETOTIFEN FUMARATE AND SALBUTAMOL SULPHATE IN COMBINED DOSAGE FORM.

895 21-05-2013 H-07 112310804013

PATEL HARSHKUMAR RASIKLAL 231


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BETAHISTINE DIHYDROCHLORIDE AND DOMPERIDONE IN THEIR COMBINED DOSAGE FORM

896 21-05-2013 H-07 112310804014

PRAJAPATI MITESH NATVARLAL 231


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR QUANTITATIVE ESTIMATION OF RACECADOTRIL AND OFLOXACIN BY RP-HPLC'

897 21-05-2013 H-07 112310804016

VAGHASHIYA AMITKUMAR ARVINDBHAI 231


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND PAMABROM IN THEIR COMBINED DOSAGE FORM

Row ID Exam Date





898 21-05-2013 H-07 112310804017KANERIYA RAVI V. 231


ANALYTICAL METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST AND ACEBROPHYLLINE IN THEIR PHARMACEUTICAL DOSAGE FORM.

899 21-05-2013 H-07 112310804018

HEDPARA ROSHNI JAMNADAS 231


ANALYTICAL METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND DICYCLOMINE HYDROCHLORIDE IN THEIR PHARMACEUTICAL DOSAGE FORM

900 21-05-2013 H-08 112540801001

GANDHI DEHAL ASHOKKUMAR 254


SYNTHESIS OF NEW2-(4-TERT BUTYLARYL) SUBSTITUTED DIARYL 5-IMIDAZOLE[2,1-B][1,3,4] THIADIAZOLE DERIVATIVES AS POTENCIAL ANTICANCER AGENTS

901 21-05-2013 H-08 112540801002

LAKHANI PIYUSHKUMAR M 254


SYNTHESIS OF NEW TRISUBSTITUTED IMIDAZO [2,1-B][1,3,4] THIADIAZOLE DERIVETIVES AS POTENCIAL ANTICANCER AGENTS

902 21-05-2013 H-08 112540801003

RANA SHEETAL DIPAKBHAI 254


SYNTHESIS OF NEW “2-AMINO-1,3-BENZOTHIAZOLE DERIVATIVES” AS POTENTIAL ANTI - CANCER AGENTS

903 21-05-2013 H-08 112540801004

THUMMAR PRAGNESH PRAVINBHAI 254


SYNTHESIS OF NEW NAPTHALIC ANHYDRIDE DERIVATIVES AS POTENCIAL ANTICANCER AGENTS

904 21-05-2013 H-08 112540801005

DESAI SHIVALIBEN BHARATBHAI 254


SYNTHESIS OF NEW DIARYLIMIDAZO [2,1-B][1,3,4] THIADIAZOLE DERIVETIVES AS POTENCIAL ANTICANCER AGENTS

905 21-05-2013 H-08 112540801006

PATEL BHOOMIBEN RAMESHBHAI 254


SYNTHESIS OF NEW COUMARIN DERIVETIVES AS POTENCIAL ANTICANCER AGENTS

906 21-05-2013 H-08 112540801007PATEL KRUTI B. 254


SYNTHESIS OF NEW 4-N-SUBSTITUTED QUINAZOLINE DERIVETIVES AS POTENCIAL ANTICANCER AGENTS

Row ID Exam Date





907 21-05-2013 H-08 112540801008

PATEL VIDHIBEN GIRISHBHAI 254


SYNTHESIS OF NEW 2,4-DIAMINO PYRIMIDINE DERIVETIVES AS POTENCIAL ANTICANCER AGENTS

908 21-05-2013 H-08 112540801009

SHAH MANSI RAJENDRAKUMAR 254


SYNTHESIS OF NEW PYRAZOLE DERIVATIVE AS POTENTIAL ANTI-CANCER AGENTS

909 21-05-2013 H-09 112170804008

MANDLI DIPEEKA KANTILAL 217


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND STABILITY INDICATING HPLC METHOD FOR AMLODIPINE AND TELMISARTAN IN SOLID DOSAGE FORM

910 21-05-2013 H-09 112170804009

PATEL DHARMINKUMAR AMRUTBHAI 217


DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PENTOPRAZOLE SODIUM AND LEVOSULPRIDE IN PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD

911 21-05-2013 H-09 112170804010

MEHTA KAVITA PRAKESHKUMAR 217


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BETAMETHASONE VALERATE AND NEOMYCIN SULPHATE IN PHARMACEUTICAL DOSAGE FORM.

912 21-05-2013 H-09 112170804011

PATEL SHILPA GHANSHYAMBHAI 217


BIOEQUIVALANCE STUDY OF CYPROTERON ACETATE AND ETHINYLESTRADIOL TABLET USING LCMS/MS IN NORMAL, HEALTHY ADULT FEMALE UNDER FASTING CONDITION

913 21-05-2013 H-09 112170804012

PARMAR KAMLESH LALJIBHAI 217


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN TABLET DOSAGE FORM.

914 21-05-2013 H-09 112170804013

DASADIYA DHARTI DILIPBHAI 217


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ARMODAFINIL IN BULK AND PHARMACEUTICAL FORMULATION

915 21-05-2013 H-09 112170804014

PADHIYAR HETALBEN NANUBHAI 217


STUDY ON CONCURRENT PROCESS VALIDATION OF RABEPRAZOLE SODIUM TABLET

Row ID Exam Date





916 21-05-2013 H-09 112170804015

PATEL BHAVIKBHAI A 217


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ANALYSIS OF CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDRBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE IN ITS SYRUP FORMULATION

917 21-05-2013 H-09 112170804016

RAO BHUPENDRASINH M 217


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND TAPENTADOL HYDROCHLORIDE IN THEIR COMBINED DOSAGE FORM

918 21-05-2013 H-09 112170804017SHAH HIMANSHI K. 217


DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ANTIHYPERLIPIDEMIC DRUGS IN TABLET DOSAGE FORM BY RRLC METHOD.

919 21-05-2013 H-09 112170804018

PATEL SHRADDHABEN R. 217


METHOD DEVELOPMENT AND ANALYTICAL VALIDATION OF MOMETASONE FUORATE IN NASAL SPRAY.

920 21-05-2013 H-10 112070808001

JOSHI MIHIRKUMAR DEEPAKKUMAR 207


DEVELOPMENT AND CHARACTERIZATION OF TRANSDERMAL PATCH FOR CONTROLLED RELEASE OF FLUOCINOLONE ACETONIDE

921 21-05-2013 H-10 112070808002

MANDARAWALA MARIYAMBIBI ABDULKADAR 207


FORMULATION AND CHARACTERIZATION OF POROUS CARRIER BASED FLOATING MICROSPHERES OF FAMOTIDINE FOR GASTRORETENTIVE DRUG DELIVERY

922 21-05-2013 H-10 112070808003

PATEL FALGUNIBEN JITENDRABHAI 207


DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF NIFEDIPINE

923 21-05-2013 H-10 112070808004

PRAJAPATI SATISHKUMAR DAHYABHAI 207


PREPARATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF GLIMEPIRIDE

Row ID Exam Date





924 21-05-2013 H-10 112070808005

PATEL RAHULKUMAR J 207


DEVELOPMENT AND EVALUATION OF MULTIPARTICULATE CONTROLLED RELEASE FORMULATION OF ZIDOVUDINE USING NON PAREIL SEEDS

925 21-05-2013 H-10 112070808006

PRAJAPATI HARDIKKUMAR KANTIBHAI 207


PREPARATION AND EVALUATION OF SUBLINGUAL TABLET OF RIZATRIPTAN BENZOATE

926 21-05-2013 H-10 112070808007

PATEL YOGESHKUMAR DAHYABHAI 207


PREPARATON AND EVALUATION OF CONTROLLED RELEASE MATRIX PELLETS OF KETOPROFEN

927 21-05-2013 H-10 112070808008

PATEL SANKETKUMAR NARESHBHAI 207


DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLET OF FLURBIPROFEN

928 21-05-2013 H-10 112070808009PATEL SIRALI BIPINBHAI 207


FORMULATION AND EVALUATION OF FLOATING PULSATILE DRUG DELIVERY SYSTEM USING LOSARTAN POTASSIUM

929 21-05-2013 H-10 112070808010

SOMANI PRIYANKA PRAHLADBHAI 207


SOLUBILITY ENHANCEMENT AND FORMULATION DEVELOPMENT OF MICROEMULSION FOR SIMVASTATIN

930 21-05-2013 H-11 112250808001

PATEL JAIMINIBEN PRAHALADBHAI 225

KALOL INSTITUTE OF PHARMACY, KALOL

DEVELOPMENT AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF OLMESARTAN MEDOXOMIL.

931 21-05-2013 H-11 112250808002

SHAH DARSHAN SUBODHKUMAR 225


DEVELOPMENT AND OPTIMIZATION OF LIQUI-SOLID TABLETS CONTAINING TELMISARTAN.

932 21-05-2013 H-11 112250808003

PATEL MAYANK BIPINKUMAR 225


FORMULATION AND EVALUATION OF SOLID DISPERSION BASED FAST DISSOLVING TABLETS OF POORLY WATER SOLUBLE DRUG.

Row ID Exam Date





933 21-05-2013 H-11 112250808004

SHAH RUSHABH KISHORBHAI 225


FORMULATION, DEVELOPMENT AND OPTIMIZATION OF FAST DISINTEGRATING TABLETS OF DESLORATIDINE USING SUPER DISINTEGRANTS.

934 21-05-2013 H-11 112250808005

PATEL PRIYANKA JATINBHAI 225


PHYSICOCHEMICAL CHARACTERIZATION AND IN VITRO DISSOLUTION ASSESMENT OF ALLOPURINOL TABLETS USING SOLID DISPERSION TECHNIQUE.

935 21-05-2013 H-11 112250808006

SHAH VIHAR KAMLESHKUMAR 225


PREPARATION, EVALUATION AND OPTIMIZATION OF TRANSDERMAL PATCH OF ROPINIROLE HCL.

936 21-05-2013 H-11 112250808007

GUPTA RUCHIT DINBANDHU 225


FORMULATION, DEVELOPMENT AND OPTIMIZATION OF MOUTH DISSOLVING TABLETS OF GLIMEPRIDE.

937 21-05-2013 H-11 112250808008

PATEL RAKESHKUMAR BALDEVBHAI 225


FORMULATION, DEVELOPMENT AND PROCESS OPTIMIZATION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS .

938 21-05-2013 H-11 112250808009

SHAH VISHVA HITEN 225


PREPARATION, OPTIMIZATION AND EVALUATION OF COLON TARGATED MICROSPHERES FOR THE TREATMENT OF ULCERATIVE COLITIS

939 21-05-2013 H-11 112250808010

PRAJAPATI NITINKUMAR BALDEVBHAI 225


DEVELOPMENT AND OPTIMIZATION OF MUCOADHESIVE BUCCAL TABLETS OF RABEPRAZOLE SODIUM.

940 21-05-2013 H-11 112250808012

CHAUDHARI VIKASKUMAR SHANKARBHAI 225


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ROXITHROMYCIN USING SUPER DISINTEGRANTS.

941 21-05-2013 H-12 112150808001

MASHROOWALA VISHNU BHUPENDRA 215

BHAGWAN MAHAVIR COLLEGE OF PHARMACY, SURAT

DESIGN AND EVALUATION OF MATRIX TABLET OF ATORVASTATIN FOR THE TREATMENT OF DYSLIPIDEMIA

942 21-05-2013 H-12 112150808002

PATHAK RUCHA SURESH 215


FORMULATION AND EVALUATION OF CONTROLLED RELEASE ETODOLAC TABLETS

Row ID Exam Date





943 21-05-2013 H-12 112150808003

ADESHARA MANSI SATISHKUMAR 215


DESIGN AND EVALUATION OF PRESS COATED TABLETS OF RABEPRAZOLE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE.

944 21-05-2013 H-12 112150808004SHAH DHARA PANKAJBHAI 215


DESIGN AND EVALUATION OF EMULGEL CONTAINING ANTIFUNGAL AGENT KETOCONAZOLE FOR THE TREATMENT OF ATHELETES FOOT

945 21-05-2013 H-12 112150808005

SABHADIYA JIGNESHBHAI GORDHANBHAI 215


FORMULATION AND EVALUTION OF METOPROLOL SUCCINATE BILAYER TABLETS FOR BIPHASIC DRUG RELEASE

946 21-05-2013 H-12 112150808006

SAIYAD ZAHIDAHMAD BAHAUDDIN 215


DESIGN AND DEVELOPMENT OF ORODISPERSIBLE FILM OF DIPHENHYDRAMINE HYDROCHLORIDE

947 21-05-2013 H-12 112250808013

CHAUDHARI RAKESH GOVINDBHAI 225


PREPARATION, EVALUATION AND OPTIMIZATION OF FAST DISSOLVING TABLETS OF TRAMADOL HCL.

948 21-05-2013 H-12 112250808014PATEL SUPRIYA P. 225


DEVELOPMENT AND OPTIMIZATION OF MICROEMULSION BASED GEL CONTAINING KETOCONAZOLE.

949 21-05-2013 H-12 112250808015

MODI NIKULKUMAR HARSHADKUMAR 225


FORMULATION, EVALUATION AND OPTIMIZATION OF SUSTAIN RELEASE MATRIX TABLETS OF NICORANDIL.

950 21-05-2013 H-12 112250808016PATEL SNEHA K 225


FORMULATION AND EVALUATION OF MATRIX TYPE TRANSDERMAL PATCH OF TIZANIDINE HCL.

951 21-05-2013 H-12 112250808017

RAVAL RAHUL DILIPKUMAR 225


FORMULATION AND EVALUATION OF FLOATING IN SITU GEL OF FAMOTIDINE.

952 21-05-2013 H-12 112250808018MITTA MIHIR D 225


FORMULATION, OPTIMIZATION AND EVALUATION OF FAST DISSOLVING ORAL FILM OF TRAMADOL HCL.

953 21-05-2013 H-13 112150808007KAKLOTTAR BHAVESH H 215


FORMULATION AND DEVELOPMENT OF MOUTH DISSOLVING TABLET OF DICYCLOMINE HYDROCHLORIDE

Row ID Exam Date





954 21-05-2013 H-13 112150808008

LATHIYA PRIYANKKUMAR R 215


FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL DRUG DELIVERY OF RIZATRIPTAN FOR THE TREATMENT OF MIGRANE

955 21-05-2013 H-13 112150808009CHAUDHARI KHYATI A 215


DESIGN AND EVALUATION OF MATRIX TABLET OF CANDENSARTAN BASED ON NATURAL POLYMER

956 21-05-2013 H-13 112150808010CHAUDHARI HEMANT D. 215


FORMULATION AND DEVELOPMENT OF GESTRORETENTIVE FLOATING BEADS OF GABA PENTIN.

957 21-05-2013 H-13 112150808011GOHIL SANJAY N 215


FORMULATION AND EVALUATION OF AN OPTHALMIC DELIVERY SYSTEM OF CIPROFLOXACIN BY PH TRIGGERED IN SITU GELATION

958 21-05-2013 H-13 112150808012

PATEL ANKETKUMAR VINODKUMAR 215


FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF QUINAPRIL HCL FOR THE TREATMENT OF HYPERTENSION

959 21-05-2013 H-13 112150808013

KADIYA MAYURI JITENDRABHAI 215


FORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN FOR THE TREATMENT OF MIGRAINE.

960 21-05-2013 H-13 112150808014

PATEL JITENKUMAR B. 215


FORMULATION AND EVALUATION OF COMPRESSION COATED GASTRO RETENTIVE TABLETS OF KETOROLAC TROMETHAMINE

961 21-05-2013 H-13 112150808015

SUTARIA SATISKUMAR HARESHBHAI 215


FORMULATION AND DEVELOPMENT OF GASTRORETENTIVE DRUG DELIVERY SYSTEM CONTAINING KETOPROFEN

962 21-05-2013 H-13 112150808016

PATEL HARDIKKUMAR UPENDRABHAI 215


FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF ETORICOXIB BY SOLID DISPERSIBLE METHOD

963 21-05-2013 H-13 112150808017BHADANI VIJAY J. 215


FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF GLIPIZIDE USING NATURAL POLYMER

Row ID Exam Date





964 21-05-2013 H-13 112150808018PATEL RUTUL SURESHBHAI 215


DESIGN AND EVALUATION OF BUCCAL TABLET OF BETAMETHASONE FOR THE TREATMENT OF ASTHMA

965 21-05-2013 H-14 112320808001DESAI VIJAY D 232

NOOTAN PHARMACY COLLEGE,VISNAGAR

FORMULATION DESIGN,OPTIMIZATION AND EVALUATION OF BILAYER FLOATING TABLET OF METOPROLOL TARTRATE

966 21-05-2013 H-14 112320808002

PATEL NILAMBEN KANUBHAI 232


SOLUBILITY ENHANCEMENT OF ATORVASTATIN BY SOLID DISPERSION TECHNIQUE.

967 21-05-2013 H-14 112320808003

PATEL SARVILKUMAR KANTILAL 232


TO FORMULATE, OPTIMIZE AND EVALUATE GASTRO-RESISTANT MULTIUNIT PARTICULATE TABLET OF PROTON PUMP INHIBITOR.

968 21-05-2013 H-14 112320808004

PATEL RACHANA GANESHBHAI 232


FORMULATION DESIGN,OPTIMIZATION AND EVALUATION OF CONTROL POROSITY OSMOTIC DRUG DELIVERY SYSTEM OF METOPROLOL TARTRATE.

969 21-05-2013 H-14 112320808005

PATEL SHAISHAV DAHYABHAI 232


IMPROVEMENT OF FLOWABILITY AND COMPRESSIBILITY OF METAXALONE BY SPHERICAL CRYSTALLIZATION TECHNIQUE.

970 21-05-2013 H-14 112320808006

PATEL BHAVESHKUMAR BALDEVBHAI 232


PREPARATION AND CHARACTERIZATION OF AMIODARONE BY SOLID DISPERSION.

971 21-05-2013 H-14 112320808007

SOLANKI APEXA RAMESHBHAI 232


FORMULATION DESIGN,OPTIMIZATION AND EVALUATION OF BUCCAL MUCOADHESIVE TABLETS OF SIMVASTATIN

972 21-05-2013 H-14 112320808008

PATEL TEJASKUMAR KANAIYALAL 232


FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLET OF OLANZAPINE

973 21-05-2013 H-14 112320808009

PRAJAPATI ANKITKUMAR BHARATBHAI 232


IMPROVEMENT OF FLOWABILITY AND COMPRESSIBILITY OF FLUCONAZOLE BY SPHERICAL CRYSTALLIZATION TECHNIQUE

Row ID Exam Date





974 21-05-2013 H-14 112320808010

PATEL DHAVALKUMAR SURESHBHAI 232


FORMULATION DESIGN,OPTIMIZATION AND IN VITRO MICROBILOGICAL EFFICASY OF BACTERIOSTATIC ANTIBIOTIC FUSIDIC ACID MICROEMULSION

975 21-05-2013 H-14 112320808011

MISTRY MUKESHKUMAR MAFATLAL 232


FORMULATION, OPTIMIZATION AND EVALUATION OF GAS POWERED CONTROLLED DRUG DELIVERY SYSTEM OF CIPROFLOXACIN HCL

976 21-05-2013 H-14 112320808012

CHAUHAN RAJUSINH DASHARATHSINH 232


FORMULATION, OPTIMIZATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF TRAMADOL HCL.

977 21-05-2013 H-14 112320808013

PRAJAPATI RAJUL SHIVABHAI 232


ENHANCEMENT OF SOLUBILITY AND BIOAVAILABILITY OF CARVEDILOL BY MICRONIZATION USING VARIOUS TECHNIQUES.

978 21-05-2013 H-14 112320808014

CHAUHAN CHETAN NARESHBHAI 232


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF MELOXICAM

979 21-05-2013 H-15 112320808015

PATEL SACHIN BHARATBHAI 232


FORMULATION DESIGN, OPTIMIZATION AND EVALUATION OF FAST DISSOLVING FILM OF FLUOXETINE HCL.

980 21-05-2013 H-15 112320808016

PATEL KUNAL MUKESHBHAI 232


FORMULATION,OPTIMIZATION AND EVALUATION OF FAST DISSOLVING FILM OF TOPIRAMATE.

981 21-05-2013 H-15 112320808017

PATEL PRATIKKUMAR VISHNUBHAI 232


FORMULATION DESIGN,OPTIMIZATION AND EVALUATION OF IMMEDIATE RELEASE AND SUSTAIN RELEASE BILAYER TABLETS OF FAMOTIDINE AND DOMPERIDONE.

982 21-05-2013 H-15 112320808018PATEL GAURANG D 232


FORMULATION DESIGN,OPTIMIZATION AND EVALUATION OF CHRONOMODULATED PRESS-COATED TABLET OF VALSARTAN.

983 21-05-2013 H-15 112570808001

PATEL HITESHKUMAR BHARATBHAI 257

Shri Satsangi Saketdham Ram ashram Group of institutions

FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF PROMETHAZINE HYDROCHLORIDE

984 21-05-2013 H-15 112570808002

CHHATRAYA NIKETA NATHABHAI 257


FORMULATION AND EVALUATION OF FLOATING TABLET OF SALBUTAMOL SULPHATE

Row ID Exam Date





985 21-05-2013 H-15 112570808003

PATEL MANSI GAURANGBHAI 257


FORMULATION AND EVALUATION OF OF HEPARIN IN PREFILLED SYRINGE

986 21-05-2013 H-15 112570808004

UPADHYAY KRUPALI VIPULKUMAR 257


DESIGN, DEVELOPMENT AND CHARACTERIZATION OF ANTI-INFLAMMATORY COLON TARGATED DRUG DELIVERY SYSTEM

987 21-05-2013 H-15 112570808005

ASODIYA SALILKUMAR BALDEVBHAI 257


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF ANTIHYPERTENSIVE DRUG

988 21-05-2013 H-15 112570808006

PATEL ANKITKUMAR KANTIBHAI 257


FORMULATION AND EVALUATION OF FLOATING TABLET OF METHYLDOPA

989 21-05-2013 H-15 112570808007

DAVE ANKITA RAJENDRAKUMAR 257


FORMULATION, DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF ANTIDIABETIC DRUGS

990 21-05-2013 H-15 112570808008

PATEL PALAKBEN VINODKUMAR 257


FORMULATION AND EVALUATION OF BUCCAL DRUG DELIVERY SYSTEM FOR ANTIHYPERTENSIVE AGENT

991 21-05-2013 H-15 112570808009

PATEL JAKSHILKUMAR JAGDISHBHAI 257


FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF ANTIHYPERTENSIVE AGENT

992 22-05-2013 H-01 112450806001PATEL JAY BHARATBHAI 245


COMPARATIVE EVALUATION AND TO STUDY THE SAFETY AND EFFICACY BETWEEN STAINLESS STEEL STENT AND COBALT CHROMIUM STENT IN PATIENT WITH CORONARY ARTERY DISEASE

993 22-05-2013 H-01 112450806002BAROT APURVA R 245


TO COMPARE THE EFFICACY AND SAFETY OF EPLERENONE AND SPIRONOLACTONE IN ACUTE MI PATIENTS

994 22-05-2013 H-01 112450806003

VANAM VANDANA JAGDISHBHAI 245


PREVALENCE AND QUALITY OF LIFE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Row ID Exam Date





995 22-05-2013 H-01 112450806004

PATEL ANKINI AMRUTBHAI 245


A STUDY TO EVALUATE THE TRENDS OF ACCIDENTAL TRAUMA

996 22-05-2013 H-01 112450806005

BADRAKIA NINAD LALITBHAI 245


IMPACT OF VITAMIN D SUPPLEMENTATION ON LIPID PROFILE AND CLINICAL STATUS IN CORONARY ARTERY DISEASE PATIENTS

997 22-05-2013 H-01 112450806006PATEL NIRMAL H 245


COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ASPIRIN ALONE OR ASPIRIN PLUS CLOPIDOGREL COMBINATION THERAPY IN MYOCARDIAL INFRACTION PATIENTS

998 22-05-2013 H-01 112450806007

DAVE SHRUTIBEN RASIKBHAI 245


TO COMPARE THE SAFETY AND EFFICACY OF ACENOCOUMAROL AND WARFARIN IN PROSTHETIC CARDIAC VALVE PATIENTS.

999 22-05-2013 H-01 112450806008

PATEL PARIMALKUMAR G 245


COMPARATIVE STUDY OF SAFETY AND EFFICACY OF PHENYTOIN AND LEVETIRACETAM VERSUS PHENYTOIN ALONE FOR SEIZURE PROPHYLAXIS IN SEVERE TRAUMATIC BRAIN INJURIY.

1000 22-05-2013 H-01 112450806009

PATEL PRALABHKUMAR VISHNUBHAI 245


A COMPARATIVE SAFETY AND EFFICACY STUDY OF ENICOSTEMMA LITTORALE AND EUGENIA JAMBOLANA AS ADD ON THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING ORAL ANTIDIABETIC AGENTS.

1001 22-05-2013 H-01 112450806010PATEL DISHA J 245


TO INVESTIGATE EFFICACY & SAFETY OF REDUCED LEVEL OF TACROLIMUS WITH EQUIMOLAR MYCOPHENOLIC ACID (ENTERIC COATED MYCOPHENOLATE SODIUM) OR MYCOPHENOLATE MOFETIL IN DE NOVO RENAL TRANSPLANT RECIPIENTS

1002 22-05-2013 H-01 112450806011

LIMBACHIYA KRUNALKUMAR SENDHABHAI 245


COMPARATIVE EFFICACY AND SAFETY OF COMBINATION OLMESARTAN/AMLODIPINE AND OLMESARTAN/HCTZ IN MILD TO MODERATELY HYPERTENSIVE PATIENTS INADEQUATELY RESPONDING TO OLMESARTAN ALONE

Row ID Exam Date





1003 22-05-2013 H-02 112390806001VYAS PARTH S 239


BIOEQUIVALENCE STUDY OF TWO TEST PRODUCTS OF TIZANIDINE 4MG TABLET IN HEALTHY HUMAN SUBJECTS UNDER FASTING CONDITION

1004 22-05-2013 H-02 112390806002

JOSHI URVI MAHENDRABHAI 239


SAFETY AND EFFICACY OF TRIMETAZIDINE, NICORANDIL, AND THEIR COMBINATION IN PATIENTS SUFFERING FROM CORONARY ARTERY DISEASE – A COMPARATIVE STUDY

1005 22-05-2013 H-02 112390806003

BHANUSHALI NITIN SHANKARLAL 239


SAFETY AND EFFICACY OF 2.5MG OD BROMOCRIPTINE AS ADD ON DRUG TO SULFONYLUREA + METFORMIN THERAPY IN PATIENTS WITH TYPE-2 DIABETES MELLITUS

1006 22-05-2013 H-02 112390806004

MOURYA MANJU LAHURIRAM 239


BIOEQUIVALENCE STUDY OF METOPROLOL SUCCINATE EXTENDED RELEASE 50 MG TABLET IN NORMAL, HEALTHY ADULT, MALE AND FEMALE HUMAN SUBJECTS UNDER FASTING CONDITION

1007 22-05-2013 H-02 112390806005

YAGNESHWAR HIRAL KAMALAKAR 239


AMINO INFUSION IN INTRAUTERINE GROWTH RESTRICTION AND OLIGOHYDRAMNIOS-A CLINICAL STUDY

1008 22-05-2013 H-02 112390806006

MANGE MANJULABEN PREMJI 239


COMPARATIVE STUDY OF L-ARGININE AND NIFIDIPINE IN THE TREATMENT OF GESTATIONAL HYPERTENSION

1009 22-05-2013 H-02 112450806012SHAH CHINTAN K 245


COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF HERBAL FORMULATION MORINGA OLEIFERA AND INULA RACEMOSA IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

1010 22-05-2013 H-02 112450806013GODESHWER RASHMI S. 245


COMPARATIVE EVALUTION OF ANTI MICROBIAL ACTIVITY OF ORAL CLAVUALATE CONTAINING B-LACTAM ANTIBIOTICS AGAINST EXTENDED SPECTRUM B-LACTAMASE PRODUCING MICRO ORGANISMS.

Row ID Exam Date





1011 22-05-2013 H-02 112450806014

SAHITA POOJA VISHNUPRASAD 245


ASSOCIATION OF ABO BLOOD GROUP WITH CARDIOVASCULAR DISEASES IN ADULT INDIAN POPULATION

1012 22-05-2013 H-02 112450806015CHAUDHARI MANISH G 245


PRESCRIPTION ANALYSIS OF PEDIATRIC OUT PATIENTS IN MEHSANA CITY

1013 22-05-2013 H-02 112450806016

SUTARIA SAGAR JIGISHBHAI 245


TO COMPARE THE EFFICACY AND SAFETY OF THROMBOLYTIC AGENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

1014 22-05-2013 H-02 112450806017

PATEL ASHABEN KANUBHAI 245


ASSESSMENT OF EXTRAPYRAMIDAL SYMPTOMS & HYPERPROLACTINEMIA WITH RISPERIDONE IN SCHIZOPHRENIC PATIENTS AND EVALUATION OF THEIR MANAGEMENT

1015 22-05-2013 H-02 112450806018JOSHI TITHI TARUNBHAI 245


ASSOCIATION OF GLAUCOMA SURGERY WITH CLINICAL OUTCOMES.

1016 22-05-2013 H-03 112020806001

JAGIWALA RACHANA HARISHCHANDRA 202


RELATIONSHIP OF SERUM TOTAL HOMOCYSTEINE AND LIPID PROFILE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

1017 22-05-2013 H-03 112020806002PATEL KUSH SURYAKANT 202


ASSESSMENT OF THE SERUM URIC ACID LEVEL IN PARKINSON'S DISEASE

1018 22-05-2013 H-03 112020806003

DUNKIN UDAYAN SHAH 202


ASSOCIATION OF PROTON PUMP INHIBITOR WITH HYPOMAGNESAEMIA: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL OF ANAND DISTRICT

Row ID Exam Date





1019 22-05-2013 H-03 112020806004

SHASHANKKUMAR CHANDRAKANTBHAI PATEL 202


COMPARISON OFEFFICACY OF 2 COMMONLY PRESCRIBED DRUGS WITH RESPECT TO ITS CARDIAC TROPONIN T LOWERING EFFECT IN MYOCARDIAL INFARCTION.

1020 22-05-2013 H-03 112020806005

GAMIT ALKESHKUMAR RAMESHBHAI 202


ANALYSIS OF PROGNOSTIC FACTORS IN EARLY AND LOCALLY ADVANCED BREAST CANCER

1021 22-05-2013 H-03 112020806006MADHU RACHANA R. 202


COMPARATIVE OBSERVATIONAL STUDY TO CHECK SAFETY AND EFFICACY OF SITAGLIPTIN ADDED TO METFORMIN WITH METFORMIN ALONE INDICATED IN UNCONTROLLED TYPE II DIABETES MELLITUS

1022 22-05-2013 H-03 112020806007

PATEL PRIYANKA DILIPBHAI 202


COMPARATIVE STUDY OF EFFICACY AND GLYCEMIC CONTROL OF RANOLAZINE VERSUS TRIMETAZIDINE IN PATIENTS HAVING ANGINA PECTORIS WITH AND WITHOUT DIABETES MELLITUS

1023 22-05-2013 H-03 112020806008JANI NILAM JANAKBHAI 202


AVAILABILITY AND RATIONAL USE OF DRUGS IN GOVERNMENT HEALTH CARE SET-UPS IN GUJARAT STATE FOLLOWING THE IMPLIMENTATION OF NATIONAL RURAL HEALTH MISSION (NRHM)

1024 22-05-2013 H-03 112020806010

CHAUHAN JANKI RAMANBHAI 202


EARLY PREGNANCY TERMINATION WITH MIFEPRISTONE ALONG WITH MISOPROSTOL-A MEDICAL METHOD

1025 22-05-2013 H-03 112020806011PATEL KINJAL A 202


A COMPARATIVE STUDY BETWEEN ETODOLAC AND ACECLOFENAC IN PATIENTS WITH OSTEOARTHRITIS OF KNEE

Row ID Exam Date





1026 22-05-2013 H-04 112330804001

LAKKAD DHAVAL BABULAL 233


STABILITY INDICATING METHOD DEVELOPMENT, VALIDATION OF CETYLPYRIDINIUM CHLORIDE IN SUSTAINED RELEASE MOUTH WASH USING HPLC

1027 22-05-2013 H-04 112330804002

SADATIYA HARSHADBHAI MANSUKHBHAI 233


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CIPROFLOXACIN HCL AND PHENAZOPYRIDINE HCL IN TABLET DOSAGE FORM

1028 22-05-2013 H-04 112330804003

RANA NIKESHKUMAR SHASHIKANTBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND EBASTINE IN BULK AND TABLET DOSAGE FORM

1029 22-05-2013 H-04 112330804004

SEVAK NITALI SUBHASHCHNDRA 233


RISK ASSESSMENT STUDY FOR THE PREPARATION OF BUDESONIDE SOLID LIPID NANOPARTICLES

1030 22-05-2013 H-04 112330804005

LIMBACHIYA UJJAVALKUMAR N 233


PROCESS VALIDATION OF LAMOTRIGINE ER TABLET 300 MG.

1031 22-05-2013 H-04 112330804006

TALAVIYA SHITAL RAMNIKLAL 233


COMPARATIVE DISSOLUTION STUDY OF SOFT GEL CAPSULE (ANTIBIOTIC) METHOD DEVELOPMENT AND VALIDATION

1032 22-05-2013 H-04 112330804007

PATEL HIRALBEN SURYAKANT 233


SPECTROPHOTOMETRIC AND RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF BUPARVAQUONE IN INJECTION

1033 22-05-2013 H-04 112330804008

PATEL HIRENKUMAR CHANDUBHAI 233


LC-MS/MS METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DRONEDARONE HYDROCHLORIDE IN HUMAN PLASMA

1034 22-05-2013 H-04 112330804009

SHAH NIDHI PUNAMCHAND 233


PROCESS VALIDATION OF ADRIDE-M (METFORMIN HCL AND GLIMEPIRIDE) BILAYERED EXTENDED RELEASE TABLET

1035 22-05-2013 H-04 112330804010THAKKAR HETALBEN D 233


IDENTIFICATION, CHARACTERISATION, METHOD DEVELOPMENT AND VALIDATION FOR RECOMBINANT DEFENSIN PROTEIN

Row ID Exam Date





1036 22-05-2013 H-04 112330804011

SHAH RONAKKUMAR PARESHBHAI 233


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-UPLC METHOD FOR DETERMINATION OF PRENOXDIAZINE HCL IN ITS BULK FORM

1037 22-05-2013 H-04 112330804012

DANGI ANKITA PANKAJKUMAR 233


A POLYMERASE CHAIN REACTION BASED APPROACH FOR METHOD DEVELOPMENT AND VALIDATION FOR DIAGNOSIS OF TYPHOID DISEASE

1038 22-05-2013 H-05 112330804013

PANCHAL BHAUMIK ASHOKBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TRAMADOL HCL AND DICLOFENAC SODIUM IN MATRIX.

1039 22-05-2013 H-05 112330804014

TIWARI PRIYAKUMARI SHASHIKANT 233


PROCESS VALIDATION OF PYE-M (METFORMIN HYDROCHLORIDE & PIOGLITAZONE) BILAYERED EXTENDED RELEASE TABLET DOSAGE FORM

1040 22-05-2013 H-05 112330804015SHAH MITALI ANIL 233


PROCESS VALIDATION OF VEGDOL (SILDENAFIL CITRATE AND TRAMADOL HYDROCHLORIDE) SOFT GELATIN CAPSULE

1041 22-05-2013 H-05 112330804016

AGRAVAT HARSHAD CHUNILAL 233


PROCESS VALIDATION OF ATENOLOL FILM COATED TABLETS

1042 22-05-2013 H-05 112330804017

VAGHASIYA JENISH VAJUBHAI 233


PROCESS VALIDATION OF NIFEDIPINE FILM COATED TABLET

1043 22-05-2013 H-05 112330804018

VAISHNAV TARAL HARSUKHLAL 233


METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF AZITHROMYCIN AND LEVOFLOXACIN HEMIHYDRATE IN BULK AND TABLET DOSAGE FORM

1044 22-05-2013 H-05 112330804019

DHANDHUKIYA VIPUL RATILAL 233


PROCESS VALIDATION OF CIPROFLOXACIN FILM COATED TABLETS

1045 22-05-2013 H-05 112330804020

KATHESIYA RAGHUVIR HEMANTBHAI 233


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR DETERMINATION OF PANTOPRAZOLE SODIUM AND DICLOFENAC SODIUM IN BULK AND FORMULATION

Row ID Exam Date





1046 22-05-2013 H-05 112330804021

PRAJAPATI MANISH PARSHATTAMBHAI 233


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF CHLORTHALIDONE AND RAMIPRIL IN BULK AND CAPSULE DOSAGE FORM

1047 22-05-2013 H-05 112330804022

CHAVDA JIGNESHKUMAR RAMESHBHAI 233


ESTIMATION OF FLUROQUINOLONE METAL COMPLEXES

1048 22-05-2013 H-05 112330804023

PATEL FALGUNI THAKORBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FLUPIRTINE MALEATE AND PARACETAMOL IN THEIR COMBINED TABLET DOSAGE FORM.

1049 22-05-2013 H-05 112330804024

VASAVA BHAVESHKUMAR YOGESHBHAI 233


PROCESS VALIDATION OF ATORVASTATIN FILM COATED TABLET

1050 22-05-2013 H-06 112330804025

VASAVA AVANTIKA NARENDRABHAI 233


DEVELOPMENT AND VALIDATION OF HPLC AND SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF IBUPROFEN AND CHLORZOXAZONE IN PHARMACEUTICAL DOSAGE FORM

1051 22-05-2013 H-06 112330804026

PATEL PRIYANKA SUMANBHAI 233


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LORNOXICAM AND EPERISONE HYDROCHLORIDE IN THEIR BULK AND SYNTHETIC MIXTURE

1052 22-05-2013 H-06 112330804027

KARTAVYA BHARATKUMAR THAKKAR 233


METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND LEVOFLOXACIN HEMIHYDRATE IN COMBINED TABLET DOSAGE FORM

1053 22-05-2013 H-06 112330804028

BHAVSAR VIJAL ATULKUMAR 233


PROCESS VALIDATION OF DILTIAZEM FILM COATED TABLET.

Row ID Exam Date





1054 22-05-2013 H-06 112330804029

PRAJAPATI HARDIKKUMAR GOKALBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF EPERISONE HCL AND DICLOFENAC SODIUM IN BULK AND CAPSULE DOSAGE FORM

1055 22-05-2013 H-06 112330804030

SHAH KRIPA PRAKASHBHAI 233


COMPARATIVE DISSOLUTION STUDY OF ANTIMALARIAL SOFT GELATIN CAPSULE:DISSOLUTION METHOD DEVELOPMENT AND VALIDATION

1056 22-05-2013 H-06 112330804031

PATEL DHARMENDRAKUMAR KANJIBHAI 233


“DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIPIME AND TAZOBACTAM IN INJECTABLE DOSAGE FORM ”

1057 22-05-2013 H-06 112330804032

PATEL DRASHTIBAHEN HITESHKUMAR 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF METOPROLOL SUCCINATE AND CHLORTHALIDONE IN BULK AND TABLET DOSAGE FORM

1058 22-05-2013 H-06 112330804033

PARIKH DHRUVI GIRISHBHAI 233


BIO ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TIOTROPIUM BROMIDE AND BUDESONIDE BY RP-HPLC METHOD

1059 22-05-2013 H-06 112330804034

PATEL DHAVALKUMAR V 233


PROCESS VALIDATION OF TRAMADOL HYDROCHLORIDE FILM COATED TABLETS

1060 22-05-2013 H-06 112330804035PATEL PARITA N. 233


RISK ASSESSMENT STUDY FOR ORAL SOLID DOSAGE FORM WITH PROCESS VALIDATION

1061 22-05-2013 H-06 112330804036Rana Krishna Medikonda 233


DEVELOPMENT OF RP- HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DIACEREIN AND GLUCOSAMINE SULPHATE

1062 22-05-2013 H-07 112330813001

YADAV ANILKUMAR BANSILAL 233


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF CO-AMOXY CLAV INJECTION

1063 22-05-2013 H-07 112330813002BHATT YASH AMIDHAR 233


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR SILODOSIN IN BULK

Row ID Exam Date





1064 22-05-2013 H-07 112330813003

PATOLIYA NIKUNJ JENTIBHAI 233


PROCESS VALIDATION OF FENBENDAZOLE & IVERMECTIN UNCOATED TABLET

1065 22-05-2013 H-07 112330813004

PATEL NAIYABEN SUBHASHBHAI 233


DEVELOPMENT AND VALIDATION OF ASSAY METHOD AND STABILITY INDICATING METHOD OF TOLPERISONE HYDROCHLORIDE & DICLOFENAC SODIUM

1066 22-05-2013 H-07 112330813005

SEVAK MAULI SATISHCHANDRA 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CETRIZINE HYDROCHLORIDE & PHENYLEPHRINE HYDROCHLORIDE IN BULK AND TABLET DOSAGE FORM

1067 22-05-2013 H-07 112330813006PATEL NIKITA JITENDRA 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF IBUPROFEN , PARACETAMOL & FAMOTIDINE IN BULK AND TABLET DOSAGE FORM

1068 22-05-2013 H-07 112330813007

RADADIYA PANKAJ MANSUKHBHAI 233


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD AND STABILITY INDICATING HPLC METHOD FOR PAROXETINE HCL HEMIHYDRATE AND CLONAZEPAM IN BULK AND CAPSULE DOSAGE FORM

1069 22-05-2013 H-07 112330813008

MAHESHWARI HARDIKKUMAR JAYANTILAL 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND DESLORATADINE IN BULK AND TABLET DOSAGE FORM

1070 22-05-2013 H-07 112330813009

DIWAN NAFISHA NASIRUDIN 233


DEVELOPMENT AND VALIDATION: RP-LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF RELATED SUBSTANCES OF ROFLUMILAST

1071 22-05-2013 H-07 112330813010

PANCHOLI MEGHA NARAYANDAS 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE & DEXKETOPROFEN TROMETAMOL

Row ID Exam Date





1072 22-05-2013 H-07 112330813011OZA DHRUV ISHVARBHAI 233


“ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SILDENAFIL CITRATE AND FLUOXETINE HYDROCHLORIDE IN BULK AND TABLET DOSAGE FORM”

1073 22-05-2013 H-07 112330813012

SHAH DHRUTI JAYESH 233


FORMULATION BY DESIGN AND VALIDATION OF CRITICAL QUALITY ATTRIBUTES FOR AN ENTERIC COATED TABLET OF A COMBINATION THERAPY

1074 22-05-2013 H-08 112330813013

PATEL SNEHALKUMAR V. 233


OPTIMIZATION AND PROCESS VALIDATION OF BACOPA MONNIERI GRANULES

1075 22-05-2013 H-08 112330813014

NAKRANI CHARULBEN ARVINDBHAI 233


PROSPECTIVE PROCESS VALIDATION OF DICLOFENAC SODIUM ENTERIC COATED TABLET

1076 22-05-2013 H-08 112330813015KACHA HIMA LAXMIDAS 233


METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF NIFEDIPINE IN HUMAN PLASMA BY LCMS/MS

1077 22-05-2013 H-08 112330813016

SOLANKI MITALKUMARI HASMUKHSINH 233


PROCESS VALIDATION OF AZITHROMYCIN CAPSULE

1078 22-05-2013 H-08 112330813017

PATEL YOGITABEN DINESHBHAI 233


DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC AND HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND OLOPATADINE HYDROCHLORIDE IN BULK FORM

1079 22-05-2013 H-08 112330813018KANTESARIA BINAL K 233


PROCESS VALIDATION OF SUGAR COATED IBUPROFEN TABLET

1080 22-05-2013 H-08 112330813019

CONTRACTOR POOJA SANJAYKUMAR 233


“DEVELOPMENT AND VALIDATION OF STABILITY INDICTING RP-UPLC ASSAY RS-METHOD FOR DETERMINATION OF CLOXACILLIN SODIUM IN ITS BULK FORM AND FORMULATION”

Row ID Exam Date





1081 22-05-2013 H-08 112330813020

PATEL NIDHIBAHEN SURESHKUMAR 233


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND LINEZOLID

1082 22-05-2013 H-08 112330813021PATEL PRIYANKA H. 233


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF CINNARIZINE AND DOMPERIDONE IN BULK AND ITS COMBINED TABLET DOSAGE FORM

1083 22-05-2013 H-08 112330813022SHAH KINJAL A. 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TINOSORB S, TINOSORB M AND UVINYL MC 80 IN CREAM DOSAGE FORM

1084 22-05-2013 H-08 112330813023

PRAJAPATI JITENDRAKUMAR VIRAMBHAI 233


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND DOXOFYLLINE IN TABLET DOSAGE FORM.

1085 22-05-2013 H-08 112330813024

PATEL YAMINIBEN DHIRUBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RUPATADINE FUMARATE AND MONTELUKAST SODIUM IN BULK AND TABLET DOSAGE FORM

1086 22-05-2013 H-09 112330813025

LUHAR ANAND MUKESHBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR AMBROXOL HYDROCHLORIDE AND DESLORATADINE IN BULK AND DOSAGE FORM

1087 22-05-2013 H-09 112330813026

CHUDASMA GAMBHIRSINH A 233


PROCESS VALIDATION OF FLUCONAZOLE TABLET

1088 22-05-2013 H-09 112330813027

DAMOR JIGARKUMAR SOMJIBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SPARFLOXACINE AND DEXAMETHASONE IN BULK AND PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1089 22-05-2013 H-09 112330813028

RANOLIYA JATIN RAMESHBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF NAPROXEN AND PARACETAMOL IN THEIR COMBINED DOSAGE FORM

1090 22-05-2013 H-09 112330813029

KHODIYAR ANKITA LAVJIBHAI 233


STABILITY INDICATING RP-HPLC ASSAY AND RELATED SUBSTANCE METHOD DEVELOPMENT AND VALIDATION OF INDAPAMIDE SR TABLET

1091 22-05-2013 H-09 112330813030PATEL SHREYA A. 233


PROCESS VALIDATION OF INDOMETHACIN CAPSULE

1092 22-05-2013 H-09 112330813031

GADHESARIYA JIGNESH BHANJIBHAI 233


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DRUG COMBINATION OF LOSARTAN POTASSIUM AND CHLORTHALIDONE

1093 22-05-2013 H-09 112330813032SHAH HARSH S 233


PROCESS VALIDATION OF PIROXICAM CAPSULE

1094 22-05-2013 H-09 112330813033

DHUKA IMARANBHAIABDULREHMAN 233


PROCESS VALIDATION OF AMLODIPINE TABLET

1095 22-05-2013 H-09 112330813034

MIRCHANDANI KAMLESHKUMAR H. 233


OPTIMIZATION AND PROCESS VALIDATION OF WITHANIA SOMNIFERA EXTRACT

1096 22-05-2013 H-09 112330813035SHAH NIYATI PINAKINBHAI 233


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD AND STABILITY INDICATING HPLC METHOD FOR DOXOFYLLINE AND TERBUTALINE SULPHATE IN BULK

1097 22-05-2013 H-09 112330813036

MEHTA VIVEK HASMUKHLAL 233


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE DETERMINATION OF RELATED SUBSTANCE OF AGOMELATINE

Row ID Exam Date





1098 22-05-2013 H-10 112280802001

PATEL CHIRAG HIRABHAI 228


FORMULATION AND DEVELOPMENT OF BILAYER FLOATING TABLET OF FEBUXOSTAT AND NSAID

1099 22-05-2013 H-10 112280802002

MEHTA KRUTIKA CHAITANYAKUMAR 228


FORMULATION AND DEVELOPMENT OF FLOATING BEADS OF AMBROXOL HYDROCHLORIDE

1100 22-05-2013 H-10 112280802003

SHETA SOHAM DEVRAJBHAI 228


FORMULATION AND DEVELOPMENT OF IMMEDIATE RELEASE DOSAGE FORM OF ARIPIPRAZOLE

1101 22-05-2013 H-10 112280802004

SACHIBEN MAHESHBHAI PATEL 228


FORMULATION AND DEVELOPMENT OF IN SITU NASAL GEL OF MIDAZOLAM

1102 22-05-2013 H-10 112280802005

SHAH SMEET SUNILKUMAR 228


FORMULATION AND DEVELOPMENT OF FAST DISSOLVING FILM OF SUMATRIPTAN SUCCINATE

Row ID Exam Date





1103 22-05-2013 H-10 112280802006

KALSARIA HITESH DEVSHIBHAI 228


FORMULATION AND DEVELOPMENT OF BILAYER FLOATING TABLET OF VERAPAMIL HYDROCHLORIDE

1104 22-05-2013 H-10 112280802007

AHALGAMA JIGNESH VIRJIBHAI 228


DISSOLUTION ENHANCEMENT OF TELMISARTAN THROUGH APPLICATION OF LIQUISOILD TABLET TECHNIQUE

1105 22-05-2013 H-10 112280802008

PRIYANKA PARESHKUMAR MISTRY 228


FORMULATION AND DEVELOPMENT OF MICROEMULSION BASED HYDROGEL OF MINOXIDIL

1106 22-05-2013 H-10 112280802009

CHAHANDE KETKI NARESHBHAI 228


FORMULATION AND DEVELOPMENT OF SUBLINGUAL FILM OF OXYBUTYNIN CHLORIDE

1107 22-05-2013 H-10 112280802010

DANGI PRADIPKUMAR PUNABHAI 228


ENHANCED IONTOPHORETIC PERMEATION OF LIDOCAINE HYDROCHLORIDE FROM HYDROGEL BASED SYSTEM

96 22-05-2013 H-11 112140810027

MALIVAD NISHITKUMAR M. 214

BARODA COLLEGE OF PHARMACY, LIMDA

FORMULATION AND CHARACTERIZATION OF MICROEMULSION BASED HYDROGEL FOR TOPICAL DRUG DELIVERY SYSTEM

Row ID Exam Date





1108 22-05-2013 H-11 112550810001PATEL PRIYA DASHRATLAL 255

SHREE KRISHNA INSTITUTE OF PHARMACY, SHANKHALPUR

CHRONOTHERAPEUTIC DRUG DELIVERY SYSTEM BY FLOATING MICROSPHERES OF KETOPROFEN

1109 22-05-2013 H-11 112550810002

PRAJAPATI RITESH ASHOKBHAI 255


FORMULARION & OPTIMIZATION OF EXTENDED RELEASE DOSAGE FORM FOR THE MANAGEMENT OF ANGINA PECTORIS

1110 22-05-2013 H-11 112550810003

PATEL VIDHIBEN RAMESHBHAI 255


FORMULATION ,OPTIMIZATION AND EVALUATION OF FAST DISSOLVING TABLET OF ANTIEPILEPTIC DRUG

1111 22-05-2013 H-11 112550810005

PATEL HIRENKUMAR RAMANLAL 255


FORMULATION DEVELOPMENT AND EVALUATION OF ETHOSOMES OF KETOROLAC FOR TOPICAL DRUG DELIVERY SYSTEM.

1112 22-05-2013 H-11 112550810006

PATEL SUNILKUMAR AMBALAL 255


FORMULATION , DEVELOPMENT AND EVALUATION OF FLOATING DRUG DELIVERY OF ANTI ULCER DRUG

1113 22-05-2013 H-11 112550810007

PATEL KALPEN NATVARLAL 255


FORMULATION DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM FOR ANTI-ASTHMATIC DRUG

1114 22-05-2013 H-11 112550810008

PATEL MANAN KIRTIKUMAR 255


FORMULATION DEVELOPMENT AND EVALUTION OF MONTELUKAST SODIUM MICROSPHERES.

1115 22-05-2013 H-11 112550810009THAKKAR DIVYA H. 255


FORMULATION AND DEVELOPMENT OF CHRONOMODULATED DRUG DELIVERY SYSTEM OF KETOPROFEN FOR RHEUMATOID ARTHRITIS

1116 22-05-2013 H-11 112550810010

PATEL PRATIKKUMAR PRAVINBHAI 255


DEVOLOPMENT ,OPTIMIZATION AND CHARACTERIZATION OF SUSTAINED RELEASE TABLET OF CEFIXIME TRIHYDRATE.

1117 22-05-2013 H-11 112550810011

PATEL ARZUBAHEN K 255


DEVELOPMENT AND CHARACTERISATION OF THERMOSENSITIVE PLURONIC BASED FLUCONAZOLE IN SITU GEL FOR VAGINAL DRUG DELIVERY.

Row ID Exam Date





1118 22-05-2013 H-11 112550810012

PATEL ANKITKUMAR KANAIYALAL 255


FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLET OF CEFIXIME BY INCLUSION COMPLEXATION USING BETA CYCLODEXTRIN

1119 22-05-2013 H-12 112170808001

CHIHLA HITESHKUMAR JIVANBHAI 217


STUDIES ON FORMULATION AND DEVELOPMENT OF BUCCAL SPRAY OF RIZATRIPTAN BENZOATE

1120 22-05-2013 H-12 112170808002

SAPARA ROHITKUMAR TRIKAMBHAI 217


STUDIES ON DESIGN AND DEVELOPMENT OF SELF MICRO EMULSIFYING DRUG DELIVERY SYSTEMS OF PALIPERIDONE

1121 22-05-2013 H-12 112170808003

SAMEJA KRUNAL DILIPKUMAR 217


STUDIES ON DEVELOPMENT AND CHARACTERIZATION OF MOUTH DISSOLVING FILM OF OLANZAPINE HYDROCHLORIDE.

1122 22-05-2013 H-12 112170808004SATAPARA RAHUL G. 217


STUDIES ON DESIGN AND DEVELOPMENT OF NASOADHESIVE AQUEOUS SPRAY OF CYANOCOBALAMIN

1123 22-05-2013 H-12 112170808005

PRAJAPATI KRUNALKUMAR NAGARBHAI 217


STUDIS ON FORMULATION AND EVALUTION OF ORAL DISPERSIBLE TABLET OF CANDASARTAN CILEXETILE

1124 22-05-2013 H-12 112170808006

SONGARA BHAVIN KISHORBHAI 217


STUDIES ON FORMULATION AND EVALUATION OF TRANSUNGUAL DRUG DELIVERY SYSTEM OF TERBINAFINE HYDROCHLORIDE.

1125 22-05-2013 H-12 112550810013

PATEL JALDHARABEN S 255


FORMULATION DEVELOPMENT AND EVALUATION OF TRAMADOL BILAYER TABLET.

1126 22-05-2013 H-12 112550810014

PARMAR MEHULKUMAR P 255


SOLUBILITY ENHANCEMENT OF ITRACONAZOLE BY SOLID DISPERSION TECHNIQUES.

1127 22-05-2013 H-12 112550810015

PATEL ANKITKUMAR V 255


SOLID DISPERSION AS A SOLUBILITY ENHANCEMENT TECHNIQUE FOR POORLY WATER SOLUBLE DRUGS

Row ID Exam Date





1128 22-05-2013 H-12 112550810016

THAKOR AMARSANG GOPALJI 255


SOLUBILITY ENHANCEMENT OF KETOCONAZOLE BY COMPLEXATION WITH CYCLODEXTRIN.

1129 22-05-2013 H-12 112550810017

NANECHA DHIRENKUMAR AMRUTLAL 255


EFFECT OF COMPONENTS AND PROCESS PARAMETERS ON FORMULATION OF RELEASE OF ANTIDIABETIC DRUG

1130 22-05-2013 H-12 112550810018

RAVAL KAUSHAL MUKESHBHAI 255


FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING FILM CONTAINING PROMETHAZINE HYDROCHLORIDE

1131 22-05-2013 H-13 112170808007

PATADIYA DHAVAL DINESHBHAI 217


STUDIES ON DESIGN AND DEVELOPMENT OF TRANSDERMAL PATCH OF CARVEDILOL

1132 22-05-2013 H-13 112170808008SHAH ZEEL ATULBHAI 217


STUDIES ON FORMULATION AND DEVELOPMENT OF IMMEDIATE RELEASE TABLET OF ETORICOXIB

1133 22-05-2013 H-13 112170808009

MAKWANA AMI RAJESHKUMAR 217


STUDIES ON DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE IN SITU GEL OF OLOPATADINE HYDROCHLORIDE FOR OPHTHALMIC DRUG DELIVERY SYSTEM

1134 22-05-2013 H-13 112170808010

ASODIYA HARSHADKUMAR VINAYKANT 217


FORMULATION AND DEVELOPMENT OF MOUTH DISSOLVING TABLETS OF AMLODIPINE BESYLATE

1135 22-05-2013 H-13 112170808011

BARIA JAGRUTIBEN RAVINDRABHAI 217


STUDIES ON FORMULATION DEVLOPMENT AND EVALUATION OF NANOSUSPENSION OF ISARADIPINE

1136 22-05-2013 H-13 112170808012

RAYKA JIGNESHKUMAR SHANKARBHAI 217


FORMULATION AND EVALUATION OF ORO DISPERSIBLE TABLET OF RIZATRIPTAN BENZOATE

1137 22-05-2013 H-13 112170808013

BAVALIYA CHIRAG DAMJIBHAI 217


STUDIES ON SOLUBILITY AND DISSOLUTION ENHANCEMENT OF ROSUVASTATIN CALCIUM BY LIQUISOLID TECHNOLOGY.

Row ID Exam Date





1138 22-05-2013 H-13 112170808014KULKARNI ASHISH B 217


STUDIES ON FORMULATION AND EVALUATIION OF DELAYED RELEASE TABLET OF DIVALPROEX SODIUM

1139 22-05-2013 H-13 112170808015LAKHTARIA GAURANG J 217


STUDIES ON DESIGN AND DEVELOPMENT OF BUCCOADHESIVE PATCH OF CANDESARTAN CILEXETIL

1140 22-05-2013 H-13 112170808016

PANDYA SANJAYKUMAR DINESHCHANDRA 217


STUDIES ON FORMULATION DEVELOPMENT AND OPTIMIZATION OF ORALLY DISINTEGRATING FILMS OF SILDENAFIL CITRATE

1141 22-05-2013 H-13 112170808017

PRAJAPATI SANKETKUMAR JAGDISHBHAI 217


STUDIES ON FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF A BETA-BLOCKER DRUG

1142 22-05-2013 H-13 112170808018

PAREKH HEJAL BIPINCHANDRA 217


STUDIES ON DESIGN AND DEVELOPMENT OF MICROPARTICULATE GEL OF CLOTRIMAZOLE

1143 22-05-2013 H-14 112500808001

SANTOKI RAJNISHKUMAR KHIMJI 250


DEVELOPMENT AND CHARACTERIZATION OF MUCOADHESIVE BUCCAL TABLET OF HYDRALAZINE USING ISOLATED MUCILAGE OF ANNONA SQUAMOSA SEEDS

1144 22-05-2013 H-14 112500808002

DHOLARIYA JAYDEEP PRAVINBHAI 250


FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF ETODOLAC FOR ARTHRITIS

1145 22-05-2013 H-14 112500808003

VNALIYA SAROJ SAVJIBHAI 250


FORMULATION AND EVALUATION OF METRONIDAZOL IN SITU GEL FOR PERIODONTAL TREATMENT

Row ID Exam Date





1146 22-05-2013 H-14 112500808004

CHAVDA VAISHALI DINESHBHAI 250


FORMULATION, EVALUATION AND OPTIMIZATION OF MOUTH DISSOLVING FILM OF DOXYLAMINE SUCCINATE

1147 22-05-2013 H-14 112500808005SANGHANI DARSHIT D 250


DEVELOPMENT AND CHARACTERIZATION OF MOUTH DISSOLVING TABLET OF RIZATRIPTAN BENZOATE

1148 22-05-2013 H-14 112500808006BORISAGAR KULDIP J 250


FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF LABETALOL HCL

1149 22-05-2013 H-14 112500808007

DHEBAR MANAN KULINCHANDRA 250


FORMULATION AND CHARACTERIZATION OF SUSTAINED RELEASE TABLETS OF ISOXSUPRINE HCL USING NOVEL LIPID EXCIPIENTS

1150 22-05-2013 H-14 112500808008BHAGAT SHREEL N 250


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF ORAL BUCCO ADHESIVE TABLETS OF TACRINE HCL

1151 22-05-2013 H-14 112500808009

MEHTA ROSHNI RAJENDRA 250


FORMULATION AND EVALUATION OF FLOATING IN SITU GEL OF CEFPODOXIME PROXETIL USING NATURAL BIODEGRADABLE POLYMERS

1152 22-05-2013 H-14 112500808010

DESHANI JAYKUMAR MANHARLAL 250


FORMULATION AND EVALUATION OF TRANSDERMAL GEL OF COLCHICINE USING NATURAL PERMEATION ENHANCERS

Row ID Exam Date





1153 22-05-2013 H-14 112500808011KAPADIYA KAMLESH R 250


FORMULATION AND EVALUATION OF BUCCAL TABLET OF LOSARTAN POTASSIUM USING NATURAL POLYMER

1154 22-05-2013 H-14 112500808012

CHAUHAN ASHVINBHAI R. 250


FORMULATION AND EVALUATION OF MOUTH DISSOLVING DIMENHYDRINATE LIQUISOLID TABLETS

1155 22-05-2013 H-14 112500808013GOSWAMI HITESHA P. 250


DESIGN, DEVELOPMENT AND CHARACTERIZATION OF ORAL MUCOADHESIVE TABLET OF PIOGLITAZONE USING NATURAL POLYMER ISOLATED FROM PITHEOCELLOBIUM DULCE

1156 22-05-2013 H-15 112500808015KAKADIYA PARTH S. 250


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF PIROXICAM

1157 22-05-2013 H-15 112500808016

KANASAGARA HETALBEN VRAJLAL 250


FORMULATION, EVALUATION AND OPTIMIZATION OF CARBAMAZEPINE FAST DISSOLVING TABLET USING LIQUISOLID COMPACT TECHNIQUE

1158 22-05-2013 H-15 112500808018

PANSURIYA HIREN DILIPBHAI 250


FORMULATION OF ONCE A DAY CONTROLLED RELEASE OSMOTIC TABLET OF ROPINIROLE HCL

1159 22-05-2013 H-15 112570808011

PATEL ANKITABEN DASHARATHBHAI 257


FORMULATION AND EVALUATION OF MICROEMULSION BASED GEL

Row ID Exam Date





1160 22-05-2013 H-15 112570808012

THAKOR VINODKUMAR KARSHANJI 257


FORMULATION AND EVALUATION OF FAST DISSOLVING STRIP

1161 22-05-2013 H-15 112570808013

PRAJAPATI YOGESHKUMAR T. 257


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF ANTIMIGRAINE DRUG

1162 22-05-2013 H-15 112570808015

PATEL JINAL RAMESHCHANDRA 257


DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET OF CEFPODOXIME PROXETIL

1163 22-05-2013 H-15 112570808016

PATEL HIRENKUMAR R. 257


FORMULATION AND EVALUATION OF IMMEDIATELY RELEASE TABLET OF CANDESARTAN CILEXETIL

1164 22-05-2013 H-15 112570808017

PATEL VINASKUMAR ASHOKBHAI 257


STUDIES ON FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF PIOGLITAZONE HYDROCHLORIDE

1165 22-05-2013 H-15 112570808018PATEL RAVI NATVARLAL 257


PREPARATION AND EVALUATION OF FAST DISINTEGRATING TABLET OF AMLODIPINE BESYLATE

1173 23-05-2013 H-02 112020805001BHARGAVA VIDITA VIKAS 202


DEVELOPMENT OF MONOGRAPH ON ANOGEISSUS LATIFOLIA(ROXB.EX DC)EX BEDD

1174 23-05-2013 H-02 112020805002DESAI KRUTI SHAILESH 202


DEVELOPMENT AND EVALUATION OF HERBAL ANTIACNE GEL

1175 23-05-2013 H-02 112070805001

SADHWANI MADHURI HEMRAJBHAI 207


DEVELOPMENT AND STANDARDIZATION OF POLY HERBAL FORMULATION FOR TUBERCULOSIS

Row ID Exam Date





1176 23-05-2013 H-02 112070805002

ASARI BRIJALBEN NARSINHBHAI 207


PREPARATION AND EVALUATION OF POLY HERBAL FORMULATION FOR KIDNEY STONE

1177 23-05-2013 H-02 112280805001

HEMANTKUMAR SHYAMSUNDAR SANKHALA 228


FORMULATION & DEVELOPMENT OF POLYHERBAL ANTI-ASTHAMATIC LOZENGES

1178 23-05-2013 H-02 112280805002

PATEL ANKITABEN ANILKUMAR 228


PHYTOCHEMICAL INVESTIGATION ON LEEA INDICA & OPTIMAL EXTRACTION OF ALKALOIDS FROM THERMOPSIS ALTERNIFLORAE USING NOVEL TECHNIQUES OF EXTRACTION.

1179 23-05-2013 H-02 112280805003

RAM PRAVINKUMAR BHOJABHAI 228


PHARMACOGNOSTICAL AND PHARMACOLOGICAL STUDY ON BAUHINIA VARIEGATA.

1180 23-05-2013 H-02 112280805004

PATEL VIHANGI KISHORKUMAR 228


PHYTOCHEMICAL INVESTIGATION ON STACHYTARPHETA INDICA.

1166 23-05-2013 H-02 112520805001

SHIROYA VIJAY NANUBHAI 252


ESTIMATION OF TOTAL TANNINS AND CAFFEINE AND EVALUATION OF ANTI-OXIDANT PROPERTY OF MARKETED TEA

1167 23-05-2013 H-02 112520805002

Patel Hiteshkumar Natavarlal 252


COMPARATIVE EVALUATION OF SELECTED MARKET TRIPHALA CHURNA FORMULATIONS

1168 23-05-2013 H-02 112520805003

THAKKAR NITIN VIJAYKUMAR 252


DEVELOPMENT AND STANDARDIZATION OF POLYHERBAL MOUTH DISSOLVING GRANULES

Row ID Exam Date





1181 23-05-2013 H-03 112600805001PATEL HETAL RAMJIBHAI 260

SHREE SWAMINARAYAN SANSKAR PHARMACY COLLEGE, ZUNDAL

DEVELOPMENT AND EVALUATION OF POLYHERBAL FORMULATION FOR HEEL FISSURES

1182 23-05-2013 H-03 112600805002

CHRISTIAN HANNAH HARISH 260


DEVELOPMENT AND EVALUATION OF POLYHERBAL MOSQUITO REPELLENT FORMULATION

1183 23-05-2013 H-03 112600805003

NEHAL NARENDRAKUMAR PARMAR 260


UTILIZATION OF PLANT PART WASTE AS BIOADSORBENT TO REMOVEWATER SOLUBLE TOXIC DYES

1184 23-05-2013 H-03 112600805004SHAH PANKTI J 260


DEVELOPMENT AND EVALUATION OF POLYHERBAL FORMULATION FOR PSORIASIS

1185 23-05-2013 H-03 112600805005

DHANANI KRUTI RAMNIKBHAI 260


DEVELOPMENT AND EVALUATION OF ANTI ACNE FACIAL SCRUB

1186 23-05-2013 H-03 112600805006

PATEL DHARTIBEN JITENDRAKUMAR 260


SCREENING OF PLANT PIGMENT AS AN INDICATOR FOR VARIOUS TITRIMETRIC ANALYSIS

1187 23-05-2013 H-03 112600805007PATEL SUCHITA D. 260


EVALUATION OF HERBICIDAL AND PESTICIDAL ACTIVITY OF PARTHENIUM HYSTEROPHORUS

1188 23-05-2013 H-03 112600805008

PATEL POOJABEN RAJENDRAKUMAR 260


DEVELOPMENT & EVALUATION OF POLYHERBAL FORMULATION FOR ALOPECIA

Row ID Exam Date





1189 23-05-2013 H-03 112600805009KOTADIYA DHARATI D 260


DEVELOPMENT AND EVALUATION OF POLYHERBAL FORMULATION FOR FACIAL SKIN REJUVENATION

1190 23-05-2013 H-03 112600805010

Makwana Priyanka Sureshkumar 260


DEVELOPMENT & EVALUATION OF POLYHERBAL FORMULATION FOR PERIORBITAL HYPERCHROMIA

1169 23-05-2013

H-03

112610805001

PATEL HIRENJALBEN P. 261


EVALUATION OF ANTI-TUSSIVE ACTIVITY OF POLYHERBAL FORMULATION

1170 23-05-2013

H-03

112610805002

ATODARIYA UNNATIBAHEN I 261


USE OF DOLICHOS BIFLORUS LINN FOR THE TREATMENT OF KIDNEY STONE

1171 23-05-2013

H-03

112610805003BHATT SWATI N 261


EVALUATION OF ANTI-ASTHMATIC ACTIVITY OF POLYHERBAL FORMULATION

1172 23-05-2013

H-03

112610805004

Barad Roshniben Arjunbhai 261


EFFECT OF WITHANIA COAGULANS AND PSIDIUM GUAJAVA ON DIABETES MELLITUS

1191 23-05-2013 H-04 112140804001

VOHRA NILOFAR ALIBHAI 214


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR ESTMATION OF FOSAPREPITANT DIMEGLUMINE IN BULK AND ITS DOSAGE FORM.

1192 23-05-2013 H-04 112140804002

UKANI MILANKUMAR BATUKBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ALPRAZOLAM AND IMIPRAMINE HCL IN BULK AND IN TABLET DOSAGE FORM.

1193 23-05-2013 H-04 112140804003

PATEL HEMINA PANKAJBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND MOXIFLOXACIN HCL IN BULK AND ITS FORMULATION.

1194 23-05-2013 H-04 112140804004

PADARIYA MONICA NARESHCHANDRA 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DOXOPHYLLINE AND AMBROXOL HCL AS API AND ITS FORMULATION.

Row ID Exam Date





1195 23-05-2013 H-04 112140804005PATEL POOJA DWARKADAS 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF PRESERVATIVES IN POLYHERBAL COUGHSYRUP

1196 23-05-2013 H-04 112140804006

PATEL JINALKUMARI B 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS OF METFORMIN HCL AND ALPHA-LIPOIC ACID IN SYNTHETIC MIXTURE.

1197 23-05-2013 H-04 112140804007SHAH BHOOMI P 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND OLOPATADINE AS API AND ITS DOSAGE FORM.

1198 23-05-2013 H-04 112140804008

PRAJAPATI JATINKUMAR NARANBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS OF LORNOXICAM AND EPERISONE AS API AND ITS FORMULATION.

1199 23-05-2013 H-04 112140804009

PATEL JITENDRA JIVRAJBHAI 214


METHOD DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CHLORTHALIDONE AS API AND ITS FORMULATION.

1200 23-05-2013 H-04 112140804010

SHAH JEMIN RAJESHKUMAR 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF CALCIUM IN HERBOMINERAL FORMULATION BY ATOMIC ABSORPTION SPECTROPHOTOMETRY.

1201 23-05-2013 H-04 112140804011

PRAJAPATI KRISHNABEN KANUBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM AND TRAMADOL HCL IN BULK AND ITS FORMULATION

1202 23-05-2013 H-04 112140804012

RATHOD HETALKUMARI JITENDRASINH 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTMATION OF DEXAMETHASONE AND SPARFLOXACIN IN EYE/EAR DROPS.

1203 23-05-2013 H-05 112140804013

CHUDASAMA PRITIBEN NAVUBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF 1,4 DIAOXNE IN HERBAL SHAMPOO BY GC

Row ID Exam Date





1204 23-05-2013 H-05 112140804014

CHAVDA HINA REVABHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE SODIUM SESQUIHYDRATE AND DICLOFENAC SODIUM IN BULK AND ITS DOSAGE FORM

1205 23-05-2013 H-05 112140804015

MANSURI NASIMABANU Y. 214


METHOD DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF AMBROXOL HCL AND OLOPATADINE HCL IN BULK AND ITS FORMULATION.

1206 23-05-2013 H-05 112140804016

PRAJAPATI DHARMESHBHAI KANTIBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DOXOFYLLINE AND TERBUTALINE SULPHATE IN BULK AND ITS FORMULATION.

1207 23-05-2013 H-05 112140804017

RETHALIYA KRUSHNKUMAR KARAMSHIBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE AND DESLORATIDINE IN BULK AND ITS FORMULATION.

1208 23-05-2013 H-05 112140804018

VAGHELA PRATIK SUNILBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF INDAPAMIDE AND NEBIVOLOL IN BULK AND TABLET DOSAGE FORM.

1209 23-05-2013 H-05 112140804019

PATEL DIPIKABAHEN RAMANLAL 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LISINOPRIL AND HYDROCHLORTHIAZIDE IN BULK AND ITS DOSAGE FORM.

1210 23-05-2013 H-05 112140804020GAVLI HIMANSHU C 214


PROCESS VALIDATION OF PROTHIONEMIDE TABLET DOSAGE FORM.

1211 23-05-2013 H-05 112140804021

SUVERA MAULIKA AJITBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFUROXIME AND CLAVULANIC ACID IN BULK AND AND ITS FORMULATION.

Row ID Exam Date





1212 23-05-2013 H-05 112140804022

PATEL DEVANGIBEN RAJNIKANT 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE IN BULK AND ITS FORMULATION

1213 23-05-2013 H-05 112140804023PATEL DIVYESH M. 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF AMIKACIN SULPHATE AND DEXAMETHASONE IN PARENTERAL.

1214 23-05-2013 H-05 112140804024VARIA NIRAV C. 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF AZITHROMYCIN AND LEVOFLOXACIN IN BULK AND IN DOSAGE FORM.

1215 23-05-2013 H-06 112140804025VYAS JIPAL H. 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF FLUOXETINE HYDROCHLORIDE AND CIDENAFIL CITRATE IN COMBINED TABLET DOSAGE FORM

1216 23-05-2013 H-06 112140804026

PATEL SAURABHKUMAR J 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF TIMOLOL MALEATE AND HYDROCHLORTHIAZIDE IN BULK AND IN THEIR TABLET DOSAGE FORM.

1217 23-05-2013 H-06 112140804027

PATEL MOHMMEDAFZAL YUNUSISMAIL 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND DESLORATADINE IN BULK AND IN THEIR TABLET DOSAGE FORM.

1218 23-05-2013 H-06 112140804028

RANA NIRAVKUMAR RAMANBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF ETIZOLAM AND PROPRANOLOL HYDROCHLORIDE IN BULK AND ITS FORMULATION.

1219 23-05-2013 H-06 112140813001

KABANI NEHAN FIROZBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE & LEVOFLOXACIN HEMIHYDRATES IN BULK & TABLET DOSAGE FORM.

Row ID Exam Date





1220 23-05-2013 H-06 112140813002

PARATE PANDURANG SUBHASHBHAI 214


METHOD DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC SODIUM & SERRATIOPEPTIDASE IN BULK & TABLET DOSAGE FORM

1221 23-05-2013 H-06 112140813003

BHATT DIVYANGKUMAR JYOTINDRAKUMAR 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE & DICLOFENAC SODIUM IN BULK & SOLID DOSAGE FORM.

1222 23-05-2013 H-06 112140813004

GONDALIYA JITENDRAKUMAR BHIKHABHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DITHRANOL AND SALICYLIC ACID IN BULK AND ITS DOSAGE FORM.

1223 23-05-2013 H-06 112140813005

SAWANT NEHA NARENDRA 214


PROCESS VALIDATION OF METFORMIN HYDROCHLORIDE TABLET

1224 23-05-2013 H-06 112140813006

PATEL DHARTI DINESHBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME & LINEZOLID IN BULK & TABLET DOSAGE FORM.

1225 23-05-2013 H-06 112140813007

BAJAJ AJAY CHANCHALBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF MOMETASONE FUROATE & TERBINAFINE IN BULK &PHARMACEUTICAL DOSAGE FORMS.

1226 23-05-2013 H-06 112140813008

BHANDERI KETANKUMAR GORDHANBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CHLORTHALIDONE & OLMESARTAN MEDOXOMIL IN BULK & TABLET DOSAGE FORMS.

1227 23-05-2013 H-07 112140813009

TALAVIYA PIYUSHKUMAR MAGANBHAI 214


DEVELOPMNT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF RABEPRAZOLE SODIUM & LAFUTIDINE IN BULK CAPSUL DOSAGE FORM

Row ID Exam Date





1228 23-05-2013 H-07 112140813010

PATEL RAVIKUMAR MANHARBHAI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF ATORVASTATIN CALCIUM & VITAMIN D3 IN BULK & SOLID DOSAGE FORM

1229 23-05-2013 H-07 112140813011

SALIYA PRASHANT PREMJIBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND FLUPIRTINE MALEATE AS API AND ITS FORMULATION.

1230 23-05-2013 H-07 112140813012

ANGHAN HEMRAJ BABUBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF RAMIPRIL AND CHLORTHALIDONE IN BULK AND TABLET DOSAGE FORM.

1231 23-05-2013 H-07 112140813013

PATEL RONAKKUMAR NAVINCHANDRA 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF RAMIPRIL AND CILNIDIPINE AS API AND ITS DOSAGE FORM.

1232 23-05-2013 H-07 112140813014

MEHTA HASMUKH DHARAMCHANDJI 214


DEVELOPMENT & VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PROPOFOL AND LIGNOCAINE IN BULK AND ITS FORMULATION.

1233 23-05-2013 H-07 112140813015

SOLANKI TUSHHARKUMAR MOHANBHAI 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF WITHANOLIDE-A AND WITHANOSIDE-IV.

1234 23-05-2013 H-07 112140813016

TRIVEDI ALPESHKUMAR MOHANBHAI 214


STABILITY INDICATING RP-HPLC METTHOD FOR ESTIMATION OF ALISKIREN HEMI FUMARATE & AMLODIPINE BESYLATE IN BULK & THEIR PHARMACEUTICAL DOSAGE FORM

1235 23-05-2013 H-07 112140813017SHAH AKASH JAGVANDAN 214


DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF PIPERINE AND GALIC ACID IN POLYHERBAL FORMULATION.

1236 23-05-2013 H-07 112140813018

LAD RACHANA JITENDRABHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF ACETAMINOPHEN AND PAMABROM IN BULK AND TBLET DOSAGE FORM

Row ID Exam Date





1237 23-05-2013 H-07 112140813019CHAUHAN ASEFA I. 214


STABILTY INDICATING ASSAY METHOD FOR SIMULTANEOUS ESTIMATION LINAGLIPTIN AND METFORMIN IN BULK AND SOLID DOSAGE FORM.

1238 23-05-2013 H-07 112140813020

CHAUHAN VAISHALIBEN DILIPBHAI 214


PROCESS VALIDATION OF ALUMINIUM HYDROXIDE,MAGNESIUM HYDROXIDE AND SEMITHICON ORAL SUSPENSION.

1239 23-05-2013 H-08 112140813021

BARIA HARDIKSINH R 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF FEBUXOSTAT AND DICLOFENAC POTASSIUM IN BULK AND IN ITS TABLET DOSAGE FORM

1240 23-05-2013 H-08 112140813022

MODI HARDIKKUMAR KISHORBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN AND FLAVOXATE HCL IN BULK AND ITS TABLET DOSAGE FORM

1241 23-05-2013 H-08 112140813023

PATEL SANJAYKUMAR P. 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CAMYLOFIN DIHYDROCHLORIDE AND MEFANAMIC ACID IN BULK AND ITS TABLET DOSAGE FORM

1242 23-05-2013 H-08 112140813024

PRAJAPATI NIKHIL ASHOKBHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LEVOSULPRIDE AND PENTOPRAZOLE SODIUM IN BULK DOSAGE FORM

1243 23-05-2013 H-08 112140813025

RATHOD NEHAL SOMABHAI 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND TAPENTADOL HYDROCHLORIDE IN BULK AND TABLET DOSAGE FORM.

1244 23-05-2013 H-08 112140813026

SOIDA SANKETKUMAR B. 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CYCLOBENZAPRINE HYDROCHLORIDE AND ACECLOFENAC IN BULK AND TABLET DOSAGE FORM.

Row ID Exam Date





1246 23-05-2013 H-08 112140813028

PATEL HIRENKUMAR KIRANKUMAR 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE AND PARACETAMOL IN THEIR TABLET DOSAGE FORM

1247 23-05-2013 H-08 112140813029BHATT MANAN S. 214


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF LINEZOLID IN K3 EDTA HUMAN PLASMA BY USING HPLC-ESI-MS/MS.

1248 23-05-2013 H-08 112140813030BHATT DEEP PARIMAL 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF ILAPRAZOLE IN ITS TABLET DOSAGE FORM.

1249 23-05-2013 H-08 112140813031

PATEL SACHIN AMATHABHAI 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF METRONIDAZOLE AND MUPIROCIN IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM

1250 23-05-2013 H-08 112140813032DESAI KETKI K 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF LOSARTAN POTASSIUM AND CHLORTHALIDONE IN BULK AND THEIR TABLET DOSAGE FORM

1251 23-05-2013 H-09 112140813033

PATEL KRUTIKABEN M. 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION EZETIMIBE AND FENOFIBRATE IN BULK AND THEIR PHARMACEUTICAL DOSAGE FORM.

1252 23-05-2013 H-09 112140813034PATEL ANKITABEN C 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN THEIR PHARMACEUTICAL DOSAGE FORM.

1253 23-05-2013 H-09 112140813035

SELIA MAHAMMADYUSUF A. 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ALISKIREN HEMIFUMARATE AND HYDROCHLOROTHIAZIBE IN BULK AND PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1254 23-05-2013 H-09 112140813036DHUKA SOHEL I 214


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF BECLOMETHASONE DIPROPIONATE AND SALICYLIC ACID IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM

1255 23-05-2013 H-09 112280804001

BHALODIYA VAISHALI MAHENDRABHAI 228


HPTLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN CALCIUM AND FENOFIBRATE IN BULK AND PHARMACEUTICAL DOSAGE FORM & DEGRADATION STUDY OF ROSUVASTATIN CALCIUM.

1256 23-05-2013 H-09 112280804002

GAMBHAVA NISHABEN SAVJI 228


ISOLATION,CHARACTERIZATION AND ESTIMATION OF PLUMIERIDE COUMARATE FROM STEM BARK OF PLUMERIA OBTUSA AND ESTIMATION OF PENTACYCLIC TRI TERPENOIDS FROM LEAVES OF PLUMERIA OBTUSA.

1257 23-05-2013 H-09 112280804003

SAYTA VARUN JAYESHBHAI 228


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND HPTLC METHODS FOR DETERMINATION OF ALENDRONATE SODIUM IN ITS BULK AND TABLET DOSAGE FORM

1258 23-05-2013 H-09 112280804004

PATEL ANKITKUMAR MAHENDRABHAI 228


ISOLATION,CHARACTERISATION AND QUANTIFICATION OF GARCINOL FROM DRY FRUIT RINDS OF GARCINIA INDICA AND ITS AVAILABLKE MARKET FORMULATION.

1259 23-05-2013 H-09 112280804005

PATEL VIJAYKUMAR S. 228


DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC AND HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF LAFUTIDINE AND DOMPERIDONE IN BULK AND ITS PHARMACEUTICAL DOSAGES FORMS &FORCE DEGRADATION STUDY OF LAFUTIDINE BY HPTLC METHOD.

1260 23-05-2013 H-09 112280804006

PATEL JITENKUMAR SUMANBHAI 228


EVALUATION OF DISSOLUTION PROFILES OF METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLET USING MATHEMATICAL MODELS.

Row ID Exam Date





1261 23-05-2013 H-09 112280804007

SURVE SHREENIDHI S 228


HPTLC AND HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RABEPRAZOL SODIUM AND LEVOSULPIRIDE IN PHARMACEUTICAL DOSAGE FORM.

1262 23-05-2013 H-09 112280804008

DAMOR MAHESHBHAI BABUBHAI 228


DISSOLUTION OF METFORMIN HYDROCHLORIDE IN EXTENDED RELEASE METFORMIN HYDROCHLORIDE AND GLIMEPIRIDE TABLETS & DETERMINATION OF CONTENT UNIFORMITY OF GLIMEPIRIDE IN PHARMACEUTICAL DOSAGE FORM BY HPTLC METHOD.

1263 23-05-2013 H-10 112310808001

HIRPARA FRENYKUMAR BABUBHAI 231


FORMULATION AND EVALUATION OF FAST DISSOLVING SUBLINGUAL FILMS OF RABEPRAZOLE SODIUM

1264 23-05-2013 H-10 112310808002

CHOTALIYA MALAYKUMAR P 231


FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF NEBIVOLOL

1265 23-05-2013 H-10 112310808003PARSANIA KISHAN J 231


FORMULATION AND EVALUTION OF MODIFIED RELEASE BILAYER TABLET OF PIOGLITZONE HCL AND GLIMEPRIDE

1266 23-05-2013 H-10 112310808005DESAI TEJAS R 231


FORMULATION AND EVALUATION OF FLOATING MICROSPHERE OF VALSARTAN

1267 23-05-2013 H-10 112310808006

PATEL PRATIK SHASHIKANTBHAI 231


FORMULATION AND EVALUATION OF FAST DISINTEGRATING SUBLINGUAL TABLETS OF BUSPIRONE HYDROCHLORIDE

1268 23-05-2013 H-10 112310808007

RAVAL BRAHMDUTTA K. 231


FORMULATION AND EVALUATION OF FAST DISSOLVING SUBLINGUAL TABLETS OF IVABRADINE HYDROCHLORIDE

1269 23-05-2013 H-10 112310808008JOSHI KRUNAL J. 231


FORMULATION AND EVALUATION OF FAST RELEASING SUBLINGUAL FILMS OF NIMODIPINE

1270 23-05-2013 H-10 112310808009

DHANDHALYA RAJIVBHAI N. 231


SOLUBILITY ENHANCEMENT OF ATORVASTATIN & COMPARATIVE STUDY OF VARIOUS SOLUBILIZATION TECHNIQUES

1271 23-05-2013 H-10 112310808010

PARMAR MUKESH BHAGVANBHAI 231


FORMULATION AND EVALUATION OF RAPID DISSOLVING SUBLINGUAL FILM OF TERBUTALINE SULPHATE

Row ID Exam Date





1272 23-05-2013 H-10 112310808011

PATEL HARSHIL JAGDISHCHANDRA 231


FORMULATION AND EVALUATION OF FLOATING INSITU GEL OF GLIPIZIDE

1273 23-05-2013 H-10 112310808012

GOLANI MANISHKUMAR L 231


FORMULATION AND EVALUATION OF FLOATING TABLETS OF REPAGLINIDE

1274 23-05-2013 H-11 112310808014PATEL RAVI ARVINDBHAI 231


FORMULATION AND EVALUATION OF INSITU FLOATING GEL OF FUROSEMIDE

1275 23-05-2013 H-11 112310808015

VACHHANI TEJASKUMAR J 231


FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF METOCLOPRAMIDE

1276 23-05-2013 H-11 112310808016

BHARADVA PRASHANT VALLABHBHAI 231


FORMULATION AND EVALUATION OF NIOSOMAL GEL OF CLINDAMYCIN PHOSPHATE AND AZELAIC ACID FOR ACNE

1277 23-05-2013 H-11 112310808017

SAPOVADIYA GAURANGKUMAR V 231


FORMULATION AND EVALUATION OF SUSTAIN RELEASE MICROSPHERES OF PIOGLITAZONE

1278 23-05-2013 H-11 112310808018VALA ASHISH S. 231


FORMULATION AND EVALUATION OF FAST DISINTEGRATING SUBLINGUAL TABLETS OF PANTOPRAZOLE

1279 23-05-2013 H-11 112610808001PATEL NITESH N 261


COMPARATIVE STUDY OF THE AMORPHOUS PREPARATION OF WATER INSOLUBLE VALSARTAN DRUG

1280 23-05-2013 H-11 112610808002

VARDE NEHABEN MAHENDRAKUMAR 261


FORMULATION OPTIMIZATION AND EVALUTION OF NANOCOCHLEATE GEL.

1281 23-05-2013 H-11 112610808003

THAKOR NAMITABEN MAHENDRASINH 261


FORMULATION AND EVALUATION OF BILAYER TABLET OF TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM

1282 23-05-2013 H-11 112610808004

JOSHI DARSHANABEN PRAVINBHAI 261


FORMULATION DEVELOPMENT AND EVALUATION OF MICROEMULSION BASED GEL OF ZALTOPROFEN

1283 23-05-2013 H-11 112610808005

PATEL PARAG VISHNUBHAI 261


FORMULATION DEVELOPMENT AND EVALUATION OF MINITABLETS FOR COMBINATION THERAPY IN DIABETES.

Row ID Exam Date





1284 23-05-2013 H-11 112610808006

GHADIYALI MAHAMMEDSHAHEBAZ N. 261


STUDY OF PROCESSING PARAMETERS AFFECTING DISSOLUTION PROFILE OF DRUGS WITH DIFFERENT PROPERTIES

1285 23-05-2013 H-12 112610808007

PARMAR KIRAN DAHIYABHAI 261


STUDY OF EXCIPIENTS AFFECTING DISSOLUTION PROFILE OF DRUG WITH SPECIAL EMPHASIS ON COPROCESSED EXCIPIENTS

1286 23-05-2013 H-12 112610808008

MEHTA NIKUNJKUMAR K 261


FORMULATION DEVELOPMENT AND EVALUATION OF CHRONOMODULATED DRUG DELIVERY SYSTEM OF KETOPROFEN

1287 23-05-2013 H-12 112610808009

PATEL NIKET MAHESHBHAI 261


FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE SUSPENSION OF DEXTROMETHORPHAN HBr

1288 23-05-2013 H-12 112610808010SHAH JIMISH S 261


FORMULATION DEVELOPMENT AND EVALUATION OF BENZOYL PEROXIDE NANOSPONGE

1289 23-05-2013 H-12 112610808011GOHEL HITESH P. 261


DEVELOPMENT AND OPTIMIZATION OF COLON TARGETED DRUG DELIVERY SYSTEM OF ACECLOFENAC BY PH AND MICROBIAL TRIGGERED COMBINED APPROACH

1290 23-05-2013 H-12 112610808012

PATEL HARSHIDA GULABBHAI 261


FORMULATION OPTIMIZATION AND EVALUATION OF ORODISPERSIBLE TABLET OF ZIPRASIDONE

1291 23-05-2013 H-12 112610808013

RATHVA SUNILKUMAR R. 261


FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLET OF ANTIHYPERTENSIVE DRUG

1292 23-05-2013 H-12 112610808014

BRAHMBHATT HARDIKKUMAR BHARATKUMAR 261


FORMULATION DEVELOPMENT AND EVALUATION OF SUBLINGUAL TABLET FOR MIGRAINE.

1293 23-05-2013 H-12 112610808015BHAVSAR DHAVAL N 261


FORMULATION DEVELOPMENT AND EVALUATION OF BILAYERED TABLETS OF KETOROLAC TROMETHAMINE AND OMEPRAZOLE.

Row ID Exam Date





1294 23-05-2013 H-12 112610808016

TRIVEDI NIKUNJ UPENDRAKUMAR 261


FORMULATION DEVELOPMENT AND EVALUATION OF OSMOTICALLY CONTROLLED COLON TARGETED DRUG DELIVERY SYSTEM.

1295 23-05-2013 H-12 112610808017 C.SINI 261


FORMULATION DEVELOPMENT AND EVALUATION OF RAPID DISSOLVING FILM OF AMITRIPTYLINE HYDROCHLORIDE

1296 23-05-2013 H-12 112610808018

SHAH VIRAL ARVINDKUMAR 261


FORMULATION DEVELOPMENT AND EVALUATION OF BUCCAL BILAYER PATCH.

1297 23-05-2013 H-14 112200808001

PATEL KEVALKUMAR PRAVINBHAI 220


DESIGN, DEVELOPMENT AND OPTIMIZATION OF ROSIGLITAZONE MALEATE FLOATING SUSTAINED RELEASE TABLET

1298 23-05-2013 H-14 112200808002

PATEL ANKIT RASHMIKANT 220


DESIGN, DEVELOPMENT AND EVALUATION OF IBUPROFEN LOADED SOLID LIPID NANOPARTICLES

1299 23-05-2013 H-14 112200808003

UPADHYAY JAGRAVI UPENDRAKUMAR 220


FORMULATION, DEVELOPMENT, OPTIMIZATION AND EVALUATION OF EXTENDED RELEASE TABLET OF LEVETIRACETAM

1300 23-05-2013 H-14 112200808004

PATEL RONAKKUMAR JAYANTILAL 220


DESIGN, DEVELOPMENT, EVALUATION OF TOPICAL HYDROGEL CONTAINING ACYCLOVIR

1301 23-05-2013 H-14 112200808005

PARMAR HITESHKUMAR T 220


FORMULATION AND EVALUATION OF LORNOXICAM RESIN COMPLEX MODIFIED RELEASE TABLET

1302 23-05-2013 H-14 112200808006

PUJARA KOMAL NAVINCHANDRA 220


FORMULATION, DEVELOPMENT, OPTIMIZATION AND EVALUATION OF PROLONG RELEASE TABLET OF ANTI PARKINSON DISEASE

1303 23-05-2013 H-15 112200808007PANCHAL KARNAV N. 220


SOLUBILITY ENHANCEMENT OF CARVEDILOL MATRIX TABLET

1304 23-05-2013 H-15 112200808008

PATEL PRAGNESHBHAI V. 220


FORMULATION, EVALUATION AND OPTIMIZATION OF BUCCOADEHESIVE TABLET OF RAMIPRIL

1305 23-05-2013 H-15 112200808009

PADHIAR BHAVESH DIPAKKUMAR 220


DESIGN, DEVELOPMENT AND EVALUATION OF ZALTOPROFEN SUSTAINED RELEASE TABLET

Row ID Exam Date





1306 23-05-2013 H-15 112200808010

PATEL YATINKUMAR VISHNUBHAI 220


DESIGN, DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE MICROSPHERES OF TRIHEXYPHENIDYL HYDROCHLORIDE

1307 23-05-2013 H-15 112200808011PATEL PALAK S 220


SOLUBILITY ENHANCEMENT OF CONVENTIONAL CLOMIPHENE CITRATE TABLET

1308 23-05-2013 H-15 112200808012

PATHAK RAVIKUMAR J. 220


DESIGN, DEVELOPMENT AND EVALUATION OF ITOPRIDE HYDROCHLORIDE MUPS SUSTAINED RELEASE TABLET

1309 23-05-2013 H-15 112200808013

SOLANKI YUVRAJSINH M 220


DESIGN, OPTIMIZATION AND EVALUATION OF INSULIN OCULAR GEL WITH CHEMICAL PENETRATION ENHANCERS

1310 23-05-2013 H-15 112200808014

SHARMA DARSHANKUMAR 220


DESIGN, DEVELOPMENT AND EVALUATION OF GALANTAMINE HYDROBROMIDE BI-LAYER SUSTAINED RELEASE TABLET

1311 23-05-2013 H-15 112200808015

KOTHARI NISHITH DAXESHKUMAR 220


DESIGN, DEVELOPMENT AND OPTIMIZATION OF CEFUROXIME AXETIL FLOATING BI-LAYER TABLET

1312 23-05-2013 H-15 112200808016PRAJAPATI HIMATLAL N. 220


DESIGN AND DEVELOPMENT OF GLICLAZIDE SUSTAINED RELEASE MATRIX TABLET

1313 23-05-2013 H-15 112200808017

PATHAK RUSHITKUMAR JYOTISHKUMAR 220


FORMULATION, DEVELOPMENT, OPTIMIZATION AND EVALUATION OF EXTENDED RELEASE TABLET FOR ANTI PSYCHOTIC DRUG

1314 23-05-2013 H-15 112200808018

RATHAUR DIPAKSINGH VIJAYSINGH 220


DESIGN, DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET CONTAINING RIZATRIPTAN BENZOATE

1315 24-05-2013 H-01 112420808001

MAHIDA RIDDHIRAJBEN VANRAJSINH 242


FORMULATION AND EVALUATION OF CLEAR LIQUID FILL SOLUTION OF CHLOROQUINE PHOSPHATE FOR SOFT GELATIN CAPSULE

1316 24-05-2013 H-01 112420808002PATEL RAMJI KANTIBHAI 242


FORMULATION, EVALUATION AND OPTIMIZATION OF LIPOSOME AS A CARRIER FOR CEFPODOXIME PROXETIL

Row ID Exam Date





1317 24-05-2013 H-01 112420808003VALA BHUMI JETHALAL 242


FORMULATION DEVLOPMENT AND EVALUATION OF ENTERIC COATED PELLETS OF A PROTON PUMP INHIBITOR

1318 24-05-2013 H-01 112420808004

PATEL HARDIK KANTILAL 242


FORMULATION, EVALUATION AND OPTIMIZATION OF EXTENDED RELEASE TABLET OF GUANFACINE HCL

1319 24-05-2013 H-01 112420808005PATEL PARAS BHARATBHAI 242


FORMULATION AND EVALUATION F BILAYER TABLET OF LEVOSULPIRIDE

1320 24-05-2013 H-01 112420808006

PATEL RAVIKUMAR KANJIBHAI 242


FORMULATION AND IN VITRO DISSOLUTION ENHANCEMENT OF COMBINATION OF ARTEMETHER AND LUMEFANTRINE USING CYCLODEXTRIN COMPLEX

1321 24-05-2013 H-01 112420808007

AGRAWAL MILAN BHARATBHAI 242


FORMULATION,CHARACTERIZATION AND OPTIMIZATION OF FUROSEMIDE NANOPARTICLES

1322 24-05-2013 H-01 112420808008

PATEL PALAK RAJENDRAKUMAR 242


FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET OF ANTIHYPERTENSIVE DRUGS.

1323 24-05-2013 H-01 112420808009

PARIKH ANKITA CHETANBHAI 242


FORMULATION AND EVALUATION OF LIPOSOMAL GEL OF ADAPALENE FOR TOPICAL USE

1324 24-05-2013 H-01 112420808010

PATEL MANOJKUMAR RAMESHBHAI 242


FORMULATION,EVALUATION AND OPTIMIZATION OF TRANSDERMAL PATCH OF LOXAPINE SUCCINATE

1325 24-05-2013 H-01 112420808011

LIMBACHIYA MAHESHKUMAR ISHVARBHAI 242


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF NITROFURANTOIN LOADED PLGA NANOPARTICLES

1326 24-05-2013 H-01 112420808012DARJI PALAK J 242


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF CETRIZINE AND DEXTROMETHORPHIN

Row ID Exam Date





1327 24-05-2013 H-02 112420808013

SAPARIYA AMIT GIRISHBHAI 242


FORMULATION AND EVALUATION OF OPHTHALMIC IN-SITU GEL OF NATAMYCIN

1328 24-05-2013 H-02 112420808014

PATEL HARDIKKUMAR MOHANBHAI 242


ENHANCEMENT OF IN VITRO DISSOLUTION RATE OF NATEGLINIDE USING LIQUID-SOLID COMPACT

1329 24-05-2013 H-02 112420808015

PATEL SACHINKUMAR RAMESHBHAI 242


FORMULATION AND EVALUATION OF MUCOADHESIVE NASAL MICROSPHERE OF HYDRALAZINE HCL

1330 24-05-2013 H-02 112420808016

CHAUHAN MANOJ KANHAISINGH 242


A STUDY ON TASTE MASKING OF QUININE SULPHATE ORAL SUSPENSION BY KYRON T-114(ION EXCHANGE RESIN)

1331 24-05-2013 H-02 112420808017

SHAH ANKITA KANUBHAI 242


FORMULATION , OPTIMIZATION AND EVALUATION OF SUSTAIN RELEASE TABLETS OF PREGABALINE

1332 24-05-2013 H-02 112420808018PATEL NARESH R 242


FORMULATION AND EVALUATION OF COMPRESSION COATED TABLET OF RIFAMPICIN AND ISONIAZIDE

1333 24-05-2013 H-02 112600808002

KADLIYA PRIYANKA NARENDRAKUMAR 260


FORMULATION, DESIGN AND EVALUATION OF TASTE MASKED ORALLY DISINTEGRATING TABLETS OF LEVO-CETRIZINE DIHCL

1334 24-05-2013 H-02 112600808003KORADIYA ARPAN M 260


FORMULATION AND EVALUATION OF DISPERSIBLE TABLETS OF CEFPODOXIME PROXETIL

1335 24-05-2013 H-02 112600808004

PATEL NIMESHKUMAR ASHOKBHAI 260


FORMULATION AND EVALUATION OF NOVEL DRUG DELIVERY SYSTEM FOR GASTRO ESOPHAGAL REFLUX DISEASE

Row ID Exam Date





1336 24-05-2013 H-02 112600808005

HALBA PRADEEP DASHRATHBHAI 260


FORMULATION OPTIMIZATION AND EVALUATION OF DELAYED RELEASE ENTERIC COATED TABLETS OF OMEPRAZOLE

1337 24-05-2013 H-02 112600808006

PATEL JINALKUMAR BHARATBHAI 260


FORMULATION OPTIMIZATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS OF TRAMADOL HYDROCHLORIDE

1338 24-05-2013 H-03 112600808007PATEL MIKI VISHNUBHAI 260


SOLUBILITY ENHANCEMENT OF CARBAMAZEPINE BY USING VARIOUS SOLUBILITY ENHANCEMENT TECHNIQUES

1339 24-05-2013 H-03 112600808008PATEL DISHA SUMANBHAI 260


FORMULATION DEVELOPMENT AND CHARACTERIZATION OF GASTRO RETENTIVE MICROSPHERES OF ANTIDIABETIC DRUG

1340 24-05-2013 H-03 112600808009BHUT VIBHA ZAVERBHAI 260


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF DILTIAZEM HCL

1341 24-05-2013 H-03 112600808010

RATHOD DIPTIBEN RAMNIKLAL 260


FORMULATION AND EVALUATION OF BILAYER GEOMATRIX TABLETS OF ANTIDEPRESSANT DRUG

1342 24-05-2013 H-03 112600808011

PATEL SHRADDHA MUKESHBHAI 260


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIPIZIDE

1343 24-05-2013 H-03 112600808012

CHAUHAN KRISHNABA VIJAYSINH 260


FORMULATION OPTIMIZATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF AN ANTIPSYCHOTIC DRUG USING SOLUBILITY ENHANCEMENT TECHNIQUE

Row ID Exam Date





1344 24-05-2013 H-03 112600808013

NASATAR SAMIRKUMAR AMRUTBHAI 260


FORMULATION AND EVALUATION OF MICROSPHERES OF RABEPRAZOLE SODIUM

1345 24-05-2013 H-03 112600808014

CHAUDHARI JIGNESH LAKHABHAI 260


FORMULATION AND EVALUATION OF GASTRO RETENTIVE FLOATING TABLETS OF VALSARTAN

1346 24-05-2013 H-03 112600808015

PATEL VATSAL RAJESH 260


FORMULATION AND EVALUATION OF ANTI SUICIDAL NASAL SPRAY OF THYRPTROPIN RELEASING HORMONE

1347 24-05-2013 H-03 112600808016PATEL JIGAR DHANJIBHAI 260


ENHANCEMENT OF DISSOLUTION PROPERTIES OF ACECLOFENAC BY LIQUISOLID TECHNIQUE

1348 24-05-2013 H-03 112600808017

PATEL JAYESHKUMAR KAMLESHBHAI 260


FORMULATION AND EVALUATION OF AMLODIPINE BESYLATE AND METOPROLOL SUCCINATE BILAYER TABLETS

1349 24-05-2013 H-03 112600808018

SHAH KRUNAL KIRTIKUMAR 260


FORMULATION AND EVALUATION OF BILAYER TABLETS CONTAINING ATENOLOL AND NIFEDIPINE AS A DRUGS

1350 24-05-2013 H-04 112820804001

PATEL BRIJESHBHAI JAGDISHBHAI 282

SHIVAM PHARMACEUTICAL STUDIES & RESEARCH CENTER, VALASAN

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE BESYLATE AND TELMISARTAN IN BULK AND COMBINED DOSAGE FORM.

1351 24-05-2013 H-04 112820804002

BANKAR RACHANA RATILAL 282


METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND PENTAPRAZOLE IN BULK AND IN PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





1352 24-05-2013 H-04 112820804003

PATEL PRATIK KANCHANBHAI 282


PROCESS VALIDATION OF CIPROFIBRATE TABLETS 1OO MG.

1353 24-05-2013 H-04 112820804004

PATEL BHAUMIK CHETANKUMAR 282


METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ENALAPRIL MALEATE AND LOSARTAN POTASSIUM IN BULK AND PHARMACEUTICAL DOSAGE FORM.

1354 24-05-2013 H-04 112820804005

PATEL PIYUSHKUMAR MUKESHBHAI 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN PHARMACEUTICAL DOSAGE FORM.

1355 24-05-2013 H-04 112820804006

DAVE CHAITANYKUMAR A 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SILDENFIL AND FLUOXETINE IN PHARMACEUTICAL DOSAGE FORM.

1356 24-05-2013 H-04 112820804007PATEL KRUPAL K 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

1357 24-05-2013 H-04 112820804008TIWARI SHASHANK K 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF SILDENAFIL CITRATE AND FLUOXETINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM.

1358 24-05-2013 H-04 112820804009

SONI ANKITKUMAR KANAIYALAL 282


PROCESS VALIDATION OF FLUCONAZOLE 150MG TABLET.

1359 24-05-2013 H-04 112820804010

PATEL RITESH MAYANKKUMAR 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARATN AND AMLODIPINE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





1360 24-05-2013 H-04 112820804011

JOSHI PARTH RAMESHKUMAR 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF METFORMIN HCL AND PIOGLITAZONE HCL IN TABLET DOSAGE FORM.

1361 24-05-2013 H-04 112820804012

BRAHMBHATT KUNALKUMAR D 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND MOXIFLOXACIN IN BULK AND PHARMACEUTICAL DOSAGE FORM.

1362 24-05-2013 H-05 112820804013

PRAJAPATI DINESHKUMAR DALAJIBHAI 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PENTOPRAZOLE AND LEVOSULPIRIDE SODIUM IN PHARMACEUTICAL DOSAGE FORM.

1363 24-05-2013 H-05 112820804014

SHAH SMIT RAJESHKUMAR 282


DEVELOPMENT AND VALIDATION METHODS FOR ESTIMATION OF MOXIFLOXACIN HCL AND DEXAMETHASONE IN OPHTHALMIC DOSAGE FORM.

1364 24-05-2013 H-05 112820804015

PATEL VIVEKKUMAR BHARATBHAI 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN OPTHALMIC DOSAGE FORM.

1365 24-05-2013 H-05 112820804016

PATEL RONAKKUMAR A. 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND MOXIFLOXACIN HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

1366 24-05-2013 H-05 112820804017SUHAGIYA MEHUL R 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF FORMOTEROL FUMARATE AND BUDESONIDE IN PMDI DOSAGE FORM.

1367 24-05-2013 H-05 112820804018

PATEL CHIRAGKUMAR M. 282


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND THOCOLCHICOSIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





1368 24-05-2013 H-05 112840804001

BHAKHAR DHARMISHTHA NAGJIBHAI 284


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF TAPENTADOL HYDROCHLORIDE AND PARACETAMOL IN THEIR COMBINED DOSAGE FORM

1369 24-05-2013 H-05 112840804002

PIPARIYA BHAGYASHREE MANJIBHAI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF CLONAZEPAM AND PAROXETINE HYDROCHLORIDE HEMIHYDRATE IN THEIR COMBINED CAPSULE DOSAGE FORM

1370 24-05-2013 H-05 112840804003KOTHDIYA NEHAL H 284


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF PENTOPRAZOLE SODIUM AND LEVOSULPIRIDE IN ITS COMBINED TABLET DOSAGE FORM

1371 24-05-2013 H-05 112840804004

KARIA KOMAL BHARATBHAI 284


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF MONTELUKAST AND ACEBROPHYLLINE IN THEIR COMBINED DOSAGE FORM BY RP-HPLC METHOD

1372 24-05-2013 H-05 112840804005

PANDYA GUNJAN NIRANJANBHAI 284


A CHROMATOGRAPHIC DETERMINATION OF OFLOXACIN AND ORNIDAZOLE IN THEIR COMBINED TABLET DOSAGE FORM USING UPLC AND HPLC: A COMPARATIVE VALIDATION STUDY

1373 24-05-2013 H-05 112840804006

PATEL NITABAHEN HIRABHAI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND INDAPAMIDE IN THEIR COMBINED TABLET DOSAGE FORM

1374 24-05-2013 H-06 112840804007

GOLAKIYA KAVITABEN NARENDRABHAI 284


DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RABEPRAZOLE AND LAFUTIDINE IN ITS COMBINED CAPSULE DOSAGE FORM BY RP-HPLC METHOD

Row ID Exam Date





1375 24-05-2013 H-06 112840804008

GORASIYA SWATI JITESHBHAI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF DICLOFENAC SODIUM AND TOLPERISONE HYDROCHLORIDE IN THEIR COMBINED TABLET DOSAGE FORM

1376 24-05-2013 H-06 112840804009

KHANT KHYATI JAGDISHBHAI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF RANITIDINE HYDROCHLORIDE AND DICYCLOMINE HYDROCHLORIDE IN THEIR COMBINED TABLET DOSAGE FORM

1377 24-05-2013 H-06 112840804010

CHHODAVDIYA YAKRISHNA BHIMAJIBHAI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION AZITHROMYCIN AND OFLOXACIN IN THEIR COMBINED TABLET DOSAGE FORM

1378 24-05-2013 H-06 112840804011VEKARIYA GAYATREE A. 284


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF MOXIFLOXACIN AND LOTEPREDNOL IN ITS EYE-DROPS BY RP-HPLC

1379 24-05-2013 H-06 112840804012

RIBADIYA CHETANA DHANJEEBHAI 284


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF CEFIXIME TRIHYDRATE AND LINEZOLID IN THEIR COMBINED DOSAGE FORM BY UV AND RP-HPLC MEHTOD

1380 24-05-2013 H-06 112840804013PATEL RACHANA G. 284


PROCESS VALIDATION ON EXTENDED RELESE FORMULATION OF METROPROLOL SUCCINATE

1381 24-05-2013 H-06 112840804014DOBARIYA SHRUTI D 284


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF ILAPRAZOLE IN ITS TABLET DOSAGE FORM

1382 24-05-2013 H-06 112840804015

PATEL JINALBEN SANJAYKUMAR 284


RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTENEOUS ESTIMATION OF TAMSULOSIN HYDROCHLORIDE AND DICLOFENAC SODIUM IN THEIR COMBINED CAPSULE DOSAGE FORM

Row ID Exam Date





1383 24-05-2013 H-06 112840804016

DODIYA DISHA BHAGVANJI 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF EPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN THEIR COMBINED CAPSULE DOSAGE FORM

1384 24-05-2013 H-06 112840804017

PATEL DIVYABEN RAMESHBHAI 284


DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND INDAPAMIDE IN THEIR COMBINED TABLET DOSAGE FORM BY RP-HPLC METHOD

1385 24-05-2013 H-06 112840804018

GHETIA GOPI NAVINCHANDRA 284


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF GETIFLOXACIN AND LOTEPREDNOL IN THEIR EYE-DROPS

1386 24-05-2013 H-07 112050804001NITESH KUMAR JAIN 205


VALIDATION OF HPTLC METHOD FOR DETERMINATION OF RIFAXIMIN ALONG WITH DEGRADATION KINETIC STUDIES

1387 24-05-2013 H-07 112050804002

MANGUKIYA RAKESH PREMJIBHAI 205


SIMULTANEOUS ESTIMATION OF DIFLUPREDNATE AND MOXIFLOXACIN IN OPHTHALMIC DOSAGE FORM BY SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS

1388 24-05-2013 H-07 112050804003

CHAMPANERI NAITIK NARESHBHAI 205


VALIDATION OF CLEANING PROCESS FOR BAROCEF RESIDUES IN PRODUCTION AREA

1389 24-05-2013 H-07 112050804004

MOTISARIYA MITESH HIMMATBHAI 205


IVABRADINE HYDROCHLORIDE: STABILITY INDICATING AND BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION

1390 24-05-2013 H-07 112050804005

MER VERSHABEN GORDHANBHAI 205


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC METHODS FOR ESTIMATION OF APIGENIN AND BIOTINYL TRIPEPTIDE-1 IN COSMETIC FORMULATION

1391 24-05-2013 H-07 112050804006

PATEL CHIRAG BHIMJIBHAI 205


SIMULTANEOUS ESTIMATION OF ASPIRIN, ATENOLOL, LISINOPRIL AND SIMVASTATIN BY CHROMATOGRAPHIC METHODS USING EXPERIMENTAL DESIGN

Row ID Exam Date





1392 24-05-2013 H-07 112050804007

MORADIYA MEHUL RANCHODBHAI 205


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR ESTIMATION OF PSHYCHOSTIMULANT DRUG AND ITS RELATED IMPURITY BY RRLC METHOD

1393 24-05-2013 H-07 112050804008

MISTRY KRISHNAKUMARI SAMIRKUMAR 205


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC METHODS FOR UNI-BONE HERBAL FORMULATION

1394 24-05-2013 H-07 112050804009

SOLANKI TRUPTI BABUBHAI 205


SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLORTHIAZIDE IN MARKETED FORMULATION

1395 24-05-2013 H-07 112050804010

PANCHAL NEHA BHARATKUMAR 205


CLEANING VALIDATION FOR DETERMINATION OF PHARMACEUTICAL RESIDUE IN PARENTERAL MANUFACTURING FACILITY

1396 24-05-2013 H-07 112050804011

TANDEL DEVANG BHAGVANDAS 205


SPHERICAL CRYSTALLIZATION TECHNIQUE FOR SOLUBILITY ENHANCEMENT OF FEBUXOSTAT AND ITS PHARMACOKINETIC APPLICATION IN RAT PLASMA BY RP-HPLC METHOD

1397 24-05-2013 H-07 112050804012VANANI DHAVAL R 205


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF DRUG USED IN CONGESTIVE HEART FAILURE

1398 24-05-2013 H-08 112020804001KHATRI ROHIT 202


ANALYTICAL METHOD DEVELOPMENT FOR ESTIMATION OF CLINDAMYCIN AND ADAPALENE IN PHARMACEUTICAL DOSAGE FORM

1399 24-05-2013 H-08 112020804002

PATEL AJAYKUMAR RAMABHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND MOXIFLOXACIN IN BULK AND IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1400 24-05-2013 H-08 112020804003

SHAH HEM GAUTAMKUMAR 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE AND DOXOFYLLINE IN BULK AND PHARMACEUTICAL DOSAGE FORM

1401 24-05-2013 H-08 112020804004

GOPANI MEHUL CHANDULAL 202


APPLICATION OF QUALITY BY DESIGN ELEMENT FOR DEVELOPMENT OF ANALYTICAL METHOD FOR ESTIMATION OF LAMIVUDINE AND ZIDOVUDINE AND CLEANING VALIDATION OF EQUIPMENT USED FOR MANUFACTURING OF AZATHIOPRINE TABLER

1402 24-05-2013 H-08 112020804005

PATEL BHAUMIK MUKESHCHANDRA 202


Development and validation of RP-HPLC and UV spectroscopic method for simultaneous estimation of Trihexyphenidyl hydrochloride & risperidone in Pharmaceutical formulation

1403 24-05-2013 H-08 112020804006

RAMCHANDANI HARESHKUMAR MADHUBHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM

1404 24-05-2013 H-08 112050804013

GADHAVI RUCHITA GAMBHIRDAN 205


QUALIFICATION AND VALIDATION OF BLOW FILL SEAL TECHNOLOGY USING QUALITY BY DESIGN APPROACH

1405 24-05-2013 H-08 112050804014

HAVELIKER HIREN KRISHNABHAI 205


SIMULTANEOUS ESTIMATION OF DRONEDARONE HYDROCHLORIDE AND ITS ACTIVE METABOLITE DESBUTYL DRONEDARONE IN HUMAN PLASMA BY USING UPLC-ESI-MS/MS

1406 24-05-2013 H-08 112050804015

PATEL HIRENKUMAR RAMESHBHAI 205


PROCESS VALIDATION OF INTRAVENOUS INFUSION USING RISK BASED ANALYSIS

1407 24-05-2013 H-08 112050804016

ANKITA SATISHCHANDRA KADIKAR 205


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF BRINZOLAMIDE AND TIMOLOL MALEATE

Row ID Exam Date





1408 24-05-2013 H-08 112050804017

KUMARI KINJAL NANUBHAI PATEL 205


SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC ESTIMATION OF CEPHALEXIN MONOHYDRATE AND KANAMYCIN MONOSULPHATE BY DERIVATIZATION METHOD

1409 24-05-2013 H-08 112050804018ARDESHANA HARDIK L. 205


SIMULTANEOUS ESTIMATION OF DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

1410 24-05-2013 H-09 112020804007

PRAJAPATI PREMALKUMAR PRABHUBHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND PAMABROM IN BULK AND PHARMACEUTICAL DOSAGE FORM

1411 24-05-2013 H-09 112020804008PATEL NIKITA DHIRAJLAL 202


DEVELOPMENT AND VALIDATION OF VARIOUS ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM AND ATENOLOL

1412 24-05-2013 H-09 112020804009

GOHEL KARANKUMAR UPENDRABHAI 202


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF METFORMIN HYDROCHLORIDE AND BENFOTIAMINE IN BULK AND IN PHARMACEUTICAL DOSAGE FORM

1413 24-05-2013 H-09 112020804010

LADUMOR PRAKASH DHANJIBHAI 202


Stability indicating RP-HPLC method for simultaneous estimation of Ambroxol hydrochloride & Desloratadine HCl in buk drug and Pharmaceutical formulation

1414 24-05-2013 H-09 112020804011

PARMAR KRENY EMANUEL 202


Development and validation of analytical methods for simultaneous estimation of Telmisartan and Chlorthalidone in bulk & Pharmaceutical dosage form

Row ID Exam Date





1415 24-05-2013 H-09 112020804012

PARMAR DARSHANABEN ASHOKKUMAR 202


Development and validation of an analytical method for Ramipril and Losartan Potassium in pharmaceutical formulation and concurrent process validation of Metformin Hydrochloride and Glimepiride tablet dosage form

1416 24-05-2013 H-09 112020804013

PATEL DANKIT SUBHASH 202


Development and validation of analytical methods for simultaneous determination of Tolperisone hydrochloride and Diclofenac sodium in its combined dosage forms

1417 24-05-2013 H-09 112020804014

GINOYA CHARMI GIRISHBHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND ATORVASTATIN CALCIUM IN BULK AND PHARMACEUTICAL DOSAGE FORM

1418 24-05-2013 H-09 112020804015

JAIN JAYDEEP ASHOKBHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL FORMULATION

1419 24-05-2013 H-09 112020804016

ZALA NITIRAJSINH MANAHARSINH 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF CHLORZOXAZONE AND DICLOFENAC SODIUM

1420 24-05-2013 H-09 112020804017

KOLI RAHULKUMAR JETHABHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR TOPIRAMATE

1421 24-05-2013 H-09 112020804018

PATEL PRITIBEN HARIBHAI 202


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF ETHAMSYLATE IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1422 24-05-2013 H-10 102310808010

PATEL HIRALBEN DINESHKUMAR 231


FORMULATION AND EVALUATION OF BILAYER TABLET OF

METFORMINE SUSTAIN RELEASE AND GLIMIPRIDE IMMEDIATE

RELEASE.

1423 24-05-2013 H-10 112050808001

PATEL HITARTHKUMAR GIRISHBHAI 205


PREPARATION AND OPTIMIZATION OF POLYHERBAL CREAM FOR SKIN DISEASE

1424 24-05-2013 H-10 112050808002

VANPARIYA KUNALKUMAR MEHULBHAI 205


FORMULATION, EVALUATION OF NEW POLYHERBAL ORAL TABLET FOR LEUCORRHOEA

1425 24-05-2013 H-10 112050808003

GOHIL MILAN KHUMANSINH 205


FORMULATION AND EVALUATION OF BI-LAYER TABLET OF TRAMADOL HYDROCHLORIDE AND ACECLOFENAC FOR OSTEOARTHRITIS

1426 24-05-2013 H-10 112050808004

AGRAWAL RUSHIKESH MAHESHCHANDRA 205


FORMULATION AND EVALUATION OF ORALLY DISINTEGRATING TABLET OF MEMANTINE HYDROCHLORIDE

1427 24-05-2013 H-10 112050808005PATEL JAINI KIRITKUMAR 205


FORMULATION AND EVALUATION OF SUSTAIN RELEASE TABLET OF VENLAFAXINE HCL USING LIQUID SOLID COMPACT TECHNIQUE

1428 24-05-2013 H-10 112050808006

DUDHAT KARTIKKUMAR HIMMATBHAI 205


DEVELOPMENT AND EVALUATION OF TRANSDERMAL THERAPEUTIC SYSTEM OF IVABRADINE HYDROCHLORIDE: IN-VITRO AND IN-VIVO CHARACTERIZATION

1429 24-05-2013 H-10 112050808007

MORADIYA PARITA SAVAJIBHAI 205


DEVELOPMENT AND OPTIMIZATION OF VAGINAL IN-SITU GEL OF HERBAL SPERMICIDAL AGENT

1430 24-05-2013 H-10 112050808008

PRAJAPATI MAYUR CHHAGANBHAI 205


FORMULATION AND EVALUATION OF VISCOUS EYE DROPS OF NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE FOR THE TREATMENT OF ALLERGIC CONJUCTIVITIS

1431 24-05-2013 H-10 112050808009

METALIYA VIRALBEN JAYANTILAL 205


DEVELOPMENT AND CHARACTERIZATION OF DEXAMETHASONE SODIUM PHOSPHATE AND TOBRAMYCIN SULPHATE OPTHALMIC IN-SITU GEL

Row ID Exam Date





1432 24-05-2013 H-10 112050808010

SHAH BHAVIN VIJESHBHAI 205


FORMULATION AND DEVELOPMENT OF FILM COATED TABLET CONTAINING CHARCOAL AND DIGESTIVE ENZYMES

1434 24-05-2013 H-11 112050808012

MAKTARPARA BHAVESHKUMAR BECHARBHAI 205


FORMULATION AND EVALUATION OF STABLE DOSAGE FORM OF PANTOPRAZOLE AND DOMPERIDONE

1437 24-05-2013 H-11 112050808015

SIJU VINODKUMAR VALJIBHAI 205


PREPARATION AND OPTIMIZATION OF DISINTIGRATION CONTROLLED, SUSTAINED RELEASE MATRIX TABLET OF LORNOXICAM

1440 24-05-2013 H-11 112640808013PUJARA NAISARG D 264


FORMULATION AND EVALUATION OF MULTI-COMPARTMENT DOSAGE FORM OF ANTI-HYPERTENSIVE DRUGS

1441 24-05-2013 H-13 112460808001

PATEL HARDIKKUMAR NATVARBHAI 246


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF TENOXICAM

1442 24-05-2013 H-13 112460808002

PATEL PRIYANKKUMAR ASHOKBHAI 246


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET CONTAINING AMLODIPINE BESYLATE BY USING NOVEL COPROCESSED SUPER DISINTEGRANTS

1443 24-05-2013 H-13 112460808003

PATEL KRUNAL AMRUTBHAI 246


FORMULATION AND CHARACTERIZATION OF FLURBIPROFEN SUSTAINED RELEASE AEROSOL

1444 24-05-2013 H-13 112460808004

JOGANI HIREN MADHUBHAI 246


FORMULATION AND EVALUATION OF AMLODIPINE BESYLATE AND VALSARTAN IMMEDIATE RELEASE TABLET

1445 24-05-2013 H-13 112460808005

KAPATEL MANSIBEN NAVINKUMAR 246


FORMULATION AND CHARACTERIZATION OF PIOGLITAZONE LIQUISOLID TABLET

1446 24-05-2013 H-13 112460808006DAVE NIYATI D. 246


FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF SOLID DISPERSION OF POORLY SOLUBLE DRUG

Row ID Exam Date





1447 24-05-2013 H-13 112460808007

SHAH HRUDAY PRAVINKUMAR 246


FORMULATION AND DEVELOPMENT OF BI-PHASIC DRUG DELIVERY SYSTEM FOR SIMULTANEOUS ADMINISTRATION OF COMBINATION OF ANTI-HYPERTENSIVE DRUGS

1448 24-05-2013 H-13 112460808008

PATEL NAIMESHKUMAR KIRITKUMAR 246


FORMULATION AND IN-VITRO CHARACTERIZATION OF SUBLINGUAL TABLET OF PERINDOPRIL

1449 24-05-2013 H-13 112460808009PATEL TUSHAR N 246


FORMULATION DEVELOPMENT AND CHARACTERIZATION OF CARVEDILOL SUSTAIN RELEASE TABLET BY USING LIQUISOLID TECHNIQUE

1450 24-05-2013 H-13 112460808010

MODH PARTH RASHMIKANT 246


FORMULATION EVALUATION AND STABILIZATION OF ORALLY DISINTEGRATING TABLET OF ANTIHISTAMINIC DRUG

1451 24-05-2013 H-13 112460808011

GADHAVI RAJDEEP SAGARDAN 246


DEVELOPMENT OF SOLID DISPERSION FOR SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUG

1452 24-05-2013 H-13 112460808012MEHTA RAHUL R 246


FORMULATION AND IN-VITRO CHARACTERIZATION OF SUSTAINED RELEASE MATRIX TABLET OF ANTIHYPERTENSIVE DRUG

1453 24-05-2013 H-14 112460808013

PRAJAPATI KANDARP MADHUKANT 246


FORMULATION AND OPTIMIZATION OF THEOPHYLLINE SUSTAINED RELEASE MATRIX TABLET

1454 24-05-2013 H-14 112460808014PATEL HARDIK R 246


FORMULATION EVALUATION AND OPTIMIZATION OF CLINDAMYCIN MICROSPONGE GEL

1455 24-05-2013 H-14 112460808015

PATEL RONAK PRAKASHBHAI 246


FORMULATION AND EVALUATION OF VERDENAFIL SUBLINGUAL TABLET

1456 24-05-2013 H-14 112460808016PATEL PARTH SHANTILAL 246


DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF VALSARTAN SUSTAINED RELEASE MATRIX TABLET

1457 24-05-2013 H-14 112460808017

PATEL NIRMESHKUMAR ASHOKBHAI 246


FORMULATION EVALUATION AND OPTIMIZATION OF SUSTAINED RELEASE TABLET OF NELFINAVIR

Row ID Exam Date





1458 24-05-2013 H-14 112460808018

DELVADIYA PINAYAKKUMAR R. 246


FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF VERAPAMIL

1459 24-05-2013 H-14 112540808001

SHAH MRUNALI MAYANKKUMAR 254


SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE DRUG

1460 24-05-2013 H-14 112540808002

JUGAL KALPESHKUMAR MODI 254


DEVELOPMENT AND EVALUATION OF POLYSACCHARIDE BASED INTERPOLYMER COMPLEXS FOR BUCCAL MUCOADHESIVE DRUG DELIVERY.

1461 24-05-2013 H-14 112540808003

VAGHANI HASMUKH PREMJIBHAI 254


DEVELOPMENT AND EVALUATION OF GEL BASED TRANSDERMAL DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF LORNOXICAM.

1462 24-05-2013 H-14 112540808004

THUMMAR PIYUSHKUMAR JIVANBHAI 254


FORMULATION DEVELOPMENT & EVALUATION OF ECONAZOLE NITRATE TOPICAL EMULGEL

1463 24-05-2013 H-14 112540808005

SHAH VYOMABEN SHANTILAL 254


FORMULATION OF ORAL SUSTAINED RELEASE FLOATING IN SITU GEL OF VERAPAMIL HCL

1464 24-05-2013 H-14 112540808006

VADDORIYA HIRENKUMAR HIMMATLAL 254


DESIGN AND DEVELOPMENT OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF LOVASTATIN

1465 24-05-2013 H-15 112540808007

DIYORA CHETANKUMAR DHIRUBHAI 254


FORMULATION, EVALUATION & OPTIMIZATION OF FAST DISINTEGRATING TABLETS OF ONDANSETRON HCL USING GLYCINE MAX MERR AS A SUPER DISINTEGRATING AGENT

1466 24-05-2013 H-15 112540808008

MAHYAVANSHI TEJASHKUMAR MAHESHBHAI 254


FORMULATION & EVALUATION OF COLON SPECIFIC TARGETED DRUG DELIVERY SYSTEM

Row ID Exam Date





1467 24-05-2013 H-15 112540808009

NEHABEN GUNVANTBHAI PRAJAPATI 254


DEVELOPMENT AND EVALUATION OF HIGH-PERFORMANCE BIOPOLYMER BASED LOCAL DELIVERY SYSTEM OF ANTIMICROBIAL AGENTS FOR TREATMENT OF PERIODONTAL DISEASE.

1468 24-05-2013 H-15 112540808010

CHALISHAZARWALA NIRALI RAJESHBHAI 254


DEVELOPMENT AND EVALUATION OF COLON TARGETED DRUG DELIEVERY SYSTEM FOR TREATMENT OF AMOEBIASIS

1469 24-05-2013 H-15 112540808011

TURAKHIYA JIGNESH MANSUKHBHAI 254


“FORMULATION AND DEVELOPMENT OF SUPERPOROUS HYDROGEL COMPOSITE-BASED FLOATING DRUG DELIVERY SYSTEM”

1470 24-05-2013 H-15 112540808012

SAVANI HITESH DHIRUBHAI 254


FORMULATION, DEVELOPMENT AND OPTIMIZATION OF FLOATING PULSATILE DELIEVERY SYSTEM FOR CHRONOTHERAPY OF NOCTURNAL ACID BREAKTHROUGH

1471 24-05-2013 H-15 112540808013

PATEL JIGNAKUMARI NAVNITBHAI 254


“FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET FOR COLON TARGETED DRUG DELIVERY SYSTEM”

1472 24-05-2013 H-15 112540808014

PATEL MAYURIBAHEN CHHABILBHAI 254


FORMULATION DEVELOPMENT & EVALUATION OFTOPICAL HYDROGEL

1473 24-05-2013 H-15 112540808015

PATEL ARTIBEN ARUNBHAI 254


DISSOLUTION ENHANCEMENT BY SURFACE SOLID DISPERSION USING POLOXAMER

1474 24-05-2013 H-15 112540808016

SHAH POOJABEN KETANKUMAR 254


PREPARATION AND EVALUATION OF MODIFIED POLYSACCHARIDE BASED MICROBEADS FOR SUSTAINED DRUG DELIVERY.

1475 24-05-2013 H-15 112540808017

CHUNDAVAT MOHANSINH BABUSINH 254


FORMULATION AND EVALUATION OF ELECTRO-RESPONSIVE HYDROGELS FOR TRANSDERMAL DRUG DELIVERY OF THERAPEUTIC AGENT

Row ID Exam Date





1476 24-05-2013 H-15 112540808018

PATEL JAINISHKUMAR MUKESHBHAI 254


“FORMULATION DEVELOPMENT AND OPTIMIZATION OF SUSTAINED RELEASE DOSAGE FORM USING INTERPENETRATING POLYMER NETWORK (IPN)”

1504 25-05-2013 H-01 112130803007

PATEL NIKUNJKUMAR D 213


EFFECT OF CARNOSINE ON CHEMICALLY INDUCED SKIN CANCER IN MICE

1505 25-05-2013 H-01 112130803008

PATEL SWETA MUKESHBHAI 213


EVALUATION OF POLYHERBAL FORMULATIONS FOR ITS ANTIULCER ACTIVITY AGAINST EXPERIMENTAL GASTRIC ULCERS IN RATS

1506 25-05-2013 H-01 112130803010

UPADHYAY JAYMIN HARSHADKUMAR 213


EVALUATION OF A POLYHERBAL FORMULATION IN HYPERLIPIDAEMIC RATS.

1477 25-05-2013 H-01 112170803002PATEL MAULIK R 217


TO INVESTIGATE MECHANISM UNDERLYING ANTIASTHAMATIC AND BRONCHODILATOR ACTIVITY OF CYNODON DACTYLON

1478 25-05-2013 H-01 112170803003

PATEL MAULIK SATISHBHAI 217


TO INVESTIGATE MECHANISM UNDERLYING HYPOGLYCEMIC, ANTIDIABETIC AND INSULIN SECRETING ACTIVITY OF ANNONA SQUAMOSA LINN. LEAVES EXTRACT IN RATS

1479 25-05-2013 H-01 112170803004

PATEL NILESHKUMAR AMRUTBHAI 217


HEPATOPROTECTIVE AND ANTIOXIDANT ACTIVITY OF TRIDEX PROCUMBENS LINN. FLOWER EXTRACT

1486 25-05-2013 H-01 112680803001

DADI JENULAABEDIN F. 268

VIDYABHARTI TRUST COLLEGE OF PHARMACY, UMRAKH, SURAT

SCREENING OF SOLANUM MELOGENA ROOT FOR ITS ANTI - ARTHRITIC POTENTIAL

1487 25-05-2013 H-01 112680803002

PATEL VILSUBEN PANKAJBHAI 268


EXPLORATION OF INHIBITORY POTENTIAL OF GLIPIZIDE ON NICOTINAMIDE STREPTOZOTOCIN INDUCED NUCLEAR DAMAGE & SPERM ABNORMALITY IN MALE WISTAR RATS

1488 25-05-2013 H-01 112680803003

PATEL SONIA JAGDISHCHANDRA 268


COMPARATIVE EVALUATION OF POLYHERBAL PREPARATION FOR ANTIHYPERLIPIDEMIC ACTIVITY IN HIGH FAT DIET INDUCED HYPERLIPIDEMIA IN WISTAR RATS

Row ID Exam Date





1489 25-05-2013 H-01 112680803004KUVAR NAMRATA A 268


PRELIMINARY PHYTOCHEMICAL INVESTIGATION & EVALUATION OF ANTIUROLITHIATIC POTENTIAL OF CRATAEVA NURVALA ROOTS

1490 25-05-2013 H-02 112130803013

PATEL BHAVIKKUMAR GHANSHYAMBHAI 213


EFFECT OF BAUHINIA VARIAGATA LINN ON EXPERIMENTALLY INDUCED CERVICAL CANCER IN CD1 MICE

1491 25-05-2013 H-02 112170803005ASODIYA ANIKET KIRIT 217


EFFECT OF HOSPITAL TO HOME DISCHARGE CARE PROGRAM IN CABG PATIENTS

1492 25-05-2013 H-02 112170803006VYAS VIVEK HITESHBHAI 217


TO ASSESE THE EFFICACY AND SAFETY OF 4 WEEK TREATMENT WITH AUS-131 (S-EQUOL) ON BENIGN PROSTATIC HYPERPLASIA PATIENTS

1493 25-05-2013 H-02 112170803008SUTHAR KUNAL P 217


TO INVESTIGATE MECHANISM UNDERLYING ANTIASTHAMATIC AND BRONCHODILATOR ACTIVITY OF SOLANUM XANTHOCARPUM LINN. FRUIT EXTRACT

1480 25-05-2013 H-02 112390803001

TANDEL ABHAYKUMAR ASHOKBHAI 239


COMPARISION OF SAFETY AND EFFICACY OF VOGLIBOSE ALONE AND IN COMBINATION WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES.

1481 25-05-2013 H-02 112390803002

SHAH MITESHKUMAR YASHWANTBHAI 239


EFFECT OF FINASTERIDE, LYCOPENE AND SELENIUM ON CITRAL INDUCED BENIGN PROSTATIC HYPERPLASIA (BPH) IN RATS

1482 25-05-2013 H-02 112390803003

DHANGAR DHAVALKUMAR AMBELAL 239


EFFICACY AND SAFETY OF LINAGLIPTIN AND VILDAGLIPTIN AS ADD ON THERAPY IN REFRACTORY CASES OF TYPE-2 DIABETIC PATIENTS RECEIVING VARIOUS COMBINATION OF METFORMIN, PIOGLITAZONE AND SULFONYLUREA

1483 25-05-2013 H-02 112390803004DESAI NIRAV B 239


STUDY ON EFFECT OF FINASTERIDE, LYCOPENE AND SELENIUM ON TESTOSTERONE -INDUCED BENIGN PROSTATIC HYPERPLASIA (BPH) IN RATS

Row ID Exam Date





1484 25-05-2013 H-02 112390803005DESAI RACHITA A 239


EFFECT OF COMBINING CHROMIUM PICOLINATE WITH METFORMIN IN FRUCTOSE -INDUCED DIABETES – AN EXPERIMENTAL STUDY IN RATS

1485 25-05-2013 H-02 112390803006

PATEL DRASHTI AMULBHAI 239


PROTECTIVE EFFECT OF COMBINATION OF ABRUS PRECATORIUS LEAF EXTRACT AND DE-GLYCYRRHIZINATED LIQUORICE EXTRACT MOUTH WASH IN APHTHOUS STOMATITIS

1494 25-05-2013 H-03 112020803001

ARODA JIGNESHKUMAR RAJENDRAKUMAR 202


STUDY OF ACTIVITY OF “ALLIUM CEPA" AND ITS COMBINATION IN INFLAMMATORY BOWEL DISEASE USING EXPERIMENTAL ANIMAL MODEL.

1495 25-05-2013 H-03 112020803002

GAJERA SNEHA ZINABHAI 202


EVALUATION OF SELECTIVE ß2 AGONIST, SALBUTAMOL AS ANTI-FIBROTIC AGENT IN PULMONARY FIBROSIS USING EXPERIMENTAL ANIMAL MODEL.

1496 25-05-2013 H-03 112020803003

RAXIT PRAVINKUMAR RACHCHH 202


EVALUATION OF ANALGESIC, ANTI-INFLAMMATORY, AND ANTI-RHEUMATIC ACTIVITY OF GRANGEA MADERASPATANA POIR. USING VARIOUS ANIMAL MODELS

1497 25-05-2013 H-03 112020803004

RAI SHIVANI SANJEEVKUMAR 202


EVALUATION OF EFFICACY AND POTENCY OF OLOPATADINE HYDROCHLORIDE IN ALLERGIC ASTHMA USING VARIOUS EXPERIMENTAL ANIMAL MODELS.

1498 25-05-2013 H-03 112020803005NIDHI PATEL S 202


EVALUATION OF NICORANDIL, A POTASSIUM CHANNEL OPENER, AS AN ANTIFIBROTIC IN BLEOMYCIN INDUCED PULMONARY FIBROSIS USING EXPERIMENTAL ANIMAL MODEL

Row ID Exam Date





1499 25-05-2013 H-03 112020803006

NANDHA KISHAN HITESHBHAI 202


TO STUDY THE EFFECT OF MEXILETINE AS A PROMISING NEW DRUG FOR THE TREATMENT OF PROGRESSIVE ALZHEIMER'S DISEASE USING VARIOUS EXPERIMENTAL ANIMAL MODELS

1500 25-05-2013 H-03 112020803007

PATEL SUNILKUMAR NATAVARLAL 202


EVALAUTION OF VALPROIC ACID AS AN ANTI-DIABETIC AGENT IN STREPTOZOTOCIN INDUCED DIABETIC RATS.

1501 25-05-2013 H-03 112020803008

GADHAVI KIRTIDAN BHAGVATSINH 202


EVALUATION OF ANTI-HYPERLIPIDEMIC ACTIVITY OF EXTRACT OF BLUMEA LACERA USING EXPERIMENTAL ANIMAL MODEL

1502 25-05-2013 H-03 112020803009

BAROT KINJALKUMAR RAMESHCHANDRA 202


EVALUATION OF ANTIHYPERLIPIDEMIC ACTIVITY OF EXTRACT OF THE DELONIX REGIA USING EXPERIMENTAL ANIMAL MODELS

1503 25-05-2013 H-03 112020803010PANCHAL RITAL R. 202


EVALUATION OF NEPHROPROTECTIVE ACTION OF CENTRATHERUM ANTHELMINTICUM USING VARIOUS EXPERIMENTAL MODELS OF NEPHROLITHIASIS

1245 25-05-2013 H-04 112140813027

DAMOR HARSHADKUMAR K 214


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFTAZIDIME AND CLAVULANIC ACID IN THEIR PHARMACEUTICAL DOSAGE FORM

1507 25-05-2013 H-04 112560804001

JETHAVA HARDIK RAMESHBHAI 256

SHRI SAMANVAY INSTITUTE OF PHARMACY, BOTAD

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC AND EPERISONE BY RP-HPLC METHOD.

1508 25-05-2013 H-04 112560804002

GOHIL RAJDEEPSINH KUMARPALSINH 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DROSPERINONE AND ETHINYLESTRADIOL.

Row ID Exam Date





1509 25-05-2013 H-04 112560804003

KALATHIYA MILANKUMAR RAMESHBHAI 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LOTEPREDNOL AND GATIFLOXACIN BY RP-HPLC METHOD.

1510 25-05-2013 H-04 112560804005

PATEL BHAKTI JAYPRAKASHBHAI 256


Stability Indicating Assay Method for Simultaneous Estimation of SPARFLOXACIN and DEXAMETHASONE in eye/ear drops Dosage form by HPLC Method.

1511 25-05-2013 H-04 112560804007

VAGHANI DHARMESHKUMAR GIRISHBHAI 256


DISSOLUTION STABILITY STUDY OF MARKETED GLICLAZIDE TABLET FORMULATION BY RP-HPLC METHOD

1512 25-05-2013 H-04 112560804008

PATEL VAIDEHI NARENDRABHAI 256


Stability Indicating Assay Method for Simultaneous Estimation of BALOFLOXACIN and ORNIDAZOLE in Tablet Dosage form by HPLC Method.

1513 25-05-2013 H-04 112560804009

NAKARANI PRADIPKUMAR PREMJIBHAI 256


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF ACEBROPHYLLINE IN ITS PHARMACEUTICAL DOSAGE FORM.

1514 25-05-2013 H-04 112560804010

CHUDASAMA MAYURDHVAJSINH SUDHIRSINH 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFUROXIME AND CLAVULANIC ACID BY RP-HPLC METHOD.

1515 25-05-2013 H-04 112560804013

PARMAR JITENDRA KALIDAS 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ACIPIMOX IN PHARMACEUTICAL DOSAGE FORM.

1516 25-05-2013 H-05 112080804001

BHATT VISHAL RAJNIKANT 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFIXIME AND LEVOFLOXACIN IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1517 25-05-2013 H-05 112080804002

PATEL HARITABAHEN DAMODARDAS 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM IN SYNTHETIC MIXTURE/ PHARMACEUTICAL FORMULATION

1518 25-05-2013 H-05 112080804003

GARANIYA ROHINI RAMBHAI 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND LINEZOLID IN TABLET DOSAGE FORM.

1519 25-05-2013 H-05 112080804004

RADHANPURI SAGUFTA ASLAM 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF MARBOFLOXACIN IN TABLET DOSAGE FORM.

1520 25-05-2013 H-05 112080804005PANDYA YOGI U 208


RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LOTEPREDNOL ETABONATE WITH FLUOROQUINOLONES IN OPHTHALMIC SUSPENSIONS

1521 25-05-2013 H-05 112080804006

RATHOD VANDANA BANSIBHAI 208


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF XYLOMETAZOLINE HYDROCHLORIDE AND IPRATROPIUM BROMIDE IN PHARMACEUTICAL DOSAGE FORM.

1522 25-05-2013 H-05 112560804014

PARIKH DIPEN HARESHKUMAR 256


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC AND CYCLOBENZAPRINE.

1523 25-05-2013 H-05 112560804015

DIYORA SHARAD HARAJI BHAI 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND OLMESARTAN MEDOXOMIL BY RP-HPLC METHOD

1524 25-05-2013 H-05 112560804017

CHOTHANI VIJAY KHIMJIBHAI 256


Bio analytical Method Development and Validation for Simultaneous Estimation of OXYBUTYNIN and it metabolite N-DESETHYL OXYBUTYNIN in human plasma by HPLC-ESI/MS/MS Method.

Row ID Exam Date





1525 25-05-2013 H-05 112560804018

BAROT PINTU HASMUKHBHAI 256


Stability Indicating HPLC Method Development and Validation of NEBIVOLOL HYDROCHLORIDE and INDAPAMIDE in Dosage Form.

1526 25-05-2013 H-05 112560804019

BARAD MEHULKUMAR BALABHAI 256


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METFORMIN HYDROCHLORIDE AND ALPHA LIPOIC ACID IN THEIR DOSAGE FORMS BY RP-HPLC METHOD.

1527 25-05-2013 H-06 112080804007

PATEL TUSHARKUMAR RASIKLAL 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND INDAPAMIDE IN PHARMACEUTICAL DOSAGE FORM.

1528 25-05-2013 H-06 112080804008

CHOSALA SAHDEVBHAI KALUBHAI 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE SODIUM AND LEVOSULPIRIDE IN PHARMACEUTICAL DOSAGE FORM.

1529 25-05-2013 H-06 112080804009PANCHAL MAHESH H. 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DROSPIRENONE AND ETHINYL ESTRADIOL IN PHARMACEUTICAL DOSAGE FORM

1530 25-05-2013 H-06 112080804010

DARJI SURESH SHANKARBHAI 208


DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC AND RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF IRBESARTAN AND ATORVASTATIN IN THEIR SYNTHETIC MIXTURE.

1531 25-05-2013 H-06 112080804011

SOYANTAR CHANDANI CHIMANBHAI 208


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF BALOFLOXACIN AND ORNIDAZOLE IN TABLET DOSAGE FORM.

1532 25-05-2013 H-06 112080804012

DAMOR VIRAL VINUBHAI 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF OLOPATADINE HYDROCHLORIDE AND MONTELUCAST SODIUM IN THEIR SYNTHETIC MIXTURE

Row ID Exam Date





1533 25-05-2013 H-06 112080804013

PATEL VINAYKUMAR N 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF SILDENAFIL CITRATE AND DULOXETINE HYDROCHLORIDE IN COMBINED DOSAGE FORM

1534 25-05-2013 H-06 112080804014

PATEL PRIYANK BHADRESHBHAI 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF DIFLUNISAL IN HUMAN PLASMA.

1535 25-05-2013 H-06 112080804015

GANDHI YASH MUKULBHAI 208


DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC AND RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF TAZAROTENE AND MOMETASONE FUROATE IN ITS FORMULATION.

1536 25-05-2013 H-06 112080804016

PATEL NILUBEN RAMESHBHAI 208


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF LAFUTIDINE AND RABEPRAZOLE IN PHAMACEUTICAL DOSAGE FORM

1537 25-05-2013 H-06 112080804017

TAILOR JHANVI SUNILKUMAR 208


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF FORMOTEROL FUMARATE AND MOMETASONE FUROATE IN PHARMACEUTICAL DOSAGE FORM.

1538 25-05-2013 H-06 112080804018

PATEL KUSHANG NITINKUMAR 208


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND ACECLOFENAC IN SYNTHETIC MIXTURE

1539 25-05-2013 H-07 112070804001

PATEL PRATIK RAMESHBHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS ESTIMATION OF ASPIRIN AND DIPYRIDAMOLE IN MARKETED PHARMACEUTICAL FORMULATION

1540 25-05-2013 H-07 112070804002AKHANI RAVI FARSURAM 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF AMLODIPINE BESYLATE AND PERINDOPRIL ERBUMINE IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1541 25-05-2013 H-07 112070804003

KANANI HITIKSHA RATILAL 207


APPLICATION OF ANALYTICAL TECHNIQUES FOR BIOEQUIVALENCE STUDY OF FEBUXOSTAT

1542 25-05-2013 H-07 112070804004

RAKHOLIYA ASHVINKUMAR HARSUKHBHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF CEFIXIME AND LINEZOLIDE IN PHARMACEUTICAL DOSAGE FORM

1543 25-05-2013 H-07 112070804005

MAHETA PRATIKKUMAR SUMANTBHAI 207


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CEFADROXIL AND PROBENECID IN SYNTHETIC MIXTURE

1544 25-05-2013 H-07 112070804006

BHAVSAR NISARG MAHENDRAKUMAR 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND ACECLOFENAC IN COMBINED PHARMACEUTICAL DOSAGE FORM

1545 25-05-2013 H-07 112070804007

DESAI YAD MAHENDRABHAI 207


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF LEVAMISOLE HYDROCHLORIDE AND OXYCLOZANIDE

1546 25-05-2013 H-07 112070804008

RATHOD DHARMENDRAKUMAR MAHENDRABHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF DICLOFENAC POTASSIUM AND SERRATIOPEPTIDASE IN PHARMACEUTICAL DOSAGE FORM

1547 25-05-2013 H-07 112070804009PRAJAPATI KEYURBHAI R 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF DICLOFENAC SODIUM AND TOLPERISONE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

1548 25-05-2013 H-07 112070804010

PATEL BHAVINKUMAR RAJENDRAKUMAR 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF LEVOSUIPIRIDE AND PENTOPRAZOLE IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1549 25-05-2013 H-07 112070804011MODI NIRAV RAJESHBHAI 207


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DICLOFENAC POTASSIUM AND FEBUXOSTAT IN PHARMACEUTICAL DOSAGE FORM

1550 25-05-2013 H-07 112070804012

MAKWANA HEENABEN DHIRUBHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF FLAVOXATE AND OFLOXACIN IN PHARMACEUTICAL DOSAGE FORM

1551 25-05-2013 H-08 112070804013

MOTHALIA CHERIS PRADIPBHAI 207


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF KETOTIFEN AND CETRIZINE DIHYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

1552 25-05-2013 H-08 112070804014

PATEL SANKETKUMAR D. 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE AND DICLOFENAC POTASSIUM IN PHARMACEUTICAL DOSAGE FORM

1553 25-05-2013 H-08 112070804015PATEL JINAL N. 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF ATENOLOL AND LOSARTAN POTASSIUM IN PHARMACEUTICAL DOSAGE FORM.

1554 25-05-2013 H-08 112070804016

PATEL RONAKBEN MULCHANDBHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF PROPRANOLOL AND HYDRALAZINE IN PHARMACEUTICAL DOSAGE FORM

1555 25-05-2013 H-08 112070804017PATEL ANUJ N 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF IIMIPRAMINE AND DIAZEPAM IN PHARMACEUTICAL DOSAGE FORM

1556 25-05-2013 H-08 112070804018

PATEL PARTHKUMAR PINAKINBHAI 207


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF KETOTIFEN AND SALBUTAMOL IN PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1557 25-05-2013 H-08 112230807001

SWAPNIL SHAILESHKUMAR DOSHI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF DIETHYL CARBAMAZINE CITRATE AND CHLORPHENIRAMINE MALEATE IN THEIR COMBINED DOSAGE FORM.

1558 25-05-2013 H-08 112230807002

JAINIKA PRADEEPSINH RANA 223


DEVELOPMENT OF ANALYTICAL METHODS FOR THE ESTIMATION OF PARACETAMOL, DICYCLOMINE HYDROCHLORIDE AND MEFENAMIC ACID IN THEIR COMBINED DOSAGE FORM.

1559 25-05-2013 H-08 112230807003

PATEL LIMABAHEN K 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE AND CETIRIZINE HYDROCHLORIDE IN THEIR COMBINED DOSAGE FORM.

1560 25-05-2013 H-08 112230807004

SHAIKH MUDASSAR GULAMDASTAGIR 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE SIMULTANEOUS ESTIMATION OF CHLORZOXAZONE AND DICLOFENAC SODIUM IN COMBINED DOSAGE FROM.

1561 25-05-2013 H-08 112230807005

UCHADADIYA NIRAV BIPINBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF EPERISONE HYDROCHLORIDE AND PARACETAMOL IN THEIR COMBINED DOSAGE FORM.

1562 25-05-2013 H-08 112230807006

PARMAR VARSHABEN LALUJI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF BENAZEPRIL HYDROCHLORIDE AND HYDROCHLORTHIAZIDE IN COMBINED DOSAGE FORM.

1563 25-05-2013 H-09 112230807007

MAYANKA BHARATKUMAR THESIYA 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF DABIGATRAN ETEXILATE MESYLATE IN PHARMACEUTICAL DOSAGE FORM.

1564 25-05-2013 H-09 112230807008

THAKKER HARSHKETU KIRTIKUMAR 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF RIVAROXABAN IN PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





1565 25-05-2013 H-09 112230807009

PATEL AKASHKUMAR KIRANBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF PANTOPRAZOLE SODIUM AND LEVOSULPIRIDE IN PHARMACEUTICAL DOSAGE FORM.

1566 25-05-2013 H-09 112230807010

DIXIT HETALBEN BAKULBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF LEVONORGESTREL IN ITS DOSAGE FORM.

1567 25-05-2013 H-09 112230807011

PINAK MANHARLAL SANCHANIYA 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF CHLORPHENIRAMINE MALEATE, IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE IN COMBINED PHARMACEUTICAL DOSAGE FORM.

1569 25-05-2013 H-09 112230807013

KHANCHANDANI LAVEENA R 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF SPIRONOLACTONE AND HYDROFLUMETHIAZIDE IN THEIR PHARMACEUTICAL DOSAGE FORM.

1570 25-05-2013 H-09 112230807014

CHAUDHARY PANKESHKUMAR VIRAMBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS ON METOPROLOL SUCCINATE AND CHLORTHALIDONE IN PHARMACEUTICAL DOSAGE FORM.

1571 25-05-2013 H-09 112230807015

CHAUDHARY PIYUSHKUMAR AJAMALBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS ON CEFPODOXIME PROXETIL AND CLAVULANIC ACID IN PHARMACEUTICAL DOSAGE FORM.

1572 25-05-2013 H-09 112230807016SEHJAD SIKANDAR S. 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF CHLORZOXAZONE AND IBUPRUFEN IN COMBINED DOSAGE FORM.

1573 25-05-2013 H-09 112230807017

PARMAR KAMINEE KANUBHAI 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF LEVOCETIRIZINE DIHYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM.

Row ID Exam Date





1574 25-05-2013 H-09 112230807018PATEL SNEHABEN N 223


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR THE ESTIMATION OF METOLAZONE AND SPIRONOLACTONE IN PHARMACEUTICAL DOSAGE FORM

1575 25-05-2013 H-10 112330808001

PATIDAR SANDEEP RAJARAM 233


CLONING AND EXPRESSION OF THERAPEUTIC PEPTIDE, HELIOMICIN, BY RECOMBINANT DNA TECHNOLOGY IN E COLI

1576 25-05-2013 H-10 112330808002

PATEL NENCYBEN VISHNUPRASAD 233


DEVELOPMENT OF ORAL NANOPARTICLE FOR BIOAVAILABILITY ENHANCEMENT OF ZALEPLON FOR BRAIN TARGETING

1577 25-05-2013 H-10 112330808003ANSARI DILSAD S 233


FORMULATION AND EVALUATION OF SELF MICROEMULSIFYING DRUG DELIVERY SYSTEMS OF CLOFAZIMINE.

1578 25-05-2013 H-10 112330808004

DESAI PANKHITA BANKIMCHANDRA 233


VESICULAR DRUG DELIVERY SYSTEM OF MOMETASONE FUROATE FOR TREATMENT OF PSORIASIS

1579 25-05-2013 H-10 112330808005

GUPTA ASHISH RAMDAYAL 233


DEVELOPMENT OF FLOATING TABLET OF FERROUS SULPHATE FOR BIOAVAILABILITY ENHANCEMENT

1580 25-05-2013 H-10 112330808006

THAKOR SURAJKUMAR KUMERSINH 233


“PREPARATION AND EVALUATION OF MULTIPLE W/O/W NANOEMULSION OF METHOTREXATE FOR TRANSDERMAL DELIVERY”

1581 25-05-2013 H-10 112330808007

TRIVEDI KAUSHIKKUMAR ARVINDBHAI 233


FORMULATION AND EVALUATION OF NSAID LOADED AQUASOMES BASED GEL FOR THE TREATMENT OF ARTHRITIS

1582 25-05-2013 H-10 112330808008BHATT RASHMI V 233


SOLID LIPID NANOPARTICLE BASED GEL OF FLUNARIZINE HYDROCHLORIDE:DESIGN AND STUDY ITS BRAIN TARGETING EFFICIENCY THROUGH NASAL ROUTE IN RAT MODEL

1583 25-05-2013 H-10 112330808009

PATEL NIRAVKUMAR SURESHBHAI 233


PREPARATION AND EVALUATION OF NANOSUSPENSION OF POORLY SOLUBLE DRUG FOR BIOAVAILABILITY ENHANCEMENT

Row ID Exam Date





1584 25-05-2013 H-10 112330808010

PRAJAPATI DIPAK RAMESHBHAI 233


BIO-PRODUCTION OF AN ANTIMICROBIAL PEPTIDE IN TRANSGENIC PLANT

1585 25-05-2013 H-10 112330808011

VANDRA ROSHNI KISHOR 233


PROLIPOSOMAL GEL OF ANTIPSORIATIC AGENT-FORMULATION,OPTIMISATION AND CHARACTERIZATION

1586 25-05-2013 H-10 112330808012

BHATT PARTH PANKAJBHAI 233


Preparation and Evaluation of Scaffold Drug Delivery System for Post Surgical Infection

1587 25-05-2013 H-11 112330808013

MAKWANA DHARMESH JIVRAJBHAI 233


FORMULATION AND EVALUATION OF ANTI FUNGAL MICROSPHERES IN BIOADHESIVE GEL FOR LOCAL THERAPY OF VAGINAL CANDIDIASIS

1588 25-05-2013 H-11 112330808014

DOSHI NIKITA PRAVINKUMAR 233


DEVELOPMENT AND EVALUATION OF ORAL DISINTEGRATING TABLET FOR THE TREATMENT OF INSOMNIA

1589 25-05-2013 H-11 112330808015

REGAR VARSHA SHANKARLAL 233


FORMULATION, DEVELOPMENT AND EVALUATION OF "IN SITU" GEL OF DORZOLAMIDE

1590 25-05-2013 H-11 112330808016PATEL TEJALBEN G 233


FORMULATION & EVALUATION OF MOUTH DISSOLVING TABLET OF ANTI-HYPERTENSIVE DRUG.

1591 25-05-2013 H-11 112330808017

PARMAR SAGAR HIMATKUMAR 233


NANOSUSPENSION OF POORLY WATER SOLUBLE ANTI DEPRESSANT AGENT:FORMULATION ,OPTIMIZATION AND CHARACTERIZATION.

1592 25-05-2013 H-11 112330808018

BHARAKHADA VAISHALI RAJNIKANTBHAI 233


FORMULATION AND OPTIMIZATION OF INSTANT FILM FORMING THERMOREVERSIBLE CHITOSAN HYDROGEL FOR WOUND HEALING.

1593 25-05-2013 H-11 112330808019

CHAUHAN HARDIKKUMAR SURESHBHAI 233


FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET FOR ANGINA PECTORIS

1594 25-05-2013 H-11 112330808020ZANPADIYA NILESH C 233


FORMULATION AND EVALUATION OF ETHOSOMAL GEL FOR TREATMENT OF ECZEMA

Row ID Exam Date





1595 25-05-2013 H-11 112330808021

DHOLAKIYA RAHULKUMAR BABUBHAI 233


CHRONOTHERAPEUTIC COMPRESSION COATED TABLET FOR THE TREATMENT OF HYPERTENSION – DESIGN, OPTIMIZATION & CHARACTERIZATION

1596 25-05-2013 H-11 112330808022

VASAVA DIPAKKUMAR MANCHHIBHAI 233


“FORMULATION AND EVALUATION OF RECONSTITUTABLE SUSPENSION OF ENTERIC COATED NSAID LOADED MICROPARTICLES”

1597 25-05-2013 H-11 112330808023

VASAVA SAMIRKUMAR RANJITBHAI 233


FORMULATION AND EVALUATION OF CHEWING GUM DRUG DELIVERY SYSTEM FOR ANTI ALLERGIC DRUG.

1598 25-05-2013 H-11 112330808024

BARIA ANILKUMAR CHHATRASINH 233


Formulation, Optimization and Evaluation of Metronidazole drug loaded microsphere for colon delivery

1599 25-05-2013 H-12 112330808025

PRAJAPATI NILAYKUMAR SOMABHAI 233


FORMULATION, DEVELOPMENT AND CHARACTERZATION OF NANO STRUCTURED LIPID CARRIER (NLC) LOADED GEL FOR PSORIASIS AND VITILIGO

1600 25-05-2013 H-12 112330808026

PATEL PRITEEBEN RAMESHBHAI 233


MENTHOLATED HYDROGEL FORMULATION FOR THE TREATMENT OF BURNS & WOUNDS

1601 25-05-2013 H-12 112330808027

GAMIT MITALBEN RAMANBHAI 233


FORMULATION AND EVALUATION OF MICROEMULSION FOR ORAL DELIVERY OF ANTI COAGULANT DRUG

1602 25-05-2013 H-12 112330808028

PATEL JAIMIN MANUBHAI 233


FORMULATION AND EVALUATION OF SUSTAINED RELEASE MICROSPHERE BY SPRAY DRYING TECHNIQUE FOR DRY POWDER INHALER.

1603 25-05-2013 H-12 112330808029

PATEL MAULIK JAYNTILAL 233


EVALUATION OF FORMULATION VARIABLES USING HERBAL SUPER DISINTEGRANTS FOR FAST DISSOLVING TABLETS

1604 25-05-2013 H-12 112330808030

MODI NIKUNJKUMAR JAGDISHBHAI 233


DESIGN AND DEVELOPMENT OF TOPICAL CURCUMIN LOADED MICROEMULSION GEL FOR THE TREATMENT OF VITILIGO

1605 25-05-2013 H-12 112330808031

JAYASWAL NILAY MANIKANT 233


FORMULATION AND EVALUATION OF LEAKY ENTERIC COATED BEADS

Row ID Exam Date





1606 25-05-2013 H-12 112330808032

PATEL JATINKUMAR S. 233


FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF AN ANTI-EMETIC DRUG

1607 25-05-2013 H-12 112330808033

SHAH JAYAL SUNILKUMAR 233


FORMULATION AND EVALUATION OF SOLID SMEDDS FOR A POORLY SOLUBLE DRUG

1608 25-05-2013 H-12 112330808034

HIRAPARA JAYDIP JAYANTIBHAI 233


ULTRADEFORMABLE ELASTIC VESICLE (TRANSFEROSOME) FOR ANTIFUNGAL DRUG

1609 25-05-2013 H-12 112330808035DAVANKAR DARPAN S. 233


FORMULATION, PREPARATION AND EVALUATION OF BUCCAL TABLET OF CARVEDILOL USING THIOLATED ALGINATE

1610 25-05-2013 H-12 112330808036 JANI MIHIR P 233


FORMULATION,CHARACTERIZATION AND EVALUATION OF NANO GEL FOR RHEUMATOID ARTHRITIS

1611 25-05-2013 H-13 112330810001

VANIYA MEHULKUMAR SATISHBHAI 233


FORMULATION AND EVALUATION OF ANTIBACTERIAL NANOFIBROUS SCAFFOLDS FOR DENTAL INFECTION

1612 25-05-2013 H-13 112330810002

PATEL PRITIBEN VISHNUBHAI 233


FORMULATION AND EVALUATION OF NANOPARTICULATE DRUG DELIVERY SYSTEM FOR ANTIINFLAMMATORY DRUG

1613 25-05-2013 H-13 112330810003

PATEL SHWETABEN SHAILESHBHAI 233


FORMULATION, OPTIMIZATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC TABLET OF AN ANTIPARKINSON AGENT

1614 25-05-2013 H-13 112330810004

BHALALA NILESHKUMAR BHAVANBHAI 233


FORMULATION, OPTIMIZATION AND EVALUATION OF NOVEL GASTRO RETENTIVE ORAL CONTROLLED RELEASE TABLET OF ANTI CANCER DRUG

1615 25-05-2013 H-13 112330810005TANK TANVI M. 233


PREPARATION AND EVALUATION OF NANOPARTICLES LOADED OPHTHALMIC IN-SITU GEL

1616 25-05-2013 H-13 112330810006

SHAH SHREYANSH KIRTIKUMAR 233


FORMULATION & EVALUATION OF PRONIOSOMES CONTAINING ANTIRETROVIRAL DRUG

Row ID Exam Date





1617 25-05-2013 H-13 112330810007

VEKARIYA NITINKUMAR SHAMJIBHAI 233


FORMULATION, OPTIMIZATION AND EVALUATION OF NANOSUSPENSION OF POORLY WATER SOLUBLE DRUG.

1618 25-05-2013 H-13 112330810008

MONPARA MANSIBEN ARVINDBHAI 233


FORMULATION AND EVALUATION OF AN ANTIFUNGAL EMULGEL.

1619 25-05-2013 H-13 112330810009

PATEL VELISHA ROHITBHAI 233


Formulation and Evaluation of Superporous hydrogel particles as Gastroretentive drug delivery for peptic ulcer

1620 25-05-2013 H-13 112330810010

VASANANI MITUL RASIKBHAI 233


MUCOADHESIVE NANOPARTICULATE SYSTEM FOR OCULAR DELIVERY OF LOTEPREDNOL ETABONATE

1621 25-05-2013 H-13 112330810011

BHESANIYA PANKAJ GOVINDBHAI 233


DEVELOPMENT OF SUSTAINED RELEASE MUCOADHESIVE BUCCAL TABLET FOR IMPROVED BIOAVAILABILITY OF PRAZOSIN HYDROCHLORIDE.

1622 25-05-2013 H-13 112330810012PATEL JIGAR N 233


“PREPARATION AND EVALUATION MATRIX TYPE TRANSDERMAL PATCH OF ANTIDIABETIC DRUG”

1623 25-05-2013 H-14 112330810013

CHAUHAN RAHUL NAROTTAMDAS 233


“FORMULATION AND OPTIMIZATION OF ORALLY DISINTEGRATING TABLET OF TRIMEPRAZINE BY SUBLIMATION TECHNIQUE”

1624 25-05-2013 H-14 112330810014

PATEL MITESHKUMAR R 233


FORMULATION, OPTIMIZATION AND EVALUATION OF MICROBEADS FOR INTESTINAL DELIVERY OF PROBIOTIC SACCHROMYCES BOULARDII AND LACTIC ACID BACILLUS

1625 25-05-2013 H-14 112330810015

PATEL CHAITALIBEN D. 233


DEVELOPMENT OF NANOSUSPENSION DRUG DELIVERY SYSTEM FOR ORAL BIOAVAILABILITY ENHANCEMENT OF SIMVASTATIN

1626 25-05-2013 H-14 112330810016

VASAVA ASHA RAMCHANDRABHAI 233


DEVELOPMENT AND EVALUATION OF SPRAY DRIED CO-PROCESSED EXCIPIENT FOR FLOATING TABLET.

Row ID Exam Date





1627 25-05-2013 H-14 112330810017

PATEL ANANDKUMAR RAJENDRAKUMAR 233


“DESIGN AND EVALUATION OF EXTENDED RELEASE FLOATING MICROBALLOONS OF CAPTOPRIL”

1628 25-05-2013 H-14 112330810018

RAJPUT NIRMALSINH B. 233


FORMULATION, CHARACTERIZATION AND EVALUATION OF LIPOSOMAL GEL FOR INTRANASAL DELIVERY OF VENLAFAXINE HYDROCHLORIDE

1629 25-05-2013 H-14 112330810019BHORANIYA TUSHAR J. 233


TOPICAL FORMULATION OF GARLIC EXTRACT FOR THE TREATMENT OF ACNE.

1630 25-05-2013 H-14 112330810020PATEL NAUMA K. 233


FORMULATION AND EVALUATION OF SUSTAINED RELEASE DRUG LOADED PELLETS BY NOVEL TECHNIQUE

1631 25-05-2013 H-14 112330810021

PRAJAPATI ATINKUMAR B 233


FORMULATION AND EVALUATION OF PH SENSITIVE POLYMERIC NANOPARTICLE

1632 25-05-2013 H-14 112330810022

PATEL JAIMINKUMAR HEMANTBHAI 233


PRONIOSOMAL GEL OF ANTIPSORIATIC AGENT- FORMULATION AND EVALUATION

1633 25-05-2013 H-14 112330810023SHAH TANVI NIKUNJ 233


DEVELOPMENT OF READY-TO-USE GRANULES AS SUSTAINED RELEASE CARRIER FOR A MODEL DRUG

1634 25-05-2013 H-14 112330810024

PATEL MITESHKUMAR RAMESHBHAI 233


FORMULATION, OPTIMIZATION AND CHARACTERIZATION OF REPAGLINIDE LOADED NANOCRYSTAL FOR DIABETES THERAPY

1635 25-05-2013 H-15 112330810025

KANZARIYA HITESHBHAI BHARATBHAI 233


FORMULATION AND EVALUATION OF MUCOADHESIVE SUBLINGUAL FILM CONTAINING NANOPARTICLES OF POORLY SOLUBLE DRUG

1636 25-05-2013 H-15 112330810026

BRAHMBHATT VIPUL NATVARLAL 233


DESIGN, FORMULATION, OPTIMIZATION AND EVALUATION OF FAST DISSOLVING TABLET OF AN ANTIEMETIC DRUG

Row ID Exam Date





1637 25-05-2013 H-15 112330810027PATEL DIVYA P. 233


TRANSFEROSOMAL GEL OF ANTIACNE AGENT: FORMULATION, OPTIMIZATION AND EVALUATION

1638 25-05-2013 H-15 112330810028

PATEL CHIRAGKUMAR N. 233


“DESIGN AND EVALUATION OF TIZANIDINE HYDROCHLORIDE TRANSDERMAL PATCH”

1639 25-05-2013 H-15 112330810029

AGGARWAL MALUK RAKESH 233


DEVELOPMENT OF MICROPARTICLES OF IBUPROFEN BY SPRAY DRYING TO ENHANCE DISSOLUTION.

1640 25-05-2013 H-15 112330810030

PRAJAPATI MEET JAGDISHBHAI 233


FORMULATION, OPTIMIZATION AND EVALUATION OF BILAYER TABLET OF SALBUTAMOL SULPHATE WITH EXTENDED RELEASE.

1641 25-05-2013 H-15 112330810032

KOTECHA RASHESH KANAIYALAL 233


FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF OPHTHALMIC NANOSUSPENSION.

1642 25-05-2013 H-15 112330810033

GOD SUFIYAN IMAMUDDIN 233


FORMULATION AND CHARACTERIZATION OF BUCCAL FILMS IMPREGNATED WITH INSULIN LOADED NANOPARTICLES FOR DIABETES MELLITUS

1643 25-05-2013 H-15 112330810034HEMANI VARSHIK P 233


FORMULATION AND CHARACTERIZATION OF STEALTH LIPOSOMES TARGETING CANCER CELLS.

1644 25-05-2013 H-15 112330810035

PATEL BHARGAVKUMAR MUKESHBHAI 233


FORMULATION DEVELOPMENT OF BIODEGRADABLE CHEWING GUM CONTAINING DICLOFENAC SODIUM

1645 25-05-2013 H-15 112330810036

PATEL HARSHITBHAI ARUNBHAI 233


FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM OF PROCHLORPERAZINE MALEATE

1646 27-05-2013 H-01 112050803001

MEHTA MITAL RAJENDRAKUMAR 205


EVALUATION OF EFFECT OF FLUNARIZINE AGAINST ATORVASTATIN INDUCED LIVER INJURY IN EXPERIMENTAL ANIMALS

Row ID Exam Date





1647 27-05-2013 H-01 112050803002

KARIA PRACHI DINESH 205


EFFECT OF IVABRADINE ON DIABETES INDUCED HYPERTENSION IN EXPERIMENTAL ANIMALS

1648 27-05-2013 H-01 112050803003

MIHIR PRAVIN PARIKH 205


EVALUATION OF LIVER X RECEPTOR AGONIST-LANSOPRAZOLE IN EXPERIMENTALLY INDUCED ATHEROSCLEROSIS IN RATS

1649 27-05-2013 H-01 112050803004

KARANGIYA VINODKUMAR BABUBHAI 205


ANTIUROLITHIATIC ACTIVITY OF COMBINATION OF CITRUS MEDICA AND ANANAS COMOSUS: INVITRO AND INVIVO STUDY

1650 27-05-2013 H-01 112050803005

PATEL PRIYANK KUMAR ASHOKKUMAR 205


EVALUATION OF ACTIVITY OF ALBIZZIA LEBBECK AGAINST STREPTOZOTOCIN-NICOTINAMIDE INDUCED TYPE 2 DIABETES

1651 27-05-2013 H-01 112050803006

QURESHI MUKHTAR NISHARHUSEN 205


EFFECT OF CUCUMIS SATIVUS IN ETHYLENE GLYCOL INDUCED UROLITHIASIS IN RATS

1652 27-05-2013 H-01 112050803007

SONI SACHINKUMAR SHANTILAL 205


REPEATED DOSE INTRAVENOUS TOXICITY STUDY OF DEXAMETHASONE PALMITATE IN SWISS ALBINO MICE.

1653 27-05-2013 H-01 112050803008

SAVSANI HARDIKKUMAR HASMUKHRAY 205


CARDIOPROTECTIVE EFFECT OF FLAVANOID RICH FRACTION OF PREMNA MUCRONATA AGAINST EXPERIMENTALLY INDUCED MYOCARDIAL INFARCTION IN RATS.

1654 27-05-2013 H-01 112050803009

RAKHOLIYA RIMPUSH JENTILAL 205


A COMPARATIVE STUDY OF FIXED DOSE COMBINATION OF TELMISARTAN-HYDROCHLOROTHIAZIDE AGAINST TELMISARTAN-AMLODIPINE IN PATIENTS WITH HYPERTENSION

1655 27-05-2013 H-01 112050803010

PATEL ALPABEN MADHAVLAL 205


EVALUATION OF EFFECT OF MOMORDICA CHARANTIA AND METHYL PALMITATE IN EXPERIMENTAL INDUCED HEPATIC ISCHEAMIC REPERFUSION INJURY.

1656 27-05-2013 H-01 112050803011

THAKAR CHIREN BANKIMCHANDRA 205


EVALUATION OF THE EFFECT OF MYRISTICA FRAGRANS AGAINST DOXORUBICIN INDUCED CARDIOTOXICITY IN RATS.

1657 27-05-2013 H-01 112050803012

BUDDHADEV AKASH NALINKUMAR 205


BIOEQUIVALENCE STUDY OF FEBUXOSTAT (80 MG) TABLET UNDER FASTING CONDITION.

Row ID Exam Date





1658 27-05-2013 H-02 112050803013

PARMAR PRADIPKUMAR RAMANBHAI 205


EVALUTION OF ANTIUROLITHIATIC ACTIVITY OF TUBERS OF CYPERUS ROTUNDUS IN ETHYLENE GLYCOL INDUCED UROLITHIASIS IN RATS.

1659 27-05-2013 H-02 112050803014

SHARMA JINKALBAHEN KAMLESHKUMAR 205


EVALUATION OF ACTIVITY OF SOLANUM XANTHOCARPUM IN EXPERIMENTALLY INDUCED INFLAMMATORY BOWEL DISEASE

1660 27-05-2013 H-02 112050803015

JOSHI SHUBHAM BHAGYESHKUMAR 205


ANTIARTHRITIC AND ULCER PROTECTIVE ACTIVITY OF HOLARRHENA ANTIDYSENTRICA IN EXPERIMENTALLY INDUCED ARTHRITIS

1661 27-05-2013 H-02 112050803016

JOSHI JIGNESH KANAIYALAL 205


BIOEQIVALENCE STUDY OF ROSUVASTATIN (40 MG ) TABLET UNDER FASTING CONDITION

1662 27-05-2013 H-02 112050803017

SHAH MITALBEN M. 205


CARDIOPROTECTIVE EFFECT OF CYP450 INHIBITOR AGAINST EXPERIMENTALLY INDUCED MYOCARDIAL INFARCTION IN RATS.

1663 27-05-2013 H-02 112050803018JAMSA ANAS A 205


EFFECT OF LINUM USITATISSIMUM IN GENTAMICIN INDUCED NEPHROTOXICITY IN RATS.

1664 27-05-2013 H-02 112140803001

PATEL CHIRAGKUMAR CHAMANBHAI 214


EVALUATION OF NEPHROPROTECTIVE ACTIVITY OF MORUS ALBA IN GENTAMICIN INDUCED NEPHROTOXICITY IN RATS

1665 27-05-2013 H-02 112140803002

PANCHAL DEVANGIBEN VIRENDRABHAI 214


EVALUATION OF ANTI ARTHRITIC ACTIVITY OF TAMARIX GALICA USING RATS

1666 27-05-2013 H-02 112140803003

JHA MOHIT KASHYAPKUMAR 214


EVALUATION OF THE EFFECT OF ABUTILON INDICUM ON EXPERIMENTALLY INDUCED ACUTE PANCREATITIS IN RATS

1667 27-05-2013 H-02 112140803004PATEL SHREYAS S. 214


EVALUATION OF ANTIHYPERHOMOCYSTEINEMIC ACTION OF WITHANIA SOMNIFERA IN L-METHIONINE INDUCED HYPERHOMOCYSTEINEMIA IN RATS

Row ID Exam Date





1668 27-05-2013 H-02 112140803005

JOSHI BHAVIN YASHVANTKUMAR 214


EFFECT OF VILDAGLIPTIN ON FRUCTOSE AND HIGH FAT DIET INDUCED METABOLIC SYNDROME IN RATS

1669 27-05-2013 H-02 112140803006

PATEL ANKITA VASANTBHAI 214


BIOEQUIVALENCE STUDY OF VERAPAMIL 250 MG EXTENDED RELEASE TABLET IN HEALTHY HUMAN VOLUNTEERS IN FASTING CONDITION

1670 27-05-2013 H-03 112140803007

PATEL RIMPLE RAJENDRAKUMAR 214


EVALUATION OF ANTIUROLITHIATIC ACTIVITY OF WITHANIA SOMNIFERA IN ETHYLENE GLYCOL INDUCED UROLITHIASIS IN RATS

1671 27-05-2013 H-03 112140803008

SHAIKH MOHAMMAD UJEF 214


SUBACUTE ORAL TOXICITY STUDY OF ROFLUMILAST ON SWISS ALBINO MICES

1672 27-05-2013 H-03 112140803009

DHOLAKIA KALPESH CHANDRAKANT 214


EVALUATION OF THE EFFECT OF SOLANUM NIGRUM ON EXPERIMENTALLY INDUCED ACUTE PANCREATITIS IN RATS

1673 27-05-2013 H-03 112140803010

TANK MITTALBEN NAGJIBHAI 214


EVALUATION OF THE EFFECT OF PPAR RECEPTORS MODULATORS IN EXPERIMENTALLY INDUCED INFLAMMATORY BOWEL DISEASE IN RATS

1674 27-05-2013 H-03 112140803011

PATEL DIRGHA KUNDANBHAI 214


EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF POLYHERBAL FORMULATION IN PARACETAMOL INDUCED HEPATOTOXICITY IN RATS

1675 27-05-2013 H-03 112140803012

GOSAI PRIYANKABEN GHANSHYAMGIRI 214


EVALUATION OF ANTIDIABETIC ACTIVITY OF THEVETIA PERUVIANA IN DIABETIC RATS.

1676 27-05-2013 H-03 112140803013

DESAI VIVEKKUMAR HASMUKHBHAI 214


EVALUATION OF ANTIDIABETIC ACTIVITY OF EXTRACT OF BUCHANANIA LANZAN IN DIABETIC RATS

1677 27-05-2013 H-03 112140803014

DAMOR KETAN PRAKASHKUMAR 214


TO EVALUATE ANTI ARTHRITIC ACTIVITY OF SOLANUM NIGRUM IN COMPLETE FREUND'S ADJUVANT INDUCED RHEUMATOID ARTHRITIS MODEL

Row ID Exam Date





1678 27-05-2013 H-03 112140803015

SHAH KRUNAL HITESHKUMAR 214


EVALATION OF NEPHROPROTECTIVE ACTIVITY OF POLYHERBAL FORMULATION IN GENTAMICIN INDUCED NEPHROTOXICITY IN RATS

1679 27-05-2013 H-03 112140803016

KAKA NIRAVKUMAR N. 214


EVALUATION OF ANTIASTHMATIC ACTIVITY OF TAMARIX GALLICA

1680 27-05-2013 H-03 112140803017

PATEL ATIF MOHAMMADSALIM 214


PHARMACOLOGICAL INVESTIGATION OF CALLOPHYLLUM INOPHYLLUM LINN. FOR THE TREATMENT OF CHRON'S DISEASE

1681 27-05-2013 H-03 112140803018PATEL TANVESH R. 214


EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF POLYHERBAL FORMULATION IN CARBONTETRACHLORIDE INDUCED HEPATOTOXICITY IN RATS

1682 27-05-2013 H-04 112410804001SHAH AMIT ASHOKBHAI 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC & CHROMATOGRAPHIC METHODS FOR THE SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN THEIR COMBINED PHARMACEUTICAL FORMULATION

1683 27-05-2013 H-04 112410804002

PATEL ZALAKBEN RAKESHBHAI 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC & STABILITY INDICATING RP-HPLC METHODS FOR THE SIMULTANEOUS ESTIMATION OF DOXYCYCLINE HYDROCHLORIDE AND AMBROXOL HYDROCHLORIDE IN THEIR COMBINED TABLET DOSAGE FORM”.

1684 27-05-2013 H-04 112410804003

SUTHAR JALPA BIHARILAL 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC & CHROMATOGRAPHIC METHODS FOR THE SIMULTANEOUS ESTIMATION OF EPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN THEIR COMBINED PHARMACEUTICAL FORMULATION

Row ID Exam Date





1685 27-05-2013 H-04 112410804004

RAMI DHARATIBEN DILIPKUMAR 241


DEVELOPMENT AND VALIDATION OF HPTLC & RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF PENTOPRAZOLE SODIUM, CHLORDIAZEPOXIDE AND CLIDINIUM BROMIDE IN THEIR COMBINED CAPSULE DOSAGE FORM

1686 27-05-2013 H-04 112410804005PATEL ANKIT KANTILAL 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND DICLOFENAC SODIUM IN COMBINED DOSAGE FORM

1687 27-05-2013 H-04 112410804006

PATEL MEHUL RAMESHBHAI 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND MOXIFLOXACIN HYDROCHLORIDE IN THEIR COMBINED DOSAGE FORM

1688 27-05-2013 H-04 112410804007

TAILOR SWETABEN MAHESHBHAI 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC & CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF DOXYCYCLINE MONOHYDRATE & ORNIDAZOLE IN THEIR COMBINED TABLET DOSAGE FORM

1689 27-05-2013 H-04 112410804008

RANA GAYATRIBEN KANUBHAI 241


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF DICYCLOMINE HCL & FAMOTIDINE IN THEIR COMBINED TABLET DOSAGE FORM

1690 27-05-2013 H-04 112410804009

PARMAR NIKHILKUMAR HARIBHAI 241


DEVELOPMENT & VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF CEFUROXIME SODIUM & SULBACTAM SODIUM IN THEIR PHARMACEUTICAL DOSAGE FORM

1691 27-05-2013 H-04 112410804010

SHARMA ZALAKKUMAR A 241


METHOD DEVELOPMENT AND VALIDATION OF CEFPOTAXIME SODIUM AND SULBACTAM SODIUM IN THEIR COMBINED DOSAGE FORM.

Row ID Exam Date





1692 27-05-2013 H-04 112410804011

CHAUDHARI MEGHAKUMARI V. 241


ANALYTICAL METHOD DEVELOPMENT & VALIDATION FOR ESTIMATION OF METFORMIN HCL IN THEIR PHARMACEUTICAL DOSAGE FORM

1693 27-05-2013 H-04 112410804012

PATEL YASHDEEP TARUNKUMAR 241


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FENOFIBRIC ACID IN HUMAN PLASMA USING HYPHENATED LIQUID CHROMATOGRAPHY - TANDEM MASS SPECTROSCOPY (LCMS/MS)”

1694 27-05-2013 H-05 112410804013PATEL SONALBEN A 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND STABITITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CHLORTHALIDONE IN THEIR COMBINED TABLET DOSAGE FORM

1695 27-05-2013 H-05 112410804014

MANAT JALPESHKUMAR KANTILAL 241


DEVELOPMENT & VALIDATION OF SPECTROPHOTOMETRIC & CHROMATOGRAPHIC METHODS FOR THE SIMULTANEOUS ESTIMATION OF DICLOFENAC NA & PENTOPRAZOLE IN THEIR COMBINED CAPSULE FORMULATION

1696 27-05-2013 H-05 112410804015PATEL SILKAN J 241


DEVELOPMENT AND VALIDATION OF SPECTRO – PHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR COMBINATION OF LEVOSULPIRIDE AND PANTOPRAZOLE SODIUM IN PHARMACEUTICAL FORMULATION

1697 27-05-2013 H-05 112410804016

PATEL KERULKUMAR D. 241


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF PANTOPRAZOLE SODIUM IN BULK & PHARMACEUTICAL DOSAGE FORM

1698 27-05-2013 H-05 112410804017

PANDYA BHAVINKUMAR UMAKANT 241


DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND TAPENTADOL HYDROCHLORIDE IN THEIR COMBINED DOSAGE FORM

Row ID Exam Date





1699 27-05-2013 H-05 112410804018

PATEL ANISHKUMAR KAMLESHKUMAR 241


TO DEVELOP & VALIDATE STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF CARVEDILOL & EVABRADINE IN THEIR COMBINED TABLET DOSAGE FORM

1700 27-05-2013 H-05 112690804014

BHATT BHAUMIK DINESHKUMAR 269

NOBLE GROUP OF INSTITUTIONS, JUNAGADH

STABILITY INDICATING ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF AVANAFIL IN PHARMACEUTICAL DOSAGE FORM

82 27-05-2013 H-06 112690804001

ANTALA HIRENKUMAR DHIRUBHAI 269


DEVELOPMENTAND VALIDATION OF ANALYTICALMETHOD FOR THE SIMULTANEOUSESTIMATION OF LAFUTIDINE AND RABEPRAZOLE SODIUM IN THEIR COMBINED MARKETED FORMULATION

83 27-05-2013 H-06 112690804002

PAGHADAR BIPINKUMAR C 269


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF VARDENAFIL HYDROCHLORIDE AND DAPOXETINE HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

85 27-05-2013 H-06 112690804004

THUMMAR PRADIPKUMAR JAYANTILAL 269


DEVELOPMENT AND VALIDATION OF ASSAY METHOD FOR THE SIMULTANEOUS ESTIMATION OF ANTI-HYPERTENSIVE AGENTS FROM ITS CAPSULE FORMULATION BY RRLC

86 27-05-2013 H-06 112690804005JITHARA HEMANGI K 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LINAGLIPTIN AND METFORMIN HYDROCHLORIDE IN THEIR COMBINED MARKETED FORMULATION

87 27-05-2013 H-06 112690804006

BHALIYA TRUSHABEN VITHALBHAI 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CITICOLINE AND METHYL COBALAMIN FROM TABLET DOSAGE FORM

88 27-05-2013 H-06 112690804007DAVE NIDHI D 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HCL AND LOTEPREDNOL ETABONATE IN THEIR COMBINE MARKETED FORMULATION

Row ID Exam Date





89 27-05-2013 H-06 112690804008VYAS SUMIT PRAFULBHAI 269


DEVELOPMENT AND VALIDATION OF NEW ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF ROSUVASTATIN CALCIUM AND FENOFIBRATE IN THEIR COMBINED MARKETED FORMULATION

90 27-05-2013 H-06 112690804009

SOJITRA SARIKA HIMTBHAI 269


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF SILDENAFIL CITRATE AND DAPOXETINE HCL IN COMBINE DOSAGE FORM

91 27-05-2013 H-06 112690804010

THAKKAR KARISHMA BHARATKUMAR 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE IN THEIR COMBINED MARKETED FORMULATION

92 27-05-2013 H-06 112690804011

VADARIA UTTAM MAGANBHAI 269


PROCESS VALIDATION OF PANUM 40 MG ORAL TABLET

93 27-05-2013 H-06 112690804012

TALA PRATIKKUMAR NARSHIBHAI 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DULOXETINE HYDROCHLORIDE AND METHYLCOBALAMIN FROM PHARMACEUTICAL DOSAGE FORM

94 27-05-2013 H-06 112690804013

VAGHASIYA NIRAVKUMAR DEVRAJBHAI 269


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT FOR THE ESTIMATION OF CLOMIPHENE CITRATE IN PHARMACEUTICAL DOSAGE FORM

95 27-05-2013 H-06 112690804015

JAVIYA SANDIP BABUBHAI 269


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CLIDINIUM BROMIDE, CHLORDIAZEPOXIDE AND DICYCLOMINE HCL IN BULK AND MARKETED PRODUCT

1701 27-05-2013 H-07 112240804001PATEL SWETA 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR AMBROXOL HYDROCHLORIDE FROM ITS TABLET DOSAGE FORM.

Row ID Exam Date





1702 27-05-2013 H-07 112240804002

SHAH VAIDEHI PANKAJKUMAR 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM IN TABLET DOSAGE FORM

1703 27-05-2013 H-07 112240804003MODI VIDHI KANAIYALAL 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF ONDANSATRON HYDROCHORIDE AND PANTOPRAZOLE SODIUM IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1704 27-05-2013 H-07 112240804004

ROHIT RASIKBHAI SASPARA 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MEROPENEM AND SULBACTAM IN THEIR COMBINED DOSAGE FORM

1705 27-05-2013 H-07 112240804005

PATEL DHRUMILKUMAR CHANDUBHAI 224


ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND APPLICATION FOR ESTIMATION OF ANTIASTHMATIC DRUGS

1706 27-05-2013 H-07 112240804006

PATEL PAYALBEN PRAHLADBHAI 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF CEFIXIME TRIHYDRATE AND LEVOFLOXACIN HEMIHYDRATE IN COMBINED PHARMACEUTICAL DOSAGE FORM

1707 27-05-2013 H-07 112240804007

SONI HANI JITENDRAKUMAR 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF FLUPIRTINE MALEATE AND PARACETAMOL IN BULK DRUG AND IN COMBINED PHARMACEUTICAL DOSAGE FORM

1708 27-05-2013 H-07 112240804008SHAH HELLY YOGESHBHAI 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF CEFIXIME TRIHYDRATE AND LINEZOLID IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

Row ID Exam Date





1709 27-05-2013 H-07 112240804009

KATARIYA ANILKUMAR GOVINDBHAI 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CHLORTHALIDONE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1710 27-05-2013 H-07 112240804010

CHAUDHARY MAHESHKUMAR MOTIBHAI 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CEFIXIME TRIHYDRATE AND MOXIFLOXACIN HYDROCHLORIDE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1711 27-05-2013 H-07 112240804011

PRAJAPATI CHINTAN GORDHANBHAI 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DIACEREIN AND PARACETAMOL IN PHARMACEUTICAL DOSAGE FORM

1712 27-05-2013 H-07 112240804012PATEL RAJ SURESHBHAI 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF TRAMADOL HYDROCHLORIDE AND PARACETAMOL IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1713 27-05-2013 H-08 112240804013ROT MONA KANTILAL 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF TRAMADOL HYDROCHLORIDE AND DICLOFENA SODIUM IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1714 27-05-2013 H-08 112240804014

BALEVIYA DARSHANABEN R. 224


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF AMOXICILLIN TRIHYDRATE AND TINIDAZOLE IN THEIR COMBINED PHARMACEUTICAL DOSAGE FORM

1715 27-05-2013 H-08 112240804015

PATEL KHUSHBU CHATURBHAI 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF OLMESARTAN MEDOXOMIL AND INDAPAMIDE IN COMBINED TABLET DOSAGE FORM

Row ID Exam Date





1716 27-05-2013 H-08 112240804016PATEL DIVYANG B 224


ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND APPLICATION FOR SIMULTANEOUS ESTIMATION OF ATENOLOL AND CHLORTHALIDONE FROM ITS TABLET DOSAGE FORM.

1717 27-05-2013 H-08 112240804017PATEL DARSHAN B 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR CLOMIPHENE CITRATE FROM ITS TABLET DOSAGE FORM.

1718 27-05-2013 H-08 112240804018BALANI VEENAKAUR 224


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE SODIUM AND LEVOSULPRIDE FROM ITS CAPSULE DOSAGE FORM.

1719 27-05-2013 H-08 112320804001

PATEL PRADEEPKUMAR ARVINDBHAI 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN HEMIHYDRATE AND CEFPODOXIME PROXETIL IN PHARMACEUTICAL DOSAGE FORM.

1720 27-05-2013 H-08 112320804002

PATEL FORAM PRAKASHKUMAR 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND TIZANIDINE IN PHARMACEUTICAL DOSAGE FORM.

1721 27-05-2013 H-08 112320804003

PATEL NISHABEN DINESHBHAI 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF ALFUZOSIN HYDROCHLORIDE & DUTASTERIDE IN PHARMACEUTICAL DOSAGE FORM.

1722 27-05-2013 H-08 112320804004

PATEL MEHULKUMAR SUKHDEVBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATIONS ESTIMATION OF LEVOSULPIRIDE AND PANTOPRAZOLE SODIUM IN BULK AND MARKETED FORMULATION.

1723 27-05-2013 H-08 112320804005

PATEL ASHISHKUMAR SHANKARBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR DETERMINATION OF ROFLUMILAST IN PHARMACEUTICAL DOSAGE FORM.

1724 27-05-2013 H-08 112320804006PATEL PALAK PRAVINBHAI 232


PROCESS VALIDATION OF CARVEDILOL TABLET

Row ID Exam Date





1725 27-05-2013 H-09 112320804007

PATEL BHAVIKKUMAR SURESHBHAI 232


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF MULTIPLE VITAMINS IN PHARMACEUTICAL DOSAGE FORM.

1726 27-05-2013 H-09 112320804008

PANDYA HIREN ARVINDKUMAR 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND RUPATADINE FUMARATE IN PHARMACEUTICAL DOSAGE FORM.

1727 27-05-2013 H-09 112320804009

RAMI MAITRI VASUDEVBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATIONS ESTIMATION OF ALPRAZOLAM AND OMEPRAZOLE IN BULK DRUG AND MARKETED FORMULATION.

1728 27-05-2013 H-09 112320804010

PATEL DINESHBHAI NARANBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF DOXOFYLLINE AND TERBUTALINE SULPHATE IN PHARMACEUTICAL DOSAGE FORM

1729 27-05-2013 H-09 112320804011PATEL AMI KANTILAL 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF BALOFLOXACIN AND ORNIDAZOLE IN PHARMACEUTICAL DOSAGE FORM.

1730 27-05-2013 H-09 112320804012

GOSWAMI SHREYAS RAMESHPURI 232


BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF LOSARTAN IN HUMAN PLASMA BY USING LC-MS/MS

1731 27-05-2013 H-09 112320804013

PRAJAPATI RAJANKUMAR VISHNUBHAI. 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DUTASTERIDE AND TAMSULOSIN IN PHARMACEUTICAL DOSAGE FORM.

1732 27-05-2013 H-09 112320804014

PARMAR ANILKUMAR PRAVINBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATIONS ESTIMATION OF MOXIFLOXACIN AND PREDNISOLONE IN BULK DRUG AND MARKETED FORMULATION.

Row ID Exam Date





1733 27-05-2013 H-09 112320804015

PATEL KHUSHUBU KAMLESHKUMAR 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATIONS ESTIMATION OF METOPROLOL SUCCINATE AND ATORVASTATIN CALCIUM IN PHARMACEUTICAL DOSAGE FORM.

1734 27-05-2013 H-09 112320804016

PATEL DEVANGKUMAR D. 232


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PAROXETINE AND CLONAZEPAM IN COMBINED DOSAGE FORM

1735 27-05-2013 H-09 112320804017

PATEL KOMAL MAHESHBHAI 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF AZITHROMYCIN AND CEFIXIME IN PHARMACEUTICAL DOSAGE FORM.

1736 27-05-2013 H-09 112320804018

PATEL KINJALBEN HASMUKHLAL 232


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULATIONS ESTIMATION OF CEFIXIME AND LINEZOLIDE IN BULK DRUG AND MARKETED FORMULATION.

1737 27-05-2013 H-10 102310808011

SOLANKI MEHULKUMAR ISHWARBHAI 231


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF

TELMISARTAN

1738 27-05-2013 H-10 112140808001SHEKHAWAT MONIKA N 214


BIODEGRADABLE IN-SITU GEL FOR SUBCUTANEOUS ADMINISTRATION OF A STATIN DRUG FOR OSTEOPOROSIS

1739 27-05-2013 H-10 112140808002

DHOLAKITYA SURESHKUMAR PRAVINBHAI 214


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF TRAMADOL HYDROCHLORIDE

1740 27-05-2013 H-10 112140808003

PATEL DAXESH SHANKARBHAI 214


LIQUISOLID TABLETS FOR DISSOLUTION ENHANCEMENT OF HYPOLIPIDEMIC DRUG

1741 27-05-2013 H-10 112140808004

PATEL BHADRESH R. 214


MUCOADHESIVE IN-SITU NASAL GEL OF ANTICHOLINESTERASE DRUG

1742 27-05-2013 H-10 112140808005

RAJPUT ROSHAN RAJENDRA 214


FORMULATION AND EVALUATION OF TOPICAL SPRAY OF ANTIACNE AGENT

Row ID Exam Date





1743 27-05-2013 H-10 112140808006

SABAVA JAYESHKUMAR AMARSHIBHAI 214


FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF ANTIULCER DRUG

1744 27-05-2013 H-10 112140808007

CHAUHAN ANKITKUMAR RAMESHBHAI 214


FORMULATION AND CHARACTERIZATION OF FILM COATED MATRIX TABLETS OF ANTIANGINAL DRUG

1745 27-05-2013 H-10 112140808008

MEHTA HITEN ANILKUMAR 214


PREPARATION AND IN-VITRO CHARACTERIZATION OF SUSTAINED RELEASE RANOLAZINE HYDROCHLORIDE SWELLABLE MICROSPHERES

1746 27-05-2013 H-10 112140808009

PATEL ANKITKUMAR JAYANTILAL 214


FORMULATION AND EVALUATION OF MICROEMULSION BASED HYDROGEL FOR TOPICAL DELIVERY OF KETOCONAZOLE

1747 27-05-2013 H-10 112140808010

BHADSAVALE SIDDHARTH MOHAN 214


PREPARATION AND CHARACTERIZATION OF LIPOSOMES OF ANTIMALARIAL AGENTS

1748 27-05-2013 H-10 112140808011

PATEL KOMALBEN GANDALAL 214


CHITOSAN-GELLAN GUM MICROBEADS AS GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR ANTIHYPERTENSIVE DRUG

1749 27-05-2013 H-11 112140808012

NAGRECHA NISHITA PIYUSHKUMAR 214


FORMULATION AND EVALUATION OF DOUBLE LAYERED MICROSPHERES OF ANTIHYPERTENSIVE DRUGS

1750 27-05-2013 H-11 112140808014RAVIRAJ GAMDHA 214


PRONIOSOMAL TOPICAL GEL OF TACROLIMUS FOR ATOPIC DERMATITIS

1751 27-05-2013 H-11 112140808015PIPALIYA RAKESH M 214


FORMULATION AND EVALUATION OF MICELLES BASED HYDROGEL FOR TOPICAL DELIVERY

1752 27-05-2013 H-11 112140808016

PARMAR NAIMIN RAJESHBHAI 214


TRANSFEROSOMES LOADED TOPICAL DRUG DELIVERY SYSTEM OF METHOTREXATE FOR RHEUMATOID ARTHRITIS

1753 27-05-2013 H-11 112140808017

DABHI PRAKASHKUMAR GHANSHYAMBHAI 214


FORMULATION AND EVALUATION OF ETHOSOMAL GEL OF ANTISCABIETIC AGENT

Row ID Exam Date





1754 27-05-2013 H-11 112140808018

DARJI ANIKET RAJESHKUMAR 214

BARODA COLLEGE OF PHARMACY, LIMDA IN SITU NASAL GEL OF ALMOTRIPTAN

1755 27-05-2013 H-11 112140808019

DANGAR PARUL KATHADBHAI 214


FORMULATION AND EVALUATION OF MICROSPONGE LOADED HYDROGEL FOR TOPICAL DELIVERY

1756 27-05-2013 H-11 112140808020

DARJI HIMANSHUKUMAR ARUNBHAI 214


FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF METOPROLOL TARTRATE

1757 27-05-2013 H-11 112140808021

ROHIT VANDANA VINUBHAI 214


FORMULATION AND EVALUATION OF FLOATING BEADS FOR CHRONOTHERAPY OF HYPERTENSION

1758 27-05-2013 H-11 112140808022

VASAVA MAYURKUMAR BACHUBHAI 214


FORMULATION AND CHARACTERIZATION OF MOUTH DISSOLVING TABLETS FOR EMESIS

1759 27-05-2013 H-11 112140808023

CHAUDHRI JIGARKUMAR MANSANGBHAI 214


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS USING BETA CYCLODEXTRINE COMPLEXATION

1760 27-05-2013 H-11 112140808024

KANZARIYA KEVAL HARESHBHAI 214


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ANTI CONVULSANT DRUG

1761 27-05-2013 H-12 112140808025BARIA DEEPAK R 214


FORMULATION AND EVALUATION OF ANTIANGINAL FLOATING MICROSPHERES

1762 27-05-2013 H-12 112140808026PATEL NIDHI A 214


FORMULATION AND EVALUATION OF NANOPARTICULATE IN SITU GEL FOR OCULAR DELIVERY

1763 27-05-2013 H-12 112140808027PATEL RIMA M 214


FORMULATION AND EVALUATION OF MICROEMULSION BASED VAGINAL GEL

1764 27-05-2013 H-12 112140808028

PATEL KEVINKUMAR JAYANTIBHAI 214


FORMULATION AND EVALUATION OF TOPICAL ANTIFUNGAL EMULGEL

1765 27-05-2013 H-12 112140808029

PATEL ARPITKUMAR KHATUBHAI 214


FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF ANTIPSYCHOTIC DRUG

Row ID Exam Date





1766 27-05-2013 H-12 112140808030

RAULJI DHRUMILSINH HARISINH 214


FORMULATION AND IN VITRO EVALUATION OF PUSH PULL OSMOTIC PUMP TABLETS OF MEFENAMIC ACID FOR ORAL CONTROLLED DRUG DELIVERY

1767 27-05-2013 H-12 112140808031

CHAUHAN BALRAJSINH SURENDRASINH 214


FORMULATION AND EVALUATION OF MICROEMULSION FOR THE TREATMENT OF HYPERTENTION.

1768 27-05-2013 H-12 112140808032PATEL JAYATI BHANUBHAI 214


DEVELOPMENT OF MICROPARTICULATE DRUG DELIVERY SYSTEM FOR COLON TARGETING USING NATURAL GUM

1769 27-05-2013 H-12 112140808033MEHTA VISHAL J 214


FORMULATION AND EVALUATION OF TIME DEPENDENT PULSATILE DRUG DELIVERY SYSTEM FOR TREATMENT OF ASTHMA

1770 27-05-2013 H-12 112140808034

DERASARI VISHALKUMAR K 214


FORMULATION AND EVALUATION OF ORAL SOLID SELF MICROEMULSION OF ANTI-PSYCHOTIC DRUG.

1771 27-05-2013 H-12 112140808035

PATEL DHAVALKUMAR SURENDRABHAI 214


FORMULATION AND EVALUATION OF GASTRO RETENTIVE FLOATING DRUG DELIVERY SYSTEM OF AN ANTI-PSYCHOTIC DRUG.

1772 27-05-2013 H-12 112140808036

SHAH KARANKUMAR N 214


FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM FOR THE TREATMENT OF HYPERTENSION.

1773 27-05-2013 H-13 112140810001

CHANDRABABU DAVULURI 214


FORMULATION AND EVALUATION OF DRY SYRUP OF ANTIRETROVIRAL DRUG

1774 27-05-2013 H-13 112140810002

BHATT RAJ VIRENDRABHAI 214


FORMULATION AND EVALUATION OF POLYMERIC PSEUDOLATICES BEARING ACETAZOLAMIDE FOR THE MANAGEMENT OF GLAUCOMA

1775 27-05-2013 H-13 112140810003

KOTHARI SWETABEN NANDLAL 214


FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES FOR OCULAR DRUG DELIVERY SYSTEM

1776 27-05-2013 H-13 112140810004

MEHTA BHUMI MAYURBHAI 214


FORMULATION AND EVALUATION OF FAST DISSOLVING SUBLINGUAL THIN FILM FOR MANAGEMENT OF MIGRANE

Row ID Exam Date





1777 27-05-2013 H-13 112140810005

PATEL SACHINKUMAR RAMESHBHAI 214


FORMULATION AND IN VITRO EVALUATION OF BUCCOADHESIVE FILM OF ANTIFUNGAL DRUG

1778 27-05-2013 H-13 112140810006

BHATT MANTHAN TUSHARBHAI 214


FORMULATION AND EVALUATION OF BUCCOADHESIVE PATCH FOR TREATMENT OF CHRONIC STABLE ANGINA PACTORIS

1779 27-05-2013 H-13 112140810007SHAH MANSI J 214


FORMULATION AND EVALUATION OF FLOATING PULSATILE DRUG DELIVERY SYSTEM FOR HYPERTENSION

1780 27-05-2013 H-13 112140810008

TRIVEDI KRISHNAPREM UMESHKUMAR 214


FORMULATION AND EVALUATION OF ORAL NANO SUSPENSION OF ANTIPSYCHOTIC DRUG

1781 27-05-2013 H-13 112140810009

PATEL KRISHNABEN ASHOKBHAI 214


FORMULATION & EVELUATION OF MICROEMULTION BASED GEL FOR ACNE VULGARIS

1782 27-05-2013 H-13 112140810010

MENDAPARA JAYKUMAR DINESHBHAI 214


FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY OF ANTIEMETIC DRUG

1783 27-05-2013 H-13 112140810011

SONERA SURAJKUMAR C 214


FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLET OF ANTIMIGRANE DRUG

1784 27-05-2013 H-13 112140810012

MATPURA HARDIK LAXMANBHAI 214


FORMULATION,DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS OF ANTIHYPERTENSIVE DRUG

1785 27-05-2013 H-14 112140810013

RAMANI AVKASHKUMAR D. 214


FORMULATION OF NANOSTRUCTURED LIPID CARRIER BASED TOPICAL DRUG DELIVERY OF ANTI FUNGAL DRUG

1786 27-05-2013 H-14 112140810014

PATEL DHRUMINKUMAR RAMESHBHAI 214


FORMULATION AND EVALUATION OF PACTIN-CHITOSAN COMPOSITE PARTICLES OF ANTICANCER DRUG FOR COLON TARGETING

Row ID Exam Date





1787 27-05-2013 H-14 112140810015

KHEROLWALA ABDULMOKIT M 214


DEVELOPEMENT AND CHARACTERIZATION OF LIQISOLID TABLET FOR POORLY WATER SOLUBLE DRUG

1788 27-05-2013 H-14 112140810016

DARJI NIRMITKUMAR U 214


DRY POWDER INHALER OF PHYSICALLY IMPROVED PULMOSPHERS FOR PEPTIDE DELIVERY

1789 27-05-2013 H-14 112140810017BORSADIYA AJAY B. 214


DEVELOPMENT AND EVALUATION OF SELF-EMULSIFIED FREEZE DRIED NASAL POWDER FOR PEPTIDE DELIVERY

1790 27-05-2013 H-14 112140810018

JOSHI MONIKABEN G 214


TOPICALLY APPLIED ULTRADEFORMABLE TRANSFEROSOMAL BASED GEL FOR THE TRETMENT OF PSORIASIS

1791 27-05-2013 H-14 112140810019

PATEL PRAKASHKUMAR J 214


ON DEMAND DRUG DELIVERY FROM SELF ASSEMBLED HYDROGEL OF METHOTREXATE FOR TREATMENT OF RHEUMATOID ARTHRITIS.

1792 27-05-2013 H-14 112140810020

PATEL HEMENDRAKUMAR H 214


DEVELOPMENT AND CHARECTERIZATION OF TIZANIDINE HYDROCHLORIDE LOADED POLYMERIC NASAL INSERT

1793 27-05-2013 H-14 112140810021

KACHHADIYA FALGUNKUMAR P. 214


FORMULATION AND CHARACTERIZATION OF FLOATING MICROSPERES OF GABAPENTINE

1794 27-05-2013 H-14 112140810022

VERMA MOHIT SHYAMMANOHAR 214


FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM OF ANTI-EMETIC DRUG

1795 27-05-2013 H-14 112140810023

PATEL NILAMBAHEN ASHOKBHAI 214


DESIGN AND EVALUATION OF LORNOXICAM TRANSDERMAL PATCH

1796 27-05-2013 H-14 112140810024PATEL AIYUB ADAM 214


FORMULATION AND EVALUATION OF SOLID DISPERSION OF ANTIEPILEPTIC DRUG

Row ID Exam Date





1797 27-05-2013 H-15 112140810025

ASHAPURI HETALKUMARI KANTILAL 214


FORMULATION AND EVALUATION OF NANO SUSPENSION OF ANTI PSYCHOTROPIC DRUG.

1798 27-05-2013 H-15 112140810026

LIMBACHIYA TURAL RAHULKUMAR 214


PREPARATION AND EVALUATION OF NANOSUSPENSION OF ERYTHROMYCIN STEARATE

1799 27-05-2013 H-15 112140810028

PATEL ANIRUDDH DHANVANTKUMAR 214


DESIGN AND DEVELOPMENT OF NIOSOME BASED TOPICAL DELIVERY OF MONETASONE FUROATE

1800 27-05-2013 H-15 112140810029PATEL KRUNAL R 214


FORMULATION DEVELOPMENT AND EVALUATION OF BILAYER MATRIX TABLET OF DICLOFENAC POTASSIUM AND FAMOTIDINE

1801 27-05-2013 H-15 112140810030PATEL TUSHAR R 214


CHARACTERIZATION AND EVALUATION OF TASTE MASKED SUSPENSION OF LORNOXICAM

1802 27-05-2013 H-15 112140810031RAVAL MIHIR V 214


PREPARATION AND EVALUATION OF NIOSOME BASED OPTHALMIC GEL OF PREDNISOLONE ACETATE

1803 27-05-2013 H-15 112140810032PATEL ANKIT C. 214


STUDIES ON DESIGN AND DEVELOPMENT OF TABLET IN CAPSULE SYSTEM OF ZOLPIDEM TARTRATE

1804 27-05-2013 H-15 112140810033

PATEL ANKITKUMAR RAJESHBHAI 214


STUDIES ON FORMULATION DEVELOPMENT AND EVALUATION OF MICROEMULSION SYSTEM OF ANTI-HYPERTENSIVE DRUG

1805 27-05-2013 H-15 112140810034

VYAS VEDANT HEMANTBHAI 214


FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DRUG DELIVERY SYSTEM OF PRAZIQUANTEL FOR THE TREATMENT OF SCHISTOSOMIASIS

1806 27-05-2013 H-15 112140810035PATEL PRIYANK N. 214


DEVELOAPMENT AND CHARACTERIZATION OF TELMISARTAN NANOSUSPENSION FOR THE TREATMENT OF HYPERTENSION

Row ID Exam Date





1807 27-05-2013 H-15 112140810036

MAUN PUNIT MAHENDRABHAI 214


DEVELOPMENT AND EVALUATION OF PUSH-PULL OSMOTIC TABLETS OF NITROFURANTOIN

1568 27-05-2013 H-15 112230807012

LADANI KHYATI SURESHBHAI 223

INDUKAKA IPCOWALA COLLEGE OF PHARMACY, NEW

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR ESTIMATION OF IMIPRAMINE HYDROCHLORIDE AND DIAZEPAM IN

date :- 20-05-2013 gujarat technological university...

Documents